<html>
    <head>
        <meta charset="utf-8">
        
            <script src="lib/bindings/utils.js"></script>
            <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/dist/vis-network.min.css" integrity="sha512-WgxfT5LWjfszlPHXRmBWHkV2eceiWTOBvrKCNbdgDYTHrT2AeLCGbF4sZlZw3UMN3WtL0tGUoIAKsu8mllg/XA==" crossorigin="anonymous" referrerpolicy="no-referrer" />
            <script src="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/vis-network.min.js" integrity="sha512-LnvoEWDFrqGHlHmDD2101OrLcbsfkrzoSpvtSQtxK3RMnRV0eOkhhBN2dXHKRrUU8p2DGRTk35n4O8nWSVe1mQ==" crossorigin="anonymous" referrerpolicy="no-referrer"></script>
            
        
<center>
<h1></h1>
</center>

<!-- <link rel="stylesheet" href="../node_modules/vis/dist/vis.min.css" type="text/css" />
<script type="text/javascript" src="../node_modules/vis/dist/vis.js"> </script>-->
        <link
          href="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/css/bootstrap.min.css"
          rel="stylesheet"
          integrity="sha384-eOJMYsd53ii+scO/bJGFsiCZc+5NDVN2yr8+0RDqr0Ql0h+rP48ckxlpbzKgwra6"
          crossorigin="anonymous"
        />
        <script
          src="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/js/bootstrap.bundle.min.js"
          integrity="sha384-JEW9xMcG8R+pH31jmWH6WWP0WintQrMb4s7ZOdauHnUtxwoG2vI5DkLtS3qm9Ekf"
          crossorigin="anonymous"
        ></script>


        <center>
          <h1></h1>
        </center>
        <style type="text/css">

             #mynetwork {
                 width: 100%;
                 height: 800px;
                 background-color: #ffffff;
                 border: 1px solid lightgray;
                 position: relative;
                 float: left;
             }

             
             #loadingBar {
                 position:absolute;
                 top:0px;
                 left:0px;
                 width: 100%;
                 height: 800px;
                 background-color:rgba(200,200,200,0.8);
                 -webkit-transition: all 0.5s ease;
                 -moz-transition: all 0.5s ease;
                 -ms-transition: all 0.5s ease;
                 -o-transition: all 0.5s ease;
                 transition: all 0.5s ease;
                 opacity:1;
             }

             #bar {
                 position:absolute;
                 top:0px;
                 left:0px;
                 width:20px;
                 height:20px;
                 margin:auto auto auto auto;
                 border-radius:11px;
                 border:2px solid rgba(30,30,30,0.05);
                 background: rgb(0, 173, 246); /* Old browsers */
                 box-shadow: 2px 0px 4px rgba(0,0,0,0.4);
             }

             #border {
                 position:absolute;
                 top:10px;
                 left:10px;
                 width:500px;
                 height:23px;
                 margin:auto auto auto auto;
                 box-shadow: 0px 0px 4px rgba(0,0,0,0.2);
                 border-radius:10px;
             }

             #text {
                 position:absolute;
                 top:8px;
                 left:530px;
                 width:30px;
                 height:50px;
                 margin:auto auto auto auto;
                 font-size:22px;
                 color: #000000;
             }

             div.outerBorder {
                 position:relative;
                 top:400px;
                 width:600px;
                 height:44px;
                 margin:auto auto auto auto;
                 border:8px solid rgba(0,0,0,0.1);
                 background: rgb(252,252,252); /* Old browsers */
                 background: -moz-linear-gradient(top,  rgba(252,252,252,1) 0%, rgba(237,237,237,1) 100%); /* FF3.6+ */
                 background: -webkit-gradient(linear, left top, left bottom, color-stop(0%,rgba(252,252,252,1)), color-stop(100%,rgba(237,237,237,1))); /* Chrome,Safari4+ */
                 background: -webkit-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Chrome10+,Safari5.1+ */
                 background: -o-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Opera 11.10+ */
                 background: -ms-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* IE10+ */
                 background: linear-gradient(to bottom,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* W3C */
                 filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#fcfcfc', endColorstr='#ededed',GradientType=0 ); /* IE6-9 */
                 border-radius:72px;
                 box-shadow: 0px 0px 10px rgba(0,0,0,0.2);
             }
             

             

             
        </style>
    </head>


    <body>
        <div class="card" style="width: 100%">
            
            
            <div id="mynetwork" class="card-body"></div>
        </div>

        
            <div id="loadingBar">
              <div class="outerBorder">
                <div id="text">0%</div>
                <div id="border">
                  <div id="bar"></div>
                </div>
              </div>
            </div>
        
        

        <script type="text/javascript">

              // initialize global variables.
              var edges;
              var nodes;
              var allNodes;
              var allEdges;
              var nodeColors;
              var originalNodes;
              var network;
              var container;
              var options, data;
              var filter = {
                  item : '',
                  property : '',
                  value : []
              };

              

              

              // This method is responsible for drawing the graph, returns the drawn network
              function drawGraph() {
                  var container = document.getElementById('mynetwork');

                  

                  // parsing and collecting nodes and edges from the python
                  nodes = new vis.DataSet([{"color": "blue", "id": "chem (clin)", "label": "chem (clin)", "shape": "dot", "size": 20}, {"color": "red", "id": "safe eur j", "label": "safe eur j", "shape": "dot", "size": 10}, {"color": "red", "id": "clin", "label": "clin", "shape": "dot", "size": 10}, {"color": "red", "id": "biochem", "label": "biochem", "shape": "dot", "size": 10}, {"color": "red", "id": "1997", "label": "1997", "shape": "dot", "size": 10}, {"color": "blue", "id": "therapies (motility)", "label": "therapies (motility)", "shape": "dot", "size": 20}, {"color": "red", "id": "clin pharmacol", "label": "clin pharmacol", "shape": "dot", "size": 10}, {"color": "red", "id": "therap", "label": "therap", "shape": "dot", "size": 10}, {"color": "red", "id": "stimulants", "label": "stimulants", "shape": "dot", "size": 10}, {"color": "red", "id": "83", "label": "83", "shape": "dot", "size": 10}, {"color": "blue", "id": "culture (gen)", "label": "culture (gen)", "shape": "dot", "size": 20}, {"color": "red", "id": "unsafe in", "label": "unsafe in", "shape": "dot", "size": 10}, {"color": "red", "id": "cell", "label": "cell", "shape": "dot", "size": 10}, {"color": "red", "id": "pharmacol", "label": "pharmacol", "shape": "dot", "size": 10}, {"color": "red", "id": "1999", "label": "1999", "shape": "dot", "size": 10}, {"color": "blue", "id": "j (clin)", "label": "j (clin)", "shape": "dot", "size": 20}, {"color": "red", "id": "safe in", "label": "safe in", "shape": "dot", "size": 10}, {"color": "red", "id": "animals", "label": "animals", "shape": "dot", "size": 10}, {"color": "red", "id": "2001", "label": "2001", "shape": "dot", "size": 10}, {"color": "blue", "id": "fr (anesth)", "label": "fr (anesth)", "shape": "dot", "size": 20}, {"color": "red", "id": "safe", "label": "safe", "shape": "dot", "size": 10}, {"color": "red", "id": "ann", "label": "ann", "shape": "dot", "size": 10}, {"color": "red", "id": "reanim", "label": "reanim", "shape": "dot", "size": 10}, {"color": "red", "id": "1989", "label": "1989", "shape": "dot", "size": 10}, {"color": "blue", "id": "use (in)", "label": "use (in)", "shape": "dot", "size": 20}, {"color": "red", "id": "one case report of", "label": "one case report of", "shape": "dot", "size": 10}, {"color": "red", "id": "uneventful", "label": "uneventful", "shape": "dot", "size": 10}, {"color": "red", "id": "a", "label": "a", "shape": "dot", "size": 10}, {"color": "red", "id": "54", "label": "54", "shape": "dot", "size": 10}, {"color": "blue", "id": "clin (chim)", "label": "clin (chim)", "shape": "dot", "size": 20}, {"color": "red", "id": "probably", "label": "probably", "shape": "dot", "size": 10}, {"color": "red", "id": "unsafe", "label": "unsafe", "shape": "dot", "size": 10}, {"color": "red", "id": "acta", "label": "acta", "shape": "dot", "size": 10}, {"color": "red", "id": "1995", "label": "1995", "shape": "dot", "size": 10}, {"color": "blue", "id": "ann (int)", "label": "ann (int)", "shape": "dot", "size": 20}, {"color": "red", "id": "patients", "label": "patients", "shape": "dot", "size": 10}, {"color": "red", "id": "med", "label": "med", "shape": "dot", "size": 10}, {"color": "red", "id": "2005", "label": "2005", "shape": "dot", "size": 10}, {"color": "blue", "id": "blockers (metab)", "label": "blockers (metab)", "shape": "dot", "size": 20}, {"color": "red", "id": "drug", "label": "drug", "shape": "dot", "size": 10}, {"color": "red", "id": "agents", "label": "agents", "shape": "dot", "size": 10}, {"color": "red", "id": "disp", "label": "disp", "shape": "dot", "size": 10}, {"color": "red", "id": "34", "label": "34", "shape": "dot", "size": 10}, {"color": "blue", "id": "lose (dosages)", "label": "lose (dosages)", "shape": "dot", "size": 20}, {"color": "red", "id": "porphyrogenic but safe", "label": "porphyrogenic but safe", "shape": "dot", "size": 10}, {"color": "red", "id": "in", "label": "in", "shape": "dot", "size": 10}, {"color": "red", "id": "neurology", "label": "neurology", "shape": "dot", "size": 10}, {"color": "red", "id": "1982", "label": "1982", "shape": "dot", "size": 10}, {"color": "blue", "id": "c (toxicol)", "label": "c (toxicol)", "shape": "dot", "size": 20}, {"color": "red", "id": "possibly\nporphyrinogenic comp biochem", "label": "possibly\nporphyrinogenic comp biochem", "shape": "dot", "size": 10}, {"color": "red", "id": "physiol", "label": "physiol", "shape": "dot", "size": 10}, {"color": "blue", "id": "int (j)", "label": "int (j)", "shape": "dot", "size": 20}, {"color": "red", "id": "1985", "label": "1985", "shape": "dot", "size": 10}, {"color": "blue", "id": "afr (med)", "label": "afr (med)", "shape": "dot", "size": 20}, {"color": "red", "id": "unsafe in animals", "label": "unsafe in animals", "shape": "dot", "size": 10}, {"color": "red", "id": "s", "label": "s", "shape": "dot", "size": 10}, {"color": "red", "id": "j", "label": "j", "shape": "dot", "size": 10}, {"color": "red", "id": "1984", "label": "1984", "shape": "dot", "size": 10}, {"color": "blue", "id": "clin (endocrinol)", "label": "clin (endocrinol)", "shape": "dot", "size": 20}, {"color": "red", "id": "metab", "label": "metab", "shape": "dot", "size": 10}, {"color": "red", "id": "1981", "label": "1981", "shape": "dot", "size": 10}, {"color": "red", "id": "exacerbates acute porphyria", "label": "exacerbates acute porphyria", "shape": "dot", "size": 10}, {"color": "red", "id": "1979", "label": "1979", "shape": "dot", "size": 10}, {"color": "red", "id": "probably porphyrinogenic eur\nmedications chemical j", "label": "probably porphyrinogenic eur\nmedications chemical j", "shape": "dot", "size": 10}, {"color": "red", "id": "br", "label": "br", "shape": "dot", "size": 10}, {"color": "blue", "id": "eprosartan (teveten)", "label": "eprosartan (teveten)", "shape": "dot", "size": 20}, {"color": "red", "id": "safe\ncardiovascular", "label": "safe\ncardiovascular", "shape": "dot", "size": 10}, {"color": "red", "id": "angiotensin", "label": "angiotensin", "shape": "dot", "size": 10}, {"color": "red", "id": "ok!", "label": "ok!", "shape": "dot", "size": 10}, {"color": "red", "id": "98", "label": "98", "shape": "dot", "size": 10}, {"color": "blue", "id": "br (j)", "label": "br (j)", "shape": "dot", "size": 20}, {"color": "red", "id": "anaesth", "label": "anaesth", "shape": "dot", "size": 10}, {"color": "blue", "id": "neurology (system)", "label": "neurology (system)", "shape": "dot", "size": 20}, {"color": "blue", "id": "neurol (neurosurg)", "label": "neurol (neurosurg)", "shape": "dot", "size": 20}, {"color": "red", "id": "probably safe", "label": "probably safe", "shape": "dot", "size": 10}, {"color": "red", "id": "psychiat", "label": "psychiat", "shape": "dot", "size": 10}, {"color": "blue", "id": "patients (and)", "label": "patients (and)", "shape": "dot", "size": 20}, {"color": "red", "id": "20", "label": "20", "shape": "dot", "size": 10}, {"color": "blue", "id": "weighing (at)", "label": "weighing (at)", "shape": "dot", "size": 20}, {"color": "red", "id": "years of age and", "label": "years of age and", "shape": "dot", "size": 10}, {"color": "red", "id": "older", "label": "older", "shape": "dot", "size": 10}, {"color": "red", "id": "least", "label": "least", "shape": "dot", "size": 10}, {"color": "red", "id": "40", "label": "40", "shape": "dot", "size": 10}, {"color": "blue", "id": "redox (agents)", "label": "redox (agents)", "shape": "dot", "size": 20}, {"color": "red", "id": "use with", "label": "use with", "shape": "dot", "size": 10}, {"color": "red", "id": "caution", "label": "caution", "shape": "dot", "size": 10}, {"color": "red", "id": "rep", "label": "rep", "shape": "dot", "size": 10}, {"color": "red", "id": "2004", "label": "2004", "shape": "dot", "size": 10}, {"color": "blue", "id": "no (info)", "label": "no (info)", "shape": "dot", "size": 20}, {"color": "red", "id": "hormones progestins norethindrone", "label": "hormones progestins norethindrone", "shape": "dot", "size": 10}, {"color": "red", "id": "loestrin", "label": "loestrin", "shape": "dot", "size": 10}, {"color": "red", "id": "jama", "label": "jama", "shape": "dot", "size": 10}, {"color": "red", "id": "1965", "label": "1965", "shape": "dot", "size": 10}, {"color": "blue", "id": "j (appl)", "label": "j (appl)", "shape": "dot", "size": 20}, {"color": "red", "id": "safe in cell", "label": "safe in cell", "shape": "dot", "size": 10}, {"color": "red", "id": "culture", "label": "culture", "shape": "dot", "size": 10}, {"color": "red", "id": "toxicol", "label": "toxicol", "shape": "dot", "size": 10}, {"color": "blue", "id": "curr (drug)", "label": "curr (drug)", "shape": "dot", "size": 20}, {"color": "red", "id": "2003", "label": "2003", "shape": "dot", "size": 10}, {"color": "red", "id": "safe in patients", "label": "safe in patients", "shape": "dot", "size": 10}, {"color": "red", "id": "1988", "label": "1988", "shape": "dot", "size": 10}, {"color": "blue", "id": "caution (pediat)", "label": "caution (pediat)", "shape": "dot", "size": 20}, {"color": "red", "id": "use", "label": "use", "shape": "dot", "size": 10}, {"color": "red", "id": "with", "label": "with", "shape": "dot", "size": 10}, {"color": "red", "id": "anesthes", "label": "anesthes", "shape": "dot", "size": 10}, {"color": "blue", "id": "drug (metab)", "label": "drug (metab)", "shape": "dot", "size": 20}, {"color": "red", "id": "expert", "label": "expert", "shape": "dot", "size": 10}, {"color": "red", "id": "opin", "label": "opin", "shape": "dot", "size": 10}, {"color": "red", "id": "4", "label": "4", "shape": "dot", "size": 10}, {"color": "blue", "id": "agents (clin)", "label": "agents (clin)", "shape": "dot", "size": 20}, {"color": "red", "id": "possibly porphyrinogenic", "label": "possibly porphyrinogenic", "shape": "dot", "size": 10}, {"color": "blue", "id": "polish (j)", "label": "polish (j)", "shape": "dot", "size": 20}, {"color": "red", "id": "1990", "label": "1990", "shape": "dot", "size": 10}, {"color": "red", "id": "probably safe in cell culture", "label": "probably safe in cell culture", "shape": "dot", "size": 10}, {"color": "blue", "id": "apf (is)", "label": "apf (is)", "shape": "dot", "size": 20}, {"color": "red", "id": "evidence insufficient for deriving any conclusion\nabout apf", "label": "evidence insufficient for deriving any conclusion\nabout apf", "shape": "dot", "size": 10}, {"color": "red", "id": "the", "label": "the", "shape": "dot", "size": 10}, {"color": "red", "id": "501", "label": "501", "shape": "dot", "size": 10}, {"color": "blue", "id": "fundraise (contact)", "label": "fundraise (contact)", "shape": "dot", "size": 20}, {"color": "red", "id": "join research\nwhat you can do\nget involved\ndonate", "label": "join research\nwhat you can do\nget involved\ndonate", "shape": "dot", "size": 10}, {"color": "red", "id": "volunteer", "label": "volunteer", "shape": "dot", "size": 10}, {"color": "red", "id": "info", "label": "info", "shape": "dot", "size": 10}, {"color": "red", "id": "6605 33", "label": "6605 33", "shape": "dot", "size": 10}, {"color": "blue", "id": "itching, skin_rash, nodal_skin_eruptions, dischromic _patches", "label": "itching, skin_rash, nodal_skin_eruptions, dischromic _patches", "shape": "dot", "size": 20}, {"color": "red", "id": "Fungal Infection", "label": "Fungal Infection", "shape": "dot", "size": 10}, {"color": "blue", "id": "skin_rash, nodal_skin_eruptions, dischromic _patches", "label": "skin_rash, nodal_skin_eruptions, dischromic _patches", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, nodal_skin_eruptions, dischromic _patches", "label": "itching, nodal_skin_eruptions, dischromic _patches", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, skin_rash, dischromic _patches", "label": "itching, skin_rash, dischromic _patches", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, skin_rash, nodal_skin_eruptions", "label": "itching, skin_rash, nodal_skin_eruptions", "shape": "dot", "size": 20}, {"color": "blue", "id": "continuous_sneezing, shivering, chills, watering_from_eyes", "label": "continuous_sneezing, shivering, chills, watering_from_eyes", "shape": "dot", "size": 20}, {"color": "red", "id": "Allergy", "label": "Allergy", "shape": "dot", "size": 10}, {"color": "blue", "id": "shivering, chills, watering_from_eyes", "label": "shivering, chills, watering_from_eyes", "shape": "dot", "size": 20}, {"color": "blue", "id": "continuous_sneezing, chills, watering_from_eyes", "label": "continuous_sneezing, chills, watering_from_eyes", "shape": "dot", "size": 20}, {"color": "blue", "id": "continuous_sneezing, shivering, watering_from_eyes", "label": "continuous_sneezing, shivering, watering_from_eyes", "shape": "dot", "size": 20}, {"color": "blue", "id": "continuous_sneezing, shivering, chills", "label": "continuous_sneezing, shivering, chills", "shape": "dot", "size": 20}, {"color": "blue", "id": "stomach_pain, acidity, ulcers_on_tongue, vomiting, cough, chest_pain", "label": "stomach_pain, acidity, ulcers_on_tongue, vomiting, cough, chest_pain", "shape": "dot", "size": 20}, {"color": "red", "id": "GERD", "label": "GERD", "shape": "dot", "size": 10}, {"color": "blue", "id": "stomach_pain, ulcers_on_tongue, vomiting, cough, chest_pain", "label": "stomach_pain, ulcers_on_tongue, vomiting, cough, chest_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "stomach_pain, acidity, vomiting, cough, chest_pain", "label": "stomach_pain, acidity, vomiting, cough, chest_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "stomach_pain, acidity, ulcers_on_tongue, cough, chest_pain", "label": "stomach_pain, acidity, ulcers_on_tongue, cough, chest_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "stomach_pain, acidity, ulcers_on_tongue, vomiting, chest_pain", "label": "stomach_pain, acidity, ulcers_on_tongue, vomiting, chest_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "stomach_pain, acidity, ulcers_on_tongue, vomiting, cough", "label": "stomach_pain, acidity, ulcers_on_tongue, vomiting, cough", "shape": "dot", "size": 20}, {"color": "blue", "id": "acidity, ulcers_on_tongue, vomiting, cough, chest_pain", "label": "acidity, ulcers_on_tongue, vomiting, cough, chest_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, vomiting, yellowish_skin, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "label": "itching, vomiting, yellowish_skin, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "shape": "dot", "size": 20}, {"color": "red", "id": "Chronic Cholestasis", "label": "Chronic Cholestasis", "shape": "dot", "size": 10}, {"color": "blue", "id": "vomiting, yellowish_skin, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "label": "vomiting, yellowish_skin, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, yellowish_skin, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "label": "itching, yellowish_skin, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, vomiting, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "label": "itching, vomiting, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, vomiting, yellowish_skin, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "label": "itching, vomiting, yellowish_skin, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, vomiting, yellowish_skin, nausea, abdominal_pain, yellowing_of_eyes", "label": "itching, vomiting, yellowish_skin, nausea, abdominal_pain, yellowing_of_eyes", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, vomiting, yellowish_skin, nausea, loss_of_appetite, yellowing_of_eyes", "label": "itching, vomiting, yellowish_skin, nausea, loss_of_appetite, yellowing_of_eyes", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, vomiting, yellowish_skin, nausea, loss_of_appetite, abdominal_pain", "label": "itching, vomiting, yellowish_skin, nausea, loss_of_appetite, abdominal_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, skin_rash, stomach_pain, burning_micturition, spotting_ urination", "label": "itching, skin_rash, stomach_pain, burning_micturition, spotting_ urination", "shape": "dot", "size": 20}, {"color": "red", "id": "Drug Reaction", "label": "Drug Reaction", "shape": "dot", "size": 10}, {"color": "blue", "id": "itching, stomach_pain, burning_micturition, spotting_ urination", "label": "itching, stomach_pain, burning_micturition, spotting_ urination", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, skin_rash, burning_micturition, spotting_ urination", "label": "itching, skin_rash, burning_micturition, spotting_ urination", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, skin_rash, stomach_pain, spotting_ urination", "label": "itching, skin_rash, stomach_pain, spotting_ urination", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, skin_rash, stomach_pain, burning_micturition", "label": "itching, skin_rash, stomach_pain, burning_micturition", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, stomach_pain, burning_micturition, spotting_ urination", "label": "skin_rash, stomach_pain, burning_micturition, spotting_ urination", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, loss_of_appetite, abdominal_pain, passage_of_gases, internal_itching", "label": "vomiting, loss_of_appetite, abdominal_pain, passage_of_gases, internal_itching", "shape": "dot", "size": 20}, {"color": "red", "id": "Peptic Ulcer Disease", "label": "Peptic Ulcer Disease", "shape": "dot", "size": 10}, {"color": "blue", "id": "vomiting, indigestion, abdominal_pain, passage_of_gases, internal_itching", "label": "vomiting, indigestion, abdominal_pain, passage_of_gases, internal_itching", "shape": "dot", "size": 20}, {"color": "blue", "id": "indigestion, loss_of_appetite, abdominal_pain, passage_of_gases, internal_itching", "label": "indigestion, loss_of_appetite, abdominal_pain, passage_of_gases, internal_itching", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, indigestion, loss_of_appetite, passage_of_gases, internal_itching", "label": "vomiting, indigestion, loss_of_appetite, passage_of_gases, internal_itching", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, indigestion, loss_of_appetite, abdominal_pain, internal_itching", "label": "vomiting, indigestion, loss_of_appetite, abdominal_pain, internal_itching", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, indigestion, loss_of_appetite, abdominal_pain, passage_of_gases", "label": "vomiting, indigestion, loss_of_appetite, abdominal_pain, passage_of_gases", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, indigestion, loss_of_appetite, abdominal_pain, passage_of_gases, internal_itching", "label": "vomiting, indigestion, loss_of_appetite, abdominal_pain, passage_of_gases, internal_itching", "shape": "dot", "size": 20}, {"color": "blue", "id": "muscle_wasting, patches_in_throat, high_fever, extra_marital_contacts", "label": "muscle_wasting, patches_in_throat, high_fever, extra_marital_contacts", "shape": "dot", "size": 20}, {"color": "red", "id": "AIDS", "label": "AIDS", "shape": "dot", "size": 10}, {"color": "blue", "id": "patches_in_throat, high_fever, extra_marital_contacts", "label": "patches_in_throat, high_fever, extra_marital_contacts", "shape": "dot", "size": 20}, {"color": "blue", "id": "muscle_wasting, high_fever, extra_marital_contacts", "label": "muscle_wasting, high_fever, extra_marital_contacts", "shape": "dot", "size": 20}, {"color": "blue", "id": "muscle_wasting, patches_in_throat, extra_marital_contacts", "label": "muscle_wasting, patches_in_throat, extra_marital_contacts", "shape": "dot", "size": 20}, {"color": "blue", "id": "muscle_wasting, patches_in_throat, high_fever", "label": "muscle_wasting, patches_in_throat, high_fever", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, weight_loss, restlessness, lethargy, irregular_sugar_level, blurred_and_distorted_vision, obesity, excessive_hunger, increased_appetite, polyuria", "label": "fatigue, weight_loss, restlessness, lethargy, irregular_sugar_level, blurred_and_distorted_vision, obesity, excessive_hunger, increased_appetite, polyuria", "shape": "dot", "size": 20}, {"color": "red", "id": "Diabetes", "label": "Diabetes", "shape": "dot", "size": 10}, {"color": "blue", "id": "weight_loss, restlessness, lethargy, irregular_sugar_level, blurred_and_distorted_vision, obesity, excessive_hunger, increased_appetite, polyuria", "label": "weight_loss, restlessness, lethargy, irregular_sugar_level, blurred_and_distorted_vision, obesity, excessive_hunger, increased_appetite, polyuria", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, restlessness, lethargy, irregular_sugar_level, blurred_and_distorted_vision, obesity, excessive_hunger, increased_appetite, polyuria", "label": "fatigue, restlessness, lethargy, irregular_sugar_level, blurred_and_distorted_vision, obesity, excessive_hunger, increased_appetite, polyuria", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, weight_loss, lethargy, irregular_sugar_level, blurred_and_distorted_vision, obesity, excessive_hunger, increased_appetite, polyuria", "label": "fatigue, weight_loss, lethargy, irregular_sugar_level, blurred_and_distorted_vision, obesity, excessive_hunger, increased_appetite, polyuria", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, weight_loss, restlessness, irregular_sugar_level, blurred_and_distorted_vision, obesity, excessive_hunger, increased_appetite, polyuria", "label": "fatigue, weight_loss, restlessness, irregular_sugar_level, blurred_and_distorted_vision, obesity, excessive_hunger, increased_appetite, polyuria", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, weight_loss, restlessness, lethargy, blurred_and_distorted_vision, obesity, excessive_hunger, increased_appetite, polyuria", "label": "fatigue, weight_loss, restlessness, lethargy, blurred_and_distorted_vision, obesity, excessive_hunger, increased_appetite, polyuria", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, weight_loss, restlessness, lethargy, irregular_sugar_level, obesity, excessive_hunger, increased_appetite, polyuria", "label": "fatigue, weight_loss, restlessness, lethargy, irregular_sugar_level, obesity, excessive_hunger, increased_appetite, polyuria", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, weight_loss, restlessness, lethargy, irregular_sugar_level, blurred_and_distorted_vision, excessive_hunger, increased_appetite, polyuria", "label": "fatigue, weight_loss, restlessness, lethargy, irregular_sugar_level, blurred_and_distorted_vision, excessive_hunger, increased_appetite, polyuria", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, weight_loss, restlessness, lethargy, irregular_sugar_level, blurred_and_distorted_vision, obesity, increased_appetite, polyuria", "label": "fatigue, weight_loss, restlessness, lethargy, irregular_sugar_level, blurred_and_distorted_vision, obesity, increased_appetite, polyuria", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, sunken_eyes, dehydration, diarrhoea", "label": "vomiting, sunken_eyes, dehydration, diarrhoea", "shape": "dot", "size": 20}, {"color": "red", "id": "Gastroenteritis", "label": "Gastroenteritis", "shape": "dot", "size": 10}, {"color": "blue", "id": "sunken_eyes, dehydration, diarrhoea", "label": "sunken_eyes, dehydration, diarrhoea", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, dehydration, diarrhoea", "label": "vomiting, dehydration, diarrhoea", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, sunken_eyes, diarrhoea", "label": "vomiting, sunken_eyes, diarrhoea", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, sunken_eyes, dehydration", "label": "vomiting, sunken_eyes, dehydration", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, cough, high_fever, breathlessness, family_history, mucoid_sputum", "label": "fatigue, cough, high_fever, breathlessness, family_history, mucoid_sputum", "shape": "dot", "size": 20}, {"color": "red", "id": "Bronchial Asthma", "label": "Bronchial Asthma", "shape": "dot", "size": 10}, {"color": "blue", "id": "cough, high_fever, breathlessness, family_history, mucoid_sputum", "label": "cough, high_fever, breathlessness, family_history, mucoid_sputum", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, high_fever, breathlessness, family_history, mucoid_sputum", "label": "fatigue, high_fever, breathlessness, family_history, mucoid_sputum", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, cough, breathlessness, family_history, mucoid_sputum", "label": "fatigue, cough, breathlessness, family_history, mucoid_sputum", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, cough, high_fever, family_history, mucoid_sputum", "label": "fatigue, cough, high_fever, family_history, mucoid_sputum", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, cough, high_fever, breathlessness, mucoid_sputum", "label": "fatigue, cough, high_fever, breathlessness, mucoid_sputum", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, cough, high_fever, breathlessness, family_history", "label": "fatigue, cough, high_fever, breathlessness, family_history", "shape": "dot", "size": 20}, {"color": "blue", "id": "headache, chest_pain, dizziness, loss_of_balance, lack_of_concentration", "label": "headache, chest_pain, dizziness, loss_of_balance, lack_of_concentration", "shape": "dot", "size": 20}, {"color": "red", "id": "Hypertension", "label": "Hypertension", "shape": "dot", "size": 10}, {"color": "blue", "id": "chest_pain, dizziness, loss_of_balance, lack_of_concentration", "label": "chest_pain, dizziness, loss_of_balance, lack_of_concentration", "shape": "dot", "size": 20}, {"color": "blue", "id": "headache, dizziness, loss_of_balance, lack_of_concentration", "label": "headache, dizziness, loss_of_balance, lack_of_concentration", "shape": "dot", "size": 20}, {"color": "blue", "id": "headache, chest_pain, loss_of_balance, lack_of_concentration", "label": "headache, chest_pain, loss_of_balance, lack_of_concentration", "shape": "dot", "size": 20}, {"color": "blue", "id": "headache, chest_pain, dizziness, lack_of_concentration", "label": "headache, chest_pain, dizziness, lack_of_concentration", "shape": "dot", "size": 20}, {"color": "blue", "id": "headache, chest_pain, dizziness, loss_of_balance", "label": "headache, chest_pain, dizziness, loss_of_balance", "shape": "dot", "size": 20}, {"color": "blue", "id": "acidity, indigestion, headache, blurred_and_distorted_vision, excessive_hunger, stiff_neck, depression, irritability, visual_disturbances", "label": "acidity, indigestion, headache, blurred_and_distorted_vision, excessive_hunger, stiff_neck, depression, irritability, visual_disturbances", "shape": "dot", "size": 20}, {"color": "red", "id": "Migraine", "label": "Migraine", "shape": "dot", "size": 10}, {"color": "blue", "id": "indigestion, headache, blurred_and_distorted_vision, excessive_hunger, stiff_neck, depression, irritability, visual_disturbances", "label": "indigestion, headache, blurred_and_distorted_vision, excessive_hunger, stiff_neck, depression, irritability, visual_disturbances", "shape": "dot", "size": 20}, {"color": "blue", "id": "acidity, headache, blurred_and_distorted_vision, excessive_hunger, stiff_neck, depression, irritability, visual_disturbances", "label": "acidity, headache, blurred_and_distorted_vision, excessive_hunger, stiff_neck, depression, irritability, visual_disturbances", "shape": "dot", "size": 20}, {"color": "blue", "id": "acidity, indigestion, blurred_and_distorted_vision, excessive_hunger, stiff_neck, depression, irritability, visual_disturbances", "label": "acidity, indigestion, blurred_and_distorted_vision, excessive_hunger, stiff_neck, depression, irritability, visual_disturbances", "shape": "dot", "size": 20}, {"color": "blue", "id": "acidity, indigestion, headache, excessive_hunger, stiff_neck, depression, irritability, visual_disturbances", "label": "acidity, indigestion, headache, excessive_hunger, stiff_neck, depression, irritability, visual_disturbances", "shape": "dot", "size": 20}, {"color": "blue", "id": "acidity, indigestion, headache, blurred_and_distorted_vision, stiff_neck, depression, irritability, visual_disturbances", "label": "acidity, indigestion, headache, blurred_and_distorted_vision, stiff_neck, depression, irritability, visual_disturbances", "shape": "dot", "size": 20}, {"color": "blue", "id": "acidity, indigestion, headache, blurred_and_distorted_vision, excessive_hunger, depression, irritability, visual_disturbances", "label": "acidity, indigestion, headache, blurred_and_distorted_vision, excessive_hunger, depression, irritability, visual_disturbances", "shape": "dot", "size": 20}, {"color": "blue", "id": "acidity, indigestion, headache, blurred_and_distorted_vision, excessive_hunger, stiff_neck, irritability, visual_disturbances", "label": "acidity, indigestion, headache, blurred_and_distorted_vision, excessive_hunger, stiff_neck, irritability, visual_disturbances", "shape": "dot", "size": 20}, {"color": "blue", "id": "acidity, indigestion, headache, blurred_and_distorted_vision, excessive_hunger, stiff_neck, depression, visual_disturbances", "label": "acidity, indigestion, headache, blurred_and_distorted_vision, excessive_hunger, stiff_neck, depression, visual_disturbances", "shape": "dot", "size": 20}, {"color": "blue", "id": "acidity, indigestion, headache, blurred_and_distorted_vision, excessive_hunger, stiff_neck, depression, irritability", "label": "acidity, indigestion, headache, blurred_and_distorted_vision, excessive_hunger, stiff_neck, depression, irritability", "shape": "dot", "size": 20}, {"color": "blue", "id": "back_pain, weakness_in_limbs, neck_pain, dizziness, loss_of_balance", "label": "back_pain, weakness_in_limbs, neck_pain, dizziness, loss_of_balance", "shape": "dot", "size": 20}, {"color": "red", "id": "Cervical Spondylosis", "label": "Cervical Spondylosis", "shape": "dot", "size": 10}, {"color": "blue", "id": "weakness_in_limbs, neck_pain, dizziness, loss_of_balance", "label": "weakness_in_limbs, neck_pain, dizziness, loss_of_balance", "shape": "dot", "size": 20}, {"color": "blue", "id": "back_pain, neck_pain, dizziness, loss_of_balance", "label": "back_pain, neck_pain, dizziness, loss_of_balance", "shape": "dot", "size": 20}, {"color": "blue", "id": "back_pain, weakness_in_limbs, dizziness, loss_of_balance", "label": "back_pain, weakness_in_limbs, dizziness, loss_of_balance", "shape": "dot", "size": 20}, {"color": "blue", "id": "back_pain, weakness_in_limbs, neck_pain, loss_of_balance", "label": "back_pain, weakness_in_limbs, neck_pain, loss_of_balance", "shape": "dot", "size": 20}, {"color": "blue", "id": "back_pain, weakness_in_limbs, neck_pain, dizziness", "label": "back_pain, weakness_in_limbs, neck_pain, dizziness", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, headache, weakness_of_one_body_side, altered_sensorium", "label": "vomiting, headache, weakness_of_one_body_side, altered_sensorium", "shape": "dot", "size": 20}, {"color": "red", "id": "Paralysis (brain hemorrhage)", "label": "Paralysis (brain hemorrhage)", "shape": "dot", "size": 10}, {"color": "blue", "id": "headache, weakness_of_one_body_side, altered_sensorium", "label": "headache, weakness_of_one_body_side, altered_sensorium", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, weakness_of_one_body_side, altered_sensorium", "label": "vomiting, weakness_of_one_body_side, altered_sensorium", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, headache, altered_sensorium", "label": "vomiting, headache, altered_sensorium", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, headache, weakness_of_one_body_side", "label": "vomiting, headache, weakness_of_one_body_side", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, vomiting, fatigue, weight_loss, high_fever, yellowish_skin, dark_urine, abdominal_pain", "label": "itching, vomiting, fatigue, weight_loss, high_fever, yellowish_skin, dark_urine, abdominal_pain", "shape": "dot", "size": 20}, {"color": "red", "id": "Jaundice", "label": "Jaundice", "shape": "dot", "size": 10}, {"color": "blue", "id": "vomiting, fatigue, weight_loss, high_fever, yellowish_skin, dark_urine, abdominal_pain", "label": "vomiting, fatigue, weight_loss, high_fever, yellowish_skin, dark_urine, abdominal_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, fatigue, weight_loss, high_fever, yellowish_skin, dark_urine, abdominal_pain", "label": "itching, fatigue, weight_loss, high_fever, yellowish_skin, dark_urine, abdominal_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, vomiting, weight_loss, high_fever, yellowish_skin, dark_urine, abdominal_pain", "label": "itching, vomiting, weight_loss, high_fever, yellowish_skin, dark_urine, abdominal_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, vomiting, fatigue, high_fever, yellowish_skin, dark_urine, abdominal_pain", "label": "itching, vomiting, fatigue, high_fever, yellowish_skin, dark_urine, abdominal_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, vomiting, fatigue, weight_loss, yellowish_skin, dark_urine, abdominal_pain", "label": "itching, vomiting, fatigue, weight_loss, yellowish_skin, dark_urine, abdominal_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, vomiting, fatigue, weight_loss, high_fever, dark_urine, abdominal_pain", "label": "itching, vomiting, fatigue, weight_loss, high_fever, dark_urine, abdominal_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, vomiting, fatigue, weight_loss, high_fever, yellowish_skin, abdominal_pain", "label": "itching, vomiting, fatigue, weight_loss, high_fever, yellowish_skin, abdominal_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, vomiting, fatigue, weight_loss, high_fever, yellowish_skin, dark_urine", "label": "itching, vomiting, fatigue, weight_loss, high_fever, yellowish_skin, dark_urine", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, vomiting, high_fever, sweating, headache, nausea, muscle_pain", "label": "chills, vomiting, high_fever, sweating, headache, nausea, muscle_pain", "shape": "dot", "size": 20}, {"color": "red", "id": "Malaria", "label": "Malaria", "shape": "dot", "size": 10}, {"color": "blue", "id": "chills, vomiting, high_fever, sweating, headache, nausea, diarrhoea, muscle_pain", "label": "chills, vomiting, high_fever, sweating, headache, nausea, diarrhoea, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, high_fever, sweating, headache, nausea, diarrhoea, muscle_pain", "label": "vomiting, high_fever, sweating, headache, nausea, diarrhoea, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, high_fever, sweating, headache, nausea, diarrhoea, muscle_pain", "label": "chills, high_fever, sweating, headache, nausea, diarrhoea, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, vomiting, sweating, headache, nausea, diarrhoea, muscle_pain", "label": "chills, vomiting, sweating, headache, nausea, diarrhoea, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, vomiting, high_fever, headache, nausea, diarrhoea, muscle_pain", "label": "chills, vomiting, high_fever, headache, nausea, diarrhoea, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, vomiting, high_fever, sweating, nausea, diarrhoea, muscle_pain", "label": "chills, vomiting, high_fever, sweating, nausea, diarrhoea, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, vomiting, high_fever, sweating, headache, diarrhoea, muscle_pain", "label": "chills, vomiting, high_fever, sweating, headache, diarrhoea, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, skin_rash, fatigue, lethargy, high_fever, headache, loss_of_appetite, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "label": "itching, skin_rash, fatigue, lethargy, high_fever, headache, loss_of_appetite, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "shape": "dot", "size": 20}, {"color": "red", "id": "Chickenpox", "label": "Chickenpox", "shape": "dot", "size": 10}, {"color": "blue", "id": "skin_rash, fatigue, lethargy, high_fever, headache, loss_of_appetite, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "label": "skin_rash, fatigue, lethargy, high_fever, headache, loss_of_appetite, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, fatigue, lethargy, high_fever, headache, loss_of_appetite, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "label": "itching, fatigue, lethargy, high_fever, headache, loss_of_appetite, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, skin_rash, lethargy, high_fever, headache, loss_of_appetite, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "label": "itching, skin_rash, lethargy, high_fever, headache, loss_of_appetite, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, skin_rash, fatigue, high_fever, headache, loss_of_appetite, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "label": "itching, skin_rash, fatigue, high_fever, headache, loss_of_appetite, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, skin_rash, fatigue, lethargy, headache, loss_of_appetite, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "label": "itching, skin_rash, fatigue, lethargy, headache, loss_of_appetite, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, skin_rash, fatigue, lethargy, high_fever, loss_of_appetite, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "label": "itching, skin_rash, fatigue, lethargy, high_fever, loss_of_appetite, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, skin_rash, fatigue, lethargy, high_fever, headache, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "label": "itching, skin_rash, fatigue, lethargy, high_fever, headache, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, skin_rash, fatigue, lethargy, high_fever, headache, loss_of_appetite, swelled_lymph_nodes, malaise, red_spots_over_body", "label": "itching, skin_rash, fatigue, lethargy, high_fever, headache, loss_of_appetite, swelled_lymph_nodes, malaise, red_spots_over_body", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, skin_rash, fatigue, lethargy, high_fever, headache, loss_of_appetite, mild_fever, malaise, red_spots_over_body", "label": "itching, skin_rash, fatigue, lethargy, high_fever, headache, loss_of_appetite, mild_fever, malaise, red_spots_over_body", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, chills, joint_pain, vomiting, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, muscle_pain, red_spots_over_body", "label": "skin_rash, chills, joint_pain, vomiting, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, muscle_pain, red_spots_over_body", "shape": "dot", "size": 20}, {"color": "red", "id": "Dengue", "label": "Dengue", "shape": "dot", "size": 10}, {"color": "blue", "id": "skin_rash, chills, joint_pain, vomiting, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, red_spots_over_body", "label": "skin_rash, chills, joint_pain, vomiting, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, red_spots_over_body", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, chills, joint_pain, vomiting, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain", "label": "skin_rash, chills, joint_pain, vomiting, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, chills, joint_pain, vomiting, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain, red_spots_over_body", "label": "skin_rash, chills, joint_pain, vomiting, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain, red_spots_over_body", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, joint_pain, vomiting, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain, red_spots_over_body", "label": "chills, joint_pain, vomiting, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain, red_spots_over_body", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, joint_pain, vomiting, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain, red_spots_over_body", "label": "skin_rash, joint_pain, vomiting, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain, red_spots_over_body", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, chills, vomiting, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain, red_spots_over_body", "label": "skin_rash, chills, vomiting, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain, red_spots_over_body", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, chills, joint_pain, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain, red_spots_over_body", "label": "skin_rash, chills, joint_pain, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain, red_spots_over_body", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, chills, joint_pain, vomiting, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain, red_spots_over_body", "label": "skin_rash, chills, joint_pain, vomiting, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain, red_spots_over_body", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, chills, joint_pain, vomiting, fatigue, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain, red_spots_over_body", "label": "skin_rash, chills, joint_pain, vomiting, fatigue, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain, red_spots_over_body", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, vomiting, fatigue, high_fever, nausea, constipation, abdominal_pain, diarrhoea, toxic_look_(typhos), belly_pain", "label": "chills, vomiting, fatigue, high_fever, nausea, constipation, abdominal_pain, diarrhoea, toxic_look_(typhos), belly_pain", "shape": "dot", "size": 20}, {"color": "red", "id": "Typhoid", "label": "Typhoid", "shape": "dot", "size": 10}, {"color": "blue", "id": "chills, vomiting, fatigue, high_fever, headache, constipation, abdominal_pain, diarrhoea, toxic_look_(typhos), belly_pain", "label": "chills, vomiting, fatigue, high_fever, headache, constipation, abdominal_pain, diarrhoea, toxic_look_(typhos), belly_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, vomiting, fatigue, high_fever, headache, nausea, abdominal_pain, diarrhoea, toxic_look_(typhos), belly_pain", "label": "chills, vomiting, fatigue, high_fever, headache, nausea, abdominal_pain, diarrhoea, toxic_look_(typhos), belly_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, vomiting, fatigue, high_fever, headache, nausea, constipation, diarrhoea, toxic_look_(typhos), belly_pain", "label": "chills, vomiting, fatigue, high_fever, headache, nausea, constipation, diarrhoea, toxic_look_(typhos), belly_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, vomiting, fatigue, high_fever, headache, nausea, constipation, abdominal_pain, toxic_look_(typhos), belly_pain", "label": "chills, vomiting, fatigue, high_fever, headache, nausea, constipation, abdominal_pain, toxic_look_(typhos), belly_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, vomiting, fatigue, high_fever, headache, nausea, constipation, abdominal_pain, diarrhoea, belly_pain", "label": "chills, vomiting, fatigue, high_fever, headache, nausea, constipation, abdominal_pain, diarrhoea, belly_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, vomiting, fatigue, high_fever, headache, nausea, constipation, abdominal_pain, diarrhoea, toxic_look_(typhos)", "label": "chills, vomiting, fatigue, high_fever, headache, nausea, constipation, abdominal_pain, diarrhoea, toxic_look_(typhos)", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, vomiting, fatigue, high_fever, headache, nausea, constipation, abdominal_pain, diarrhoea, toxic_look_(typhos), belly_pain", "label": "chills, vomiting, fatigue, high_fever, headache, nausea, constipation, abdominal_pain, diarrhoea, toxic_look_(typhos), belly_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, fatigue, high_fever, headache, nausea, constipation, abdominal_pain, diarrhoea, toxic_look_(typhos), belly_pain", "label": "chills, fatigue, high_fever, headache, nausea, constipation, abdominal_pain, diarrhoea, toxic_look_(typhos), belly_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, vomiting, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "label": "joint_pain, vomiting, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "shape": "dot", "size": 20}, {"color": "red", "id": "Hepatitis A", "label": "Hepatitis A", "shape": "dot", "size": 10}, {"color": "blue", "id": "vomiting, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "label": "vomiting, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "label": "joint_pain, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, vomiting, dark_urine, nausea, loss_of_appetite, abdominal_pain, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "label": "joint_pain, vomiting, dark_urine, nausea, loss_of_appetite, abdominal_pain, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, vomiting, yellowish_skin, nausea, loss_of_appetite, abdominal_pain, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "label": "joint_pain, vomiting, yellowish_skin, nausea, loss_of_appetite, abdominal_pain, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, vomiting, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "label": "joint_pain, vomiting, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, vomiting, yellowish_skin, dark_urine, nausea, abdominal_pain, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "label": "joint_pain, vomiting, yellowish_skin, dark_urine, nausea, abdominal_pain, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, vomiting, yellowish_skin, dark_urine, nausea, loss_of_appetite, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "label": "joint_pain, vomiting, yellowish_skin, dark_urine, nausea, loss_of_appetite, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, vomiting, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, mild_fever, yellowing_of_eyes, muscle_pain", "label": "joint_pain, vomiting, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, mild_fever, yellowing_of_eyes, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, fatigue, lethargy, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "label": "itching, fatigue, lethargy, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "shape": "dot", "size": 20}, {"color": "red", "id": "Hepatitis B", "label": "Hepatitis B", "shape": "dot", "size": 10}, {"color": "blue", "id": "fatigue, lethargy, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "label": "fatigue, lethargy, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, lethargy, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "label": "itching, lethargy, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, fatigue, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "label": "itching, fatigue, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, fatigue, lethargy, dark_urine, loss_of_appetite, abdominal_pain, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "label": "itching, fatigue, lethargy, dark_urine, loss_of_appetite, abdominal_pain, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, fatigue, lethargy, yellowish_skin, loss_of_appetite, abdominal_pain, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "label": "itching, fatigue, lethargy, yellowish_skin, loss_of_appetite, abdominal_pain, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, fatigue, lethargy, yellowish_skin, dark_urine, abdominal_pain, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "label": "itching, fatigue, lethargy, yellowish_skin, dark_urine, abdominal_pain, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, fatigue, lethargy, yellowish_skin, dark_urine, loss_of_appetite, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "label": "itching, fatigue, lethargy, yellowish_skin, dark_urine, loss_of_appetite, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "shape": "dot", "size": 20}, {"color": "blue", "id": "itching, fatigue, lethargy, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "label": "itching, fatigue, lethargy, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, yellowish_skin, nausea, loss_of_appetite, family_history", "label": "fatigue, yellowish_skin, nausea, loss_of_appetite, family_history", "shape": "dot", "size": 20}, {"color": "red", "id": "Hepatitis C", "label": "Hepatitis C", "shape": "dot", "size": 10}, {"color": "blue", "id": "fatigue, yellowish_skin, nausea, loss_of_appetite, yellowing_of_eyes, family_history", "label": "fatigue, yellowish_skin, nausea, loss_of_appetite, yellowing_of_eyes, family_history", "shape": "dot", "size": 20}, {"color": "blue", "id": "yellowish_skin, nausea, loss_of_appetite, yellowing_of_eyes, family_history", "label": "yellowish_skin, nausea, loss_of_appetite, yellowing_of_eyes, family_history", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, nausea, loss_of_appetite, yellowing_of_eyes, family_history", "label": "fatigue, nausea, loss_of_appetite, yellowing_of_eyes, family_history", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, yellowish_skin, loss_of_appetite, yellowing_of_eyes, family_history", "label": "fatigue, yellowish_skin, loss_of_appetite, yellowing_of_eyes, family_history", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, yellowish_skin, nausea, yellowing_of_eyes, family_history", "label": "fatigue, yellowish_skin, nausea, yellowing_of_eyes, family_history", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, yellowish_skin, nausea, loss_of_appetite, yellowing_of_eyes", "label": "fatigue, yellowish_skin, nausea, loss_of_appetite, yellowing_of_eyes", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, vomiting, fatigue, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "label": "joint_pain, vomiting, fatigue, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "shape": "dot", "size": 20}, {"color": "red", "id": "Hepatitis D", "label": "Hepatitis D", "shape": "dot", "size": 10}, {"color": "blue", "id": "vomiting, fatigue, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "label": "vomiting, fatigue, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, fatigue, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "label": "joint_pain, fatigue, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, vomiting, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "label": "joint_pain, vomiting, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, vomiting, fatigue, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "label": "joint_pain, vomiting, fatigue, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, vomiting, fatigue, yellowish_skin, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "label": "joint_pain, vomiting, fatigue, yellowish_skin, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, vomiting, fatigue, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "label": "joint_pain, vomiting, fatigue, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, vomiting, fatigue, yellowish_skin, dark_urine, nausea, abdominal_pain, yellowing_of_eyes", "label": "joint_pain, vomiting, fatigue, yellowish_skin, dark_urine, nausea, abdominal_pain, yellowing_of_eyes", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, vomiting, fatigue, yellowish_skin, dark_urine, nausea, loss_of_appetite, yellowing_of_eyes", "label": "joint_pain, vomiting, fatigue, yellowish_skin, dark_urine, nausea, loss_of_appetite, yellowing_of_eyes", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, vomiting, fatigue, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain", "label": "joint_pain, vomiting, fatigue, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, vomiting, fatigue, high_fever, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, coma, stomach_bleeding", "label": "joint_pain, vomiting, fatigue, high_fever, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, coma, stomach_bleeding", "shape": "dot", "size": 20}, {"color": "red", "id": "Hepatitis E", "label": "Hepatitis E", "shape": "dot", "size": 10}, {"color": "blue", "id": "joint_pain, vomiting, fatigue, high_fever, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "label": "joint_pain, vomiting, fatigue, high_fever, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, fatigue, high_fever, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "label": "vomiting, fatigue, high_fever, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, fatigue, high_fever, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "label": "joint_pain, fatigue, high_fever, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, vomiting, high_fever, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "label": "joint_pain, vomiting, high_fever, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, vomiting, fatigue, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "label": "joint_pain, vomiting, fatigue, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, vomiting, fatigue, high_fever, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "label": "joint_pain, vomiting, fatigue, high_fever, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, vomiting, fatigue, high_fever, yellowish_skin, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "label": "joint_pain, vomiting, fatigue, high_fever, yellowish_skin, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, vomiting, fatigue, high_fever, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "label": "joint_pain, vomiting, fatigue, high_fever, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, yellowish_skin, abdominal_pain, swelling_of_stomach, distention_of_abdomen, history_of_alcohol_consumption, fluid_overload.1", "label": "vomiting, yellowish_skin, abdominal_pain, swelling_of_stomach, distention_of_abdomen, history_of_alcohol_consumption, fluid_overload.1", "shape": "dot", "size": 20}, {"color": "red", "id": "Alcoholic Hepatitis", "label": "Alcoholic Hepatitis", "shape": "dot", "size": 10}, {"color": "blue", "id": "yellowish_skin, abdominal_pain, swelling_of_stomach, distention_of_abdomen, history_of_alcohol_consumption, fluid_overload.1", "label": "yellowish_skin, abdominal_pain, swelling_of_stomach, distention_of_abdomen, history_of_alcohol_consumption, fluid_overload.1", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, abdominal_pain, swelling_of_stomach, distention_of_abdomen, history_of_alcohol_consumption, fluid_overload.1", "label": "vomiting, abdominal_pain, swelling_of_stomach, distention_of_abdomen, history_of_alcohol_consumption, fluid_overload.1", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, yellowish_skin, swelling_of_stomach, distention_of_abdomen, history_of_alcohol_consumption, fluid_overload.1", "label": "vomiting, yellowish_skin, swelling_of_stomach, distention_of_abdomen, history_of_alcohol_consumption, fluid_overload.1", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, yellowish_skin, abdominal_pain, distention_of_abdomen, history_of_alcohol_consumption, fluid_overload.1", "label": "vomiting, yellowish_skin, abdominal_pain, distention_of_abdomen, history_of_alcohol_consumption, fluid_overload.1", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, yellowish_skin, abdominal_pain, swelling_of_stomach, history_of_alcohol_consumption, fluid_overload.1", "label": "vomiting, yellowish_skin, abdominal_pain, swelling_of_stomach, history_of_alcohol_consumption, fluid_overload.1", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, yellowish_skin, abdominal_pain, swelling_of_stomach, distention_of_abdomen, fluid_overload.1", "label": "vomiting, yellowish_skin, abdominal_pain, swelling_of_stomach, distention_of_abdomen, fluid_overload.1", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, yellowish_skin, abdominal_pain, swelling_of_stomach, distention_of_abdomen, history_of_alcohol_consumption", "label": "vomiting, yellowish_skin, abdominal_pain, swelling_of_stomach, distention_of_abdomen, history_of_alcohol_consumption", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, vomiting, fatigue, weight_loss, cough, high_fever, breathlessness, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "label": "chills, vomiting, fatigue, weight_loss, cough, high_fever, breathlessness, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "shape": "dot", "size": 20}, {"color": "red", "id": "Tuberculosis", "label": "Tuberculosis", "shape": "dot", "size": 10}, {"color": "blue", "id": "vomiting, fatigue, weight_loss, cough, high_fever, breathlessness, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "label": "vomiting, fatigue, weight_loss, cough, high_fever, breathlessness, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, fatigue, weight_loss, cough, high_fever, breathlessness, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "label": "chills, fatigue, weight_loss, cough, high_fever, breathlessness, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, vomiting, weight_loss, cough, high_fever, breathlessness, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "label": "chills, vomiting, weight_loss, cough, high_fever, breathlessness, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, vomiting, fatigue, cough, high_fever, breathlessness, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "label": "chills, vomiting, fatigue, cough, high_fever, breathlessness, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, vomiting, fatigue, weight_loss, high_fever, breathlessness, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "label": "chills, vomiting, fatigue, weight_loss, high_fever, breathlessness, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, vomiting, fatigue, weight_loss, cough, breathlessness, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "label": "chills, vomiting, fatigue, weight_loss, cough, breathlessness, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, vomiting, fatigue, weight_loss, cough, high_fever, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "label": "chills, vomiting, fatigue, weight_loss, cough, high_fever, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, vomiting, fatigue, weight_loss, cough, high_fever, breathlessness, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "label": "chills, vomiting, fatigue, weight_loss, cough, high_fever, breathlessness, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "shape": "dot", "size": 20}, {"color": "blue", "id": "continuous_sneezing, chills, fatigue, cough, high_fever, headache, swelled_lymph_nodes, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "label": "continuous_sneezing, chills, fatigue, cough, high_fever, headache, swelled_lymph_nodes, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "shape": "dot", "size": 20}, {"color": "red", "id": "Common Cold", "label": "Common Cold", "shape": "dot", "size": 10}, {"color": "blue", "id": "chills, fatigue, cough, high_fever, headache, swelled_lymph_nodes, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "label": "chills, fatigue, cough, high_fever, headache, swelled_lymph_nodes, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "continuous_sneezing, fatigue, cough, high_fever, headache, swelled_lymph_nodes, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "label": "continuous_sneezing, fatigue, cough, high_fever, headache, swelled_lymph_nodes, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "continuous_sneezing, chills, cough, high_fever, headache, swelled_lymph_nodes, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "label": "continuous_sneezing, chills, cough, high_fever, headache, swelled_lymph_nodes, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "continuous_sneezing, chills, fatigue, high_fever, headache, swelled_lymph_nodes, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "label": "continuous_sneezing, chills, fatigue, high_fever, headache, swelled_lymph_nodes, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "continuous_sneezing, chills, fatigue, cough, headache, swelled_lymph_nodes, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "label": "continuous_sneezing, chills, fatigue, cough, headache, swelled_lymph_nodes, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "continuous_sneezing, chills, fatigue, cough, high_fever, swelled_lymph_nodes, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "label": "continuous_sneezing, chills, fatigue, cough, high_fever, swelled_lymph_nodes, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "continuous_sneezing, chills, fatigue, cough, high_fever, headache, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "label": "continuous_sneezing, chills, fatigue, cough, high_fever, headache, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "continuous_sneezing, chills, fatigue, cough, high_fever, headache, swelled_lymph_nodes, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "label": "continuous_sneezing, chills, fatigue, cough, high_fever, headache, swelled_lymph_nodes, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, fatigue, cough, high_fever, breathlessness, sweating, malaise, chest_pain, fast_heart_rate, rusty_sputum", "label": "chills, fatigue, cough, high_fever, breathlessness, sweating, malaise, chest_pain, fast_heart_rate, rusty_sputum", "shape": "dot", "size": 20}, {"color": "red", "id": "Pneumonia", "label": "Pneumonia", "shape": "dot", "size": 10}, {"color": "blue", "id": "chills, fatigue, cough, high_fever, breathlessness, sweating, malaise, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "label": "chills, fatigue, cough, high_fever, breathlessness, sweating, malaise, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, cough, high_fever, breathlessness, sweating, malaise, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "label": "fatigue, cough, high_fever, breathlessness, sweating, malaise, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, cough, high_fever, breathlessness, sweating, malaise, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "label": "chills, cough, high_fever, breathlessness, sweating, malaise, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, fatigue, high_fever, breathlessness, sweating, malaise, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "label": "chills, fatigue, high_fever, breathlessness, sweating, malaise, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, fatigue, cough, breathlessness, sweating, malaise, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "label": "chills, fatigue, cough, breathlessness, sweating, malaise, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, fatigue, cough, high_fever, sweating, malaise, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "label": "chills, fatigue, cough, high_fever, sweating, malaise, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, fatigue, cough, high_fever, breathlessness, malaise, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "label": "chills, fatigue, cough, high_fever, breathlessness, malaise, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "shape": "dot", "size": 20}, {"color": "blue", "id": "chills, fatigue, cough, high_fever, breathlessness, sweating, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "label": "chills, fatigue, cough, high_fever, breathlessness, sweating, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "shape": "dot", "size": 20}, {"color": "blue", "id": "constipation, pain_during_bowel_movements, pain_in_anal_region, bloody_stool, irritation_in_anus", "label": "constipation, pain_during_bowel_movements, pain_in_anal_region, bloody_stool, irritation_in_anus", "shape": "dot", "size": 20}, {"color": "red", "id": "Dimorphic Hemmorhoids (piles)", "label": "Dimorphic Hemmorhoids (piles)", "shape": "dot", "size": 10}, {"color": "blue", "id": "pain_during_bowel_movements, pain_in_anal_region, bloody_stool, irritation_in_anus", "label": "pain_during_bowel_movements, pain_in_anal_region, bloody_stool, irritation_in_anus", "shape": "dot", "size": 20}, {"color": "blue", "id": "constipation, pain_in_anal_region, bloody_stool, irritation_in_anus", "label": "constipation, pain_in_anal_region, bloody_stool, irritation_in_anus", "shape": "dot", "size": 20}, {"color": "blue", "id": "constipation, pain_during_bowel_movements, bloody_stool, irritation_in_anus", "label": "constipation, pain_during_bowel_movements, bloody_stool, irritation_in_anus", "shape": "dot", "size": 20}, {"color": "blue", "id": "constipation, pain_during_bowel_movements, pain_in_anal_region, irritation_in_anus", "label": "constipation, pain_during_bowel_movements, pain_in_anal_region, irritation_in_anus", "shape": "dot", "size": 20}, {"color": "blue", "id": "constipation, pain_during_bowel_movements, pain_in_anal_region, bloody_stool", "label": "constipation, pain_during_bowel_movements, pain_in_anal_region, bloody_stool", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, breathlessness, sweating, chest_pain", "label": "vomiting, breathlessness, sweating, chest_pain", "shape": "dot", "size": 20}, {"color": "red", "id": "Heart Attack", "label": "Heart Attack", "shape": "dot", "size": 10}, {"color": "blue", "id": "breathlessness, sweating, chest_pain", "label": "breathlessness, sweating, chest_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, sweating, chest_pain", "label": "vomiting, sweating, chest_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, breathlessness, chest_pain", "label": "vomiting, breathlessness, chest_pain", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, breathlessness, sweating", "label": "vomiting, breathlessness, sweating", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, cramps, bruising, obesity, swollen_legs, swollen_blood_vessels, prominent_veins_on_calf", "label": "fatigue, cramps, bruising, obesity, swollen_legs, swollen_blood_vessels, prominent_veins_on_calf", "shape": "dot", "size": 20}, {"color": "red", "id": "Varicose Veins", "label": "Varicose Veins", "shape": "dot", "size": 10}, {"color": "blue", "id": "cramps, bruising, obesity, swollen_legs, swollen_blood_vessels, prominent_veins_on_calf", "label": "cramps, bruising, obesity, swollen_legs, swollen_blood_vessels, prominent_veins_on_calf", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, bruising, obesity, swollen_legs, swollen_blood_vessels, prominent_veins_on_calf", "label": "fatigue, bruising, obesity, swollen_legs, swollen_blood_vessels, prominent_veins_on_calf", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, cramps, obesity, swollen_legs, swollen_blood_vessels, prominent_veins_on_calf", "label": "fatigue, cramps, obesity, swollen_legs, swollen_blood_vessels, prominent_veins_on_calf", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, cramps, bruising, swollen_legs, swollen_blood_vessels, prominent_veins_on_calf", "label": "fatigue, cramps, bruising, swollen_legs, swollen_blood_vessels, prominent_veins_on_calf", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, cramps, bruising, obesity, swollen_blood_vessels, prominent_veins_on_calf", "label": "fatigue, cramps, bruising, obesity, swollen_blood_vessels, prominent_veins_on_calf", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, cramps, bruising, obesity, swollen_legs, prominent_veins_on_calf", "label": "fatigue, cramps, bruising, obesity, swollen_legs, prominent_veins_on_calf", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, cramps, bruising, obesity, swollen_legs, swollen_blood_vessels", "label": "fatigue, cramps, bruising, obesity, swollen_legs, swollen_blood_vessels", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, weight_gain, cold_hands_and_feets, mood_swings, lethargy, dizziness, puffy_face_and_eyes, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "label": "fatigue, weight_gain, cold_hands_and_feets, mood_swings, lethargy, dizziness, puffy_face_and_eyes, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "shape": "dot", "size": 20}, {"color": "red", "id": "Hypothyroidism", "label": "Hypothyroidism", "shape": "dot", "size": 10}, {"color": "blue", "id": "weight_gain, cold_hands_and_feets, mood_swings, lethargy, dizziness, puffy_face_and_eyes, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "label": "weight_gain, cold_hands_and_feets, mood_swings, lethargy, dizziness, puffy_face_and_eyes, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, cold_hands_and_feets, mood_swings, lethargy, dizziness, puffy_face_and_eyes, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "label": "fatigue, cold_hands_and_feets, mood_swings, lethargy, dizziness, puffy_face_and_eyes, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, weight_gain, mood_swings, lethargy, dizziness, puffy_face_and_eyes, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "label": "fatigue, weight_gain, mood_swings, lethargy, dizziness, puffy_face_and_eyes, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, weight_gain, cold_hands_and_feets, lethargy, dizziness, puffy_face_and_eyes, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "label": "fatigue, weight_gain, cold_hands_and_feets, lethargy, dizziness, puffy_face_and_eyes, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, weight_gain, cold_hands_and_feets, mood_swings, dizziness, puffy_face_and_eyes, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "label": "fatigue, weight_gain, cold_hands_and_feets, mood_swings, dizziness, puffy_face_and_eyes, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, weight_gain, cold_hands_and_feets, mood_swings, lethargy, puffy_face_and_eyes, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "label": "fatigue, weight_gain, cold_hands_and_feets, mood_swings, lethargy, puffy_face_and_eyes, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, weight_gain, cold_hands_and_feets, mood_swings, lethargy, dizziness, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "label": "fatigue, weight_gain, cold_hands_and_feets, mood_swings, lethargy, dizziness, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, mood_swings, weight_loss, restlessness, sweating, diarrhoea, fast_heart_rate, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "label": "fatigue, mood_swings, weight_loss, restlessness, sweating, diarrhoea, fast_heart_rate, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "shape": "dot", "size": 20}, {"color": "red", "id": "Hyperthyroidism", "label": "Hyperthyroidism", "shape": "dot", "size": 10}, {"color": "blue", "id": "mood_swings, weight_loss, restlessness, sweating, diarrhoea, fast_heart_rate, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "label": "mood_swings, weight_loss, restlessness, sweating, diarrhoea, fast_heart_rate, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, weight_loss, restlessness, sweating, diarrhoea, fast_heart_rate, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "label": "fatigue, weight_loss, restlessness, sweating, diarrhoea, fast_heart_rate, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, mood_swings, restlessness, sweating, diarrhoea, fast_heart_rate, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "label": "fatigue, mood_swings, restlessness, sweating, diarrhoea, fast_heart_rate, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, mood_swings, weight_loss, sweating, diarrhoea, fast_heart_rate, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "label": "fatigue, mood_swings, weight_loss, sweating, diarrhoea, fast_heart_rate, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, mood_swings, weight_loss, restlessness, diarrhoea, fast_heart_rate, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "label": "fatigue, mood_swings, weight_loss, restlessness, diarrhoea, fast_heart_rate, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, mood_swings, weight_loss, restlessness, sweating, fast_heart_rate, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "label": "fatigue, mood_swings, weight_loss, restlessness, sweating, fast_heart_rate, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, mood_swings, weight_loss, restlessness, sweating, diarrhoea, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "label": "fatigue, mood_swings, weight_loss, restlessness, sweating, diarrhoea, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, mood_swings, weight_loss, restlessness, sweating, diarrhoea, fast_heart_rate, muscle_weakness, irritability, abnormal_menstruation", "label": "fatigue, mood_swings, weight_loss, restlessness, sweating, diarrhoea, fast_heart_rate, muscle_weakness, irritability, abnormal_menstruation", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, fatigue, anxiety, sweating, headache, nausea, blurred_and_distorted_vision, excessive_hunger, slurred_speech, irritability, palpitations", "label": "vomiting, fatigue, anxiety, sweating, headache, nausea, blurred_and_distorted_vision, excessive_hunger, slurred_speech, irritability, palpitations", "shape": "dot", "size": 20}, {"color": "red", "id": "Hypoglycemia", "label": "Hypoglycemia", "shape": "dot", "size": 10}, {"color": "blue", "id": "vomiting, fatigue, anxiety, sweating, headache, nausea, blurred_and_distorted_vision, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "label": "vomiting, fatigue, anxiety, sweating, headache, nausea, blurred_and_distorted_vision, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "shape": "dot", "size": 20}, {"color": "blue", "id": "fatigue, anxiety, sweating, headache, nausea, blurred_and_distorted_vision, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "label": "fatigue, anxiety, sweating, headache, nausea, blurred_and_distorted_vision, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, anxiety, sweating, headache, nausea, blurred_and_distorted_vision, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "label": "vomiting, anxiety, sweating, headache, nausea, blurred_and_distorted_vision, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, fatigue, sweating, headache, nausea, blurred_and_distorted_vision, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "label": "vomiting, fatigue, sweating, headache, nausea, blurred_and_distorted_vision, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, fatigue, anxiety, headache, nausea, blurred_and_distorted_vision, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "label": "vomiting, fatigue, anxiety, headache, nausea, blurred_and_distorted_vision, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, fatigue, anxiety, sweating, nausea, blurred_and_distorted_vision, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "label": "vomiting, fatigue, anxiety, sweating, nausea, blurred_and_distorted_vision, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, fatigue, anxiety, sweating, headache, blurred_and_distorted_vision, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "label": "vomiting, fatigue, anxiety, sweating, headache, blurred_and_distorted_vision, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, fatigue, anxiety, sweating, headache, nausea, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "label": "vomiting, fatigue, anxiety, sweating, headache, nausea, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, neck_pain, knee_pain, hip_joint_pain, swelling_joints, painful_walking", "label": "joint_pain, neck_pain, knee_pain, hip_joint_pain, swelling_joints, painful_walking", "shape": "dot", "size": 20}, {"color": "red", "id": "Osteoarthritis", "label": "Osteoarthritis", "shape": "dot", "size": 10}, {"color": "blue", "id": "neck_pain, knee_pain, hip_joint_pain, swelling_joints, painful_walking", "label": "neck_pain, knee_pain, hip_joint_pain, swelling_joints, painful_walking", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, knee_pain, hip_joint_pain, swelling_joints, painful_walking", "label": "joint_pain, knee_pain, hip_joint_pain, swelling_joints, painful_walking", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, neck_pain, hip_joint_pain, swelling_joints, painful_walking", "label": "joint_pain, neck_pain, hip_joint_pain, swelling_joints, painful_walking", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, neck_pain, knee_pain, swelling_joints, painful_walking", "label": "joint_pain, neck_pain, knee_pain, swelling_joints, painful_walking", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, neck_pain, knee_pain, hip_joint_pain, painful_walking", "label": "joint_pain, neck_pain, knee_pain, hip_joint_pain, painful_walking", "shape": "dot", "size": 20}, {"color": "blue", "id": "joint_pain, neck_pain, knee_pain, hip_joint_pain, swelling_joints", "label": "joint_pain, neck_pain, knee_pain, hip_joint_pain, swelling_joints", "shape": "dot", "size": 20}, {"color": "blue", "id": "muscle_weakness, stiff_neck, swelling_joints, movement_stiffness, painful_walking", "label": "muscle_weakness, stiff_neck, swelling_joints, movement_stiffness, painful_walking", "shape": "dot", "size": 20}, {"color": "red", "id": "Arthritis", "label": "Arthritis", "shape": "dot", "size": 10}, {"color": "blue", "id": "stiff_neck, swelling_joints, movement_stiffness, painful_walking", "label": "stiff_neck, swelling_joints, movement_stiffness, painful_walking", "shape": "dot", "size": 20}, {"color": "blue", "id": "muscle_weakness, swelling_joints, movement_stiffness, painful_walking", "label": "muscle_weakness, swelling_joints, movement_stiffness, painful_walking", "shape": "dot", "size": 20}, {"color": "blue", "id": "muscle_weakness, stiff_neck, movement_stiffness, painful_walking", "label": "muscle_weakness, stiff_neck, movement_stiffness, painful_walking", "shape": "dot", "size": 20}, {"color": "blue", "id": "muscle_weakness, stiff_neck, swelling_joints, painful_walking", "label": "muscle_weakness, stiff_neck, swelling_joints, painful_walking", "shape": "dot", "size": 20}, {"color": "blue", "id": "muscle_weakness, stiff_neck, swelling_joints, movement_stiffness", "label": "muscle_weakness, stiff_neck, swelling_joints, movement_stiffness", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, headache, nausea, spinning_movements, loss_of_balance, unsteadiness", "label": "vomiting, headache, nausea, spinning_movements, loss_of_balance, unsteadiness", "shape": "dot", "size": 20}, {"color": "red", "id": "Vertigo", "label": "Vertigo", "shape": "dot", "size": 10}, {"color": "blue", "id": "headache, nausea, spinning_movements, loss_of_balance, unsteadiness", "label": "headache, nausea, spinning_movements, loss_of_balance, unsteadiness", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, nausea, spinning_movements, loss_of_balance, unsteadiness", "label": "vomiting, nausea, spinning_movements, loss_of_balance, unsteadiness", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, headache, spinning_movements, loss_of_balance, unsteadiness", "label": "vomiting, headache, spinning_movements, loss_of_balance, unsteadiness", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, headache, nausea, loss_of_balance, unsteadiness", "label": "vomiting, headache, nausea, loss_of_balance, unsteadiness", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, headache, nausea, spinning_movements, unsteadiness", "label": "vomiting, headache, nausea, spinning_movements, unsteadiness", "shape": "dot", "size": 20}, {"color": "blue", "id": "vomiting, headache, nausea, spinning_movements, loss_of_balance", "label": "vomiting, headache, nausea, spinning_movements, loss_of_balance", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, pus_filled_pimples, blackheads, scurring", "label": "skin_rash, pus_filled_pimples, blackheads, scurring", "shape": "dot", "size": 20}, {"color": "red", "id": "Acne", "label": "Acne", "shape": "dot", "size": 10}, {"color": "blue", "id": "pus_filled_pimples, blackheads, scurring", "label": "pus_filled_pimples, blackheads, scurring", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, blackheads, scurring", "label": "skin_rash, blackheads, scurring", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, pus_filled_pimples, scurring", "label": "skin_rash, pus_filled_pimples, scurring", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, pus_filled_pimples, blackheads", "label": "skin_rash, pus_filled_pimples, blackheads", "shape": "dot", "size": 20}, {"color": "blue", "id": "burning_micturition, bladder_discomfort, foul_smell_of urine, continuous_feel_of_urine", "label": "burning_micturition, bladder_discomfort, foul_smell_of urine, continuous_feel_of_urine", "shape": "dot", "size": 20}, {"color": "red", "id": "Urinary Tract Infection", "label": "Urinary Tract Infection", "shape": "dot", "size": 10}, {"color": "blue", "id": "bladder_discomfort, foul_smell_of urine, continuous_feel_of_urine", "label": "bladder_discomfort, foul_smell_of urine, continuous_feel_of_urine", "shape": "dot", "size": 20}, {"color": "blue", "id": "burning_micturition, foul_smell_of urine, continuous_feel_of_urine", "label": "burning_micturition, foul_smell_of urine, continuous_feel_of_urine", "shape": "dot", "size": 20}, {"color": "blue", "id": "burning_micturition, bladder_discomfort, continuous_feel_of_urine", "label": "burning_micturition, bladder_discomfort, continuous_feel_of_urine", "shape": "dot", "size": 20}, {"color": "blue", "id": "burning_micturition, bladder_discomfort, foul_smell_of urine", "label": "burning_micturition, bladder_discomfort, foul_smell_of urine", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, joint_pain, skin_peeling, silver_like_dusting, small_dents_in_nails, inflammatory_nails", "label": "skin_rash, joint_pain, skin_peeling, silver_like_dusting, small_dents_in_nails, inflammatory_nails", "shape": "dot", "size": 20}, {"color": "red", "id": "Psoriasis", "label": "Psoriasis", "shape": "dot", "size": 10}, {"color": "blue", "id": "joint_pain, skin_peeling, silver_like_dusting, small_dents_in_nails, inflammatory_nails", "label": "joint_pain, skin_peeling, silver_like_dusting, small_dents_in_nails, inflammatory_nails", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, skin_peeling, silver_like_dusting, small_dents_in_nails, inflammatory_nails", "label": "skin_rash, skin_peeling, silver_like_dusting, small_dents_in_nails, inflammatory_nails", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, joint_pain, silver_like_dusting, small_dents_in_nails, inflammatory_nails", "label": "skin_rash, joint_pain, silver_like_dusting, small_dents_in_nails, inflammatory_nails", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, joint_pain, skin_peeling, small_dents_in_nails, inflammatory_nails", "label": "skin_rash, joint_pain, skin_peeling, small_dents_in_nails, inflammatory_nails", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, joint_pain, skin_peeling, silver_like_dusting, inflammatory_nails", "label": "skin_rash, joint_pain, skin_peeling, silver_like_dusting, inflammatory_nails", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, joint_pain, skin_peeling, silver_like_dusting, small_dents_in_nails", "label": "skin_rash, joint_pain, skin_peeling, silver_like_dusting, small_dents_in_nails", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, high_fever, blister, red_sore_around_nose, yellow_crust_ooze", "label": "skin_rash, high_fever, blister, red_sore_around_nose, yellow_crust_ooze", "shape": "dot", "size": 20}, {"color": "red", "id": "Impetigo", "label": "Impetigo", "shape": "dot", "size": 10}, {"color": "blue", "id": "high_fever, blister, red_sore_around_nose, yellow_crust_ooze", "label": "high_fever, blister, red_sore_around_nose, yellow_crust_ooze", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, blister, red_sore_around_nose, yellow_crust_ooze", "label": "skin_rash, blister, red_sore_around_nose, yellow_crust_ooze", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, high_fever, red_sore_around_nose, yellow_crust_ooze", "label": "skin_rash, high_fever, red_sore_around_nose, yellow_crust_ooze", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, high_fever, blister, yellow_crust_ooze", "label": "skin_rash, high_fever, blister, yellow_crust_ooze", "shape": "dot", "size": 20}, {"color": "blue", "id": "skin_rash, high_fever, blister, red_sore_around_nose", "label": "skin_rash, high_fever, blister, red_sore_around_nose", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: abacavir and lamivudine, Active Ingredient: abacavir sulfate;lamivudine", "label": "Drug Name: abacavir and lamivudine, Active Ingredient: abacavir sulfate;lamivudine", "shape": "dot", "size": 20}, {"color": "red", "id": "TABLET;ORAL", "label": "TABLET;ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "12/22/2023", "label": "12/22/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204311s000lbl.pdf#page=34", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204311s000lbl.pdf#page=34", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: abilify, Active Ingredient: aripiprazole", "label": "Drug Name: abilify, Active Ingredient: aripiprazole", "shape": "dot", "size": 20}, {"color": "red", "id": "SOLUTION;ORAL", "label": "SOLUTION;ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "02/05/2020", "label": "02/05/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf#page=77", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf#page=77", "shape": "dot", "size": 10}, {"color": "red", "id": "TABLET", "label": "TABLET", "shape": "dot", "size": 10}, {"color": "red", "id": "ORALLY DISINTEGRATING;ORAL", "label": "ORALLY DISINTEGRATING;ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "11/30/2022", "label": "11/30/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021436s048lbl.pdf#page=47", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021436s048lbl.pdf#page=47", "shape": "dot", "size": 10}, {"color": "red", "id": "INJECTABLE;INTRAMUSCULAR", "label": "INJECTABLE;INTRAMUSCULAR", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: abilify maintena kit, Active Ingredient: aripiprazole", "label": "Drug Name: abilify maintena kit, Active Ingredient: aripiprazole", "shape": "dot", "size": 20}, {"color": "red", "id": "FOR SUSPENSION", "label": "FOR SUSPENSION", "shape": "dot", "size": 10}, {"color": "red", "id": "EXTENDED RELEASE;INTRAMUSCULAR", "label": "EXTENDED RELEASE;INTRAMUSCULAR", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202971s013lbl.pdf#page=52", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202971s013lbl.pdf#page=52", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: abilify mycite kit, Active Ingredient: aripiprazole", "label": "Drug Name: abilify mycite kit, Active Ingredient: aripiprazole", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207202s006lbl.pdf#page=64", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207202s006lbl.pdf#page=64", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: abrilada, Active Ingredient: adalimumab-afzb", "label": "Drug Name: abrilada, Active Ingredient: adalimumab-afzb", "shape": "dot", "size": 20}, {"color": "red", "id": "INJECTABLE;INJECTION", "label": "INJECTABLE;INJECTION", "shape": "dot", "size": 10}, {"color": "red", "id": "10/04/2023", "label": "10/04/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761118s007lbl.pdf#page=47", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761118s007lbl.pdf#page=47", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: absorica, Active Ingredient: isotretinoin", "label": "Drug Name: absorica, Active Ingredient: isotretinoin", "shape": "dot", "size": 20}, {"color": "red", "id": "CAPSULE;ORAL", "label": "CAPSULE;ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "07/18/2023", "label": "07/18/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021951s013lbl.pdf#page=32", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021951s013lbl.pdf#page=32", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: abstral, Active Ingredient: fentanyl citrate", "label": "Drug Name: abstral, Active Ingredient: fentanyl citrate", "shape": "dot", "size": 20}, {"color": "red", "id": "TABLET;SUBLINGUAL", "label": "TABLET;SUBLINGUAL", "shape": "dot", "size": 10}, {"color": "red", "id": "10/07/2019", "label": "10/07/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022510s018lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022510s018lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: accutane, Active Ingredient: isotretinoin", "label": "Drug Name: accutane, Active Ingredient: isotretinoin", "shape": "dot", "size": 20}, {"color": "red", "id": "10/22/2010", "label": "10/22/2010", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018662s061MedGuide.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018662s061MedGuide.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: aciphex, Active Ingredient: rabeprazole sodium", "label": "Drug Name: aciphex, Active Ingredient: rabeprazole sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "DELAYED RELEASE;ORAL", "label": "DELAYED RELEASE;ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020973s043lbl.pdf#page=34", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020973s043lbl.pdf#page=34", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: aciphex sprinkle, Active Ingredient: rabeprazole sodium", "label": "Drug Name: aciphex sprinkle, Active Ingredient: rabeprazole sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "CAPSULE", "label": "CAPSULE", "shape": "dot", "size": 10}, {"color": "red", "id": "11/27/2020", "label": "11/27/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204736s012lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204736s012lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: actemra, Active Ingredient: tocilizumab", "label": "Drug Name: actemra, Active Ingredient: tocilizumab", "shape": "dot", "size": 20}, {"color": "red", "id": "INJECTABLE; INJECTION", "label": "INJECTABLE; INJECTION", "shape": "dot", "size": 10}, {"color": "red", "id": "09/20/2024", "label": "09/20/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125276s144,125472s056lbl.pdf#page=55", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125276s144,125472s056lbl.pdf#page=55", "shape": "dot", "size": 10}, {"color": "red", "id": "INJECTABLE;INTRAVENOUS", "label": "INJECTABLE;INTRAVENOUS", "shape": "dot", "size": 10}, {"color": "red", "id": "SUBCUTANEOUS", "label": "SUBCUTANEOUS", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: acthar gel, Active Ingredient: corticotropin", "label": "Drug Name: acthar gel, Active Ingredient: corticotropin", "shape": "dot", "size": 20}, {"color": "red", "id": "02/29/2024", "label": "02/29/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/008372s071lbl.pdf#page=17", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/008372s071lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: actiq, Active Ingredient: fentanyl citrate", "label": "Drug Name: actiq, Active Ingredient: fentanyl citrate", "shape": "dot", "size": 20}, {"color": "red", "id": "TROCHE/LOZENGE;TRANSMUCOSAL", "label": "TROCHE/LOZENGE;TRANSMUCOSAL", "shape": "dot", "size": 10}, {"color": "red", "id": "12/15/2023", "label": "12/15/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020747s062lbl.pdf#page=44", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020747s062lbl.pdf#page=44", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: actonel, Active Ingredient: risedronate sodium", "label": "Drug Name: actonel, Active Ingredient: risedronate sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "11/05/2019", "label": "11/05/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020835s052lbl.pdf#page=38", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020835s052lbl.pdf#page=38", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: actonel with calcium (copackaged), Active Ingredient: calcium carbonate; risedronate sodium", "label": "Drug Name: actonel with calcium (copackaged), Active Ingredient: calcium carbonate; risedronate sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "04/08/2015", "label": "04/08/2015", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021823s011lbl.pdf#page=27", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021823s011lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: actoplus met, Active Ingredient: metformin hydrochloride; pioglitazone hydrochloride", "label": "Drug Name: actoplus met, Active Ingredient: metformin hydrochloride; pioglitazone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "12/21/2017", "label": "12/21/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021842s022lbl.pdf#page=41", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021842s022lbl.pdf#page=41", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: actoplus met xr, Active Ingredient: metformin hydrochloride; pioglitazone hydrochloride", "label": "Drug Name: actoplus met xr, Active Ingredient: metformin hydrochloride; pioglitazone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "EXTENDED RELEASE;ORAL", "label": "EXTENDED RELEASE;ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022024s014lbl.pdf#page=41", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022024s014lbl.pdf#page=41", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: actos, Active Ingredient: pioglitazone hydrochloride", "label": "Drug Name: actos, Active Ingredient: pioglitazone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021073s049lbl.pdf#page=35", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021073s049lbl.pdf#page=35", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: adasuve, Active Ingredient: loxapine", "label": "Drug Name: adasuve, Active Ingredient: loxapine", "shape": "dot", "size": 20}, {"color": "red", "id": "POWDER;INHALATION", "label": "POWDER;INHALATION", "shape": "dot", "size": 10}, {"color": "red", "id": "02/01/2022", "label": "02/01/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022549s010lbl.pdf#page=28", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022549s010lbl.pdf#page=28", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: adderall 10, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "label": "Drug Name: adderall 10, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "10/13/2023", "label": "10/13/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf#page=15", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf#page=15", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: adderall 12.5, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "label": "Drug Name: adderall 12.5, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: adderall 15, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "label": "Drug Name: adderall 15, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: adderall 20, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "label": "Drug Name: adderall 20, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: adderall 30, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "label": "Drug Name: adderall 30, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "02/25/2022", "label": "02/25/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/011522s044lbl.pdf#page=15", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/011522s044lbl.pdf#page=15", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: adderall 5, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "label": "Drug Name: adderall 5, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: adderall 7.5, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "label": "Drug Name: adderall 7.5, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: adderall xr 10, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "label": "Drug Name: adderall xr 10, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021303s038lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021303s038lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: adderall xr 15, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "label": "Drug Name: adderall xr 15, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: adderall xr 20, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "label": "Drug Name: adderall xr 20, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: adderall xr 25, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "label": "Drug Name: adderall xr 25, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: adderall xr 30, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "label": "Drug Name: adderall xr 30, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "07/03/2019", "label": "07/03/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021303s034lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021303s034lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: adderall xr 5, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "label": "Drug Name: adderall xr 5, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: addyi, Active Ingredient: flibanserin", "label": "Drug Name: addyi, Active Ingredient: flibanserin", "shape": "dot", "size": 20}, {"color": "red", "id": "09/29/2021", "label": "09/29/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022526s009lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022526s009lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: adempas, Active Ingredient: riociguat", "label": "Drug Name: adempas, Active Ingredient: riociguat", "shape": "dot", "size": 20}, {"color": "red", "id": "09/10/2021", "label": "09/10/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204819s015lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204819s015lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: adhansia xr, Active Ingredient: methylphenidate hydrochloride", "label": "Drug Name: adhansia xr, Active Ingredient: methylphenidate hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "06/28/2021", "label": "06/28/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212038s002lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212038s002lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: adlyxin, Active Ingredient: lixisenatide", "label": "Drug Name: adlyxin, Active Ingredient: lixisenatide", "shape": "dot", "size": 20}, {"color": "red", "id": "SOLUTION;SUBCUTANEOUS", "label": "SOLUTION;SUBCUTANEOUS", "shape": "dot", "size": 10}, {"color": "red", "id": "09/28/2023", "label": "09/28/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208471s007lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208471s007lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: aduhelm, Active Ingredient: aducanumab-avwa", "label": "Drug Name: aduhelm, Active Ingredient: aducanumab-avwa", "shape": "dot", "size": 20}, {"color": "red", "id": "08/30/2023", "label": "08/30/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761178s011lbl.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761178s011lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: adzenys er, Active Ingredient: amphetamine", "label": "Drug Name: adzenys er, Active Ingredient: amphetamine", "shape": "dot", "size": 20}, {"color": "red", "id": "SUSPENSION", "label": "SUSPENSION", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204325s003lbl.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204325s003lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: adzenys xr-odt, Active Ingredient: amphetamine", "label": "Drug Name: adzenys xr-odt, Active Ingredient: amphetamine", "shape": "dot", "size": 20}, {"color": "red", "id": "ORALLY DISINTEGRATING", "label": "ORALLY DISINTEGRATING", "shape": "dot", "size": 10}, {"color": "red", "id": "03/12/2024", "label": "03/12/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204326s011lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204326s011lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: afrezza, Active Ingredient: insulin recombinant human", "label": "Drug Name: afrezza, Active Ingredient: insulin recombinant human", "shape": "dot", "size": 20}, {"color": "red", "id": "02/03/2023", "label": "02/03/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022472s023lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022472s023lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: alkindi sprinkle, Active Ingredient: hydrocortisone", "label": "Drug Name: alkindi sprinkle, Active Ingredient: hydrocortisone", "shape": "dot", "size": 20}, {"color": "red", "id": "GRANULE;ORAL", "label": "GRANULE;ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "06/05/2024", "label": "06/05/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213876s002lbl.pdf#page=14", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213876s002lbl.pdf#page=14", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: alvaiz, Active Ingredient: eltrombopag choline", "label": "Drug Name: alvaiz, Active Ingredient: eltrombopag choline", "shape": "dot", "size": 20}, {"color": "red", "id": "11/29/2023", "label": "11/29/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216774s000lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216774s000lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ambien, Active Ingredient: zolpidem tartrate", "label": "Drug Name: ambien, Active Ingredient: zolpidem tartrate", "shape": "dot", "size": 20}, {"color": "red", "id": "02/23/2022", "label": "02/23/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019908s40s044s047lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019908s40s044s047lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ambien cr, Active Ingredient: zolpidem tartrate", "label": "Drug Name: ambien cr, Active Ingredient: zolpidem tartrate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021774s021s025s028lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021774s021s025s028lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: amjevita, Active Ingredient: adalimumab-atto", "label": "Drug Name: amjevita, Active Ingredient: adalimumab-atto", "shape": "dot", "size": 20}, {"color": "red", "id": "08/14/2023", "label": "08/14/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761024s015lbl.pdf#page=50", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761024s015lbl.pdf#page=50", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ampyra, Active Ingredient: dalfampridine", "label": "Drug Name: ampyra, Active Ingredient: dalfampridine", "shape": "dot", "size": 20}, {"color": "red", "id": "11/18/2021", "label": "11/18/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022250s019lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022250s019lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: anafranil, Active Ingredient: clomipramine hydrochloride", "label": "Drug Name: anafranil, Active Ingredient: clomipramine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "05/10/2019", "label": "05/10/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019906s043lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019906s043lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: anaprox, Active Ingredient: naproxen sodium", "label": "Drug Name: anaprox, Active Ingredient: naproxen sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "11/21/2024", "label": "11/21/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017581s117,018164s067,020067s026lbl.pdf", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017581s117,018164s067,020067s026lbl.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: anaprox ds, Active Ingredient: naproxen sodium", "label": "Drug Name: anaprox ds, Active Ingredient: naproxen sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "05/13/2024", "label": "05/13/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017581s115,018164s065,020067s024lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017581s115,018164s065,020067s024lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: androgel, Active Ingredient: testosterone", "label": "Drug Name: androgel, Active Ingredient: testosterone", "shape": "dot", "size": 20}, {"color": "red", "id": "GEL", "label": "GEL", "shape": "dot", "size": 10}, {"color": "red", "id": "METERED;TRANSDERMAL", "label": "METERED;TRANSDERMAL", "shape": "dot", "size": 10}, {"color": "red", "id": "05/30/2019", "label": "05/30/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022309s020lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022309s020lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "red", "id": "GEL;TRANSDERMAL", "label": "GEL;TRANSDERMAL", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021015s045lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021015s045lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ansaid, Active Ingredient: flurbiprofen", "label": "Drug Name: ansaid, Active Ingredient: flurbiprofen", "shape": "dot", "size": 20}, {"color": "red", "id": "05/09/2016", "label": "05/09/2016", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018766s015MedGuide.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018766s015MedGuide.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: apadaz, Active Ingredient: acetaminophen; benzhydrocodone hydrochloride", "label": "Drug Name: apadaz, Active Ingredient: acetaminophen; benzhydrocodone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208653s008lbl.pdf#page=40", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208653s008lbl.pdf#page=40", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: aplenzin, Active Ingredient: bupropion hydrobromide", "label": "Drug Name: aplenzin, Active Ingredient: bupropion hydrobromide", "shape": "dot", "size": 20}, {"color": "red", "id": "05/07/2024", "label": "05/07/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022108s022lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022108s022lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: aptensio xr, Active Ingredient: methylphenidate hydrochloride", "label": "Drug Name: aptensio xr, Active Ingredient: methylphenidate hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205831s008lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205831s008lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: aptiom, Active Ingredient: eslicarbazepine acetate", "label": "Drug Name: aptiom, Active Ingredient: eslicarbazepine acetate", "shape": "dot", "size": 20}, {"color": "red", "id": "03/15/2019", "label": "03/15/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022416s011lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022416s011lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: aptryxol, Active Ingredient: desvenlafaxine", "label": "Drug Name: aptryxol, Active Ingredient: desvenlafaxine", "shape": "dot", "size": 20}, {"color": "red", "id": "TABLET,EXTENDED RELEASE;ORAL", "label": "TABLET,EXTENDED RELEASE;ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "08/18/2023", "label": "08/18/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205583s014lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205583s014lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: aranesp, Active Ingredient: darbepoetin alfa", "label": "Drug Name: aranesp, Active Ingredient: darbepoetin alfa", "shape": "dot", "size": 20}, {"color": "red", "id": "VIAL; INTRAVENOUS", "label": "VIAL; INTRAVENOUS", "shape": "dot", "size": 10}, {"color": "red", "id": "01/30/2019", "label": "01/30/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103951s5377lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103951s5377lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "red", "id": "VIAL; SUBCUTANEOUS", "label": "VIAL; SUBCUTANEOUS", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: arcapta neohaler, Active Ingredient: indacaterol maleate", "label": "Drug Name: arcapta neohaler, Active Ingredient: indacaterol maleate", "shape": "dot", "size": 20}, {"color": "red", "id": "07/30/2021", "label": "07/30/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022383s000MedG.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022383s000MedG.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: arikayce kit, Active Ingredient: amikacin sulfate", "label": "Drug Name: arikayce kit, Active Ingredient: amikacin sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "LIPOSOMAL;INHALATION", "label": "LIPOSOMAL;INHALATION", "shape": "dot", "size": 10}, {"color": "red", "id": "02/10/2023", "label": "02/10/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207356s004lbl.pdf#page=15", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207356s004lbl.pdf#page=15", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: aristada, Active Ingredient: aripiprazole lauroxil", "label": "Drug Name: aristada, Active Ingredient: aripiprazole lauroxil", "shape": "dot", "size": 20}, {"color": "red", "id": "03/30/2021", "label": "03/30/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207533s017,209830s005lbl.pdf#page=36", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207533s017,209830s005lbl.pdf#page=36", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: aristada initio kit, Active Ingredient: aripiprazole lauroxil", "label": "Drug Name: aristada initio kit, Active Ingredient: aripiprazole lauroxil", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207533s017,209830s005lbl.pdf#page=72", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207533s017,209830s005lbl.pdf#page=72", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: arthrotec, Active Ingredient: diclofenac sodium; misoprostol", "label": "Drug Name: arthrotec, Active Ingredient: diclofenac sodium; misoprostol", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020607s043lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020607s043lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: arymo er, Active Ingredient: morphine sulfate", "label": "Drug Name: arymo er, Active Ingredient: morphine sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208603s005lbl.pdf#page=34", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208603s005lbl.pdf#page=34", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: astagraf xl, Active Ingredient: tacrolimus", "label": "Drug Name: astagraf xl, Active Ingredient: tacrolimus", "shape": "dot", "size": 20}, {"color": "red", "id": "11/22/2022", "label": "11/22/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050708s054,050709s047,204096s010lbl.pdf#page=91", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050708s054,050709s047,204096s010lbl.pdf#page=91", "shape": "dot", "size": 10}, {"color": "red", "id": "09/14/2023", "label": "09/14/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210115s006lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210115s006lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204096s011lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204096s011lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: atelvia, Active Ingredient: risedronate sodium", "label": "Drug Name: atelvia, Active Ingredient: risedronate sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "08/18/2020", "label": "08/18/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022560s011lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022560s011lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ativan, Active Ingredient: lorazepam", "label": "Drug Name: ativan, Active Ingredient: lorazepam", "shape": "dot", "size": 20}, {"color": "red", "id": "01/13/2023", "label": "01/13/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017794s049lbl.pdf#page=14", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017794s049lbl.pdf#page=14", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: aubagio, Active Ingredient: teriflunomide", "label": "Drug Name: aubagio, Active Ingredient: teriflunomide", "shape": "dot", "size": 20}, {"color": "red", "id": "06/10/2024", "label": "06/10/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202992s013s015lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202992s013s015lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: austedo, Active Ingredient: deutetrabenazine", "label": "Drug Name: austedo, Active Ingredient: deutetrabenazine", "shape": "dot", "size": 20}, {"color": "red", "id": "05/29/2024", "label": "05/29/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216354s000lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216354s000lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "red", "id": "11/26/2024", "label": "11/26/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/208082s016s017lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/208082s016s017lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: auvelity, Active Ingredient: bupropion; dextromethorphan", "label": "Drug Name: auvelity, Active Ingredient: bupropion; dextromethorphan", "shape": "dot", "size": 20}, {"color": "red", "id": "EXTENDED RELEASE; ORAL", "label": "EXTENDED RELEASE; ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215430s000lblCorrect3.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215430s000lblCorrect3.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: avandamet, Active Ingredient: metformin hydrochloride; rosiglitazone maleate", "label": "Drug Name: avandamet, Active Ingredient: metformin hydrochloride; rosiglitazone maleate", "shape": "dot", "size": 20}, {"color": "red", "id": "04/05/2017", "label": "04/05/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021410s040lbl.pdf#page=38", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021410s040lbl.pdf#page=38", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: avandaryl, Active Ingredient: glimepiride; rosiglitazone maleate", "label": "Drug Name: avandaryl, Active Ingredient: glimepiride; rosiglitazone maleate", "shape": "dot", "size": 20}, {"color": "red", "id": "04/27/2023", "label": "04/27/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217006s000lbl.pdf#page=39", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217006s000lbl.pdf#page=39", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: avandia, Active Ingredient: rosiglitazone maleate", "label": "Drug Name: avandia, Active Ingredient: rosiglitazone maleate", "shape": "dot", "size": 20}, {"color": "red", "id": "02/05/2019", "label": "02/05/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021071s052lbl.pdf#page=38", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021071s052lbl.pdf#page=38", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: aveed, Active Ingredient: testosterone undecanoate", "label": "Drug Name: aveed, Active Ingredient: testosterone undecanoate", "shape": "dot", "size": 20}, {"color": "red", "id": "08/16/2021", "label": "08/16/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022219s014lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022219s014lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: avelox, Active Ingredient: moxifloxacin hydrochloride", "label": "Drug Name: avelox, Active Ingredient: moxifloxacin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "05/06/2020", "label": "05/06/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021085s066,021277s062lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021085s066,021277s062lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: avelox in sodium chloride 0.8% in plastic container, Active Ingredient: moxifloxacin hydrochloride", "label": "Drug Name: avelox in sodium chloride 0.8% in plastic container, Active Ingredient: moxifloxacin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "SOLUTION;INTRAVENOUS", "label": "SOLUTION;INTRAVENOUS", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: avinza, Active Ingredient: morphine sulfate", "label": "Drug Name: avinza, Active Ingredient: morphine sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "06/26/2015", "label": "06/26/2015", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM311346.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM311346.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: avonex, Active Ingredient: interferon beta-1a", "label": "Drug Name: avonex, Active Ingredient: interferon beta-1a", "shape": "dot", "size": 20}, {"color": "red", "id": "VIAL", "label": "VIAL", "shape": "dot", "size": 10}, {"color": "red", "id": "07/28/2023", "label": "07/28/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103628s5269lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103628s5269lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: avsola, Active Ingredient: infliximab-axxq", "label": "Drug Name: avsola, Active Ingredient: infliximab-axxq", "shape": "dot", "size": 20}, {"color": "red", "id": "09/09/2021", "label": "09/09/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761086s000lbl.pdf#page=48", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761086s000lbl.pdf#page=48", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: axiron, Active Ingredient: testosterone", "label": "Drug Name: axiron, Active Ingredient: testosterone", "shape": "dot", "size": 20}, {"color": "red", "id": "SOLUTION", "label": "SOLUTION", "shape": "dot", "size": 10}, {"color": "red", "id": "07/13/2017", "label": "07/13/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022504s016lbl.pdf#page=15", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022504s016lbl.pdf#page=15", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: azstarys, Active Ingredient: dexmethylphenidate hydrochloride; serdexmethylphenidate chloride", "label": "Drug Name: azstarys, Active Ingredient: dexmethylphenidate hydrochloride; serdexmethylphenidate chloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212994s000lbl.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212994s000lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: banzel, Active Ingredient: rufinamide", "label": "Drug Name: banzel, Active Ingredient: rufinamide", "shape": "dot", "size": 20}, {"color": "red", "id": "SUSPENSION;ORAL", "label": "SUSPENSION;ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "05/30/2023", "label": "05/30/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201367Orig1s011lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201367Orig1s011lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "red", "id": "11/28/2019", "label": "11/28/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021911s017,201367s008lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021911s017,201367s008lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: bavencio, Active Ingredient: avelumab", "label": "Drug Name: bavencio, Active Ingredient: avelumab", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761049s020lbl.pdf#page=36", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761049s020lbl.pdf#page=36", "shape": "dot", "size": 10}, {"color": "red", "id": "05/09/2017", "label": "05/09/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761078s000lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761078s000lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: baxdela, Active Ingredient: delafloxacin meglumine", "label": "Drug Name: baxdela, Active Ingredient: delafloxacin meglumine", "shape": "dot", "size": 20}, {"color": "red", "id": "06/19/2017", "label": "06/19/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208610s007,208611s006lbl.pdf#page=28", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208610s007,208611s006lbl.pdf#page=28", "shape": "dot", "size": 10}, {"color": "red", "id": "POWDER;INTRAVENOUS", "label": "POWDER;INTRAVENOUS", "shape": "dot", "size": 10}, {"color": "red", "id": "12/01/2023", "label": "12/01/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208611s007lbl.pdf#page=28", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208611s007lbl.pdf#page=28", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: belbuca, Active Ingredient: buprenorphine hydrochloride", "label": "Drug Name: belbuca, Active Ingredient: buprenorphine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "FILM;BUCCAL", "label": "FILM;BUCCAL", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207932s023lbl.pdf#page=40", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207932s023lbl.pdf#page=40", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: belsomra, Active Ingredient: suvorexant", "label": "Drug Name: belsomra, Active Ingredient: suvorexant", "shape": "dot", "size": 20}, {"color": "red", "id": "03/25/2021", "label": "03/25/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204569s008lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204569s008lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: benlysta, Active Ingredient: belimumab", "label": "Drug Name: benlysta, Active Ingredient: belimumab", "shape": "dot", "size": 20}, {"color": "red", "id": "05/16/2024", "label": "05/16/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125370s079,761043s022lbl.pdf#page=41", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125370s079,761043s022lbl.pdf#page=41", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: besremi, Active Ingredient: ropeginterferon alfa-2b-njft", "label": "Drug Name: besremi, Active Ingredient: ropeginterferon alfa-2b-njft", "shape": "dot", "size": 20}, {"color": "red", "id": "INJECTABLE;SUBCUTANEOUS", "label": "INJECTABLE;SUBCUTANEOUS", "shape": "dot", "size": 10}, {"color": "red", "id": "04/29/2024", "label": "04/29/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761166s000lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761166s000lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: betaseron, Active Ingredient: interferon beta-1b", "label": "Drug Name: betaseron, Active Ingredient: interferon beta-1b", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103471s5202lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103471s5202lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: bevyxxa, Active Ingredient: betrixaban", "label": "Drug Name: bevyxxa, Active Ingredient: betrixaban", "shape": "dot", "size": 20}, {"color": "red", "id": "08/24/2020", "label": "08/24/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208383s000lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208383s000lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: bimzelx, Active Ingredient: bimekizumab-bkzx", "label": "Drug Name: bimzelx, Active Ingredient: bimekizumab-bkzx", "shape": "dot", "size": 20}, {"color": "red", "id": "INJECTABLE; SUBCUTANEOUS", "label": "INJECTABLE; SUBCUTANEOUS", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761151s005s006s007lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761151s005s006s007lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: binosto, Active Ingredient: alendronate sodium", "label": "Drug Name: binosto, Active Ingredient: alendronate sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "EFFERVESCENT;ORAL", "label": "EFFERVESCENT;ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "10/13/2020", "label": "10/13/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202344s008lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202344s008lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: blenrep, Active Ingredient: belantamab mafodotin-blmf", "label": "Drug Name: blenrep, Active Ingredient: belantamab mafodotin-blmf", "shape": "dot", "size": 20}, {"color": "red", "id": "02/28/2022", "label": "02/28/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761158s006lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761158s006lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: blincyto, Active Ingredient: blinatumomab", "label": "Drug Name: blincyto, Active Ingredient: blinatumomab", "shape": "dot", "size": 20}, {"color": "red", "id": "06/14/2024", "label": "06/14/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125557s023s026lbl.pdf#page=41", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125557s023s026lbl.pdf#page=41", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: boniva, Active Ingredient: ibandronate sodium", "label": "Drug Name: boniva, Active Ingredient: ibandronate sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "01/11/2022", "label": "01/11/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021858s022lbl.pdf#page=18", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021858s022lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "red", "id": "12/07/2016", "label": "12/07/2016", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021455s021lbl.pdf#page=19", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021455s021lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: bonsity, Active Ingredient: teriparatide", "label": "Drug Name: bonsity, Active Ingredient: teriparatide", "shape": "dot", "size": 20}, {"color": "red", "id": "11/16/2023", "label": "11/16/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211939s004lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211939s004lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: botox, Active Ingredient: onabotulinumtoxina", "label": "Drug Name: botox, Active Ingredient: onabotulinumtoxina", "shape": "dot", "size": 20}, {"color": "red", "id": "VIAL; SINGLE-USE", "label": "VIAL; SINGLE-USE", "shape": "dot", "size": 10}, {"color": "red", "id": "08/10/2023", "label": "08/10/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103000s5327lbl.pdf#page=49", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103000s5327lbl.pdf#page=49", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: botox cosmetic, Active Ingredient: onabotulinumtoxina", "label": "Drug Name: botox cosmetic, Active Ingredient: onabotulinumtoxina", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: braftovi, Active Ingredient: encorafenib", "label": "Drug Name: braftovi, Active Ingredient: encorafenib", "shape": "dot", "size": 20}, {"color": "red", "id": "09/12/2024", "label": "09/12/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210496s016lbl.pdf#page=31", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210496s016lbl.pdf#page=31", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: brenzavvy, Active Ingredient: bexagliflozin", "label": "Drug Name: brenzavvy, Active Ingredient: bexagliflozin", "shape": "dot", "size": 20}, {"color": "red", "id": "09/12/2023", "label": "09/12/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214373s001lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214373s001lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: brexafemme, Active Ingredient: ibrexafungerp", "label": "Drug Name: brexafemme, Active Ingredient: ibrexafungerp", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214900s002lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214900s002lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: brilinta, Active Ingredient: ticagrelor", "label": "Drug Name: brilinta, Active Ingredient: ticagrelor", "shape": "dot", "size": 20}, {"color": "red", "id": "03/22/2024", "label": "03/22/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022433s034lbl.pdf#page=35", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022433s034lbl.pdf#page=35", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: brisdelle, Active Ingredient: paroxetine mesylate", "label": "Drug Name: brisdelle, Active Ingredient: paroxetine mesylate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204516s013lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204516s013lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: briumvi, Active Ingredient: ublituximab-xiiy", "label": "Drug Name: briumvi, Active Ingredient: ublituximab-xiiy", "shape": "dot", "size": 20}, {"color": "red", "id": "12/28/2022", "label": "12/28/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761238s000lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761238s000lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: briviact, Active Ingredient: brivaracetam", "label": "Drug Name: briviact, Active Ingredient: brivaracetam", "shape": "dot", "size": 20}, {"color": "red", "id": "05/17/2023", "label": "05/17/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205836s014,205837s011,205838s011lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205836s014,205837s011,205838s011lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: brixadi, Active Ingredient: buprenorphine", "label": "Drug Name: brixadi, Active Ingredient: buprenorphine", "shape": "dot", "size": 20}, {"color": "red", "id": "INJECTION", "label": "INJECTION", "shape": "dot", "size": 10}, {"color": "red", "id": "EXTENDED RELEASE;SUBCUTANEOUS", "label": "EXTENDED RELEASE;SUBCUTANEOUS", "shape": "dot", "size": 10}, {"color": "red", "id": "05/23/2023", "label": "05/23/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210136s000lbl.pdf#page=52", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210136s000lbl.pdf#page=52", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: brovana, Active Ingredient: arformoterol tartrate", "label": "Drug Name: brovana, Active Ingredient: arformoterol tartrate", "shape": "dot", "size": 20}, {"color": "red", "id": "SOLUTION;INHALATION", "label": "SOLUTION;INHALATION", "shape": "dot", "size": 10}, {"color": "red", "id": "05/29/2019", "label": "05/29/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021912s013lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021912s013lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: bunavail, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "label": "Drug Name: bunavail, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "06/17/2022", "label": "06/17/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205637s023s024lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205637s023s024lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: butrans, Active Ingredient: buprenorphine", "label": "Drug Name: butrans, Active Ingredient: buprenorphine", "shape": "dot", "size": 20}, {"color": "red", "id": "FILM", "label": "FILM", "shape": "dot", "size": 10}, {"color": "red", "id": "EXTENDED RELEASE;TRANSDERMAL", "label": "EXTENDED RELEASE;TRANSDERMAL", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021306s041lbl.pdf#page=45", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021306s041lbl.pdf#page=45", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: bydureon, Active Ingredient: exenatide synthetic", "label": "Drug Name: bydureon, Active Ingredient: exenatide synthetic", "shape": "dot", "size": 20}, {"color": "red", "id": "12/21/2022", "label": "12/21/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022200s034lbl.pdf#page=37", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022200s034lbl.pdf#page=37", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: bydureon bcise, Active Ingredient: exenatide synthetic", "label": "Drug Name: bydureon bcise, Active Ingredient: exenatide synthetic", "shape": "dot", "size": 20}, {"color": "red", "id": "03/06/2024", "label": "03/06/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209210s022lbl.pdf#page=36", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209210s022lbl.pdf#page=36", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: bydureon pen, Active Ingredient: exenatide synthetic", "label": "Drug Name: bydureon pen, Active Ingredient: exenatide synthetic", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: byetta, Active Ingredient: exenatide synthetic", "label": "Drug Name: byetta, Active Ingredient: exenatide synthetic", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021773s048lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021773s048lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "red", "id": "10/30/2009", "label": "10/30/2009", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM191084.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM191084.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: cambia, Active Ingredient: diclofenac potassium", "label": "Drug Name: cambia, Active Ingredient: diclofenac potassium", "shape": "dot", "size": 20}, {"color": "red", "id": "FOR SOLUTION;ORAL", "label": "FOR SOLUTION;ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022165s016lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022165s016lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: camzyos, Active Ingredient: mavacamten", "label": "Drug Name: camzyos, Active Ingredient: mavacamten", "shape": "dot", "size": 20}, {"color": "red", "id": "06/15/2023", "label": "06/15/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214998s001lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214998s001lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: caplyta, Active Ingredient: lumateperone tosylate", "label": "Drug Name: caplyta, Active Ingredient: lumateperone tosylate", "shape": "dot", "size": 20}, {"color": "red", "id": "06/28/2023", "label": "06/28/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209500s011lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209500s011lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: caprelsa, Active Ingredient: vandetanib", "label": "Drug Name: caprelsa, Active Ingredient: vandetanib", "shape": "dot", "size": 20}, {"color": "red", "id": "03/28/2022", "label": "03/28/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022405s019lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022405s019lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: carbatrol, Active Ingredient: carbamazepine", "label": "Drug Name: carbatrol, Active Ingredient: carbamazepine", "shape": "dot", "size": 20}, {"color": "red", "id": "04/11/2023", "label": "04/11/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020712s038lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020712s038lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: cassipa, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "label": "Drug Name: cassipa, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "FILM;SUBLINGUAL", "label": "FILM;SUBLINGUAL", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208042s011lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208042s011lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: cataflam, Active Ingredient: diclofenac potassium", "label": "Drug Name: cataflam, Active Ingredient: diclofenac potassium", "shape": "dot", "size": 20}, {"color": "red", "id": "04/28/2021", "label": "04/28/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020142s029lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020142s029lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: celebrex, Active Ingredient: celecoxib", "label": "Drug Name: celebrex, Active Ingredient: celecoxib", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020998s058lbl.pdf#page=41", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020998s058lbl.pdf#page=41", "shape": "dot", "size": 10}, {"color": "red", "id": "02/04/2011", "label": "02/04/2011", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020998s033,021156s003MedG.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020998s033,021156s003MedG.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: celexa, Active Ingredient: citalopram hydrobromide", "label": "Drug Name: celexa, Active Ingredient: citalopram hydrobromide", "shape": "dot", "size": 20}, {"color": "red", "id": "12/03/2012", "label": "12/03/2012", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020822s042,021046s019lbl.pdf#page=32", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020822s042,021046s019lbl.pdf#page=32", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020822s054lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020822s054lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: cellcept, Active Ingredient: mycophenolate mofetil", "label": "Drug Name: cellcept, Active Ingredient: mycophenolate mofetil", "shape": "dot", "size": 20}, {"color": "red", "id": "08/10/2022", "label": "08/10/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050722s050,050723s050,050758s048,050759s055lbl.pdf#page=39", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050722s050,050723s050,050758s048,050759s055lbl.pdf#page=39", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: cellcept, Active Ingredient: mycophenolate mofetil hydrochloride", "label": "Drug Name: cellcept, Active Ingredient: mycophenolate mofetil hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "FOR SUSPENSION;ORAL", "label": "FOR SUSPENSION;ORAL", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: celontin, Active Ingredient: methsuximide", "label": "Drug Name: celontin, Active Ingredient: methsuximide", "shape": "dot", "size": 20}, {"color": "red", "id": "06/15/2011", "label": "06/15/2011", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229201.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229201.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: cerdelga, Active Ingredient: eliglustat tartrate", "label": "Drug Name: cerdelga, Active Ingredient: eliglustat tartrate", "shape": "dot", "size": 20}, {"color": "red", "id": "08/29/2018", "label": "08/29/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205494s003lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205494s003lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: chantix, Active Ingredient: varenicline tartrate", "label": "Drug Name: chantix, Active Ingredient: varenicline tartrate", "shape": "dot", "size": 20}, {"color": "red", "id": "02/22/2019", "label": "02/22/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021928s048lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021928s048lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: chlordiazepoxide and amitriptyline hydrochloride, Active Ingredient: amitriptyline hydrochloride; chlordiazepoxide", "label": "Drug Name: chlordiazepoxide and amitriptyline hydrochloride, Active Ingredient: amitriptyline hydrochloride; chlordiazepoxide", "shape": "dot", "size": 20}, {"color": "red", "id": "02/05/2021", "label": "02/05/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/071297Orig1s026MG.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/071297Orig1s026MG.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: cibinqo, Active Ingredient: abrocitinib", "label": "Drug Name: cibinqo, Active Ingredient: abrocitinib", "shape": "dot", "size": 20}, {"color": "red", "id": "TABLET; ORAL", "label": "TABLET; ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213871s004lblcorrected.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213871s004lblcorrected.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: cimzia, Active Ingredient: certolizumab pegol", "label": "Drug Name: cimzia, Active Ingredient: certolizumab pegol", "shape": "dot", "size": 20}, {"color": "red", "id": "09/13/2024", "label": "09/13/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125160s275lbl.pdf#page=42", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125160s275lbl.pdf#page=42", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: cipro, Active Ingredient: ciprofloxacin hydrochloride", "label": "Drug Name: cipro, Active Ingredient: ciprofloxacin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/019537s095,020780s050lbl.pdf#page=40", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/019537s095,020780s050lbl.pdf#page=40", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: cipro, Active Ingredient: ciprofloxacin", "label": "Drug Name: cipro, Active Ingredient: ciprofloxacin", "shape": "dot", "size": 20}, {"color": "red", "id": "03/25/2022", "label": "03/25/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019847s063lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019847s063lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: cipro in dextrose 5% in plastic container, Active Ingredient: ciprofloxacin", "label": "Drug Name: cipro in dextrose 5% in plastic container, Active Ingredient: ciprofloxacin", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019857s073lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019857s073lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: cipro xr, Active Ingredient: ciprofloxacin; ciprofloxacin hydrochloride", "label": "Drug Name: cipro xr, Active Ingredient: ciprofloxacin; ciprofloxacin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021473s043lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021473s043lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: citalopram, Active Ingredient: citalopram hydrobromide", "label": "Drug Name: citalopram, Active Ingredient: citalopram hydrobromide", "shape": "dot", "size": 20}, {"color": "red", "id": "CAPSULE; ORAL", "label": "CAPSULE; ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215428s002lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215428s002lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: clenpiq, Active Ingredient: citric acid; magnesium oxide; sodium picosulfate", "label": "Drug Name: clenpiq, Active Ingredient: citric acid; magnesium oxide; sodium picosulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "08/29/2023", "label": "08/29/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209589s015lbl.pdf#page=14", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209589s015lbl.pdf#page=14", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: clinoril, Active Ingredient: sulindac", "label": "Drug Name: clinoril, Active Ingredient: sulindac", "shape": "dot", "size": 20}, {"color": "red", "id": "12/23/2010", "label": "12/23/2010", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088573.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088573.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: codeine sulfate, Active Ingredient: codeine sulfate", "label": "Drug Name: codeine sulfate, Active Ingredient: codeine sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202245s010lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202245s010lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022402s015lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022402s015lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: colcrys, Active Ingredient: colchicine", "label": "Drug Name: colcrys, Active Ingredient: colchicine", "shape": "dot", "size": 20}, {"color": "red", "id": "05/14/2020", "label": "05/14/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022352s026lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022352s026lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "red", "id": "10/16/2019", "label": "10/16/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022353lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022353lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: columvi, Active Ingredient: glofitamab-gxbm", "label": "Drug Name: columvi, Active Ingredient: glofitamab-gxbm", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761309s000lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761309s000lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: combogesic, Active Ingredient: acetaminophen; ibuprofen", "label": "Drug Name: combogesic, Active Ingredient: acetaminophen; ibuprofen", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209471s001lbl.pdf#page=28", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209471s001lbl.pdf#page=28", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: combunox, Active Ingredient: ibuprofen; oxycodone hydrochloride", "label": "Drug Name: combunox, Active Ingredient: ibuprofen; oxycodone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "09/02/2010", "label": "09/02/2010", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021378s006lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021378s006lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: concerta, Active Ingredient: methylphenidate hydrochloride", "label": "Drug Name: concerta, Active Ingredient: methylphenidate hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021121s049lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021121s049lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: consensi, Active Ingredient: amlodipine besylate; celecoxib", "label": "Drug Name: consensi, Active Ingredient: amlodipine besylate; celecoxib", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210045s009lbl.pdf#page=10", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210045s009lbl.pdf#page=10", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: contrave, Active Ingredient: bupropion hydrochloride; naltrexone hydrochloride", "label": "Drug Name: contrave, Active Ingredient: bupropion hydrochloride; naltrexone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200063s021lbl.pdf#page=40", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200063s021lbl.pdf#page=40", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: conzip, Active Ingredient: tramadol hydrochloride", "label": "Drug Name: conzip, Active Ingredient: tramadol hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022370s025lbl.pdf#page=37", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022370s025lbl.pdf#page=37", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: copegus, Active Ingredient: ribavirin", "label": "Drug Name: copegus, Active Ingredient: ribavirin", "shape": "dot", "size": 20}, {"color": "red", "id": "08/11/2015", "label": "08/11/2015", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021511s029lbl.pdf#page=27", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021511s029lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: copiktra, Active Ingredient: duvelisib", "label": "Drug Name: copiktra, Active Ingredient: duvelisib", "shape": "dot", "size": 20}, {"color": "red", "id": "12/17/2021", "label": "12/17/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211155s005lbl.pdf#page=28", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211155s005lbl.pdf#page=28", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: cordarone, Active Ingredient: amiodarone hydrochloride", "label": "Drug Name: cordarone, Active Ingredient: amiodarone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "10/17/2018", "label": "10/17/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018972s054lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018972s054lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: corlanor, Active Ingredient: ivabradine hydrochloride", "label": "Drug Name: corlanor, Active Ingredient: ivabradine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "08/04/2021", "label": "08/04/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206143s008,209964s002lblrpl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206143s008,209964s002lblrpl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: corlanor, Active Ingredient: ivabradine", "label": "Drug Name: corlanor, Active Ingredient: ivabradine", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: cosentyx, Active Ingredient: secukinumab", "label": "Drug Name: cosentyx, Active Ingredient: secukinumab", "shape": "dot", "size": 20}, {"color": "red", "id": "INTRAVENOUS", "label": "INTRAVENOUS", "shape": "dot", "size": 10}, {"color": "red", "id": "10/06/2023", "label": "10/06/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761349s000lbl.pdf#page=32", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761349s000lbl.pdf#page=32", "shape": "dot", "size": 10}, {"color": "red", "id": "08/16/2024", "label": "08/16/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125504s082lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125504s082lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: cotempla xr-odt, Active Ingredient: methylphenidate", "label": "Drug Name: cotempla xr-odt, Active Ingredient: methylphenidate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205489s012lbl.pdf##page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205489s012lbl.pdf##page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: coumadin, Active Ingredient: warfarin sodium", "label": "Drug Name: coumadin, Active Ingredient: warfarin sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "08/14/2017", "label": "08/14/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009218s118lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009218s118lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: coxanto, Active Ingredient: oxaprozin", "label": "Drug Name: coxanto, Active Ingredient: oxaprozin", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217927s002lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217927s002lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: creon, Active Ingredient: pancrelipase (amylase;lipase;protease)", "label": "Drug Name: creon, Active Ingredient: pancrelipase (amylase;lipase;protease)", "shape": "dot", "size": 20}, {"color": "red", "id": "06/02/2024", "label": "06/02/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020725s028lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020725s028lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: cyltezo, Active Ingredient: adalimumab-adbm", "label": "Drug Name: cyltezo, Active Ingredient: adalimumab-adbm", "shape": "dot", "size": 20}, {"color": "red", "id": "04/30/2024", "label": "04/30/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761058s018lbl.pdf#page=38", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761058s018lbl.pdf#page=38", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: cymbalta, Active Ingredient: duloxetine hydrochloride", "label": "Drug Name: cymbalta, Active Ingredient: duloxetine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "DELAYED REL PELLETS;ORAL", "label": "DELAYED REL PELLETS;ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021427s055s057lbl.pdf#page=38", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021427s055s057lbl.pdf#page=38", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: daliresp, Active Ingredient: roflumilast", "label": "Drug Name: daliresp, Active Ingredient: roflumilast", "shape": "dot", "size": 20}, {"color": "red", "id": "01/23/2018", "label": "01/23/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022522s009lbl.pdf#page=17", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022522s009lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: dalmane, Active Ingredient: flurazepam hydrochloride", "label": "Drug Name: dalmane, Active Ingredient: flurazepam hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "03/27/2009", "label": "03/27/2009", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/016721s077lbl.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/016721s077lbl.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: darvocet-n 100, Active Ingredient: acetaminophen; propoxyphene napsylate", "label": "Drug Name: darvocet-n 100, Active Ingredient: acetaminophen; propoxyphene napsylate", "shape": "dot", "size": 20}, {"color": "red", "id": "09/25/2009", "label": "09/25/2009", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187067.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187067.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: darvocet-n 50, Active Ingredient: acetaminophen; propoxyphene napsylate", "label": "Drug Name: darvocet-n 50, Active Ingredient: acetaminophen; propoxyphene napsylate", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: darvon, Active Ingredient: propoxyphene hydrochloride", "label": "Drug Name: darvon, Active Ingredient: propoxyphene hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187068.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187068.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: darvon-n, Active Ingredient: propoxyphene napsylate", "label": "Drug Name: darvon-n, Active Ingredient: propoxyphene napsylate", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: daurismo, Active Ingredient: glasdegib maleate", "label": "Drug Name: daurismo, Active Ingredient: glasdegib maleate", "shape": "dot", "size": 20}, {"color": "red", "id": "03/27/2023", "label": "03/27/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210656s005lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210656s005lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: daxxify, Active Ingredient: daxibotulinumtoxina-lanm", "label": "Drug Name: daxxify, Active Ingredient: daxibotulinumtoxina-lanm", "shape": "dot", "size": 20}, {"color": "red", "id": "08/11/2023", "label": "08/11/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761127s002lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761127s002lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: daypro, Active Ingredient: oxaprozin", "label": "Drug Name: daypro, Active Ingredient: oxaprozin", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018841s036lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018841s036lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: daypro alta, Active Ingredient: oxaprozin potassium", "label": "Drug Name: daypro alta, Active Ingredient: oxaprozin potassium", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020776s013lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020776s013lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: daytrana, Active Ingredient: methylphenidate", "label": "Drug Name: daytrana, Active Ingredient: methylphenidate", "shape": "dot", "size": 20}, {"color": "red", "id": "SYSTEM;TRANSDERMAL", "label": "SYSTEM;TRANSDERMAL", "shape": "dot", "size": 10}, {"color": "red", "id": "11/29/2024", "label": "11/29/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021514s039lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021514s039lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021514s036lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021514s036lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: dayvigo, Active Ingredient: lemborexant", "label": "Drug Name: dayvigo, Active Ingredient: lemborexant", "shape": "dot", "size": 20}, {"color": "red", "id": "04/20/2023", "label": "04/20/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212028s008lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212028s008lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: demerol, Active Ingredient: meperidine hydrochloride", "label": "Drug Name: demerol, Active Ingredient: meperidine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005010s060lbl.pdf#page=31", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005010s060lbl.pdf#page=31", "shape": "dot", "size": 10}, {"color": "red", "id": "SYRUP;ORAL", "label": "SYRUP;ORAL", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: depakene, Active Ingredient: valproic acid", "label": "Drug Name: depakene, Active Ingredient: valproic acid", "shape": "dot", "size": 20}, {"color": "red", "id": "05/19/2020", "label": "05/19/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018081s070,018082s053lbl.pdf#page=41", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018081s070,018082s053lbl.pdf#page=41", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018081Orig1s068%20018082Orig1s051lbl.pdf#page=38", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018081Orig1s068%20018082Orig1s051lbl.pdf#page=38", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: depakote, Active Ingredient: divalproex sodium", "label": "Drug Name: depakote, Active Ingredient: divalproex sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "03/18/2024", "label": "03/18/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019680s052lbl.pdf#page=42", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019680s052lbl.pdf#page=42", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018723s066lbledt.pdf#page=48", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018723s066lbledt.pdf#page=48", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: depakote er, Active Ingredient: divalproex sodium", "label": "Drug Name: depakote er, Active Ingredient: divalproex sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021168s044lbl.pdf#page=48", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021168s044lbl.pdf#page=48", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: descovy, Active Ingredient: emtricitabine; tenofovir alafenamide fumarate", "label": "Drug Name: descovy, Active Ingredient: emtricitabine; tenofovir alafenamide fumarate", "shape": "dot", "size": 20}, {"color": "red", "id": "01/07/2022", "label": "01/07/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208215s019lbl.pdf#page=37", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208215s019lbl.pdf#page=37", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: desoxyn, Active Ingredient: methamphetamine hydrochloride", "label": "Drug Name: desoxyn, Active Ingredient: methamphetamine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005378s038lbl.pdf#page=12", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005378s038lbl.pdf#page=12", "shape": "dot", "size": 10}, {"color": "red", "id": "09/24/2024", "label": "09/24/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/005378s032lbl.pdf#page=17", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/005378s032lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: desvenlafaxine, Active Ingredient: desvenlafaxine fumarate", "label": "Drug Name: desvenlafaxine, Active Ingredient: desvenlafaxine fumarate", "shape": "dot", "size": 20}, {"color": "red", "id": "07/18/2014", "label": "07/18/2014", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205208Orig1s001lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205208Orig1s001lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: desvenlafaxine, Active Ingredient: desvenlafaxine", "label": "Drug Name: desvenlafaxine, Active Ingredient: desvenlafaxine", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204150s020lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204150s020lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: desyrel, Active Ingredient: trazodone hydrochloride", "label": "Drug Name: desyrel, Active Ingredient: trazodone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "10/18/2018", "label": "10/18/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018207s032lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018207s032lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018207s033lbl.pdf#page=14", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018207s033lbl.pdf#page=14", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: dexedrine, Active Ingredient: dextroamphetamine sulfate", "label": "Drug Name: dexedrine, Active Ingredient: dextroamphetamine sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017078s055lbl.pdf#page=14", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017078s055lbl.pdf#page=14", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: dexilant, Active Ingredient: dexlansoprazole", "label": "Drug Name: dexilant, Active Ingredient: dexlansoprazole", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022287s038lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022287s038lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: dextroamphetamine sulfate, Active Ingredient: dextroamphetamine sulfate", "label": "Drug Name: dextroamphetamine sulfate, Active Ingredient: dextroamphetamine sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "01/04/2017", "label": "01/04/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/40776MG.pdf#page=7", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/40776MG.pdf#page=7", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: diacomit, Active Ingredient: stiripentol", "label": "Drug Name: diacomit, Active Ingredient: stiripentol", "shape": "dot", "size": 20}, {"color": "red", "id": "08/20/2018", "label": "08/20/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206709s000,207223s000lbl.pdf#page=17", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206709s000,207223s000lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: dilantin, Active Ingredient: phenytoin sodium", "label": "Drug Name: dilantin, Active Ingredient: phenytoin sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "09/07/2022", "label": "09/07/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/084349s088lbl.pdf#page=21", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/084349s088lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: dilantin, Active Ingredient: phenytoin", "label": "Drug Name: dilantin, Active Ingredient: phenytoin", "shape": "dot", "size": 20}, {"color": "red", "id": "CHEWABLE;ORAL", "label": "CHEWABLE;ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "10/22/2021", "label": "10/22/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/084427s039s041lbl.pdf#page=17", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/084427s039s041lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: dilantin-125, Active Ingredient: phenytoin", "label": "Drug Name: dilantin-125, Active Ingredient: phenytoin", "shape": "dot", "size": 20}, {"color": "red", "id": "03/03/2022", "label": "03/03/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/008762s066lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/008762s066lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: dilantin-30, Active Ingredient: phenytoin", "label": "Drug Name: dilantin-30, Active Ingredient: phenytoin", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: dilaudid, Active Ingredient: hydromorphone hydrochloride", "label": "Drug Name: dilaudid, Active Ingredient: hydromorphone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019891s031,019892s041lbl.pdf#page=32", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019891s031,019892s041lbl.pdf#page=32", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: dolophine hydrochloride, Active Ingredient: methadone hydrochloride", "label": "Drug Name: dolophine hydrochloride, Active Ingredient: methadone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "06/02/2021", "label": "06/02/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/006134s050lbl.pdf#page=36", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/006134s050lbl.pdf#page=36", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: doral, Active Ingredient: quazepam", "label": "Drug Name: doral, Active Ingredient: quazepam", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018708s029lbl.pdf#page=11", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018708s029lbl.pdf#page=11", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: dotarem, Active Ingredient: gadoterate meglumine", "label": "Drug Name: dotarem, Active Ingredient: gadoterate meglumine", "shape": "dot", "size": 20}, {"color": "red", "id": "01/26/2024", "label": "01/26/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204781s012lbl.pdf#page=17", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204781s012lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: drizalma sprinkle, Active Ingredient: duloxetine hydrochloride", "label": "Drug Name: drizalma sprinkle, Active Ingredient: duloxetine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212516s005lbl.pdf#page=45", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212516s005lbl.pdf#page=45", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: droxia, Active Ingredient: hydroxyurea", "label": "Drug Name: droxia, Active Ingredient: hydroxyurea", "shape": "dot", "size": 20}, {"color": "red", "id": "11/28/2023", "label": "11/28/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016295s058lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016295s058lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: duetact, Active Ingredient: glimepiride; pioglitazone hydrochloride", "label": "Drug Name: duetact, Active Ingredient: glimepiride; pioglitazone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021925s017lbl.pdf#page=39", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021925s017lbl.pdf#page=39", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: duexis, Active Ingredient: famotidine; ibuprofen", "label": "Drug Name: duexis, Active Ingredient: famotidine; ibuprofen", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022519s014lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022519s014lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: duragesic-100, Active Ingredient: fentanyl", "label": "Drug Name: duragesic-100, Active Ingredient: fentanyl", "shape": "dot", "size": 20}, {"color": "red", "id": "03/04/2021", "label": "03/04/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: duragesic-12, Active Ingredient: fentanyl", "label": "Drug Name: duragesic-12, Active Ingredient: fentanyl", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: duragesic-25, Active Ingredient: fentanyl", "label": "Drug Name: duragesic-25, Active Ingredient: fentanyl", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: duragesic-37, Active Ingredient: fentanyl", "label": "Drug Name: duragesic-37, Active Ingredient: fentanyl", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: duragesic-50, Active Ingredient: fentanyl", "label": "Drug Name: duragesic-50, Active Ingredient: fentanyl", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: duragesic-75, Active Ingredient: fentanyl", "label": "Drug Name: duragesic-75, Active Ingredient: fentanyl", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: duzallo, Active Ingredient: allopurinol; lesinurad", "label": "Drug Name: duzallo, Active Ingredient: allopurinol; lesinurad", "shape": "dot", "size": 20}, {"color": "red", "id": "08/18/2017", "label": "08/18/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209203s000lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209203s000lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: dyanavel xr, Active Ingredient: amphetamine", "label": "Drug Name: dyanavel xr, Active Ingredient: amphetamine", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208147s016,210526s008lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208147s016,210526s008lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: dyanavel xr 10, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "label": "Drug Name: dyanavel xr 10, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: dyanavel xr 15, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "label": "Drug Name: dyanavel xr 15, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: dyanavel xr 20, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "label": "Drug Name: dyanavel xr 20, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: dyanavel xr 5, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "label": "Drug Name: dyanavel xr 5, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: dysport, Active Ingredient: abobotulinumtoxina", "label": "Drug Name: dysport, Active Ingredient: abobotulinumtoxina", "shape": "dot", "size": 20}, {"color": "red", "id": "09/21/2023", "label": "09/21/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125274s125lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125274s125lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ec-naprosyn, Active Ingredient: naproxen", "label": "Drug Name: ec-naprosyn, Active Ingredient: naproxen", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: edluar, Active Ingredient: zolpidem tartrate", "label": "Drug Name: edluar, Active Ingredient: zolpidem tartrate", "shape": "dot", "size": 20}, {"color": "red", "id": "08/18/2019", "label": "08/18/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021997s011lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021997s011lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: effexor, Active Ingredient: venlafaxine hydrochloride", "label": "Drug Name: effexor, Active Ingredient: venlafaxine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "12/12/2012", "label": "12/12/2012", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020151s031s055s058s060lbl.pdf#page=34", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020151s031s055s058s060lbl.pdf#page=34", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: effexor xr, Active Ingredient: venlafaxine hydrochloride", "label": "Drug Name: effexor xr, Active Ingredient: venlafaxine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020699s118lbl.pdf#page=41", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020699s118lbl.pdf#page=41", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: effient, Active Ingredient: prasugrel hydrochloride", "label": "Drug Name: effient, Active Ingredient: prasugrel hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "12/22/2020", "label": "12/22/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022307s018lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022307s018lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: elepsia xr, Active Ingredient: levetiracetam", "label": "Drug Name: elepsia xr, Active Ingredient: levetiracetam", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204417s004lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204417s004lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: elidel, Active Ingredient: pimecrolimus", "label": "Drug Name: elidel, Active Ingredient: pimecrolimus", "shape": "dot", "size": 20}, {"color": "red", "id": "CREAM;TOPICAL", "label": "CREAM;TOPICAL", "shape": "dot", "size": 10}, {"color": "red", "id": "06/09/2016", "label": "06/09/2016", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088587.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088587.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: eliquis, Active Ingredient: apixaban", "label": "Drug Name: eliquis, Active Ingredient: apixaban", "shape": "dot", "size": 20}, {"color": "red", "id": "10/12/2021", "label": "10/12/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202155s034lbl.pdf#page=38", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202155s034lbl.pdf#page=38", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: elmiron, Active Ingredient: pentosan polysulfate sodium", "label": "Drug Name: elmiron, Active Ingredient: pentosan polysulfate sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "03/12/2021", "label": "03/12/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020193s015lbl.pdf#page=11", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020193s015lbl.pdf#page=11", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: elrexfio, Active Ingredient: elranatamab-bcmm", "label": "Drug Name: elrexfio, Active Ingredient: elranatamab-bcmm", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761345s000lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761345s000lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: elucirem, Active Ingredient: gadopiclenol", "label": "Drug Name: elucirem, Active Ingredient: gadopiclenol", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216986s000lbl.pdf#page=17", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216986s000lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: elyxyb, Active Ingredient: celecoxib", "label": "Drug Name: elyxyb, Active Ingredient: celecoxib", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/212157s003lbl.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/212157s003lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: embeda, Active Ingredient: morphine sulfate; naltrexone hydrochloride", "label": "Drug Name: embeda, Active Ingredient: morphine sulfate; naltrexone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022321s030lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022321s030lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: empavel, Active Ingredient: pegcetacoplan", "label": "Drug Name: empavel, Active Ingredient: pegcetacoplan", "shape": "dot", "size": 20}, {"color": "red", "id": "02/08/2024", "label": "02/08/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215014s003lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215014s003lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: emsam, Active Ingredient: selegiline", "label": "Drug Name: emsam, Active Ingredient: selegiline", "shape": "dot", "size": 20}, {"color": "red", "id": "07/14/2017", "label": "07/14/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021336s014lbl.pdf#page=34", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021336s014lbl.pdf#page=34", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: enbrel, Active Ingredient: etanercept", "label": "Drug Name: enbrel, Active Ingredient: etanercept", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/103795s5600lbl.pdf#page=36", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/103795s5600lbl.pdf#page=36", "shape": "dot", "size": 10}, {"color": "red", "id": "SYRINGE", "label": "SYRINGE", "shape": "dot", "size": 10}, {"color": "red", "id": "06/09/2023", "label": "06/09/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103795s5594lbl.pdf#page=35", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103795s5594lbl.pdf#page=35", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: enhertu, Active Ingredient: fam-trastuzumab deruxtecan-nxki", "label": "Drug Name: enhertu, Active Ingredient: fam-trastuzumab deruxtecan-nxki", "shape": "dot", "size": 20}, {"color": "red", "id": "04/05/2024", "label": "04/05/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761139s022lbl.pdf#page=31", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761139s022lbl.pdf#page=31", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: enjaymo, Active Ingredient: sutimlimab-jome", "label": "Drug Name: enjaymo, Active Ingredient: sutimlimab-jome", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761164s000lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761164s000lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: enspryng, Active Ingredient: satralizumab-mwge", "label": "Drug Name: enspryng, Active Ingredient: satralizumab-mwge", "shape": "dot", "size": 20}, {"color": "red", "id": "09/14/2022", "label": "09/14/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761149s005lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761149s005lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: entyvio, Active Ingredient: vedolizumab", "label": "Drug Name: entyvio, Active Ingredient: vedolizumab", "shape": "dot", "size": 20}, {"color": "red", "id": "04/18/2024", "label": "04/18/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761133s000lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761133s000lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125476s038s039lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125476s038s039lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: entyvio pen, Active Ingredient: vedolizumab", "label": "Drug Name: entyvio pen, Active Ingredient: vedolizumab", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: envarsus xr, Active Ingredient: tacrolimus", "label": "Drug Name: envarsus xr, Active Ingredient: tacrolimus", "shape": "dot", "size": 20}, {"color": "red", "id": "04/08/2024", "label": "04/08/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206406s010lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206406s010lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: eovist, Active Ingredient: gadoxetate disodium", "label": "Drug Name: eovist, Active Ingredient: gadoxetate disodium", "shape": "dot", "size": 20}, {"color": "red", "id": "01/30/2024", "label": "01/30/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022090s020lbledt.pdf#page=15", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022090s020lbledt.pdf#page=15", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: epidiolex, Active Ingredient: cannabidiol", "label": "Drug Name: epidiolex, Active Ingredient: cannabidiol", "shape": "dot", "size": 20}, {"color": "red", "id": "03/04/2024", "label": "03/04/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210365s020lbl.pdf#page=31", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210365s020lbl.pdf#page=31", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: epkinly, Active Ingredient: epcoritamab-bysp", "label": "Drug Name: epkinly, Active Ingredient: epcoritamab-bysp", "shape": "dot", "size": 20}, {"color": "red", "id": "06/26/2024", "label": "06/26/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761324s000lbl.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761324s000lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: epogen, Active Ingredient: epoetin alfa", "label": "Drug Name: epogen, Active Ingredient: epoetin alfa", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103234s5363s5366lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103234s5363s5366lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: epzicom, Active Ingredient: abacavir sulfate; lamivudine", "label": "Drug Name: epzicom, Active Ingredient: abacavir sulfate; lamivudine", "shape": "dot", "size": 20}, {"color": "red", "id": "12/10/2021", "label": "12/10/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021652s029lbl.pdf#page=28", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021652s029lbl.pdf#page=28", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: equetro, Active Ingredient: carbamazepine", "label": "Drug Name: equetro, Active Ingredient: carbamazepine", "shape": "dot", "size": 20}, {"color": "red", "id": "10/14/2022", "label": "10/14/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021710s018lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021710s018lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: erelzi, Active Ingredient: etanercept-szzs", "label": "Drug Name: erelzi, Active Ingredient: etanercept-szzs", "shape": "dot", "size": 20}, {"color": "red", "id": "11/10/2022", "label": "11/10/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761042s018lbl.pdf#page=41", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761042s018lbl.pdf#page=41", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: erivedge, Active Ingredient: vismodegib", "label": "Drug Name: erivedge, Active Ingredient: vismodegib", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203388s017lbl.pdf#page=15", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203388s017lbl.pdf#page=15", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: esomeprazole strontium, Active Ingredient: esomeprazole strontium", "label": "Drug Name: esomeprazole strontium, Active Ingredient: esomeprazole strontium", "shape": "dot", "size": 20}, {"color": "red", "id": "03/04/2022", "label": "03/04/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202342s007lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202342s007lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: estazolam, Active Ingredient: estazolam", "label": "Drug Name: estazolam, Active Ingredient: estazolam", "shape": "dot", "size": 20}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM359235.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM359235.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: eticovo, Active Ingredient: etanercept-ykro", "label": "Drug Name: eticovo, Active Ingredient: etanercept-ykro", "shape": "dot", "size": 20}, {"color": "red", "id": "05/03/2024", "label": "05/03/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761066s000lbl.pdf#page=31", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761066s000lbl.pdf#page=31", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: evekeo odt, Active Ingredient: amphetamine sulfate", "label": "Drug Name: evekeo odt, Active Ingredient: amphetamine sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209905s004lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209905s004lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: evenity, Active Ingredient: romosozumab-aqqg", "label": "Drug Name: evenity, Active Ingredient: romosozumab-aqqg", "shape": "dot", "size": 20}, {"color": "red", "id": "12/20/2019", "label": "12/20/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761062s000lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761062s000lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: evista, Active Ingredient: raloxifene hydrochloride", "label": "Drug Name: evista, Active Ingredient: raloxifene hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "09/13/2007", "label": "09/13/2007", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088593.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088593.pdf", "shape": "dot", "size": 10}, {"color": "red", "id": "06/27/2018", "label": "06/27/2018", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: exalgo, Active Ingredient: hydromorphone hydrochloride", "label": "Drug Name: exalgo, Active Ingredient: hydromorphone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021217s025lbl.pdf#page=31", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021217s025lbl.pdf#page=31", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: exjade, Active Ingredient: deferasirox", "label": "Drug Name: exjade, Active Ingredient: deferasirox", "shape": "dot", "size": 20}, {"color": "red", "id": "07/23/2020", "label": "07/23/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021882s033lbl.pdf#page=28", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021882s033lbl.pdf#page=28", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: extavia, Active Ingredient: interferon beta-1b", "label": "Drug Name: extavia, Active Ingredient: interferon beta-1b", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125290s074lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125290s074lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: fabhalta, Active Ingredient: iptacopan", "label": "Drug Name: fabhalta, Active Ingredient: iptacopan", "shape": "dot", "size": 20}, {"color": "red", "id": "08/07/2024", "label": "08/07/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218276s001lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218276s001lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: factive, Active Ingredient: gemifloxacin mesylate", "label": "Drug Name: factive, Active Ingredient: gemifloxacin mesylate", "shape": "dot", "size": 20}, {"color": "red", "id": "07/26/2016", "label": "07/26/2016", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021158s026lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021158s026lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: farxiga, Active Ingredient: dapagliflozin", "label": "Drug Name: farxiga, Active Ingredient: dapagliflozin", "shape": "dot", "size": 20}, {"color": "red", "id": "06/12/2024", "label": "06/12/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202293s030lbl.pdf#page=53", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202293s030lbl.pdf#page=53", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: farydak, Active Ingredient: panobinostat lactate", "label": "Drug Name: farydak, Active Ingredient: panobinostat lactate", "shape": "dot", "size": 20}, {"color": "red", "id": "06/06/2016", "label": "06/06/2016", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM436377.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM436377.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: felbatol, Active Ingredient: felbamate", "label": "Drug Name: felbatol, Active Ingredient: felbamate", "shape": "dot", "size": 20}, {"color": "red", "id": "08/31/2012", "label": "08/31/2012", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020189s027mg.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020189s027mg.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: feldene, Active Ingredient: piroxicam", "label": "Drug Name: feldene, Active Ingredient: piroxicam", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018147s050lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018147s050lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: fensolvi kit, Active Ingredient: leuprolide acetate", "label": "Drug Name: fensolvi kit, Active Ingredient: leuprolide acetate", "shape": "dot", "size": 20}, {"color": "red", "id": "POWDER;SUBCUTANEOUS", "label": "POWDER;SUBCUTANEOUS", "shape": "dot", "size": 10}, {"color": "red", "id": "04/22/2022", "label": "04/22/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213150s002lbl.pdf#page=15", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213150s002lbl.pdf#page=15", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: fentanyl citrate, Active Ingredient: fentanyl citrate", "label": "Drug Name: fentanyl citrate, Active Ingredient: fentanyl citrate", "shape": "dot", "size": 20}, {"color": "red", "id": "09/07/2017", "label": "09/07/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/077312MedGuide.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/077312MedGuide.pdf", "shape": "dot", "size": 10}, {"color": "red", "id": "12/03/2021", "label": "12/03/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/078907MedGuide.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/078907MedGuide.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: fentora, Active Ingredient: fentanyl citrate", "label": "Drug Name: fentora, Active Ingredient: fentanyl citrate", "shape": "dot", "size": 20}, {"color": "red", "id": "TABLET;BUCCAL", "label": "TABLET;BUCCAL", "shape": "dot", "size": 10}, {"color": "red", "id": "SUBLINGUAL", "label": "SUBLINGUAL", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021947s043lbl.pdf#page=43", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021947s043lbl.pdf#page=43", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ferriprox, Active Ingredient: deferiprone", "label": "Drug Name: ferriprox, Active Ingredient: deferiprone", "shape": "dot", "size": 20}, {"color": "red", "id": "11/30/2021", "label": "11/30/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212269s003lbl.pdf#page=17", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212269s003lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021825s010lbl.pdf#page=17", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021825s010lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208030s007lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208030s007lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: fetzima, Active Ingredient: levomilnacipran hydrochloride", "label": "Drug Name: fetzima, Active Ingredient: levomilnacipran hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "04/19/2024", "label": "04/19/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204168s011lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204168s011lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: filspari, Active Ingredient: sparsentan", "label": "Drug Name: filspari, Active Ingredient: sparsentan", "shape": "dot", "size": 20}, {"color": "red", "id": "02/17/2023", "label": "02/17/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216403s000lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216403s000lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: fintepla, Active Ingredient: fenfluramine hydrochloride", "label": "Drug Name: fintepla, Active Ingredient: fenfluramine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212102s013lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212102s013lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: fioricet w/ codeine, Active Ingredient: acetaminophen; butalbital; caffeine; codeine phosphate", "label": "Drug Name: fioricet w/ codeine, Active Ingredient: acetaminophen; butalbital; caffeine; codeine phosphate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020232s047lbl.pdf#page=44", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020232s047lbl.pdf#page=44", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: fiorinal w/codeine, Active Ingredient: aspirin; butalbital; caffeine; codeine phosphate", "label": "Drug Name: fiorinal w/codeine, Active Ingredient: aspirin; butalbital; caffeine; codeine phosphate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019429s043lbl.pdf#page=39", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019429s043lbl.pdf#page=39", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: firdapse, Active Ingredient: amifampridine phosphate", "label": "Drug Name: firdapse, Active Ingredient: amifampridine phosphate", "shape": "dot", "size": 20}, {"color": "red", "id": "05/30/2024", "label": "05/30/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208078s009lbl.pdf#page=12", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208078s009lbl.pdf#page=12", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: flector, Active Ingredient: diclofenac epolamine", "label": "Drug Name: flector, Active Ingredient: diclofenac epolamine", "shape": "dot", "size": 20}, {"color": "red", "id": "SYSTEM;TOPICAL", "label": "SYSTEM;TOPICAL", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021234s024lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021234s024lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: flowtuss, Active Ingredient: guaifenesin; hydrocodone bitartrate", "label": "Drug Name: flowtuss, Active Ingredient: guaifenesin; hydrocodone bitartrate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022424s003lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022424s003lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: floxin, Active Ingredient: ofloxacin", "label": "Drug Name: floxin, Active Ingredient: ofloxacin", "shape": "dot", "size": 20}, {"color": "red", "id": "02/25/2011", "label": "02/25/2011", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019735s061MedG.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019735s061MedG.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: fluoxetine hydrochloride, Active Ingredient: fluoxetine hydrochloride", "label": "Drug Name: fluoxetine hydrochloride, Active Ingredient: fluoxetine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202133s009s016lbl.pdf#page=36", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202133s009s016lbl.pdf#page=36", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: focalin, Active Ingredient: dexmethylphenidate hydrochloride", "label": "Drug Name: focalin, Active Ingredient: dexmethylphenidate hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021278s028s031lbl.pdf#page=17", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021278s028s031lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: focalin xr, Active Ingredient: dexmethylphenidate hydrochloride", "label": "Drug Name: focalin xr, Active Ingredient: dexmethylphenidate hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021802s038s041lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021802s038s041lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: foradil, Active Ingredient: formoterol fumarate", "label": "Drug Name: foradil, Active Ingredient: formoterol fumarate", "shape": "dot", "size": 20}, {"color": "red", "id": "03/02/2016", "label": "03/02/2016", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088602.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088602.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: foradil certihaler, Active Ingredient: formoterol fumarate", "label": "Drug Name: foradil certihaler, Active Ingredient: formoterol fumarate", "shape": "dot", "size": 20}, {"color": "red", "id": "06/02/2010", "label": "06/02/2010", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021592s003lbl.pdf#page=35", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021592s003lbl.pdf#page=35", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: forfivo xl, Active Ingredient: bupropion hydrochloride", "label": "Drug Name: forfivo xl, Active Ingredient: bupropion hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022497s008lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022497s008lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: forteo, Active Ingredient: teriparatide", "label": "Drug Name: forteo, Active Ingredient: teriparatide", "shape": "dot", "size": 20}, {"color": "red", "id": "09/07/2021", "label": "09/07/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021318Orig1s054lbl.pdf#page=16", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021318Orig1s054lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: fortesta, Active Ingredient: testosterone", "label": "Drug Name: fortesta, Active Ingredient: testosterone", "shape": "dot", "size": 20}, {"color": "red", "id": "06/30/2020", "label": "06/30/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021463s025lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021463s025lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: fosamax, Active Ingredient: alendronate sodium", "label": "Drug Name: fosamax, Active Ingredient: alendronate sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "11/30/2015", "label": "11/30/2015", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020560s068,021575s024lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020560s068,021575s024lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "red", "id": "08/16/2019", "label": "08/16/2019", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: fosamax plus d, Active Ingredient: alendronate sodium; cholecalciferol", "label": "Drug Name: fosamax plus d, Active Ingredient: alendronate sodium; cholecalciferol", "shape": "dot", "size": 20}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM241521.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM241521.pdf", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021762s022lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021762s022lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: fosrenol, Active Ingredient: lanthanum carbonate", "label": "Drug Name: fosrenol, Active Ingredient: lanthanum carbonate", "shape": "dot", "size": 20}, {"color": "red", "id": "POWDER;ORAL", "label": "POWDER;ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "08/29/2024", "label": "08/29/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204734s007,021468s025lbl.pdf#page=12", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204734s007,021468s025lbl.pdf#page=12", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: fycompa, Active Ingredient: perampanel", "label": "Drug Name: fycompa, Active Ingredient: perampanel", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202834s016,208277s004lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202834s016,208277s004lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "red", "id": "02/23/2021", "label": "02/23/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208277s005lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208277s005lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: gabitril, Active Ingredient: tiagabine hydrochloride", "label": "Drug Name: gabitril, Active Ingredient: tiagabine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "08/09/2016", "label": "08/09/2016", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229203.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229203.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: gadavist, Active Ingredient: gadobutrol", "label": "Drug Name: gadavist, Active Ingredient: gadobutrol", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201277s020lbl.pdf#page=42", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201277s020lbl.pdf#page=42", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: gattex kit, Active Ingredient: teduglutide recombinant", "label": "Drug Name: gattex kit, Active Ingredient: teduglutide recombinant", "shape": "dot", "size": 20}, {"color": "red", "id": "09/19/2024", "label": "09/19/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203441s022lbl.pdf#page=32", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203441s022lbl.pdf#page=32", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: gilenya, Active Ingredient: fingolimod hydrochloride", "label": "Drug Name: gilenya, Active Ingredient: fingolimod hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022527s038lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022527s038lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: gimoti, Active Ingredient: metoclopramide hydrochloride", "label": "Drug Name: gimoti, Active Ingredient: metoclopramide hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "SPRAY", "label": "SPRAY", "shape": "dot", "size": 10}, {"color": "red", "id": "METERED;NASAL", "label": "METERED;NASAL", "shape": "dot", "size": 10}, {"color": "red", "id": "01/14/2021", "label": "01/14/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209388s001lbl.pdf#page=17", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209388s001lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: gloperba, Active Ingredient: colchicine", "label": "Drug Name: gloperba, Active Ingredient: colchicine", "shape": "dot", "size": 20}, {"color": "red", "id": "08/28/2024", "label": "08/28/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210942s002lbl.pdf#page=14", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210942s002lbl.pdf#page=14", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: glyxambi, Active Ingredient: empagliflozin; linagliptin", "label": "Drug Name: glyxambi, Active Ingredient: empagliflozin; linagliptin", "shape": "dot", "size": 20}, {"color": "red", "id": "10/30/2023", "label": "10/30/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206073s036lbl.pdf#page=34", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206073s036lbl.pdf#page=34", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: golytely, Active Ingredient: polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous", "label": "Drug Name: golytely, Active Ingredient: polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous", "shape": "dot", "size": 20}, {"color": "red", "id": "05/14/2021", "label": "05/14/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019011s033lbl.pdf#page=9", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019011s033lbl.pdf#page=9", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: gralise, Active Ingredient: gabapentin", "label": "Drug Name: gralise, Active Ingredient: gabapentin", "shape": "dot", "size": 20}, {"color": "red", "id": "04/18/2023", "label": "04/18/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022544Orig1s029lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022544Orig1s029lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: h.p. acthar gel, Active Ingredient: repository corticotropin", "label": "Drug Name: h.p. acthar gel, Active Ingredient: repository corticotropin", "shape": "dot", "size": 20}, {"color": "red", "id": "10/15/2010", "label": "10/15/2010", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM231714.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM231714.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: hadlima, Active Ingredient: adalimumab-bwwd", "label": "Drug Name: hadlima, Active Ingredient: adalimumab-bwwd", "shape": "dot", "size": 20}, {"color": "red", "id": "06/28/2024", "label": "06/28/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761059s008lbl.pdf#page=46", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761059s008lbl.pdf#page=46", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: halcion, Active Ingredient: triazolam", "label": "Drug Name: halcion, Active Ingredient: triazolam", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017892s057lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017892s057lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: halflytely, Active Ingredient: bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride", "label": "Drug Name: halflytely, Active Ingredient: bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride", "shape": "dot", "size": 20}, {"color": "red", "id": "FOR SOLUTION", "label": "FOR SOLUTION", "shape": "dot", "size": 10}, {"color": "red", "id": "06/03/2013", "label": "06/03/2013", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM220644.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM220644.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: hemangeol, Active Ingredient: propranolol hydrochloride", "label": "Drug Name: hemangeol, Active Ingredient: propranolol hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "06/22/2021", "label": "06/22/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205410s006lbl.pdf#page=11", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205410s006lbl.pdf#page=11", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: hemlibra, Active Ingredient: emicizumab", "label": "Drug Name: hemlibra, Active Ingredient: emicizumab", "shape": "dot", "size": 20}, {"color": "red", "id": "01/31/2024", "label": "01/31/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761083s015lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761083s015lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: horizant, Active Ingredient: gabapentin enacarbil", "label": "Drug Name: horizant, Active Ingredient: gabapentin enacarbil", "shape": "dot", "size": 20}, {"color": "red", "id": "04/17/2020", "label": "04/17/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022399s010lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022399s010lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: hulio, Active Ingredient: adalimumab-fkjp", "label": "Drug Name: hulio, Active Ingredient: adalimumab-fkjp", "shape": "dot", "size": 20}, {"color": "red", "id": "08/25/2023", "label": "08/25/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761154s005lbl.pdf#page=57", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761154s005lbl.pdf#page=57", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: humira, Active Ingredient: adalimumab", "label": "Drug Name: humira, Active Ingredient: adalimumab", "shape": "dot", "size": 20}, {"color": "red", "id": "11/03/2023", "label": "11/03/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125057s423lbl.pdf#page=57", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125057s423lbl.pdf#page=57", "shape": "dot", "size": 10}, {"color": "red", "id": "02/24/2021", "label": "02/24/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125057s417lbl.pdf#page=60", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125057s417lbl.pdf#page=60", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: hycodan, Active Ingredient: homatropine methylbromide; hydrocodone bitartrate", "label": "Drug Name: hycodan, Active Ingredient: homatropine methylbromide; hydrocodone bitartrate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005213s046lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005213s046lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: hycofenix, Active Ingredient: hydrocodone bitartrate;pseudoephedrine hydrochloride;guaifenesin", "label": "Drug Name: hycofenix, Active Ingredient: hydrocodone bitartrate;pseudoephedrine hydrochloride;guaifenesin", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022279s003lbl.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022279s003lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: hydromorphone hydrochloride, Active Ingredient: hydromorphone hydrochloride", "label": "Drug Name: hydromorphone hydrochloride, Active Ingredient: hydromorphone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204278Orig1s000MG.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204278Orig1s000MG.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: hyrimoz, Active Ingredient: adalimumab-adaz", "label": "Drug Name: hyrimoz, Active Ingredient: adalimumab-adaz", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761071s016lbl.pdf#page=60", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761071s016lbl.pdf#page=60", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: hysingla er, Active Ingredient: hydrocodone bitartrate", "label": "Drug Name: hysingla er, Active Ingredient: hydrocodone bitartrate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206627s015lbl.pdf#page=40", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206627s015lbl.pdf#page=40", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ibsrela, Active Ingredient: tenapanor hydrochloride", "label": "Drug Name: ibsrela, Active Ingredient: tenapanor hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "04/05/2022", "label": "04/05/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211801s004lbl.pdf#page=14", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211801s004lbl.pdf#page=14", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: iclusig, Active Ingredient: ponatinib hydrochloride", "label": "Drug Name: iclusig, Active Ingredient: ponatinib hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "03/19/2024", "label": "03/19/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203469s035lbl.pdf#page=34", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203469s035lbl.pdf#page=34", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: idacio, Active Ingredient: adalimumab-aacf", "label": "Drug Name: idacio, Active Ingredient: adalimumab-aacf", "shape": "dot", "size": 20}, {"color": "red", "id": "06/04/2024", "label": "06/04/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761255s004lbl.pdf#page=48", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761255s004lbl.pdf#page=48", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: idhifa, Active Ingredient: enasidenib mesylate", "label": "Drug Name: idhifa, Active Ingredient: enasidenib mesylate", "shape": "dot", "size": 20}, {"color": "red", "id": "12/21/2023", "label": "12/21/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209606s006lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209606s006lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ilaris, Active Ingredient: canakinumab", "label": "Drug Name: ilaris, Active Ingredient: canakinumab", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125319s107lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125319s107lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ilumya, Active Ingredient: tildrakizumab-asmn", "label": "Drug Name: ilumya, Active Ingredient: tildrakizumab-asmn", "shape": "dot", "size": 20}, {"color": "red", "id": "04/03/2024", "label": "04/03/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761067s000lbl.pdf#page=10", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761067s000lbl.pdf#page=10", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: imfinzi, Active Ingredient: durvalumab", "label": "Drug Name: imfinzi, Active Ingredient: durvalumab", "shape": "dot", "size": 20}, {"color": "red", "id": "12/04/2024", "label": "12/04/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761069s049lbl.pdf#page=68", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761069s049lbl.pdf#page=68", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: imipramine hydrochloride, Active Ingredient: imipramine hydrochloride", "label": "Drug Name: imipramine hydrochloride, Active Ingredient: imipramine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "06/29/2017", "label": "06/29/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/087846s028,087844s027,087845s027lbl.pdf#page=3", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/087846s028,087844s027,087845s027lbl.pdf#page=3", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: imjudo, Active Ingredient: tremelimumab-actl", "label": "Drug Name: imjudo, Active Ingredient: tremelimumab-actl", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761270s000lbl.pdf#page=32", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761270s000lbl.pdf#page=32", "shape": "dot", "size": 10}, {"color": "red", "id": "01/25/2024", "label": "01/25/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761289s002lbl.pdf#page=31", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761289s002lbl.pdf#page=31", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: incivek, Active Ingredient: telaprevir", "label": "Drug Name: incivek, Active Ingredient: telaprevir", "shape": "dot", "size": 20}, {"color": "red", "id": "03/25/2014", "label": "03/25/2014", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM256383.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM256383.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: indocin, Active Ingredient: indomethacin", "label": "Drug Name: indocin, Active Ingredient: indomethacin", "shape": "dot", "size": 20}, {"color": "red", "id": "SUPPOSITORY;RECTAL", "label": "SUPPOSITORY;RECTAL", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017814s045lbl.pdf", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017814s045lbl.pdf", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018332s043lbl.pdf", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018332s043lbl.pdf", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/016059s102lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/016059s102lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: indocin sr, Active Ingredient: indomethacin", "label": "Drug Name: indocin sr, Active Ingredient: indomethacin", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018185s059lbl.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018185s059lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: indomethacin, Active Ingredient: indomethacin", "label": "Drug Name: indomethacin, Active Ingredient: indomethacin", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018829s025lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018829s025lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018851s028lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018851s028lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018858s049lbl.pdf", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018858s049lbl.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: inflectra, Active Ingredient: infliximab-dyyb", "label": "Drug Name: inflectra, Active Ingredient: infliximab-dyyb", "shape": "dot", "size": 20}, {"color": "red", "id": "06/17/2021", "label": "06/17/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125544s018lbl.pdf#page=61", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125544s018lbl.pdf#page=61", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: inpefa, Active Ingredient: sotagliflozin", "label": "Drug Name: inpefa, Active Ingredient: sotagliflozin", "shape": "dot", "size": 20}, {"color": "red", "id": "05/26/2023", "label": "05/26/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216203s000lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216203s000lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: inrebic, Active Ingredient: fedratinib hydrochloride", "label": "Drug Name: inrebic, Active Ingredient: fedratinib hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "05/15/2023", "label": "05/15/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212327s005lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212327s005lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: intermezzo, Active Ingredient: zolpidem tartrate", "label": "Drug Name: intermezzo, Active Ingredient: zolpidem tartrate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022328s008lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022328s008lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: intron a, Active Ingredient: interferon alfa-2b", "label": "Drug Name: intron a, Active Ingredient: interferon alfa-2b", "shape": "dot", "size": 20}, {"color": "red", "id": "11/26/2021", "label": "11/26/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103132s5196lbl.pdf#page=40", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103132s5196lbl.pdf#page=40", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: invirase, Active Ingredient: saquinavir mesylate", "label": "Drug Name: invirase, Active Ingredient: saquinavir mesylate", "shape": "dot", "size": 20}, {"color": "red", "id": "03/28/2019", "label": "03/28/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020628s047,021785s023lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020628s047,021785s023lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "red", "id": "09/18/2020", "label": "09/18/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021785s025lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021785s025lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: invokamet, Active Ingredient: canagliflozin; metformin hydrochloride", "label": "Drug Name: invokamet, Active Ingredient: canagliflozin; metformin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "08/23/2024", "label": "08/23/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204353s045,205879s022lbl.pdf#page=58", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204353s045,205879s022lbl.pdf#page=58", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: invokamet xr, Active Ingredient: canagliflozin; metformin hydrochloride", "label": "Drug Name: invokamet xr, Active Ingredient: canagliflozin; metformin hydrochloride", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: invokana, Active Ingredient: canagliflozin", "label": "Drug Name: invokana, Active Ingredient: canagliflozin", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204042s041s042lbl.pdf#page=48", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204042s041s042lbl.pdf#page=48", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ixifi, Active Ingredient: infliximab-qbtx", "label": "Drug Name: ixifi, Active Ingredient: infliximab-qbtx", "shape": "dot", "size": 20}, {"color": "red", "id": "12/26/2023", "label": "12/26/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761072s009lbl.pdf#page=46", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761072s009lbl.pdf#page=46", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: jadenu, Active Ingredient: deferasirox", "label": "Drug Name: jadenu, Active Ingredient: deferasirox", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206910s015lbl.pdf#page=31", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206910s015lbl.pdf#page=31", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: jadenu sprinkle, Active Ingredient: deferasirox", "label": "Drug Name: jadenu sprinkle, Active Ingredient: deferasirox", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207968s009lbl.pdf#page=31", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207968s009lbl.pdf#page=31", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: janumet, Active Ingredient: metformin hydrochloride; sitagliptin phosphate", "label": "Drug Name: janumet, Active Ingredient: metformin hydrochloride; sitagliptin phosphate", "shape": "dot", "size": 20}, {"color": "red", "id": "06/21/2022", "label": "06/21/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022044s052lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022044s052lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: janumet xr, Active Ingredient: metformin hydrochloride; sitagliptin phosphate", "label": "Drug Name: janumet xr, Active Ingredient: metformin hydrochloride; sitagliptin phosphate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202270s026lbl.pdf#page=34", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202270s026lbl.pdf#page=34", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: januvia, Active Ingredient: sitagliptin phosphate", "label": "Drug Name: januvia, Active Ingredient: sitagliptin phosphate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021995s050lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021995s050lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: jardiance, Active Ingredient: empagliflozin", "label": "Drug Name: jardiance, Active Ingredient: empagliflozin", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204629s040lbl.pdf#page=47", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204629s040lbl.pdf#page=47", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: jemperli, Active Ingredient: dostarlimab-gxly", "label": "Drug Name: jemperli, Active Ingredient: dostarlimab-gxly", "shape": "dot", "size": 20}, {"color": "red", "id": "08/01/2024", "label": "08/01/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761174s009lbl.pdf#page=37", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761174s009lbl.pdf#page=37", "shape": "dot", "size": 10}, {"color": "red", "id": "08/17/2021", "label": "08/17/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761223s000lbl.pdf#page=25", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761223s000lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: jentadueto, Active Ingredient: linagliptin; metformin hydrochloride", "label": "Drug Name: jentadueto, Active Ingredient: linagliptin; metformin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "06/20/2023", "label": "06/20/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201281s035lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201281s035lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: jentadueto xr, Active Ingredient: linagliptin; metformin hydrochloride", "label": "Drug Name: jentadueto xr, Active Ingredient: linagliptin; metformin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208026s024lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208026s024lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: jesduvroq, Active Ingredient: daprodustat", "label": "Drug Name: jesduvroq, Active Ingredient: daprodustat", "shape": "dot", "size": 20}, {"color": "red", "id": "02/01/2023", "label": "02/01/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216951s000lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216951s000lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: jeuveau, Active Ingredient: prabotulinumtoxina-xvfs", "label": "Drug Name: jeuveau, Active Ingredient: prabotulinumtoxina-xvfs", "shape": "dot", "size": 20}, {"color": "red", "id": "07/12/2019", "label": "07/12/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761085s000lbl.pdf#page=9", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761085s000lbl.pdf#page=9", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: jornay pm, Active Ingredient: methylphenidate hydrochloride", "label": "Drug Name: jornay pm, Active Ingredient: methylphenidate hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209311s010lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209311s010lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: juvisync, Active Ingredient: simvastatin; sitagliptin phosphate", "label": "Drug Name: juvisync, Active Ingredient: simvastatin; sitagliptin phosphate", "shape": "dot", "size": 20}, {"color": "red", "id": "02/24/2014", "label": "02/24/2014", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM275945.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM275945.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: juxtapid, Active Ingredient: lomitapide mesylate", "label": "Drug Name: juxtapid, Active Ingredient: lomitapide mesylate", "shape": "dot", "size": 20}, {"color": "red", "id": "05/27/2021", "label": "05/27/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203858s017lbl.pdf#page=32", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203858s017lbl.pdf#page=32", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: jynarque, Active Ingredient: tolvaptan", "label": "Drug Name: jynarque, Active Ingredient: tolvaptan", "shape": "dot", "size": 20}, {"color": "red", "id": "11/25/2020", "label": "11/25/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204441lbl.pdf#page=18", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204441lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: kadian, Active Ingredient: morphine sulfate", "label": "Drug Name: kadian, Active Ingredient: morphine sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020616s065lbl.pdf#page=36", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020616s065lbl.pdf#page=36", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: kalbitor, Active Ingredient: ecallantide", "label": "Drug Name: kalbitor, Active Ingredient: ecallantide", "shape": "dot", "size": 20}, {"color": "red", "id": "12/28/2020", "label": "12/28/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125277s081lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125277s081lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: kaletra, Active Ingredient: lopinavir; ritonavir", "label": "Drug Name: kaletra, Active Ingredient: lopinavir; ritonavir", "shape": "dot", "size": 20}, {"color": "red", "id": "10/21/2020", "label": "10/21/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021251s059,021906s054lbl.pdf#page=53", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021251s059,021906s054lbl.pdf#page=53", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021226s049lbl.pdf#page=53", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021226s049lbl.pdf#page=53", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: kazano, Active Ingredient: alogliptin benzoate; metformin hydrochloride", "label": "Drug Name: kazano, Active Ingredient: alogliptin benzoate; metformin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "07/27/2023", "label": "07/27/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203414s016lbl.pdf#page=32", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203414s016lbl.pdf#page=32", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: keppra, Active Ingredient: levetiracetam", "label": "Drug Name: keppra, Active Ingredient: levetiracetam", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021035s113,021505s052lbl.pdf#page=32", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021035s113,021505s052lbl.pdf#page=32", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: keppra xr, Active Ingredient: levetiracetam", "label": "Drug Name: keppra xr, Active Ingredient: levetiracetam", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022285s034lbl.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022285s034lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: kesimpta, Active Ingredient: ofatumumab", "label": "Drug Name: kesimpta, Active Ingredient: ofatumumab", "shape": "dot", "size": 20}, {"color": "red", "id": "04/12/2024", "label": "04/12/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125326s075lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125326s075lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ketek, Active Ingredient: telithromycin", "label": "Drug Name: ketek, Active Ingredient: telithromycin", "shape": "dot", "size": 20}, {"color": "red", "id": "11/04/2015", "label": "11/04/2015", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021144s019lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021144s019lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: kevzara, Active Ingredient: sarilumab", "label": "Drug Name: kevzara, Active Ingredient: sarilumab", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761037s013lbl.pdf#page=31", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761037s013lbl.pdf#page=31", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: keytruda, Active Ingredient: pembrolizumab", "label": "Drug Name: keytruda, Active Ingredient: pembrolizumab", "shape": "dot", "size": 20}, {"color": "red", "id": "09/17/2024", "label": "09/17/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125514s161lbl.pdf#page=165", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125514s161lbl.pdf#page=165", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: khedezla, Active Ingredient: desvenlafaxine", "label": "Drug Name: khedezla, Active Ingredient: desvenlafaxine", "shape": "dot", "size": 20}, {"color": "red", "id": "09/20/2021", "label": "09/20/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204683s007lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204683s007lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: klonopin, Active Ingredient: clonazepam", "label": "Drug Name: klonopin, Active Ingredient: clonazepam", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017533s062lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017533s062lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: kombiglyze xr, Active Ingredient: metformin hydrochloride; saxagliptin hydrochloride", "label": "Drug Name: kombiglyze xr, Active Ingredient: metformin hydrochloride; saxagliptin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "07/01/2019", "label": "07/01/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200678s024lbl.pdf#page=47", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200678s024lbl.pdf#page=47", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: konvomep, Active Ingredient: omeprazole; sodium bicarbonate", "label": "Drug Name: konvomep, Active Ingredient: omeprazole; sodium bicarbonate", "shape": "dot", "size": 20}, {"color": "red", "id": "08/30/2022", "label": "08/30/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213593s000lbl.pdf#page=28", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213593s000lbl.pdf#page=28", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: korlym, Active Ingredient: mifepristone", "label": "Drug Name: korlym, Active Ingredient: mifepristone", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202107s008lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202107s008lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: krystexxa, Active Ingredient: pegloticase", "label": "Drug Name: krystexxa, Active Ingredient: pegloticase", "shape": "dot", "size": 20}, {"color": "red", "id": "07/07/2022", "label": "07/07/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125293s104lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125293s104lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: kynamro, Active Ingredient: mipomersen sodium", "label": "Drug Name: kynamro, Active Ingredient: mipomersen sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "03/18/2019", "label": "03/18/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM337730.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM337730.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lacosamide, Active Ingredient: lacosamide", "label": "Drug Name: lacosamide, Active Ingredient: lacosamide", "shape": "dot", "size": 20}, {"color": "red", "id": "10/27/2017", "label": "10/27/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LacosamideTabletsCVMedGuide.pdf", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LacosamideTabletsCVMedGuide.pdf", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LACOSAMIDE TABLETSMedGuide.pdf", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LACOSAMIDE TABLETSMedGuide.pdf", "shape": "dot", "size": 10}, {"color": "red", "id": "08/10/2021", "label": "08/10/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LACOSAMIDE ORAL SOLUTIONMed Guide.pdf", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LACOSAMIDE ORAL SOLUTIONMed Guide.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lamictal, Active Ingredient: lamotrigine", "label": "Drug Name: lamictal, Active Ingredient: lamotrigine", "shape": "dot", "size": 20}, {"color": "red", "id": "03/31/2021", "label": "03/31/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020241s064,020764s057,022251s028lbl.pdf#page=65", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020241s064,020764s057,022251s028lbl.pdf#page=65", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lamictal cd, Active Ingredient: lamotrigine", "label": "Drug Name: lamictal cd, Active Ingredient: lamotrigine", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: lamictal odt, Active Ingredient: lamotrigine", "label": "Drug Name: lamictal odt, Active Ingredient: lamotrigine", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: lamictal xr, Active Ingredient: lamotrigine", "label": "Drug Name: lamictal xr, Active Ingredient: lamotrigine", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022115s029lbl.pdf#page=51", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022115s029lbl.pdf#page=51", "shape": "dot", "size": 10}, {"color": "red", "id": "01/29/2010", "label": "01/29/2010", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022509lbl.pdf#page=39", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022509lbl.pdf#page=39", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lamisil, Active Ingredient: terbinafine hydrochloride", "label": "Drug Name: lamisil, Active Ingredient: terbinafine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "03/29/2019", "label": "03/29/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020539s033lbl.pdf#page=11", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020539s033lbl.pdf#page=11", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020539s029,022071s013lbl.pdf#page=10", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020539s029,022071s013lbl.pdf#page=10", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lamivudine, nevirapine and zidovudine, Active Ingredient: lamivudine; nevirapine; zidovudine", "label": "Drug Name: lamivudine, nevirapine and zidovudine, Active Ingredient: lamivudine; nevirapine; zidovudine", "shape": "dot", "size": 20}, {"color": "red", "id": "08/13/2018", "label": "08/13/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205626s000lbl.pdf#page=50", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205626s000lbl.pdf#page=50", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lariam, Active Ingredient: mefloquine hydrochloride", "label": "Drug Name: lariam, Active Ingredient: mefloquine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "04/29/2011", "label": "04/29/2011", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019591s026s028lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019591s026s028lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: latuda, Active Ingredient: lurasidone hydrochloride", "label": "Drug Name: latuda, Active Ingredient: lurasidone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "12/04/2019", "label": "12/04/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200603s035lbl.pdf#page=62", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200603s035lbl.pdf#page=62", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lazanda, Active Ingredient: fentanyl citrate", "label": "Drug Name: lazanda, Active Ingredient: fentanyl citrate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022569s030lbl.pdf#page=35", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022569s030lbl.pdf#page=35", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lemtrada, Active Ingredient: alemtuzumab", "label": "Drug Name: lemtrada, Active Ingredient: alemtuzumab", "shape": "dot", "size": 20}, {"color": "red", "id": "05/20/2024", "label": "05/20/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/103948s5185lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/103948s5185lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: leqembi, Active Ingredient: ecanemab-irmb", "label": "Drug Name: leqembi, Active Ingredient: ecanemab-irmb", "shape": "dot", "size": 20}, {"color": "red", "id": "07/06/2023", "label": "07/06/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761269Orig1s001lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761269Orig1s001lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: letairis, Active Ingredient: ambrisentan", "label": "Drug Name: letairis, Active Ingredient: ambrisentan", "shape": "dot", "size": 20}, {"color": "red", "id": "06/08/2021", "label": "06/08/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022081s041lbl.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022081s041lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: levaquin, Active Ingredient: levofloxacin", "label": "Drug Name: levaquin, Active Ingredient: levofloxacin", "shape": "dot", "size": 20}, {"color": "red", "id": "02/08/2017", "label": "02/08/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020634s068,020635s074,021721s035lbl.pdf#page=59", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020634s068,020635s074,021721s035lbl.pdf#page=59", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020634s073lbl.pdf#page=54", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020634s073lbl.pdf#page=54", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lexapro, Active Ingredient: escitalopram oxalate", "label": "Drug Name: lexapro, Active Ingredient: escitalopram oxalate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021323s057,021365s040lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021323s057,021365s040lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: librax, Active Ingredient: chlordiazepoxide hydrochloride; clidinium bromide", "label": "Drug Name: librax, Active Ingredient: chlordiazepoxide hydrochloride; clidinium bromide", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/012750s068lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/012750s068lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: librium, Active Ingredient: chlordiazepoxide hydrochloride", "label": "Drug Name: librium, Active Ingredient: chlordiazepoxide hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "12/16/2016", "label": "12/16/2016", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/012249s049lbl.pdf#page=8", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/012249s049lbl.pdf#page=8", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: libtayo, Active Ingredient: cemiplimab-rwlc", "label": "Drug Name: libtayo, Active Ingredient: cemiplimab-rwlc", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761097s016lbl.pdf#page=36", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761097s016lbl.pdf#page=36", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: licart, Active Ingredient: diclofenac epolamine", "label": "Drug Name: licart, Active Ingredient: diclofenac epolamine", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/206976s016lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/206976s016lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: limbitrol, Active Ingredient: amitriptyline hydrochloride; chlordiazepoxide", "label": "Drug Name: limbitrol, Active Ingredient: amitriptyline hydrochloride; chlordiazepoxide", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016949s041lbl.pdf#page=14", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016949s041lbl.pdf#page=14", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: limbitrol ds, Active Ingredient: amitriptyline hydrochloride; chlordiazepoxide", "label": "Drug Name: limbitrol ds, Active Ingredient: amitriptyline hydrochloride; chlordiazepoxide", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: lindane, Active Ingredient: lindane", "label": "Drug Name: lindane, Active Ingredient: lindane", "shape": "dot", "size": 20}, {"color": "red", "id": "SHAMPOO;TOPICAL", "label": "SHAMPOO;TOPICAL", "shape": "dot", "size": 10}, {"color": "red", "id": "04/05/2004", "label": "04/05/2004", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LindaneLotionMedGuide.pdf", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LindaneLotionMedGuide.pdf", "shape": "dot", "size": 10}, {"color": "red", "id": "LOTION;TOPICAL", "label": "LOTION;TOPICAL", "shape": "dot", "size": 10}, {"color": "red", "id": "09/04/2001", "label": "09/04/2001", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LindaneShampooMedGuide.pdf", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LindaneShampooMedGuide.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: linzess, Active Ingredient: linaclotide", "label": "Drug Name: linzess, Active Ingredient: linaclotide", "shape": "dot", "size": 20}, {"color": "red", "id": "06/12/2023", "label": "06/12/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202811s021lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202811s021lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lithium carbonate, Active Ingredient: lithium carbonate", "label": "Drug Name: lithium carbonate, Active Ingredient: lithium carbonate", "shape": "dot", "size": 20}, {"color": "red", "id": "10/13/2022", "label": "10/13/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017812s036,018421s035,018558s030lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017812s036,018421s035,018558s030lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lithium citrate, Active Ingredient: lithium citrate", "label": "Drug Name: lithium citrate, Active Ingredient: lithium citrate", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: loqtorzi, Active Ingredient: toripalimab-tpzi", "label": "Drug Name: loqtorzi, Active Ingredient: toripalimab-tpzi", "shape": "dot", "size": 20}, {"color": "red", "id": "04/22/2024", "label": "04/22/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761240s000lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761240s000lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: loreev xr, Active Ingredient: lorazepam", "label": "Drug Name: loreev xr, Active Ingredient: lorazepam", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214826s003lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214826s003lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lotronex, Active Ingredient: alosetron hydrochloride", "label": "Drug Name: lotronex, Active Ingredient: alosetron hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "04/03/2019", "label": "04/03/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088624.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088624.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lumoxiti, Active Ingredient: moxetumomab pasudotox-tdfk", "label": "Drug Name: lumoxiti, Active Ingredient: moxetumomab pasudotox-tdfk", "shape": "dot", "size": 20}, {"color": "red", "id": "08/20/2020", "label": "08/20/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761104s003lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761104s003lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lunesta, Active Ingredient: eszopiclone", "label": "Drug Name: lunesta, Active Ingredient: eszopiclone", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021476Orig1s038rplLBL.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021476Orig1s038rplLBL.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lunsumio, Active Ingredient: mosunetuzumab-axgb", "label": "Drug Name: lunsumio, Active Ingredient: mosunetuzumab-axgb", "shape": "dot", "size": 20}, {"color": "red", "id": "11/22/2024", "label": "11/22/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761263s005lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761263s005lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lupaneta pack, Active Ingredient: leuprolide acetate for depot suspension, norethindrone acetate usp", "label": "Drug Name: lupaneta pack, Active Ingredient: leuprolide acetate for depot suspension, norethindrone acetate usp", "shape": "dot", "size": 20}, {"color": "red", "id": "INJECTABLE;INTRAMUSCULAR; TABLET;ORAL", "label": "INJECTABLE;INTRAMUSCULAR; TABLET;ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "08/09/2023", "label": "08/09/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203696s005s006lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203696s005s006lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lupkynis, Active Ingredient: voclosporin", "label": "Drug Name: lupkynis, Active Ingredient: voclosporin", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213716s000lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213716s000lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lupron, Active Ingredient: leuprolide acetate", "label": "Drug Name: lupron, Active Ingredient: leuprolide acetate", "shape": "dot", "size": 20}, {"color": "red", "id": "12/10/2018", "label": "12/10/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019010s038lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019010s038lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lupron depot-ped kit, Active Ingredient: leuprolide acetate", "label": "Drug Name: lupron depot-ped kit, Active Ingredient: leuprolide acetate", "shape": "dot", "size": 20}, {"color": "red", "id": "POWDER;INTRAMUSCULAR", "label": "POWDER;INTRAMUSCULAR", "shape": "dot", "size": 10}, {"color": "red", "id": "04/14/2023", "label": "04/14/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020263s053lbl.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020263s053lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: luvox, Active Ingredient: fluvoxamine maleate", "label": "Drug Name: luvox, Active Ingredient: fluvoxamine maleate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021519s026lbl.pdf#page=32", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021519s026lbl.pdf#page=32", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: luvox cr, Active Ingredient: fluvoxamine maleate", "label": "Drug Name: luvox cr, Active Ingredient: fluvoxamine maleate", "shape": "dot", "size": 20}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022033s011lbl.pdf#page=26", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022033s011lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lybalvi, Active Ingredient: olanzapine; samidorphan l-malate", "label": "Drug Name: lybalvi, Active Ingredient: olanzapine; samidorphan l-malate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213378s000lbl.pdf#page=40", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213378s000lbl.pdf#page=40", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lynparza, Active Ingredient: olaparib", "label": "Drug Name: lynparza, Active Ingredient: olaparib", "shape": "dot", "size": 20}, {"color": "red", "id": "09/27/2018", "label": "09/27/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206162s011lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206162s011lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "red", "id": "11/06/2023", "label": "11/06/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208558s028lbl.pdf#page=58", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208558s028lbl.pdf#page=58", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lyrica, Active Ingredient: pregabalin", "label": "Drug Name: lyrica, Active Ingredient: pregabalin", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021446s041,022488s018lbl.pdf#page=57", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021446s041,022488s018lbl.pdf#page=57", "shape": "dot", "size": 10}, {"color": "red", "id": "12/13/2023", "label": "12/13/2023", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: lyrica cr, Active Ingredient: pregabalin", "label": "Drug Name: lyrica cr, Active Ingredient: pregabalin", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209501s005lbl.pdf#page=31", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209501s005lbl.pdf#page=31", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: magnevist, Active Ingredient: gadopentetate dimeglumine", "label": "Drug Name: magnevist, Active Ingredient: gadopentetate dimeglumine", "shape": "dot", "size": 20}, {"color": "red", "id": "07/25/2018", "label": "07/25/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019596s064s065lbl.pdf#page=12", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019596s064s065lbl.pdf#page=12", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021037s037s038lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021037s037s038lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: marplan, Active Ingredient: isocarboxazid", "label": "Drug Name: marplan, Active Ingredient: isocarboxazid", "shape": "dot", "size": 20}, {"color": "red", "id": "11/08/2018", "label": "11/08/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/011961s045lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/011961s045lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: mavenclad, Active Ingredient: cladribine", "label": "Drug Name: mavenclad, Active Ingredient: cladribine", "shape": "dot", "size": 20}, {"color": "red", "id": "09/19/2022", "label": "09/19/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022561s006lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022561s006lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: mayzent, Active Ingredient: siponimod fumaric acid", "label": "Drug Name: mayzent, Active Ingredient: siponimod fumaric acid", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209884s016s018lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209884s016s018lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: mektov, Active Ingredient: binimetinib", "label": "Drug Name: mektov, Active Ingredient: binimetinib", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210498s010lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210498s010lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: meridia, Active Ingredient: sibutramine hydrochloride", "label": "Drug Name: meridia, Active Ingredient: sibutramine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "08/04/2010", "label": "08/04/2010", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020632s034s035MedGuide.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020632s034s035MedGuide.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: metadate cd, Active Ingredient: methylphenidate hydrochloride", "label": "Drug Name: metadate cd, Active Ingredient: methylphenidate hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021259s034lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021259s034lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: methylin, Active Ingredient: methylphenidate hydrochloride", "label": "Drug Name: methylin, Active Ingredient: methylphenidate hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021419s023lbl.pdf#page=17", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021419s023lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021475s012lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021475s012lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: metoclopramide hydrochloride, Active Ingredient: metoclopramide hydrochloride", "label": "Drug Name: metoclopramide hydrochloride, Active Ingredient: metoclopramide hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "04/08/2014", "label": "04/08/2014", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM244086.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM244086.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: metozolv odt, Active Ingredient: metoclopramide hydrochloride", "label": "Drug Name: metozolv odt, Active Ingredient: metoclopramide hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "02/28/2019", "label": "02/28/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022246s009lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022246s009lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: mifeprex, Active Ingredient: mifepristone", "label": "Drug Name: mifeprex, Active Ingredient: mifepristone", "shape": "dot", "size": 20}, {"color": "red", "id": "03/23/2023", "label": "03/23/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020687Orig1s026lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020687Orig1s026lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: mircera, Active Ingredient: methoxy polyethylene glycol-epoetin beta", "label": "Drug Name: mircera, Active Ingredient: methoxy polyethylene glycol-epoetin beta", "shape": "dot", "size": 20}, {"color": "red", "id": "SOLUTION; INJECTION", "label": "SOLUTION; INJECTION", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125164s087lblcorretion.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125164s087lblcorretion.pdf#page=23", "shape": "dot", "size": 10}, {"color": "red", "id": "04/13/2023", "label": "04/13/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/126164s087lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/126164s087lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: mitigare, Active Ingredient: colchicine", "label": "Drug Name: mitigare, Active Ingredient: colchicine", "shape": "dot", "size": 20}, {"color": "red", "id": "09/26/2014", "label": "09/26/2014", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204820s000lbl.pdf#page=11", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204820s000lbl.pdf#page=11", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM417495.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM417495.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: mobic, Active Ingredient: meloxicam", "label": "Drug Name: mobic, Active Ingredient: meloxicam", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020938s030lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020938s030lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021530s020lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021530s020lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: morphabond er, Active Ingredient: morphine sulfate", "label": "Drug Name: morphabond er, Active Ingredient: morphine sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206544s012lbl.pdf#page=38", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206544s012lbl.pdf#page=38", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: morphine sulfate, Active Ingredient: morphine sulfate", "label": "Drug Name: morphine sulfate, Active Ingredient: morphine sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201517s018lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201517s018lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022195s021lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022195s021lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022207s011lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022207s011lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: motpoly xr, Active Ingredient: lacosamide", "label": "Drug Name: motpoly xr, Active Ingredient: lacosamide", "shape": "dot", "size": 20}, {"color": "red", "id": "06/07/2024", "label": "06/07/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216185s000lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216185s000lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: motrin, Active Ingredient: ibuprofen", "label": "Drug Name: motrin, Active Ingredient: ibuprofen", "shape": "dot", "size": 20}, {"color": "red", "id": "09/10/2007", "label": "09/10/2007", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/017463s104lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/017463s104lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: mounjaro, Active Ingredient: tirzepatide", "label": "Drug Name: mounjaro, Active Ingredient: tirzepatide", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215866s002s006lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215866s002s006lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: movantik, Active Ingredient: naloxegol oxalate", "label": "Drug Name: movantik, Active Ingredient: naloxegol oxalate", "shape": "dot", "size": 20}, {"color": "red", "id": "04/13/2020", "label": "04/13/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204760s009lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204760s009lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: moviprep, Active Ingredient: ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate", "label": "Drug Name: moviprep, Active Ingredient: ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021881s023lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021881s023lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: moxifloxacin hydrochloride, Active Ingredient: moxifloxacin hydrochloride", "label": "Drug Name: moxifloxacin hydrochloride, Active Ingredient: moxifloxacin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205572s007lbl.pdf#page=49", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205572s007lbl.pdf#page=49", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ms contin, Active Ingredient: morphine sulfate", "label": "Drug Name: ms contin, Active Ingredient: morphine sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019516s058lbl.pdf#page=32", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019516s058lbl.pdf#page=32", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: multaq, Active Ingredient: dronedarone hydrochloride", "label": "Drug Name: multaq, Active Ingredient: dronedarone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "10/23/2023", "label": "10/23/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022425s028s030lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022425s028s030lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: multihance, Active Ingredient: gadobenate dimeglumine", "label": "Drug Name: multihance, Active Ingredient: gadobenate dimeglumine", "shape": "dot", "size": 20}, {"color": "red", "id": "08/14/2024", "label": "08/14/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021357s026,021358s024lbl.pdf#page=36", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021357s026,021358s024lbl.pdf#page=36", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: multihance multipack, Active Ingredient: gadobenate dimeglumine", "label": "Drug Name: multihance multipack, Active Ingredient: gadobenate dimeglumine", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: myalept, Active Ingredient: metreleptin", "label": "Drug Name: myalept, Active Ingredient: metreleptin", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125390s024lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125390s024lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: mydayis, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "label": "Drug Name: mydayis, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022063s005lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022063s005lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: myfortic, Active Ingredient: mycophenolic sodium", "label": "Drug Name: myfortic, Active Ingredient: mycophenolic sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "03/15/2022", "label": "03/15/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050791s035lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050791s035lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: myobloc, Active Ingredient: botulinum toxin type b", "label": "Drug Name: myobloc, Active Ingredient: botulinum toxin type b", "shape": "dot", "size": 20}, {"color": "red", "id": "03/10/2021", "label": "03/10/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103846s5195lbl.pdf#page=17", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103846s5195lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: mysoline, Active Ingredient: primidone", "label": "Drug Name: mysoline, Active Ingredient: primidone", "shape": "dot", "size": 20}, {"color": "red", "id": "06/10/2020", "label": "06/10/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/009170Orig1s040lbl.pdf#page=7", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/009170Orig1s040lbl.pdf#page=7", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: nalfon, Active Ingredient: fenoprofen calcium", "label": "Drug Name: nalfon, Active Ingredient: fenoprofen calcium", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017604s054lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017604s054lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: naprelan, Active Ingredient: naproxen sodium", "label": "Drug Name: naprelan, Active Ingredient: naproxen sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020353s041lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020353s041lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: naprosyn, Active Ingredient: naproxen", "label": "Drug Name: naprosyn, Active Ingredient: naproxen", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018965s028lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018965s028lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: nardil, Active Ingredient: phenelzine sulfate", "label": "Drug Name: nardil, Active Ingredient: phenelzine sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "08/02/2007", "label": "08/02/2007", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088660.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088660.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: natpara, Active Ingredient: parathyroid hormone", "label": "Drug Name: natpara, Active Ingredient: parathyroid hormone", "shape": "dot", "size": 20}, {"color": "red", "id": "07/01/2020", "label": "07/01/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125511s016lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125511s016lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: nayzilam, Active Ingredient: midazolam", "label": "Drug Name: nayzilam, Active Ingredient: midazolam", "shape": "dot", "size": 20}, {"color": "red", "id": "SPRAY;NASAL", "label": "SPRAY;NASAL", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211321s008lbl.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211321s008lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: nesina, Active Ingredient: alogliptin benzoate", "label": "Drug Name: nesina, Active Ingredient: alogliptin benzoate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022271s015lbl.pdf#page=28", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022271s015lbl.pdf#page=28", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: neurontin, Active Ingredient: gabapentin", "label": "Drug Name: neurontin, Active Ingredient: gabapentin", "shape": "dot", "size": 20}, {"color": "red", "id": "12/16/2020", "label": "12/16/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020235s069,020882s050,021129s050lbl.pdf#Page=28", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020235s069,020882s050,021129s050lbl.pdf#Page=28", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: nexium, Active Ingredient: esomeprazole magnesium", "label": "Drug Name: nexium, Active Ingredient: esomeprazole magnesium", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021153s060,021957s027,022101s024lbl.pdf#page=40", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021153s060,021957s027,022101s024lbl.pdf#page=40", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: nizoral, Active Ingredient: ketoconazole", "label": "Drug Name: nizoral, Active Ingredient: ketoconazole", "shape": "dot", "size": 20}, {"color": "red", "id": "07/30/2013", "label": "07/30/2013", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018533s040lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018533s040lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: nocdurna, Active Ingredient: desmopressin acetate", "label": "Drug Name: nocdurna, Active Ingredient: desmopressin acetate", "shape": "dot", "size": 20}, {"color": "red", "id": "06/21/2018", "label": "06/21/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022517s000lbl.pdf#page=14", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022517s000lbl.pdf#page=14", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: noctiva, Active Ingredient: desmopressin acetate", "label": "Drug Name: noctiva, Active Ingredient: desmopressin acetate", "shape": "dot", "size": 20}, {"color": "red", "id": "03/03/2017", "label": "03/03/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/201656lbl.pdf#page=13", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/201656lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: nolvadex, Active Ingredient: tamoxifen citrate", "label": "Drug Name: nolvadex, Active Ingredient: tamoxifen citrate", "shape": "dot", "size": 20}, {"color": "red", "id": "03/13/2009", "label": "03/13/2009", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088661.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088661.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: norco, Active Ingredient: acetaminophen; hydrocodone bitartrate", "label": "Drug Name: norco, Active Ingredient: acetaminophen; hydrocodone bitartrate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/040099s023lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/040099s023lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: noroxin, Active Ingredient: norfloxacin", "label": "Drug Name: noroxin, Active Ingredient: norfloxacin", "shape": "dot", "size": 20}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM246795.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM246795.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: norpramin, Active Ingredient: desipramine hydrochloride", "label": "Drug Name: norpramin, Active Ingredient: desipramine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "11/09/2018", "label": "11/09/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/014399s066s067mg.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/014399s066s067mg.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: novantrone, Active Ingredient: mitoxantrone hydrochloride", "label": "Drug Name: novantrone, Active Ingredient: mitoxantrone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "03/23/2012", "label": "03/23/2012", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019297s035mg.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019297s035mg.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: nplate, Active Ingredient: romiplostim", "label": "Drug Name: nplate, Active Ingredient: romiplostim", "shape": "dot", "size": 20}, {"color": "red", "id": "02/10/2021", "label": "02/10/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125268s167lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125268s167lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: nucynta, Active Ingredient: tapentadol hydrochloride", "label": "Drug Name: nucynta, Active Ingredient: tapentadol hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022304s026lbl.pdf#page=40", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022304s026lbl.pdf#page=40", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203794s011lbl.pdf#page=37", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203794s011lbl.pdf#page=37", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: nucynta er, Active Ingredient: tapentadol hydrochloride", "label": "Drug Name: nucynta er, Active Ingredient: tapentadol hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200533s027lbl.pdf#page=40", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200533s027lbl.pdf#page=40", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: nulojix, Active Ingredient: belatacept", "label": "Drug Name: nulojix, Active Ingredient: belatacept", "shape": "dot", "size": 20}, {"color": "red", "id": "07/28/2021", "label": "07/28/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125288s075lbl.pdf#page=49", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125288s075lbl.pdf#page=49", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: nulytely, Active Ingredient: polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride", "label": "Drug Name: nulytely, Active Ingredient: polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride", "shape": "dot", "size": 20}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM370636.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM370636.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: nulytely-flavored, Active Ingredient: polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride", "label": "Drug Name: nulytely-flavored, Active Ingredient: polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: nuvigil, Active Ingredient: armodafinil", "label": "Drug Name: nuvigil, Active Ingredient: armodafinil", "shape": "dot", "size": 20}, {"color": "red", "id": "02/07/2017", "label": "02/07/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021875s023lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021875s023lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: obredon, Active Ingredient: guaifenesin; hydrocodone bitartrate", "label": "Drug Name: obredon, Active Ingredient: guaifenesin; hydrocodone bitartrate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205474s008lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205474s008lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ocaliva, Active Ingredient: obeticholic acid", "label": "Drug Name: ocaliva, Active Ingredient: obeticholic acid", "shape": "dot", "size": 20}, {"color": "red", "id": "05/26/2021", "label": "05/26/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207999s007lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207999s007lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ocrevus, Active Ingredient: ocrelizumab", "label": "Drug Name: ocrevus, Active Ingredient: ocrelizumab", "shape": "dot", "size": 20}, {"color": "red", "id": "06/21/2024", "label": "06/21/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761053s031lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761053s031lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ocrevus zunovo, Active Ingredient: ocrelizumab and hyaluronidazse-ocsq", "label": "Drug Name: ocrevus zunovo, Active Ingredient: ocrelizumab and hyaluronidazse-ocsq", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761371s000lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761371s000lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: odomzo, Active Ingredient: sonidegib phosphate", "label": "Drug Name: odomzo, Active Ingredient: sonidegib phosphate", "shape": "dot", "size": 20}, {"color": "red", "id": "08/22/2023", "label": "08/22/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205266s009lbl.pdf#page=14", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205266s009lbl.pdf#page=14", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: oleptro, Active Ingredient: trazodone hydrochloride", "label": "Drug Name: oleptro, Active Ingredient: trazodone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "07/17/2014", "label": "07/17/2014", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM202202.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM202202.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: olumiant, Active Ingredient: baricitinib", "label": "Drug Name: olumiant, Active Ingredient: baricitinib", "shape": "dot", "size": 20}, {"color": "red", "id": "05/10/2022", "label": "05/10/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207924s006lbl.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207924s006lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: omniscan, Active Ingredient: gadodiamide", "label": "Drug Name: omniscan, Active Ingredient: gadodiamide", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022066s008lbl.pdf#page=1", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022066s008lbl.pdf#page=1", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020123s046lbl.pdf#page=1", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020123s046lbl.pdf#page=1", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: omontys, Active Ingredient: peginesatide acetate", "label": "Drug Name: omontys, Active Ingredient: peginesatide acetate", "shape": "dot", "size": 20}, {"color": "red", "id": "12/04/2012", "label": "12/04/2012", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202799s001lbl.pdf#page=15", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202799s001lbl.pdf#page=15", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: omvoh, Active Ingredient: mirikizumab-mrkz", "label": "Drug Name: omvoh, Active Ingredient: mirikizumab-mrkz", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761279s000lbl.pdf#page=15", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761279s000lbl.pdf#page=15", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: onfi, Active Ingredient: clobazam", "label": "Drug Name: onfi, Active Ingredient: clobazam", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202067s007,203993s009lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202067s007,203993s009lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: onglyza, Active Ingredient: saxagliptin hydrochloride", "label": "Drug Name: onglyza, Active Ingredient: saxagliptin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022350s023lbl.pdf#page=31", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022350s023lbl.pdf#page=31", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: onsolis, Active Ingredient: fentanyl citrate", "label": "Drug Name: onsolis, Active Ingredient: fentanyl citrate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022266s025lbl.pdf#page=32", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022266s025lbl.pdf#page=32", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: opana, Active Ingredient: oxymorphone hydrochloride", "label": "Drug Name: opana, Active Ingredient: oxymorphone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "10/25/2019", "label": "10/25/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021611s016lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021611s016lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: opana er, Active Ingredient: oxymorphone hydrochloride", "label": "Drug Name: opana er, Active Ingredient: oxymorphone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021610s031lbl.pdf#page=32", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021610s031lbl.pdf#page=32", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201655s026lbl.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201655s026lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: opdivo, Active Ingredient: nivolumab", "label": "Drug Name: opdivo, Active Ingredient: nivolumab", "shape": "dot", "size": 20}, {"color": "red", "id": "10/03/2024", "label": "10/03/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125554s127lbl.pdf#page=166", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125554s127lbl.pdf#page=166", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: opsumit, Active Ingredient: macitentan", "label": "Drug Name: opsumit, Active Ingredient: macitentan", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204410s024lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204410s024lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: optimark, Active Ingredient: gadoversetamide", "label": "Drug Name: optimark, Active Ingredient: gadoversetamide", "shape": "dot", "size": 20}, {"color": "red", "id": "11/02/2018", "label": "11/02/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020937s028,020975s029,020976s030lbl.pdf#page=14", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020937s028,020975s029,020976s030lbl.pdf#page=14", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020975s028lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020975s028lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: optimark in plastic container, Active Ingredient: gadoversetamide", "label": "Drug Name: optimark in plastic container, Active Ingredient: gadoversetamide", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020976s029lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020976s029lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: opzelura, Active Ingredient: ruxolitinib phosphate", "label": "Drug Name: opzelura, Active Ingredient: ruxolitinib phosphate", "shape": "dot", "size": 20}, {"color": "red", "id": "03/13/2023", "label": "03/13/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215309s004lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215309s004lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: oriahnn (copackaged), Active Ingredient: elagolix sodium,estradiol,norethindrone acetate; elagolix sodium", "label": "Drug Name: oriahnn (copackaged), Active Ingredient: elagolix sodium,estradiol,norethindrone acetate; elagolix sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "05/29/2023", "label": "05/29/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213388s003lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213388s003lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: orilissa, Active Ingredient: elagolix sodium", "label": "Drug Name: orilissa, Active Ingredient: elagolix sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "06/05/2023", "label": "06/05/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210450s009lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210450s009lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: oseni, Active Ingredient: alogliptin benzoate; pioglitazone hydrochloride", "label": "Drug Name: oseni, Active Ingredient: alogliptin benzoate; pioglitazone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022426s012lbl.pdf#page=43", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022426s012lbl.pdf#page=43", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: osmoprep, Active Ingredient: sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate", "label": "Drug Name: osmoprep, Active Ingredient: sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate", "shape": "dot", "size": 20}, {"color": "red", "id": "11/29/2018", "label": "11/29/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021892s014lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021892s014lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: otulfi, Active Ingredient: ustekinumab-aauz", "label": "Drug Name: otulfi, Active Ingredient: ustekinumab-aauz", "shape": "dot", "size": 20}, {"color": "red", "id": "09/27/2024", "label": "09/27/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761379s000lbl.pdf#page=36", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761379s000lbl.pdf#page=36", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: oxaydo, Active Ingredient: oxycodone hydrochloride", "label": "Drug Name: oxaydo, Active Ingredient: oxycodone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202080s013lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202080s013lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: oxtellar xr, Active Ingredient: oxcarbazepine", "label": "Drug Name: oxtellar xr, Active Ingredient: oxcarbazepine", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202810s020lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202810s020lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: oxycodone hydrochloride, Active Ingredient: oxycodone hydrochloride", "label": "Drug Name: oxycodone hydrochloride, Active Ingredient: oxycodone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200535s022lbl.pdf#page=35", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200535s022lbl.pdf#page=35", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201194s017lbl.pdf#page=34", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201194s017lbl.pdf#page=34", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: oxycodone hydrochloride capsules, Active Ingredient: oxycodone hydrochloride", "label": "Drug Name: oxycodone hydrochloride capsules, Active Ingredient: oxycodone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200534s013lbl.pdf#page=32", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200534s013lbl.pdf#page=32", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: oxycontin, Active Ingredient: oxycodone hydrochloride", "label": "Drug Name: oxycontin, Active Ingredient: oxycodone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022272s048lbl.pdf#page=49", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022272s048lbl.pdf#page=49", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: oxymorphone hydrochloride, Active Ingredient: oxymorphone hydrochloride", "label": "Drug Name: oxymorphone hydrochloride, Active Ingredient: oxymorphone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/079046s000mg.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/079046s000mg.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ozempic, Active Ingredient: semaglutide", "label": "Drug Name: ozempic, Active Ingredient: semaglutide", "shape": "dot", "size": 20}, {"color": "red", "id": "10/06/2022", "label": "10/06/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209637s012lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209637s012lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: pacerone, Active Ingredient: amiodarone hydrochloride", "label": "Drug Name: pacerone, Active Ingredient: amiodarone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "11/01/2019", "label": "11/01/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088668.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088668.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: palladone, Active Ingredient: hydromorphone hydrochloride", "label": "Drug Name: palladone, Active Ingredient: hydromorphone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "04/16/2014", "label": "04/16/2014", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088670.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088670.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: palynziq, Active Ingredient: pegvaliase-pqpz", "label": "Drug Name: palynziq, Active Ingredient: pegvaliase-pqpz", "shape": "dot", "size": 20}, {"color": "red", "id": "11/20/2020", "label": "11/20/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761079s000lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761079s000lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: pamelor, Active Ingredient: nortriptyline hydrochloride", "label": "Drug Name: pamelor, Active Ingredient: nortriptyline hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "07/28/2014", "label": "07/28/2014", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088671.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088671.pdf", "shape": "dot", "size": 10}, {"color": "red", "id": "04/09/2019", "label": "04/09/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018013s064lbl.pdf#page=15", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018013s064lbl.pdf#page=15", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: pancreaze, Active Ingredient: pancrelipase (amylase;lipase;protease)", "label": "Drug Name: pancreaze, Active Ingredient: pancrelipase (amylase;lipase;protease)", "shape": "dot", "size": 20}, {"color": "red", "id": "02/28/2024", "label": "02/28/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022523s013lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022523s013lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: parnate, Active Ingredient: tranylcypromine sulfate", "label": "Drug Name: parnate, Active Ingredient: tranylcypromine sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "01/04/2018", "label": "01/04/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012342s064lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012342s064lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: paxil, Active Ingredient: paroxetine hydrochloride", "label": "Drug Name: paxil, Active Ingredient: paroxetine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020031s083,020710s051lbl.pdf#page=39", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020031s083,020710s051lbl.pdf#page=39", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: paxil cr, Active Ingredient: paroxetine hydrochloride", "label": "Drug Name: paxil cr, Active Ingredient: paroxetine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "02/23/2024", "label": "02/23/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020936s057s064lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020936s057s064lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: peganone, Active Ingredient: ethotoin", "label": "Drug Name: peganone, Active Ingredient: ethotoin", "shape": "dot", "size": 20}, {"color": "red", "id": "02/27/2017", "label": "02/27/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/010841s022MedGuide.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/010841s022MedGuide.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: pegasys, Active Ingredient: peginterferon alfa-2a", "label": "Drug Name: pegasys, Active Ingredient: peginterferon alfa-2a", "shape": "dot", "size": 20}, {"color": "red", "id": "12/11/2023", "label": "12/11/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103964s5276lbl.pdf#page=37", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103964s5276lbl.pdf#page=37", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: pegintron, Active Ingredient: peginterferon alfa-2b", "label": "Drug Name: pegintron, Active Ingredient: peginterferon alfa-2b", "shape": "dot", "size": 20}, {"color": "red", "id": "12/21/2018", "label": "12/21/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103949s5313lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103949s5313lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: pennsaid, Active Ingredient: diclofenac sodium", "label": "Drug Name: pennsaid, Active Ingredient: diclofenac sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "SOLUTION;TOPICAL", "label": "SOLUTION;TOPICAL", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM191085.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM191085.pdf", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204623s013lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204623s013lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: percocet, Active Ingredient: acetaminophen; oxycodone hydrochloride", "label": "Drug Name: percocet, Active Ingredient: acetaminophen; oxycodone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/040330s052lbl.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/040330s052lbl.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: percodan, Active Ingredient: aspirin; oxycodone hydrochloride; oxycodone terephthalate", "label": "Drug Name: percodan, Active Ingredient: aspirin; oxycodone hydrochloride; oxycodone terephthalate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/007337s057lbl.pdf", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/007337s057lbl.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: percodan, Active Ingredient: aspirin; oxycodone hydrochloride", "label": "Drug Name: percodan, Active Ingredient: aspirin; oxycodone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/007337s053lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/007337s053lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: perforomist, Active Ingredient: formoterol fumarate", "label": "Drug Name: perforomist, Active Ingredient: formoterol fumarate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022007s014lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022007s014lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: pertzye, Active Ingredient: pancrelipase (amylase;lipase;protease)", "label": "Drug Name: pertzye, Active Ingredient: pancrelipase (amylase;lipase;protease)", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022175s008lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022175s008lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: pexeva, Active Ingredient: paroxetine mesylate", "label": "Drug Name: pexeva, Active Ingredient: paroxetine mesylate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021299s035s038lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021299s035s038lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: phenergan vc w/ codeine, Active Ingredient: codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride", "label": "Drug Name: phenergan vc w/ codeine, Active Ingredient: codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/008306s035lbl.pdf#page=66", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/008306s035lbl.pdf#page=66", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: phenergan w/ codeine, Active Ingredient: codeine phosphate; promethazine hydrochloride", "label": "Drug Name: phenergan w/ codeine, Active Ingredient: codeine phosphate; promethazine hydrochloride", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: plavix, Active Ingredient: clopidogrel bisulfate", "label": "Drug Name: plavix, Active Ingredient: clopidogrel bisulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "03/01/2021", "label": "03/01/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020839s074lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020839s074lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: plegridy, Active Ingredient: peginterferon beta-1a", "label": "Drug Name: plegridy, Active Ingredient: peginterferon beta-1a", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125499s028lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125499s028lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: plenvu, Active Ingredient: ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate", "label": "Drug Name: plenvu, Active Ingredient: ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "09/08/2023", "label": "09/08/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209381s013lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209381s013lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: pomalyst, Active Ingredient: pomalidomide", "label": "Drug Name: pomalyst, Active Ingredient: pomalidomide", "shape": "dot", "size": 20}, {"color": "red", "id": "03/24/2023", "label": "03/24/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204026s031lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204026s031lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ponstel, Active Ingredient: mefenamic acid", "label": "Drug Name: ponstel, Active Ingredient: mefenamic acid", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/015034s046lbl.pdf", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/015034s046lbl.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ponvory, Active Ingredient: ponesimod", "label": "Drug Name: ponvory, Active Ingredient: ponesimod", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213498s004lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213498s004lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: potiga, Active Ingredient: ezogabine", "label": "Drug Name: potiga, Active Ingredient: ezogabine", "shape": "dot", "size": 20}, {"color": "red", "id": "05/20/2016", "label": "05/20/2016", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM259619.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM259619.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: pradaxa, Active Ingredient: dabigatran etexilate mesylate", "label": "Drug Name: pradaxa, Active Ingredient: dabigatran etexilate mesylate", "shape": "dot", "size": 20}, {"color": "red", "id": "11/17/2023", "label": "11/17/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022512s047lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022512s047lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "red", "id": "PELLETS;ORAL", "label": "PELLETS;ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "11/14/2023", "label": "11/14/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214358s007lbl.pdf#page=14", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214358s007lbl.pdf#page=14", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: prepopik, Active Ingredient: citric acid; magnesium oxide; sodium picosulfate", "label": "Drug Name: prepopik, Active Ingredient: citric acid; magnesium oxide; sodium picosulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202535s006lbl.pdf#page=15", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202535s006lbl.pdf#page=15", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: pretomanid, Active Ingredient: pretomanid", "label": "Drug Name: pretomanid, Active Ingredient: pretomanid", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/212862s008lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/212862s008lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: prevacid, Active Ingredient: lansoprazole", "label": "Drug Name: prevacid, Active Ingredient: lansoprazole", "shape": "dot", "size": 20}, {"color": "red", "id": "08/08/2023", "label": "08/08/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020406s095,021428s042lbl.pdf#page=45", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020406s095,021428s042lbl.pdf#page=45", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: prevacid naprapac 250 (copackaged), Active Ingredient: lansoprazole; naproxen", "label": "Drug Name: prevacid naprapac 250 (copackaged), Active Ingredient: lansoprazole; naproxen", "shape": "dot", "size": 20}, {"color": "red", "id": "DELAYED REL PELLETS", "label": "DELAYED REL PELLETS", "shape": "dot", "size": 10}, {"color": "red", "id": "07/31/2009", "label": "07/31/2009", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088694.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088694.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: prevacid naprapac 375 (copackaged), Active Ingredient: lansoprazole; naproxen", "label": "Drug Name: prevacid naprapac 375 (copackaged), Active Ingredient: lansoprazole; naproxen", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: prevacid naprapac 500 (copackaged), Active Ingredient: lansoprazole; naproxen", "label": "Drug Name: prevacid naprapac 500 (copackaged), Active Ingredient: lansoprazole; naproxen", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: priftin, Active Ingredient: rifapentine", "label": "Drug Name: priftin, Active Ingredient: rifapentine", "shape": "dot", "size": 20}, {"color": "red", "id": "07/01/2015", "label": "07/01/2015", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021024s017s018lbl.pdf#page=28", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021024s017s018lbl.pdf#page=28", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: prilosec, Active Ingredient: omeprazole magnesium", "label": "Drug Name: prilosec, Active Ingredient: omeprazole magnesium", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022056s026lbl.pdf#page=34", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022056s026lbl.pdf#page=34", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: prilosec, Active Ingredient: omeprazole", "label": "Drug Name: prilosec, Active Ingredient: omeprazole", "shape": "dot", "size": 20}, {"color": "red", "id": "12/19/2016", "label": "12/19/2016", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019810s103,022056s020lbl.pdf#page=34", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019810s103,022056s020lbl.pdf#page=34", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: pristiq, Active Ingredient: desvenlafaxine succinate", "label": "Drug Name: pristiq, Active Ingredient: desvenlafaxine succinate", "shape": "dot", "size": 20}, {"color": "red", "id": "11/10/2021", "label": "11/10/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021992s047lbl.pdf#page=36", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021992s047lbl.pdf#page=36", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: probuphine, Active Ingredient: buprenorphine hydrochloride", "label": "Drug Name: probuphine, Active Ingredient: buprenorphine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "IMPLANT;IMPLANTATION", "label": "IMPLANT;IMPLANTATION", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204442s014lbl.pdf#page=47", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204442s014lbl.pdf#page=47", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: procrit, Active Ingredient: epoetin alfa", "label": "Drug Name: procrit, Active Ingredient: epoetin alfa", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.fda.gov/media/73511/download", "label": "https://www.fda.gov/media/73511/download", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: prohance, Active Ingredient: gadoteridol", "label": "Drug Name: prohance, Active Ingredient: gadoteridol", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020131s042,021489s023lbl.pdf#page=32", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020131s042,021489s023lbl.pdf#page=32", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: prohance multipack, Active Ingredient: gadoteridol", "label": "Drug Name: prohance multipack, Active Ingredient: gadoteridol", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: prolia, Active Ingredient: denosumab", "label": "Drug Name: prolia, Active Ingredient: denosumab", "shape": "dot", "size": 20}, {"color": "red", "id": "01/03/2023", "label": "01/03/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125320s211lbl.pdf#page=31", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125320s211lbl.pdf#page=31", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: promacta, Active Ingredient: eltrombopag olamine", "label": "Drug Name: promacta, Active Ingredient: eltrombopag olamine", "shape": "dot", "size": 20}, {"color": "red", "id": "03/09/2023", "label": "03/09/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022291s037,207027s017lbl.pdf#page=35", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022291s037,207027s017lbl.pdf#page=35", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: promacta kit, Active Ingredient: eltrombopag olamine", "label": "Drug Name: promacta kit, Active Ingredient: eltrombopag olamine", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: propulsid, Active Ingredient: cisapride monohydrate", "label": "Drug Name: propulsid, Active Ingredient: cisapride monohydrate", "shape": "dot", "size": 20}, {"color": "red", "id": "03/06/2000", "label": "03/06/2000", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Propulsid.pdf", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Propulsid.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: propylthiouracil, Active Ingredient: propylthiouracil", "label": "Drug Name: propylthiouracil, Active Ingredient: propylthiouracil", "shape": "dot", "size": 20}, {"color": "red", "id": "09/19/2018", "label": "09/19/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/006188s026lbl.pdf#page=7", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/006188s026lbl.pdf#page=7", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: proquin xr, Active Ingredient: ciprofloxacin hydrochloride", "label": "Drug Name: proquin xr, Active Ingredient: ciprofloxacin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "08/15/2011", "label": "08/15/2011", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Proquin XR.pdf", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Proquin XR.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: protonix, Active Ingredient: pantoprazole sodium", "label": "Drug Name: protonix, Active Ingredient: pantoprazole sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020987s060,022020s023lbl.pdf#page=31", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020987s060,022020s023lbl.pdf#page=31", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: protopic, Active Ingredient: tacrolimus", "label": "Drug Name: protopic, Active Ingredient: tacrolimus", "shape": "dot", "size": 20}, {"color": "red", "id": "OINTMENT;TOPICAL", "label": "OINTMENT;TOPICAL", "shape": "dot", "size": 10}, {"color": "red", "id": "02/25/2019", "label": "02/25/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088996.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088996.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: provigil, Active Ingredient: modafinil", "label": "Drug Name: provigil, Active Ingredient: modafinil", "shape": "dot", "size": 20}, {"color": "red", "id": "01/15/2015", "label": "01/15/2015", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020717s030s034s036MedGuide.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020717s030s034s036MedGuide.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: prozac, Active Ingredient: fluoxetine hydrochloride", "label": "Drug Name: prozac, Active Ingredient: fluoxetine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018936 s112lbl.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018936 s112lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: prozac weekly, Active Ingredient: fluoxetine hydrochloride", "label": "Drug Name: prozac weekly, Active Ingredient: fluoxetine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "03/24/2017", "label": "03/24/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018936s103,021235s023lbl.pdf#page=28", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018936s103,021235s023lbl.pdf#page=28", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: qdolo, Active Ingredient: tramadol hydrochloride", "label": "Drug Name: qdolo, Active Ingredient: tramadol hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214044s002lbl.pdf#page=28", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214044s002lbl.pdf#page=28", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: qelbree, Active Ingredient: viloxazine hydrochloride", "label": "Drug Name: qelbree, Active Ingredient: viloxazine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "04/29/2022", "label": "04/29/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211964s003lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211964s003lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: qmiiz odt, Active Ingredient: meloxicam", "label": "Drug Name: qmiiz odt, Active Ingredient: meloxicam", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211210s002lbl.pdf#page=37", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211210s002lbl.pdf#page=37", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: qsymia, Active Ingredient: phentermine hydrochloride; topiramate", "label": "Drug Name: qsymia, Active Ingredient: phentermine hydrochloride; topiramate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022580s025lbl.pdf#page=43", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022580s025lbl.pdf#page=43", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: qtern, Active Ingredient: dapagliflozin; saxagliptin hydrochloride", "label": "Drug Name: qtern, Active Ingredient: dapagliflozin; saxagliptin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209091s008lbl.pdf#page=37", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209091s008lbl.pdf#page=37", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: qternmet xr, Active Ingredient: dapagliflozin; metformin hydrochloride; saxagliptin hydrochloride", "label": "Drug Name: qternmet xr, Active Ingredient: dapagliflozin; metformin hydrochloride; saxagliptin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "01/24/2020", "label": "01/24/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210874s003lbl.pdf#page=47", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210874s003lbl.pdf#page=47", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: qualaquin, Active Ingredient: quinine sulfate", "label": "Drug Name: qualaquin, Active Ingredient: quinine sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "06/19/2019", "label": "06/19/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021799s029lbl.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021799s029lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: qudexy xr, Active Ingredient: topiramate", "label": "Drug Name: qudexy xr, Active Ingredient: topiramate", "shape": "dot", "size": 20}, {"color": "red", "id": "03/28/2024", "label": "03/28/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205122s014lbl.pdf#page=54", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205122s014lbl.pdf#page=54", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: quillichew er, Active Ingredient: methylphenidate hydrochloride", "label": "Drug Name: quillichew er, Active Ingredient: methylphenidate hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "EXTENDED RELEASE", "label": "EXTENDED RELEASE", "shape": "dot", "size": 10}, {"color": "red", "id": "06/25/2021", "label": "06/25/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207960s012lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207960s012lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: quillivant xr, Active Ingredient: methylphenidate hydrochloride", "label": "Drug Name: quillivant xr, Active Ingredient: methylphenidate hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202100s018lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202100s018lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: quviviq, Active Ingredient: daridorexant", "label": "Drug Name: quviviq, Active Ingredient: daridorexant", "shape": "dot", "size": 20}, {"color": "red", "id": "09/30/2024", "label": "09/30/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214985s010s012lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214985s010s012lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: raldesy, Active Ingredient: trazodone hydrochloride, usp", "label": "Drug Name: raldesy, Active Ingredient: trazodone hydrochloride, usp", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218637s000lbl.pdf#page=12", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218637s000lbl.pdf#page=12", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: rapamune, Active Ingredient: sirolimus", "label": "Drug Name: rapamune, Active Ingredient: sirolimus", "shape": "dot", "size": 20}, {"color": "red", "id": "01/02/2020", "label": "01/02/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021083s067,021110s085lbl.pdf#page=43", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021083s067,021110s085lbl.pdf#page=43", "shape": "dot", "size": 10}, {"color": "red", "id": "08/09/2021", "label": "08/09/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021110s086lbl.pdf#page=43", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021110s086lbl.pdf#page=43", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ravicti, Active Ingredient: glycerol phenylbutyrate", "label": "Drug Name: ravicti, Active Ingredient: glycerol phenylbutyrate", "shape": "dot", "size": 20}, {"color": "red", "id": "LIQUID;ORAL", "label": "LIQUID;ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "09/03/2021", "label": "09/03/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203284s012lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203284s012lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: rebetol, Active Ingredient: ribavirin", "label": "Drug Name: rebetol, Active Ingredient: ribavirin", "shape": "dot", "size": 20}, {"color": "red", "id": "03/16/2022", "label": "03/16/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020903s057,021546s013lbl.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020903s057,021546s013lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: rebif, Active Ingredient: interferon beta-1a", "label": "Drug Name: rebif, Active Ingredient: interferon beta-1a", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103780s5214lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103780s5214lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: reclast, Active Ingredient: zoledronic acid", "label": "Drug Name: reclast, Active Ingredient: zoledronic acid", "shape": "dot", "size": 20}, {"color": "red", "id": "04/29/2020", "label": "04/29/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021817s028lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021817s028lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: recorlev, Active Ingredient: levoketoconazole", "label": "Drug Name: recorlev, Active Ingredient: levoketoconazole", "shape": "dot", "size": 20}, {"color": "red", "id": "08/16/2023", "label": "08/16/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214133s003lbl.pdf#page=3", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214133s003lbl.pdf#page=3", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: reglan, Active Ingredient: metoclopramide hydrochloride", "label": "Drug Name: reglan, Active Ingredient: metoclopramide hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "08/29/2017", "label": "08/29/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM235574.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM235574.pdf", "shape": "dot", "size": 10}, {"color": "red", "id": "11/18/2010", "label": "11/18/2010", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/017862s063MedGuide.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/017862s063MedGuide.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: reglan odt, Active Ingredient: metoclopramide hydrochloride", "label": "Drug Name: reglan odt, Active Ingredient: metoclopramide hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "11/30/2011", "label": "11/30/2011", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021793s011mg.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021793s011mg.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: regranex, Active Ingredient: becaplermin", "label": "Drug Name: regranex, Active Ingredient: becaplermin", "shape": "dot", "size": 20}, {"color": "red", "id": "GEL; TOPICAL", "label": "GEL; TOPICAL", "shape": "dot", "size": 10}, {"color": "red", "id": "08/26/2019", "label": "08/26/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103691s5138lbl.pdf#page=8", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103691s5138lbl.pdf#page=8", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: relexxii, Active Ingredient: methylphenidate hydrochloride", "label": "Drug Name: relexxii, Active Ingredient: methylphenidate hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216117s001lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216117s001lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: relistor, Active Ingredient: methylnaltrexone bromide", "label": "Drug Name: relistor, Active Ingredient: methylnaltrexone bromide", "shape": "dot", "size": 20}, {"color": "red", "id": "03/14/2018", "label": "03/14/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021964s019,208271s003lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021964s019,208271s003lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: remeron, Active Ingredient: mirtazapine", "label": "Drug Name: remeron, Active Ingredient: mirtazapine", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020415s038,021208s028lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020415s038,021208s028lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: remeron soltab, Active Ingredient: mirtazapine", "label": "Drug Name: remeron soltab, Active Ingredient: mirtazapine", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: remicade, Active Ingredient: infliximab", "label": "Drug Name: remicade, Active Ingredient: infliximab", "shape": "dot", "size": 20}, {"color": "red", "id": "10/05/2021", "label": "10/05/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103772s5401lbl.pdf#page=50", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103772s5401lbl.pdf#page=50", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: renflexis, Active Ingredient: infliximab-abda", "label": "Drug Name: renflexis, Active Ingredient: infliximab-abda", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761054s021lbl.pdf#page=55", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761054s021lbl.pdf#page=55", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: restoril, Active Ingredient: temazepam", "label": "Drug Name: restoril, Active Ingredient: temazepam", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018163s071lbl.pdf#page=17", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018163s071lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: retacrit, Active Ingredient: epoetin alfa-epbx", "label": "Drug Name: retacrit, Active Ingredient: epoetin alfa-epbx", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125545s005lbl.pdf#page=31", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125545s005lbl.pdf#page=31", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: revlimid, Active Ingredient: lenalidomide", "label": "Drug Name: revlimid, Active Ingredient: lenalidomide", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021880s067lbl.pdf#page=48", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021880s067lbl.pdf#page=48", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: rexulti, Active Ingredient: brexpiprazole", "label": "Drug Name: rexulti, Active Ingredient: brexpiprazole", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205422s009lbl.pdf#page=36", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205422s009lbl.pdf#page=36", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: reyvow, Active Ingredient: lasmiditan succinate", "label": "Drug Name: reyvow, Active Ingredient: lasmiditan succinate", "shape": "dot", "size": 20}, {"color": "red", "id": "09/15/2022", "label": "09/15/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211280s008lbl.pdf#page=15", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211280s008lbl.pdf#page=15", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: rezira, Active Ingredient: hydrocodone bitartrate; pseudoephedrine hydrochloride", "label": "Drug Name: rezira, Active Ingredient: hydrocodone bitartrate; pseudoephedrine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "06/28/2018", "label": "06/28/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022442s010lbl.pdf#page=26", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022442s010lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: riabni, Active Ingredient: rituximab-arrx", "label": "Drug Name: riabni, Active Ingredient: rituximab-arrx", "shape": "dot", "size": 20}, {"color": "red", "id": "06/03/2022", "label": "06/03/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761140s001lbl.pdf#page=41", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761140s001lbl.pdf#page=41", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: rinvoq, Active Ingredient: upadacitinib", "label": "Drug Name: rinvoq, Active Ingredient: upadacitinib", "shape": "dot", "size": 20}, {"color": "red", "id": "04/26/2024", "label": "04/26/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211675s019lbl.pdf#page=72", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211675s019lbl.pdf#page=72", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ritalin, Active Ingredient: methylphenidate hydrochloride", "label": "Drug Name: ritalin, Active Ingredient: methylphenidate hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/010187s092s096lbl.pdf#page18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/010187s092s096lbl.pdf#page18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ritalin la, Active Ingredient: methylphenidate hydrochloride", "label": "Drug Name: ritalin la, Active Ingredient: methylphenidate hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021284s042s046lbl.pdf#page18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021284s042s046lbl.pdf#page18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ritalin-sr, Active Ingredient: methylphenidate hydrochloride", "label": "Drug Name: ritalin-sr, Active Ingredient: methylphenidate hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "11/19/2019", "label": "11/19/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010187s091,018029s059lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010187s091,018029s059lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: rituxan, Active Ingredient: rituximab", "label": "Drug Name: rituxan, Active Ingredient: rituximab", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103705s5465lbl.pdf#page=56", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103705s5465lbl.pdf#page=56", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: rituxan hycela, Active Ingredient: rituximab; hyaluronidase (human recombinant)", "label": "Drug Name: rituxan hycela, Active Ingredient: rituximab; hyaluronidase (human recombinant)", "shape": "dot", "size": 20}, {"color": "red", "id": "06/10/2021", "label": "06/10/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761064s013lbl.pdf#page=28", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761064s013lbl.pdf#page=28", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: roxicodone, Active Ingredient: oxycodone hydrochloride", "label": "Drug Name: roxicodone, Active Ingredient: oxycodone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021011s013lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021011s013lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: roxybond, Active Ingredient: oxycodone hydrochloride", "label": "Drug Name: roxybond, Active Ingredient: oxycodone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209777s008lbl.pdf#page=38", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209777s008lbl.pdf#page=38", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: rozerem, Active Ingredient: ramelteon", "label": "Drug Name: rozerem, Active Ingredient: ramelteon", "shape": "dot", "size": 20}, {"color": "red", "id": "11/03/2021", "label": "11/03/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021782s022lbl.pdf#page=17", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021782s022lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ruxience, Active Ingredient: rituximab-pvvr", "label": "Drug Name: ruxience, Active Ingredient: rituximab-pvvr", "shape": "dot", "size": 20}, {"color": "red", "id": "10/16/2023", "label": "10/16/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761103s011lbl.pdf#page=42", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761103s011lbl.pdf#page=42", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ruzurgi, Active Ingredient: amifampridine", "label": "Drug Name: ruzurgi, Active Ingredient: amifampridine", "shape": "dot", "size": 20}, {"color": "red", "id": "08/21/2020", "label": "08/21/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209321s000lbl.pdf#page=15", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209321s000lbl.pdf#page=15", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: rybelsus, Active Ingredient: semaglutide", "label": "Drug Name: rybelsus, Active Ingredient: semaglutide", "shape": "dot", "size": 20}, {"color": "red", "id": "01/24/2024", "label": "01/24/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213051s012lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213051s012lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "red", "id": "01/16/2020", "label": "01/16/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213182s000,213051s001lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213182s000,213051s001lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: sabril, Active Ingredient: vigabatrin", "label": "Drug Name: sabril, Active Ingredient: vigabatrin", "shape": "dot", "size": 20}, {"color": "red", "id": "10/20/2021", "label": "10/20/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020427s025,022006s026lbl.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020427s025,022006s026lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: samsca, Active Ingredient: tolvaptan", "label": "Drug Name: samsca, Active Ingredient: tolvaptan", "shape": "dot", "size": 20}, {"color": "red", "id": "04/22/2021", "label": "04/22/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022275s017lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022275s017lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: sarafem, Active Ingredient: fluoxetine hydrochloride", "label": "Drug Name: sarafem, Active Ingredient: fluoxetine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021860s015lbl.pdf#page=32", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021860s015lbl.pdf#page=32", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: savaysa, Active Ingredient: edoxaban tosylate", "label": "Drug Name: savaysa, Active Ingredient: edoxaban tosylate", "shape": "dot", "size": 20}, {"color": "red", "id": "10/18/2023", "label": "10/18/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206316s019lbl.pdf#page=35", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206316s019lbl.pdf#page=35", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: savella, Active Ingredient: milnacipran hydrochloride", "label": "Drug Name: savella, Active Ingredient: milnacipran hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "05/22/2024", "label": "05/22/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022256s028lbl.pdf#page=31", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022256s028lbl.pdf#page=31", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: saxenda, Active Ingredient: liraglutide recombinant", "label": "Drug Name: saxenda, Active Ingredient: liraglutide recombinant", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206321s016lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206321s016lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: seglentis, Active Ingredient: celecoxib; tramadol hydrochloride", "label": "Drug Name: seglentis, Active Ingredient: celecoxib; tramadol hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213426s003lbl.pdf#page=57", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213426s003lbl.pdf#page=57", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: segluromet, Active Ingredient: ertugliflozin; metformin hydrochloride", "label": "Drug Name: segluromet, Active Ingredient: ertugliflozin; metformin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209806s010lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209806s010lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: selzentry, Active Ingredient: maraviroc", "label": "Drug Name: selzentry, Active Ingredient: maraviroc", "shape": "dot", "size": 20}, {"color": "red", "id": "10/30/2020", "label": "10/30/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022128s019,208984s002lbl.pdf#page=43", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022128s019,208984s002lbl.pdf#page=43", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: serevent, Active Ingredient: salmeterol xinafoate", "label": "Drug Name: serevent, Active Ingredient: salmeterol xinafoate", "shape": "dot", "size": 20}, {"color": "red", "id": "07/22/2019", "label": "07/22/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020692s047lbl.pdf#page=35", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020692s047lbl.pdf#page=35", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: seroquel, Active Ingredient: quetiapine fumarate", "label": "Drug Name: seroquel, Active Ingredient: quetiapine fumarate", "shape": "dot", "size": 20}, {"color": "red", "id": "01/31/2022", "label": "01/31/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020639s072lbl.pdf#page=49", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020639s072lbl.pdf#page=49", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: seroquel xr, Active Ingredient: quetiapine fumarate", "label": "Drug Name: seroquel xr, Active Ingredient: quetiapine fumarate", "shape": "dot", "size": 20}, {"color": "red", "id": "01/28/2022", "label": "01/28/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022047s046lbl.pdf#page=53", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022047s046lbl.pdf#page=53", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: sertraline, Active Ingredient: sertraline hydrochloride", "label": "Drug Name: sertraline, Active Ingredient: sertraline hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215133s001lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215133s001lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: signifor, Active Ingredient: pasireotide diaspartate", "label": "Drug Name: signifor, Active Ingredient: pasireotide diaspartate", "shape": "dot", "size": 20}, {"color": "red", "id": "01/15/2020", "label": "01/15/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/200677s006lbl.pdf#page=15", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/200677s006lbl.pdf#page=15", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: siklos, Active Ingredient: hydroxyurea", "label": "Drug Name: siklos, Active Ingredient: hydroxyurea", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208843s004lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208843s004lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: silenor, Active Ingredient: doxepin hydrochloride", "label": "Drug Name: silenor, Active Ingredient: doxepin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "10/29/2020", "label": "10/29/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022036s006lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022036s006lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: siliq, Active Ingredient: brodalumab", "label": "Drug Name: siliq, Active Ingredient: brodalumab", "shape": "dot", "size": 20}, {"color": "red", "id": "08/12/2024", "label": "08/12/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761032s014lbl.pdf#page=14", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761032s014lbl.pdf#page=14", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: simponi, Active Ingredient: golimumab", "label": "Drug Name: simponi, Active Ingredient: golimumab", "shape": "dot", "size": 20}, {"color": "red", "id": "09/24/2019", "label": "09/24/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125289s146lbl.pdf#page=38", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125289s146lbl.pdf#page=38", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: simponi aria, Active Ingredient: golimumab", "label": "Drug Name: simponi aria, Active Ingredient: golimumab", "shape": "dot", "size": 20}, {"color": "red", "id": "02/01/2021", "label": "02/01/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125433s032lbl.pdf#page=34", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125433s032lbl.pdf#page=34", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: sinequan, Active Ingredient: doxepin hydrochloride", "label": "Drug Name: sinequan, Active Ingredient: doxepin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "07/14/2014", "label": "07/14/2014", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089129.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089129.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: singulair, Active Ingredient: montelukast sodium", "label": "Drug Name: singulair, Active Ingredient: montelukast sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "02/22/2021", "label": "02/22/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s0760,021409s052lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s0760,021409s052lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s076,021409s052lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s076,021409s052lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: sirturo, Active Ingredient: bedaquiline fumarate", "label": "Drug Name: sirturo, Active Ingredient: bedaquiline fumarate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204384s017lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204384s017lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: skyrizi, Active Ingredient: risankizumab-rzaa", "label": "Drug Name: skyrizi, Active Ingredient: risankizumab-rzaa", "shape": "dot", "size": 20}, {"color": "red", "id": "06/18/2024", "label": "06/18/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761262s001lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761262s001lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761105s018lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761105s018lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: sodium oxybate, Active Ingredient: sodium oxybate", "label": "Drug Name: sodium oxybate, Active Ingredient: sodium oxybate", "shape": "dot", "size": 20}, {"color": "red", "id": "01/03/2022", "label": "01/03/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202090lbl.pdf#page=18", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202090lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: sohonos, Active Ingredient: paloverotene", "label": "Drug Name: sohonos, Active Ingredient: paloverotene", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215559s000lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215559s000lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: solaraze, Active Ingredient: diclofenac sodium", "label": "Drug Name: solaraze, Active Ingredient: diclofenac sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "GEL;TOPICAL", "label": "GEL;TOPICAL", "shape": "dot", "size": 10}, {"color": "red", "id": "11/14/2022", "label": "11/14/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021005s024lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021005s024lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM501655.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM501655.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: soliqua 100/33, Active Ingredient: insulin glargine; lixisenatide", "label": "Drug Name: soliqua 100/33, Active Ingredient: insulin glargine; lixisenatide", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208673s013lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208673s013lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: soliris, Active Ingredient: eculizumab", "label": "Drug Name: soliris, Active Ingredient: eculizumab", "shape": "dot", "size": 20}, {"color": "red", "id": "INJECTABLE; IV (INFUSION)", "label": "INJECTABLE; IV (INFUSION)", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125166s431lbl.pdf#page=40", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125166s431lbl.pdf#page=40", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: soltamox, Active Ingredient: tamoxifen citrate", "label": "Drug Name: soltamox, Active Ingredient: tamoxifen citrate", "shape": "dot", "size": 20}, {"color": "red", "id": "04/08/2019", "label": "04/08/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021807s006lbl.pdf#page=36", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021807s006lbl.pdf#page=36", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: sonata, Active Ingredient: zaleplon", "label": "Drug Name: sonata, Active Ingredient: zaleplon", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020859s016lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020859s016lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: soriatane, Active Ingredient: acitretin", "label": "Drug Name: soriatane, Active Ingredient: acitretin", "shape": "dot", "size": 20}, {"color": "red", "id": "02/22/2023", "label": "02/22/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019821s029lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019821s029lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: sotret, Active Ingredient: isotretinoin", "label": "Drug Name: sotret, Active Ingredient: isotretinoin", "shape": "dot", "size": 20}, {"color": "red", "id": "04/12/2012", "label": "04/12/2012", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Sotret.pdf", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Sotret.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: sotyktu, Active Ingredient: deucravacitinib", "label": "Drug Name: sotyktu, Active Ingredient: deucravacitinib", "shape": "dot", "size": 20}, {"color": "red", "id": "09/09/2022", "label": "09/09/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214958s000lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214958s000lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: spevigo, Active Ingredient: spesolimab-sbzo", "label": "Drug Name: spevigo, Active Ingredient: spesolimab-sbzo", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761244s000lbl.pdf#page=11", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761244s000lbl.pdf#page=11", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: spravato, Active Ingredient: esketamine hydrochloride", "label": "Drug Name: spravato, Active Ingredient: esketamine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211243s012lbl.pdf#page=43", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211243s012lbl.pdf#page=43", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: spritam, Active Ingredient: levetiracetam", "label": "Drug Name: spritam, Active Ingredient: levetiracetam", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207958s023lbl.pdf#page=36", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207958s023lbl.pdf#page=36", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: sprix, Active Ingredient: ketorolac tromethamine", "label": "Drug Name: sprix, Active Ingredient: ketorolac tromethamine", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022382s022lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022382s022lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: stavzor, Active Ingredient: valproic acid", "label": "Drug Name: stavzor, Active Ingredient: valproic acid", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022152s009lbl.pdf#page=42", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022152s009lbl.pdf#page=42", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: steglatro, Active Ingredient: ertugliflozin", "label": "Drug Name: steglatro, Active Ingredient: ertugliflozin", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209803s007lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209803s007lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: steglujan, Active Ingredient: ertugliflozin; sitagliptin phosphate", "label": "Drug Name: steglujan, Active Ingredient: ertugliflozin; sitagliptin phosphate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209805s016lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209805s016lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: stelara, Active Ingredient: ustekinumab", "label": "Drug Name: stelara, Active Ingredient: ustekinumab", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761044s009lbl.pdf#page=37", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761044s009lbl.pdf#page=37", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125261s158,761044s009lbl.pdf#page=36", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125261s158,761044s009lbl.pdf#page=36", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: strattera, Active Ingredient: atomoxetine hydrochloride", "label": "Drug Name: strattera, Active Ingredient: atomoxetine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "01/06/2022", "label": "01/06/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021411s050lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021411s050lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: striverdi respimat, Active Ingredient: olodaterol hydrochloride", "label": "Drug Name: striverdi respimat, Active Ingredient: olodaterol hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "METERED;INHALATION", "label": "METERED;INHALATION", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/striverdi respimatMedGuide2016.pdf", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/striverdi respimatMedGuide2016.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: sublocade, Active Ingredient: buprenorphine", "label": "Drug Name: sublocade, Active Ingredient: buprenorphine", "shape": "dot", "size": 20}, {"color": "red", "id": "09/22/2021", "label": "09/22/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209819s018lbl.pdf#page=45", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209819s018lbl.pdf#page=45", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: suboxone, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "label": "Drug Name: suboxone, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022410s046s047lbl.pdf#page=35", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022410s046s047lbl.pdf#page=35", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020733s031s032lbl.pdf#page=32", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020733s031s032lbl.pdf#page=32", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: subsys, Active Ingredient: fentanyl", "label": "Drug Name: subsys, Active Ingredient: fentanyl", "shape": "dot", "size": 20}, {"color": "red", "id": "SPRAY;SUBLINGUAL", "label": "SPRAY;SUBLINGUAL", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202788s023lbl.pdf#page=40", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202788s023lbl.pdf#page=40", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: subutex, Active Ingredient: buprenorphine hydrochloride", "label": "Drug Name: subutex, Active Ingredient: buprenorphine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020732s027s028lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020732s027s028lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: suclear, Active Ingredient: magnesium sulfate; polyethylene glycol 3350; potassium chloride; potassium sulfate; sodium bicarbonate; sodium chloride; sodium sulfate", "label": "Drug Name: suclear, Active Ingredient: magnesium sulfate; polyethylene glycol 3350; potassium chloride; potassium sulfate; sodium bicarbonate; sodium chloride; sodium sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "08/15/2013", "label": "08/15/2013", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203595s000lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203595s000lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: suflave, Active Ingredient: polyethylene glycol 3350; sodium sulfate; potassium chloride; magnesium sulfate; sodium chloride", "label": "Drug Name: suflave, Active Ingredient: polyethylene glycol 3350; sodium sulfate; potassium chloride; magnesium sulfate; sodium chloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215344s000lbl.pdf#page=14", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215344s000lbl.pdf#page=14", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: sunosi, Active Ingredient: solriamfetol hydrochloride", "label": "Drug Name: sunosi, Active Ingredient: solriamfetol hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211230s009lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211230s009lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: supprelin la, Active Ingredient: histrelin acetate", "label": "Drug Name: supprelin la, Active Ingredient: histrelin acetate", "shape": "dot", "size": 20}, {"color": "red", "id": "IMPLANT;SUBCUTANEOUS", "label": "IMPLANT;SUBCUTANEOUS", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022058s017lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022058s017lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: suprep bowel prep kit, Active Ingredient: magnesium sulfate; potassium sulfate; sodium sulfate", "label": "Drug Name: suprep bowel prep kit, Active Ingredient: magnesium sulfate; potassium sulfate; sodium sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "08/05/2020", "label": "08/05/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022372s013lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022372s013lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: surmontil, Active Ingredient: trimipramine maleate", "label": "Drug Name: surmontil, Active Ingredient: trimipramine maleate", "shape": "dot", "size": 20}, {"color": "red", "id": "09/30/2014", "label": "09/30/2014", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/016792s037lbl.pdf#page=12", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/016792s037lbl.pdf#page=12", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: sustol, Active Ingredient: granisetron", "label": "Drug Name: sustol, Active Ingredient: granisetron", "shape": "dot", "size": 20}, {"color": "red", "id": "05/25/2023", "label": "05/25/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022445s010lbl.pdf#page=17", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022445s010lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: sutab, Active Ingredient: magnesium sulfate; potassium chloride; sodium sulfate", "label": "Drug Name: sutab, Active Ingredient: magnesium sulfate; potassium chloride; sodium sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "10/24/2023", "label": "10/24/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213135s004lbl.pdf#page=15", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213135s004lbl.pdf#page=15", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: sutent, Active Ingredient: sunitinib malate", "label": "Drug Name: sutent, Active Ingredient: sunitinib malate", "shape": "dot", "size": 20}, {"color": "red", "id": "08/30/2021", "label": "08/30/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021938s039lbledt.pdf#page=34", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021938s039lbledt.pdf#page=34", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: sylatron, Active Ingredient: peginterferon alfa-2b", "label": "Drug Name: sylatron, Active Ingredient: peginterferon alfa-2b", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103949s5312lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103949s5312lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: symbyax, Active Ingredient: fluoxetine hydrochloride; olanzapine", "label": "Drug Name: symbyax, Active Ingredient: fluoxetine hydrochloride; olanzapine", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021520s055lbl.pdf#page=42", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021520s055lbl.pdf#page=42", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: symlin, Active Ingredient: pramlintide acetate", "label": "Drug Name: symlin, Active Ingredient: pramlintide acetate", "shape": "dot", "size": 20}, {"color": "red", "id": "12/18/2019", "label": "12/18/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089141.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089141.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: sympazan, Active Ingredient: clobazam", "label": "Drug Name: sympazan, Active Ingredient: clobazam", "shape": "dot", "size": 20}, {"color": "red", "id": "FILM;ORAL", "label": "FILM;ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210833s004lbl.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210833s004lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: symproic, Active Ingredient: naldemedine tosylate", "label": "Drug Name: symproic, Active Ingredient: naldemedine tosylate", "shape": "dot", "size": 20}, {"color": "red", "id": "01/24/2018", "label": "01/24/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208854s002lbl.pdf#page=13", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208854s002lbl.pdf#page=13", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: synalgos-dc, Active Ingredient: aspirin; caffeine; dihydrocodeine bitartrate", "label": "Drug Name: synalgos-dc, Active Ingredient: aspirin; caffeine; dihydrocodeine bitartrate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/011483s037lbl.pdf", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/011483s037lbl.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: synarel, Active Ingredient: nafarelin acetate", "label": "Drug Name: synarel, Active Ingredient: nafarelin acetate", "shape": "dot", "size": 20}, {"color": "red", "id": "01/31/2023", "label": "01/31/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019886s039lbl.pdf#page=28", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019886s039lbl.pdf#page=28", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: synjardy, Active Ingredient: empagliflozin; metformin hydrochloride", "label": "Drug Name: synjardy, Active Ingredient: empagliflozin; metformin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206111s042,208658s028lbl.pdf#page=44", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206111s042,208658s028lbl.pdf#page=44", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: synjardy xr, Active Ingredient: empagliflozin; metformin hydrochloride", "label": "Drug Name: synjardy xr, Active Ingredient: empagliflozin; metformin hydrochloride", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: synribo, Active Ingredient: omacetaxine mepesuccinate", "label": "Drug Name: synribo, Active Ingredient: omacetaxine mepesuccinate", "shape": "dot", "size": 20}, {"color": "red", "id": "05/12/2021", "label": "05/12/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203585Orig1s008lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203585Orig1s008lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tafinlar, Active Ingredient: dabrafenib mesylate", "label": "Drug Name: tafinlar, Active Ingredient: dabrafenib mesylate", "shape": "dot", "size": 20}, {"color": "red", "id": "03/29/2024", "label": "03/29/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202806s027lbl.pdf#page=46", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202806s027lbl.pdf#page=46", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tafinlar, Active Ingredient: dabrafenib", "label": "Drug Name: tafinlar, Active Ingredient: dabrafenib", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217514s000lbl.pdf#page=46", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217514s000lbl.pdf#page=46", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: taltz, Active Ingredient: ixekizumab", "label": "Drug Name: taltz, Active Ingredient: ixekizumab", "shape": "dot", "size": 20}, {"color": "red", "id": "07/27/2022", "label": "07/27/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125521s024lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125521s024lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: talvey, Active Ingredient: talquetamab-tgvs", "label": "Drug Name: talvey, Active Ingredient: talquetamab-tgvs", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761342s000lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761342s000lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tanzeum, Active Ingredient: albiglutide", "label": "Drug Name: tanzeum, Active Ingredient: albiglutide", "shape": "dot", "size": 20}, {"color": "red", "id": "12/20/2017", "label": "12/20/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125431s019lbl.pdf#page=36", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125431s019lbl.pdf#page=36", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: targiniq, Active Ingredient: naloxone hydrochloride; oxycodone hydrochloride", "label": "Drug Name: targiniq, Active Ingredient: naloxone hydrochloride; oxycodone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "09/18/2018", "label": "09/18/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205777s010s011lbl.pdf#page=47", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205777s010s011lbl.pdf#page=47", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tasigna, Active Ingredient: nilotinib hydrochloride", "label": "Drug Name: tasigna, Active Ingredient: nilotinib hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022068s035s036lbl.pdf#page=36", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022068s035s036lbl.pdf#page=36", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tavneos, Active Ingredient: avacopan", "label": "Drug Name: tavneos, Active Ingredient: avacopan", "shape": "dot", "size": 20}, {"color": "red", "id": "06/03/2024", "label": "06/03/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214487s000lbl.pdf#page=17", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214487s000lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tazverik, Active Ingredient: tazemetostat hydrobromide", "label": "Drug Name: tazverik, Active Ingredient: tazemetostat hydrobromide", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211723s004lbl.pdf#page=17", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211723s004lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "red", "id": "06/18/2020", "label": "06/18/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213400s000lbl.pdf#page=17", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213400s000lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tecentriq, Active Ingredient: atezolizumab", "label": "Drug Name: tecentriq, Active Ingredient: atezolizumab", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761034s049s051lbl.pdf#page=62", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761034s049s051lbl.pdf#page=62", "shape": "dot", "size": 10}, {"color": "red", "id": "10/18/2016", "label": "10/18/2016", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761041s000lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761041s000lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: technivie, Active Ingredient: ombitasvir; paritaprevir; ritonavir", "label": "Drug Name: technivie, Active Ingredient: ombitasvir; paritaprevir; ritonavir", "shape": "dot", "size": 20}, {"color": "red", "id": "12/06/2019", "label": "12/06/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207931s013lbl.pdf#page=39", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207931s013lbl.pdf#page=39", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tecvayli, Active Ingredient: teclistamab-cqyv", "label": "Drug Name: tecvayli, Active Ingredient: teclistamab-cqyv", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761291s009lbl.pdf#page=28", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761291s009lbl.pdf#page=28", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tegretol, Active Ingredient: carbamazepine", "label": "Drug Name: tegretol, Active Ingredient: carbamazepine", "shape": "dot", "size": 20}, {"color": "red", "id": "09/13/2023", "label": "09/13/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016608s121_018927s60_020234s054lbl.pdf#page=19", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016608s121_018927s60_020234s054lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "red", "id": "03/20/2018", "label": "03/20/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016608s115_018281_s058_018927s055_020234_s047.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016608s115_018281_s058_018927s055_020234_s047.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tegretol-xr, Active Ingredient: carbamazepine", "label": "Drug Name: tegretol-xr, Active Ingredient: carbamazepine", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: tegsedi, Active Ingredient: inotersen sodium", "label": "Drug Name: tegsedi, Active Ingredient: inotersen sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "01/12/2024", "label": "01/12/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211172s010lbl.pdf#page=28", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211172s010lbl.pdf#page=28", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: testim, Active Ingredient: testosterone", "label": "Drug Name: testim, Active Ingredient: testosterone", "shape": "dot", "size": 20}, {"color": "red", "id": "08/20/2021", "label": "08/20/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021454s030s031lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021454s030s031lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: testosterone, Active Ingredient: testosterone", "label": "Drug Name: testosterone, Active Ingredient: testosterone", "shape": "dot", "size": 20}, {"color": "red", "id": "10/25/2016", "label": "10/25/2016", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202763s000mg.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202763s000mg.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: testosterone cypionate injection, Active Ingredient: testosterone cypionate", "label": "Drug Name: testosterone cypionate injection, Active Ingredient: testosterone cypionate", "shape": "dot", "size": 20}, {"color": "red", "id": "02/01/2024", "label": "02/01/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216318Orig1s002lbl.pdf#page=14", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216318Orig1s002lbl.pdf#page=14", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: thalomid, Active Ingredient: thalidomide", "label": "Drug Name: thalomid, Active Ingredient: thalidomide", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020785s071lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020785s071lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tibsovo, Active Ingredient: ivosidenib", "label": "Drug Name: tibsovo, Active Ingredient: ivosidenib", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211192s011lbl.pdf#page=38", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211192s011lbl.pdf#page=38", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tikosyn, Active Ingredient: dofetilide", "label": "Drug Name: tikosyn, Active Ingredient: dofetilide", "shape": "dot", "size": 20}, {"color": "red", "id": "08/08/2019", "label": "08/08/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020931s017lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020931s017lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tivdak, Active Ingredient: tisotumab vedotin-tftv", "label": "Drug Name: tivdak, Active Ingredient: tisotumab vedotin-tftv", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761208s005lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761208s005lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tivorbex, Active Ingredient: indomethacin", "label": "Drug Name: tivorbex, Active Ingredient: indomethacin", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204768s008lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204768s008lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tofidence, Active Ingredient: tocilizumab-bavi", "label": "Drug Name: tofidence, Active Ingredient: tocilizumab-bavi", "shape": "dot", "size": 20}, {"color": "red", "id": "12/03/2024", "label": "12/03/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761354s004lbl.pdf#page=55", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761354s004lbl.pdf#page=55", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tofranil, Active Ingredient: imipramine hydrochloride", "label": "Drug Name: tofranil, Active Ingredient: imipramine hydrochloride", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: tofranil-pm, Active Ingredient: imipramine pamoate", "label": "Drug Name: tofranil-pm, Active Ingredient: imipramine pamoate", "shape": "dot", "size": 20}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM326090.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM326090.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tolectin, Active Ingredient: tolmetin sodium", "label": "Drug Name: tolectin, Active Ingredient: tolmetin sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "01/22/2008", "label": "01/22/2008", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089162.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089162.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tolectin 600, Active Ingredient: tolmetin sodium", "label": "Drug Name: tolectin 600, Active Ingredient: tolmetin sodium", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: tolectin ds, Active Ingredient: tolmetin sodium", "label": "Drug Name: tolectin ds, Active Ingredient: tolmetin sodium", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: topamax, Active Ingredient: topiramate", "label": "Drug Name: topamax, Active Ingredient: topiramate", "shape": "dot", "size": 20}, {"color": "red", "id": "05/03/2023", "label": "05/03/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020505s065,020844s056lbl.pdf#page=56", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020505s065,020844s056lbl.pdf#page=56", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: topamax sprinkle, Active Ingredient: topiramate", "label": "Drug Name: topamax sprinkle, Active Ingredient: topiramate", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: toradol, Active Ingredient: ketorolac tromethamine", "label": "Drug Name: toradol, Active Ingredient: ketorolac tromethamine", "shape": "dot", "size": 20}, {"color": "red", "id": "03/26/2013", "label": "03/26/2013", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019645s019lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019645s019lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tracleer, Active Ingredient: bosentan", "label": "Drug Name: tracleer, Active Ingredient: bosentan", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021290s039,209279s005lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021290s039,209279s005lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tradjenta, Active Ingredient: linagliptin", "label": "Drug Name: tradjenta, Active Ingredient: linagliptin", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201280s027lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201280s027lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tranxene, Active Ingredient: clorazepate dipotassium", "label": "Drug Name: tranxene, Active Ingredient: clorazepate dipotassium", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017105s085lbl.pdf#page=14", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017105s085lbl.pdf#page=14", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tranxene sd, Active Ingredient: clorazepate dipotassium", "label": "Drug Name: tranxene sd, Active Ingredient: clorazepate dipotassium", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: trazodone hydrochloride, Active Ingredient: trazodone hydrochloride", "label": "Drug Name: trazodone hydrochloride, Active Ingredient: trazodone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "04/20/2020", "label": "04/20/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/071196s062lbl.pdf#page=3", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/071196s062lbl.pdf#page=3", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: trelegy ellipta, Active Ingredient: fluticasone furoate; umeclidinium bromide; vilanterol trifenatate", "label": "Drug Name: trelegy ellipta, Active Ingredient: fluticasone furoate; umeclidinium bromide; vilanterol trifenatate", "shape": "dot", "size": 20}, {"color": "red", "id": "06/02/2023", "label": "06/02/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209482s000lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209482s000lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tremfya, Active Ingredient: guselkumab", "label": "Drug Name: tremfya, Active Ingredient: guselkumab", "shape": "dot", "size": 20}, {"color": "red", "id": "06/29/2023", "label": "06/29/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761061s009lbl.pdf#page=15", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761061s009lbl.pdf#page=15", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: treximet, Active Ingredient: naproxen sodium; sumatriptan succinate", "label": "Drug Name: treximet, Active Ingredient: naproxen sodium; sumatriptan succinate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021926s019lbl.pdf#page=32", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021926s019lbl.pdf#page=32", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tridione, Active Ingredient: trimethadione", "label": "Drug Name: tridione, Active Ingredient: trimethadione", "shape": "dot", "size": 20}, {"color": "red", "id": "06/07/2016", "label": "06/07/2016", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM308402.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM308402.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: trijardy xr, Active Ingredient: empagliflozin; linagliptin; metformin hydrochloride", "label": "Drug Name: trijardy xr, Active Ingredient: empagliflozin; linagliptin; metformin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212614s020lbl.pdf#page=44", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212614s020lbl.pdf#page=44", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: trileptal, Active Ingredient: oxcarbazepine", "label": "Drug Name: trileptal, Active Ingredient: oxcarbazepine", "shape": "dot", "size": 20}, {"color": "red", "id": "01/04/2019", "label": "01/04/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021014s042,021285s035lbl.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021014s042,021285s035lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: trintellix, Active Ingredient: vortioxetine hydrobromide", "label": "Drug Name: trintellix, Active Ingredient: vortioxetine hydrobromide", "shape": "dot", "size": 20}, {"color": "red", "id": "08/23/2023", "label": "08/23/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204447s026lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204447s026lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: triptodur kit, Active Ingredient: triptorelin pamoate", "label": "Drug Name: triptodur kit, Active Ingredient: triptorelin pamoate", "shape": "dot", "size": 20}, {"color": "red", "id": "12/07/2022", "label": "12/07/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208956s010lbl.pdf#page=12", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208956s010lbl.pdf#page=12", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: triumeq, Active Ingredient: abacavir sulfate; dolutegravir sodium; lamivudine", "label": "Drug Name: triumeq, Active Ingredient: abacavir sulfate; dolutegravir sodium; lamivudine", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205551s31,215413s02lbl.pdf#page=56", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205551s31,215413s02lbl.pdf#page=56", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: triumeq pd, Active Ingredient: abacavir sulfate; dolutegravir sodium; lamivudine", "label": "Drug Name: triumeq pd, Active Ingredient: abacavir sulfate; dolutegravir sodium; lamivudine", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: trizivir, Active Ingredient: abacavir sulfate; lamivudine; zidovudine", "label": "Drug Name: trizivir, Active Ingredient: abacavir sulfate; lamivudine; zidovudine", "shape": "dot", "size": 20}, {"color": "red", "id": "02/17/2021", "label": "02/17/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021205s038lbl.pdf#page=34", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021205s038lbl.pdf#page=34", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: trokendi xr, Active Ingredient: topiramate", "label": "Drug Name: trokendi xr, Active Ingredient: topiramate", "shape": "dot", "size": 20}, {"color": "red", "id": "01/04/2024", "label": "01/04/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201635s030lbl.pdf#page=52", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201635s030lbl.pdf#page=52", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: troxyca er, Active Ingredient: naltrexone hydrochloride; oxycodone hydrochloride", "label": "Drug Name: troxyca er, Active Ingredient: naltrexone hydrochloride; oxycodone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "05/26/2017", "label": "05/26/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207621s004lbl.pdf#page=32", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207621s004lbl.pdf#page=32", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: trudhesa, Active Ingredient: dihydroergotamine mesylate", "label": "Drug Name: trudhesa, Active Ingredient: dihydroergotamine mesylate", "shape": "dot", "size": 20}, {"color": "red", "id": "09/02/2021", "label": "09/02/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213436s000lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213436s000lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: trulance, Active Ingredient: plecanatide", "label": "Drug Name: trulance, Active Ingredient: plecanatide", "shape": "dot", "size": 20}, {"color": "red", "id": "04/13/2021", "label": "04/13/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208745s011lbl.pdf#page=15", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208745s011lbl.pdf#page=15", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: trulicity, Active Ingredient: dulaglutide", "label": "Drug Name: trulicity, Active Ingredient: dulaglutide", "shape": "dot", "size": 20}, {"color": "red", "id": "11/17/2022", "label": "11/17/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125469s051lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125469s051lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: truvada, Active Ingredient: emtricitabine; tenofovir disoproxil fumarate", "label": "Drug Name: truvada, Active Ingredient: emtricitabine; tenofovir disoproxil fumarate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021752Orig1s063lbl.pdf#page=35", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021752Orig1s063lbl.pdf#page=35", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: truxima, Active Ingredient: rituximab-abbs", "label": "Drug Name: truxima, Active Ingredient: rituximab-abbs", "shape": "dot", "size": 20}, {"color": "red", "id": "02/04/2022", "label": "02/04/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761088s018lbl.pdf#page=49", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761088s018lbl.pdf#page=49", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: turalio, Active Ingredient: pexidartinib hydrochloride", "label": "Drug Name: turalio, Active Ingredient: pexidartinib hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211810s012lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211810s012lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tussionex pennkinetic, Active Ingredient: chlorpheniramine polistirex; hydrocodone polistirex", "label": "Drug Name: tussionex pennkinetic, Active Ingredient: chlorpheniramine polistirex; hydrocodone polistirex", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019111s022lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019111s022lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tuxarin er, Active Ingredient: chlorpheniramine maleate; codeine phosphate", "label": "Drug Name: tuxarin er, Active Ingredient: chlorpheniramine maleate; codeine phosphate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206323s008lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206323s008lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tuzistra xr, Active Ingredient: chlorpheniramine polistirex; codeine polistirex", "label": "Drug Name: tuzistra xr, Active Ingredient: chlorpheniramine polistirex; codeine polistirex", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207768s013lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207768s013lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tyenne, Active Ingredient: tocilizumab--aazg", "label": "Drug Name: tyenne, Active Ingredient: tocilizumab--aazg", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761275s011lbl.pdf#page=46", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761275s011lbl.pdf#page=46", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tymlos, Active Ingredient: abaloparatide", "label": "Drug Name: tymlos, Active Ingredient: abaloparatide", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208743s009lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208743s009lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tysabri, Active Ingredient: natalizumab", "label": "Drug Name: tysabri, Active Ingredient: natalizumab", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125104s976s979lbl.pdf#page=32", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125104s976s979lbl.pdf#page=32", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: tyzeka, Active Ingredient: telbivudine", "label": "Drug Name: tyzeka, Active Ingredient: telbivudine", "shape": "dot", "size": 20}, {"color": "red", "id": "12/27/2018", "label": "12/27/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022011s022,022154s019lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022011s022,022154s019lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ukoniq, Active Ingredient: umbralisib tosylate", "label": "Drug Name: ukoniq, Active Ingredient: umbralisib tosylate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213176s000lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213176s000lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: uloric, Active Ingredient: febuxostat", "label": "Drug Name: uloric, Active Ingredient: febuxostat", "shape": "dot", "size": 20}, {"color": "red", "id": "04/17/2023", "label": "04/17/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021856s015lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021856s015lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ultomiris, Active Ingredient: ravulizumab-cwvz", "label": "Drug Name: ultomiris, Active Ingredient: ravulizumab-cwvz", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761108s023lbl.pdf#page=41", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761108s023lbl.pdf#page=41", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ultracet, Active Ingredient: acetaminophen; tramadol hydrochloride", "label": "Drug Name: ultracet, Active Ingredient: acetaminophen; tramadol hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "02/13/2023", "label": "02/13/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021123s015lbl.pdf#page=46", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021123s015lbl.pdf#page=46", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ultram, Active Ingredient: tramadol hydrochloride", "label": "Drug Name: ultram, Active Ingredient: tramadol hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020281s040lbl.pdf#page=42", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020281s040lbl.pdf#page=42", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ultram er, Active Ingredient: tramadol hydrochloride", "label": "Drug Name: ultram er, Active Ingredient: tramadol hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021692s015lbl.pdf#page=36", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021692s015lbl.pdf#page=36", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: uplizna, Active Ingredient: inebilizumab-cdon", "label": "Drug Name: uplizna, Active Ingredient: inebilizumab-cdon", "shape": "dot", "size": 20}, {"color": "red", "id": "06/11/2020", "label": "06/11/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761142s000lbl.pdf#page=17", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761142s000lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: valchlor, Active Ingredient: mechlorethamine hydrochloride", "label": "Drug Name: valchlor, Active Ingredient: mechlorethamine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "05/01/2020", "label": "05/01/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202317s009lbl.pdf#page=10", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202317s009lbl.pdf#page=10", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: valium, Active Ingredient: diazepam", "label": "Drug Name: valium, Active Ingredient: diazepam", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/013263Orig1s100lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/013263Orig1s100lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: valtoco, Active Ingredient: diazepam", "label": "Drug Name: valtoco, Active Ingredient: diazepam", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211635s008lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211635s008lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: vanflyta, Active Ingredient: quizartinib", "label": "Drug Name: vanflyta, Active Ingredient: quizartinib", "shape": "dot", "size": 20}, {"color": "red", "id": "06/25/2024", "label": "06/25/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216993s000lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216993s000lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: vantrela er, Active Ingredient: hydrocodone bitartrate", "label": "Drug Name: vantrela er, Active Ingredient: hydrocodone bitartrate", "shape": "dot", "size": 20}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207975s000lbl.pdf#page=39", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207975s000lbl.pdf#page=39", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: velsipity, Active Ingredient: etrasimod arganine", "label": "Drug Name: velsipity, Active Ingredient: etrasimod arganine", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216956s000lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216956s000lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: venbysi xr, Active Ingredient: venlafaxine besylate", "label": "Drug Name: venbysi xr, Active Ingredient: venlafaxine besylate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215429s001lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215429s001lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: venclexta, Active Ingredient: venetoclax", "label": "Drug Name: venclexta, Active Ingredient: venetoclax", "shape": "dot", "size": 20}, {"color": "red", "id": "06/15/2022", "label": "06/15/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208573s026lbl.pdf#page=54", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208573s026lbl.pdf#page=54", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: venlafaxine hydrochloride, Active Ingredient: venlafaxine hydrochloride", "label": "Drug Name: venlafaxine hydrochloride, Active Ingredient: venlafaxine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022104s023lbl.pdf#page=35", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022104s023lbl.pdf#page=35", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: veopoz, Active Ingredient: pozelimab-bbfg", "label": "Drug Name: veopoz, Active Ingredient: pozelimab-bbfg", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761339s000lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761339s000lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: verquvo, Active Ingredient: vericiguat", "label": "Drug Name: verquvo, Active Ingredient: vericiguat", "shape": "dot", "size": 20}, {"color": "red", "id": "05/10/2023", "label": "05/10/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214377s002lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214377s002lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: vibativ, Active Ingredient: telavancin", "label": "Drug Name: vibativ, Active Ingredient: telavancin", "shape": "dot", "size": 20}, {"color": "red", "id": "06/21/2013", "label": "06/21/2013", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM183838.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM183838.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: vibativ, Active Ingredient: telavancin hydrochloride", "label": "Drug Name: vibativ, Active Ingredient: telavancin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "07/07/2020", "label": "07/07/2020", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: viberzi, Active Ingredient: eluxadoline", "label": "Drug Name: viberzi, Active Ingredient: eluxadoline", "shape": "dot", "size": 20}, {"color": "red", "id": "06/17/2020", "label": "06/17/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206940s007lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206940s007lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: vicoprofen, Active Ingredient: hydrocodone bitartrate; ibuprofen", "label": "Drug Name: vicoprofen, Active Ingredient: hydrocodone bitartrate; ibuprofen", "shape": "dot", "size": 20}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020716s012s013s014s015s016lbl.pdf#page=36", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020716s012s013s014s015s016lbl.pdf#page=36", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: victoza, Active Ingredient: liraglutide recombinant", "label": "Drug Name: victoza, Active Ingredient: liraglutide recombinant", "shape": "dot", "size": 20}, {"color": "red", "id": "07/05/2023", "label": "07/05/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022341s039lbl.pdf#page=31", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022341s039lbl.pdf#page=31", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: victrelis, Active Ingredient: boceprevir", "label": "Drug Name: victrelis, Active Ingredient: boceprevir", "shape": "dot", "size": 20}, {"color": "red", "id": "01/30/2017", "label": "01/30/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202258MG.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202258MG.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: videx, Active Ingredient: didanosine", "label": "Drug Name: videx, Active Ingredient: didanosine", "shape": "dot", "size": 20}, {"color": "red", "id": "12/17/2018", "label": "12/17/2018", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020156s054lbl.pdf#page=34", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020156s054lbl.pdf#page=34", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: videx ec, Active Ingredient: didanosine", "label": "Drug Name: videx ec, Active Ingredient: didanosine", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021183s029lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021183s029lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: viekira pak (copackaged), Active Ingredient: dasabuvir sodium; ombitasvir, paritaprevir, ritonavir", "label": "Drug Name: viekira pak (copackaged), Active Ingredient: dasabuvir sodium; ombitasvir, paritaprevir, ritonavir", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206619s020lbl.pdf#page=49", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206619s020lbl.pdf#page=49", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: viekira xr, Active Ingredient: dasabuvir sodium; ombitasvir; paritaprevir; ritonavir", "label": "Drug Name: viekira xr, Active Ingredient: dasabuvir sodium; ombitasvir; paritaprevir; ritonavir", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208624s008lbl.pdf#page=49", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208624s008lbl.pdf#page=49", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: viibryd, Active Ingredient: vilazodone hydrochloride", "label": "Drug Name: viibryd, Active Ingredient: vilazodone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022567s024lbl.pdf#page=17", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022567s024lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: vimovo, Active Ingredient: esomeprazole magnesium; naproxen", "label": "Drug Name: vimovo, Active Ingredient: esomeprazole magnesium; naproxen", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022511s030lbl.pdf#page=40", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022511s030lbl.pdf#page=40", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: vimpat, Active Ingredient: lacosamide", "label": "Drug Name: vimpat, Active Ingredient: lacosamide", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022253s057,022254s047,022255s039lbl.pdf#page=31", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022253s057,022254s047,022255s039lbl.pdf#page=31", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: viokace, Active Ingredient: pancrelipase (amylase;lipase;protease)", "label": "Drug Name: viokace, Active Ingredient: pancrelipase (amylase;lipase;protease)", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022542s007lbl.pdf#page=12", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022542s007lbl.pdf#page=12", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: viramune, Active Ingredient: nevirapine", "label": "Drug Name: viramune, Active Ingredient: nevirapine", "shape": "dot", "size": 20}, {"color": "red", "id": "06/10/2022", "label": "06/10/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020636s052,020933s043lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020636s052,020933s043lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: viramune xr, Active Ingredient: nevirapine", "label": "Drug Name: viramune xr, Active Ingredient: nevirapine", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201152s014lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201152s014lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: visicol, Active Ingredient: sodium phosphate, dibasic anhydrous; sodium phosphate, monobasic, monohydrate", "label": "Drug Name: visicol, Active Ingredient: sodium phosphate, dibasic anhydrous; sodium phosphate, monobasic, monohydrate", "shape": "dot", "size": 20}, {"color": "red", "id": "03/07/2013", "label": "03/07/2013", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021097s016lbl.pdf#page=11", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021097s016lbl.pdf#page=11", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: vituz, Active Ingredient: chlorpheniramine maleate; hydrocodone bitartrate", "label": "Drug Name: vituz, Active Ingredient: chlorpheniramine maleate; hydrocodone bitartrate", "shape": "dot", "size": 20}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204307s004lbl.pdf#page=25", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204307s004lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: vivactil, Active Ingredient: protriptyline hydrochloride", "label": "Drug Name: vivactil, Active Ingredient: protriptyline hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Vivactil.pdf", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Vivactil.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: vivitrol, Active Ingredient: naltrexone", "label": "Drug Name: vivitrol, Active Ingredient: naltrexone", "shape": "dot", "size": 20}, {"color": "red", "id": "09/30/2022", "label": "09/30/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021897s052lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021897s052lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: vivlodex, Active Ingredient: meloxicam", "label": "Drug Name: vivlodex, Active Ingredient: meloxicam", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/207233s005lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/207233s005lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: vogelxo, Active Ingredient: testosterone", "label": "Drug Name: vogelxo, Active Ingredient: testosterone", "shape": "dot", "size": 20}, {"color": "red", "id": "04/30/2020", "label": "04/30/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204399s012lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204399s012lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: voltaren, Active Ingredient: diclofenac sodium", "label": "Drug Name: voltaren, Active Ingredient: diclofenac sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019201s048lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019201s048lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: voltaren arthritis pain, Active Ingredient: diclofenac sodium", "label": "Drug Name: voltaren arthritis pain, Active Ingredient: diclofenac sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022122s011lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022122s011lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: voltaren-xr, Active Ingredient: diclofenac sodium", "label": "Drug Name: voltaren-xr, Active Ingredient: diclofenac sodium", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020254s030lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020254s030lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: votrient, Active Ingredient: pazopanib hydrochloride", "label": "Drug Name: votrient, Active Ingredient: pazopanib hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022465s031s032lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022465s031s032lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: vraylar, Active Ingredient: cariprazine hydrochloride", "label": "Drug Name: vraylar, Active Ingredient: cariprazine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204370s012lbl.pdf#page=46", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204370s012lbl.pdf#page=46", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: vyvanse, Active Ingredient: lisdexamfetamine dimesylate", "label": "Drug Name: vyvanse, Active Ingredient: lisdexamfetamine dimesylate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021977s050,208510s007lbl.pdf#page=38", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021977s050,208510s007lbl.pdf#page=38", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: wegovy, Active Ingredient: semaglutide", "label": "Drug Name: wegovy, Active Ingredient: semaglutide", "shape": "dot", "size": 20}, {"color": "red", "id": "11/27/2024", "label": "11/27/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215256s015lbl.pdf#page=35", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215256s015lbl.pdf#page=35", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: welireg, Active Ingredient: belzutifan", "label": "Drug Name: welireg, Active Ingredient: belzutifan", "shape": "dot", "size": 20}, {"color": "red", "id": "02/26/2024", "label": "02/26/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215383s006lbl.pdf#page=17", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215383s006lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: wellbutrin, Active Ingredient: bupropion hydrochloride", "label": "Drug Name: wellbutrin, Active Ingredient: bupropion hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018644s057lbl.pdf#page=32", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018644s057lbl.pdf#page=32", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: wellbutrin sr, Active Ingredient: bupropion hydrochloride", "label": "Drug Name: wellbutrin sr, Active Ingredient: bupropion hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020358s064lbl.pdf#page=34", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020358s064lbl.pdf#page=34", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: wellbutrin xl, Active Ingredient: bupropion hydrochloride", "label": "Drug Name: wellbutrin xl, Active Ingredient: bupropion hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021515s044lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021515s044lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: wezlana, Active Ingredient: ustekinumab-auub", "label": "Drug Name: wezlana, Active Ingredient: ustekinumab-auub", "shape": "dot", "size": 20}, {"color": "red", "id": "10/31/2023", "label": "10/31/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761285s000,761331s000lbl.pdf#page=36", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761285s000,761331s000lbl.pdf#page=36", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: xalkori, Active Ingredient: crizotinib", "label": "Drug Name: xalkori, Active Ingredient: crizotinib", "shape": "dot", "size": 20}, {"color": "red", "id": "09/07/2023", "label": "09/07/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202570s036lbl.pdf#page=46", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202570s036lbl.pdf#page=46", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: xanax, Active Ingredient: alprazolam", "label": "Drug Name: xanax, Active Ingredient: alprazolam", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018276s059lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018276s059lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: xanax xr, Active Ingredient: alprazolam", "label": "Drug Name: xanax xr, Active Ingredient: alprazolam", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021434s022lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021434s022lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: xarelto, Active Ingredient: rivaroxaban", "label": "Drug Name: xarelto, Active Ingredient: rivaroxaban", "shape": "dot", "size": 20}, {"color": "red", "id": "02/08/2023", "label": "02/08/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215859s000lbl.pdf#page=77", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215859s000lbl.pdf#page=77", "shape": "dot", "size": 10}, {"color": "red", "id": "03/01/2022", "label": "03/01/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022406s039,202439s038lbl.pdf#page=77", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022406s039,202439s038lbl.pdf#page=77", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: xartemis xr, Active Ingredient: acetaminophen; oxycodone hydrochloride", "label": "Drug Name: xartemis xr, Active Ingredient: acetaminophen; oxycodone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204031s004s005lbl.pdf#page=34", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204031s004s005lbl.pdf#page=34", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: xcopri, Active Ingredient: cenobamate", "label": "Drug Name: xcopri, Active Ingredient: cenobamate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212839s006s007lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212839s006s007lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: xeljanz, Active Ingredient: tofacitinib citrate", "label": "Drug Name: xeljanz, Active Ingredient: tofacitinib citrate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203214s036,208246s023,213082s008lbl.pdf#page=65", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203214s036,208246s023,213082s008lbl.pdf#page=65", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: xeljanz xr, Active Ingredient: tofacitinib citrate", "label": "Drug Name: xeljanz xr, Active Ingredient: tofacitinib citrate", "shape": "dot", "size": 20}, {"color": "blue", "id": "Drug Name: xelstrym, Active Ingredient: dextroamphetamine", "label": "Drug Name: xelstrym, Active Ingredient: dextroamphetamine", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215401s008lbl.pdf#page=28", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215401s008lbl.pdf#page=28", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: xenazine, Active Ingredient: tetrabenazine", "label": "Drug Name: xenazine, Active Ingredient: tetrabenazine", "shape": "dot", "size": 20}, {"color": "red", "id": "09/13/2017", "label": "09/13/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021894s013lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021894s013lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: xeomin, Active Ingredient: incobotulinumtoxina", "label": "Drug Name: xeomin, Active Ingredient: incobotulinumtoxina", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125360s097lbl.pdf#page=23", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125360s097lbl.pdf#page=23", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: xiaflex, Active Ingredient: collagenase clostridium histolyticum", "label": "Drug Name: xiaflex, Active Ingredient: collagenase clostridium histolyticum", "shape": "dot", "size": 20}, {"color": "red", "id": "07/12/2023", "label": "07/12/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125338s111lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125338s111lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: xigduo xr, Active Ingredient: dapagliflozin; metformin hydrochloride", "label": "Drug Name: xigduo xr, Active Ingredient: dapagliflozin; metformin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205649s021lbl.pdf#page=59", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205649s021lbl.pdf#page=59", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: xolair, Active Ingredient: omalizumab", "label": "Drug Name: xolair, Active Ingredient: omalizumab", "shape": "dot", "size": 20}, {"color": "red", "id": "02/16/2024", "label": "02/16/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103976s5242lbl.pdf#page=37", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103976s5242lbl.pdf#page=37", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: xospata, Active Ingredient: gilteritinib fumarate", "label": "Drug Name: xospata, Active Ingredient: gilteritinib fumarate", "shape": "dot", "size": 20}, {"color": "red", "id": "01/12/2022", "label": "01/12/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211349s003lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211349s003lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: xpovio, Active Ingredient: selinexor", "label": "Drug Name: xpovio, Active Ingredient: selinexor", "shape": "dot", "size": 20}, {"color": "red", "id": "07/15/2022", "label": "07/15/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212306s010lbl.pdf#page=31", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212306s010lbl.pdf#page=31", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: xtampza er, Active Ingredient: oxycodone", "label": "Drug Name: xtampza er, Active Ingredient: oxycodone", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208090s021lbl.pdf#page=40", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208090s021lbl.pdf#page=40", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: xtrelus, Active Ingredient: hydrocodone bitartrate;guaifenesin", "label": "Drug Name: xtrelus, Active Ingredient: hydrocodone bitartrate;guaifenesin", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208085s002lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208085s002lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: xultophy 100/3.6, Active Ingredient: insulin degludec; liraglutide", "label": "Drug Name: xultophy 100/3.6, Active Ingredient: insulin degludec; liraglutide", "shape": "dot", "size": 20}, {"color": "red", "id": "07/10/2023", "label": "07/10/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208583s021lbl.pdf#page=42", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208583s021lbl.pdf#page=42", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: xyosted (autoinjector), Active Ingredient: testosterone enanthate", "label": "Drug Name: xyosted (autoinjector), Active Ingredient: testosterone enanthate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209863s000lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209863s000lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: xyrem, Active Ingredient: sodium oxybate", "label": "Drug Name: xyrem, Active Ingredient: sodium oxybate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021196s042lbl.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021196s042lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: xywav, Active Ingredient: calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate", "label": "Drug Name: xywav, Active Ingredient: calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212690s011lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212690s011lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: yervoy, Active Ingredient: ipilimumab", "label": "Drug Name: yervoy, Active Ingredient: ipilimumab", "shape": "dot", "size": 20}, {"color": "red", "id": "02/15/2023", "label": "02/15/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125377s129lbl.pdf#page=72", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125377s129lbl.pdf#page=72", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: yesintek, Active Ingredient: ustekinumab-kfce", "label": "Drug Name: yesintek, Active Ingredient: ustekinumab-kfce", "shape": "dot", "size": 20}, {"color": "red", "id": "Invalid date", "label": "Invalid date", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761406s000lbl.pdf#page=37", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761406s000lbl.pdf#page=37", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: yosprala, Active Ingredient: aspirin; omeprazole", "label": "Drug Name: yosprala, Active Ingredient: aspirin; omeprazole", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205103s010lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205103s010lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: yuflyma, Active Ingredient: adalimumab-aaty", "label": "Drug Name: yuflyma, Active Ingredient: adalimumab-aaty", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761219s011lbl.pdf#page=43", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761219s011lbl.pdf#page=43", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: yusimry, Active Ingredient: adalimumab-aqvh", "label": "Drug Name: yusimry, Active Ingredient: adalimumab-aqvh", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761216s004lbl.pdf#page=56", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761216s004lbl.pdf#page=56", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zarontin, Active Ingredient: ethosuximide", "label": "Drug Name: zarontin, Active Ingredient: ethosuximide", "shape": "dot", "size": 20}, {"color": "red", "id": "10/28/2021", "label": "10/28/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/012380s034mg.pdf", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/012380s034mg.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zegerid, Active Ingredient: omeprazole; sodium bicarbonate", "label": "Drug Name: zegerid, Active Ingredient: omeprazole; sodium bicarbonate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021849s020,021636s025lbl.pdf#page=31", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021849s020,021636s025lbl.pdf#page=31", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zelboraf, Active Ingredient: vemurafenib", "label": "Drug Name: zelboraf, Active Ingredient: vemurafenib", "shape": "dot", "size": 20}, {"color": "red", "id": "05/18/2020", "label": "05/18/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202429s016lbl.pdf#page=21", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202429s016lbl.pdf#page=21", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zenpep, Active Ingredient: pancrelipase;lipase;protease;amylase", "label": "Drug Name: zenpep, Active Ingredient: pancrelipase;lipase;protease;amylase", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022210s024lbl.pdf#page=14", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022210s024lbl.pdf#page=14", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zenpep, Active Ingredient: pancrelipase (amylase;lipase;protease)", "label": "Drug Name: zenpep, Active Ingredient: pancrelipase (amylase;lipase;protease)", "shape": "dot", "size": 20}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM180714.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM180714.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zeposia, Active Ingredient: ozanimod hydrochloride", "label": "Drug Name: zeposia, Active Ingredient: ozanimod hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209899s006s009lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209899s006s009lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zerit, Active Ingredient: stavudine", "label": "Drug Name: zerit, Active Ingredient: stavudine", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020412s041,020413s033lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020412s041,020413s033lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ziagen, Active Ingredient: abacavir sulfate", "label": "Drug Name: ziagen, Active Ingredient: abacavir sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "11/24/2020", "label": "11/24/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020977s035,020978s038lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020977s035,020978s038lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zilbrysq, Active Ingredient: zilucoplan", "label": "Drug Name: zilbrysq, Active Ingredient: zilucoplan", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216834s000lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216834s000lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zinbryta, Active Ingredient: daclizumab", "label": "Drug Name: zinbryta, Active Ingredient: daclizumab", "shape": "dot", "size": 20}, {"color": "red", "id": "11/01/2017", "label": "11/01/2017", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761029s001lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761029s001lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zipsor, Active Ingredient: diclofenac potassium", "label": "Drug Name: zipsor, Active Ingredient: diclofenac potassium", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022202s016lbl.pdf#page=24", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022202s016lbl.pdf#page=24", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zituvimet, Active Ingredient: sitagliptin, metformin hydrochloride", "label": "Drug Name: zituvimet, Active Ingredient: sitagliptin, metformin hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216743s000lbl.pdf#page=38", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216743s000lbl.pdf#page=38", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zituvio, Active Ingredient: sitagliptin", "label": "Drug Name: zituvio, Active Ingredient: sitagliptin", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211566s000lbl.pdf#page=33", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211566s000lbl.pdf#page=33", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zohydro er, Active Ingredient: hydrocodone bitartrate", "label": "Drug Name: zohydro er, Active Ingredient: hydrocodone bitartrate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202880s020lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202880s020lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zoloft, Active Ingredient: sertraline hydrochloride", "label": "Drug Name: zoloft, Active Ingredient: sertraline hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "CONCENTRATE;ORAL", "label": "CONCENTRATE;ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019839s108,20990s062lbl.pdf#page=37", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019839s108,20990s062lbl.pdf#page=37", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zolpidem tartrate, Active Ingredient: zolpidem tartrate", "label": "Drug Name: zolpidem tartrate, Active Ingredient: zolpidem tartrate", "shape": "dot", "size": 20}, {"color": "red", "id": "03/07/2023", "label": "03/07/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Zolpidem.pdf", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Zolpidem.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zolpidem tartrate capsules, Active Ingredient: zolpidem tartrate", "label": "Drug Name: zolpidem tartrate capsules, Active Ingredient: zolpidem tartrate", "shape": "dot", "size": 20}, {"color": "red", "id": "05/09/2023", "label": "05/09/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215721s000lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215721s000lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zolpimist, Active Ingredient: zolpidem tartrate", "label": "Drug Name: zolpimist, Active Ingredient: zolpidem tartrate", "shape": "dot", "size": 20}, {"color": "red", "id": "METERED;ORAL", "label": "METERED;ORAL", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022196s012lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022196s012lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zonegran, Active Ingredient: zonisamide", "label": "Drug Name: zonegran, Active Ingredient: zonisamide", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020789s036lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020789s036lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zonisade, Active Ingredient: zonisamide", "label": "Drug Name: zonisade, Active Ingredient: zonisamide", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214273s000lbl.pdf#page=27", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214273s000lbl.pdf#page=27", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zontivity, Active Ingredient: vorapaxar sulfate", "label": "Drug Name: zontivity, Active Ingredient: vorapaxar sulfate", "shape": "dot", "size": 20}, {"color": "red", "id": "11/07/2019", "label": "11/07/2019", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM447698.pdf", "label": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM447698.pdf", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zortress, Active Ingredient: everolimus", "label": "Drug Name: zortress, Active Ingredient: everolimus", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021560s033lbl.pdf#page=31", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021560s033lbl.pdf#page=31", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zorvolex, Active Ingredient: diclofenac", "label": "Drug Name: zorvolex, Active Ingredient: diclofenac", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204592s014lbl.pdf#page=26", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204592s014lbl.pdf#page=26", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: ztalmy, Active Ingredient: ganaxolone", "label": "Drug Name: ztalmy, Active Ingredient: ganaxolone", "shape": "dot", "size": 20}, {"color": "red", "id": "06/21/2023", "label": "06/21/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215904s003s004lbl.pdf#page=16", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215904s003s004lbl.pdf#page=16", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zubsolv, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "label": "Drug Name: zubsolv, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "03/20/2024", "label": "03/20/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204242s027lbl.pdf#page=19", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204242s027lbl.pdf#page=19", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zulresso, Active Ingredient: brexanolone", "label": "Drug Name: zulresso, Active Ingredient: brexanolone", "shape": "dot", "size": 20}, {"color": "red", "id": "10/17/2023", "label": "10/17/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211371s007lbl.pdf#page=20", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211371s007lbl.pdf#page=20", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zurampic, Active Ingredient: lesinurad", "label": "Drug Name: zurampic, Active Ingredient: lesinurad", "shape": "dot", "size": 20}, {"color": "red", "id": "08/04/2016", "label": "08/04/2016", "shape": "dot", "size": 10}, {"color": "red", "id": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207988lbl.pdf#page=17", "label": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207988lbl.pdf#page=17", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zurzuvae, Active Ingredient: zuranolone", "label": "Drug Name: zurzuvae, Active Ingredient: zuranolone", "shape": "dot", "size": 20}, {"color": "red", "id": "08/04/2023", "label": "08/04/2023", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217369Orig2s000Corrected_lbl.pdf#page=22", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217369Orig2s000Corrected_lbl.pdf#page=22", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zutripro, Active Ingredient: chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride", "label": "Drug Name: zutripro, Active Ingredient: chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022439s010lbl.pdf#page=28", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022439s010lbl.pdf#page=28", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zyban, Active Ingredient: bupropion hydrochloride", "label": "Drug Name: zyban, Active Ingredient: bupropion hydrochloride", "shape": "dot", "size": 20}, {"color": "red", "id": "03/09/2021", "label": "03/09/2021", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020711s052lbl.pdf#page=38", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020711s052lbl.pdf#page=38", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zydelig, Active Ingredient: idelalisib", "label": "Drug Name: zydelig, Active Ingredient: idelalisib", "shape": "dot", "size": 20}, {"color": "red", "id": "07/06/2022", "label": "07/06/2022", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205858s016lbl.pdf#page=25", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205858s016lbl.pdf#page=25", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zymfentra, Active Ingredient: infliximab-dyyb", "label": "Drug Name: zymfentra, Active Ingredient: infliximab-dyyb", "shape": "dot", "size": 20}, {"color": "red", "id": "02/22/2024", "label": "02/22/2024", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761358s000lbl.pdf#page=30", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761358s000lbl.pdf#page=30", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zynyz, Active Ingredient: retifanlimab-dlwr", "label": "Drug Name: zynyz, Active Ingredient: retifanlimab-dlwr", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761334s000lbl.pdf#page=18", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761334s000lbl.pdf#page=18", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zyprexa, Active Ingredient: olanzapine", "label": "Drug Name: zyprexa, Active Ingredient: olanzapine", "shape": "dot", "size": 20}, {"color": "red", "id": "04/23/2020", "label": "04/23/2020", "shape": "dot", "size": 10}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s075,021086s049,021253s062lbl.pdf#page=37", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s075,021086s049,021253s062lbl.pdf#page=37", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zyprexa relprevv, Active Ingredient: olanzapine pamoate", "label": "Drug Name: zyprexa relprevv, Active Ingredient: olanzapine pamoate", "shape": "dot", "size": 20}, {"color": "red", "id": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022173s036lbl.pdf#page=29", "label": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022173s036lbl.pdf#page=29", "shape": "dot", "size": 10}, {"color": "blue", "id": "Drug Name: zyprexa zydis, Active Ingredient: olanzapine", "label": "Drug Name: zyprexa zydis, Active Ingredient: olanzapine", "shape": "dot", "size": 20}]);
                  edges = new vis.DataSet([{"arrows": "to", "from": "chem (clin)", "title": "Class", "to": "safe eur j"}, {"arrows": "to", "from": "chem (clin)", "title": "Type", "to": "clin"}, {"arrows": "to", "from": "chem (clin)", "title": "Conclusion", "to": "biochem"}, {"arrows": "to", "from": "chem (clin)", "title": "References", "to": "1997"}, {"arrows": "to", "from": "chem (clin)", "title": "Class", "to": "probably porphyrinogenic eur\nmedications chemical j"}, {"arrows": "to", "from": "therapies (motility)", "title": "Class", "to": "clin pharmacol"}, {"arrows": "to", "from": "therapies (motility)", "title": "Type", "to": "therap"}, {"arrows": "to", "from": "therapies (motility)", "title": "Conclusion", "to": "stimulants"}, {"arrows": "to", "from": "therapies (motility)", "title": "References", "to": "83"}, {"arrows": "to", "from": "culture (gen)", "title": "Class", "to": "unsafe in"}, {"arrows": "to", "from": "culture (gen)", "title": "Type", "to": "cell"}, {"arrows": "to", "from": "culture (gen)", "title": "Conclusion", "to": "pharmacol"}, {"arrows": "to", "from": "culture (gen)", "title": "References", "to": "1999"}, {"arrows": "to", "from": "j (clin)", "title": "Class", "to": "safe in"}, {"arrows": "to", "from": "j (clin)", "title": "Type", "to": "animals"}, {"arrows": "to", "from": "j (clin)", "title": "Conclusion", "to": "pharmacol"}, {"arrows": "to", "from": "j (clin)", "title": "References", "to": "2001"}, {"arrows": "to", "from": "j (clin)", "title": "Class", "to": "unsafe in"}, {"arrows": "to", "from": "j (clin)", "title": "Class", "to": "safe"}, {"arrows": "to", "from": "j (clin)", "title": "Type", "to": "br"}, {"arrows": "to", "from": "j (clin)", "title": "References", "to": "1997"}, {"arrows": "to", "from": "j (clin)", "title": "Class", "to": "safe in patients"}, {"arrows": "to", "from": "j (clin)", "title": "References", "to": "1990"}, {"arrows": "to", "from": "fr (anesth)", "title": "Class", "to": "safe"}, {"arrows": "to", "from": "fr (anesth)", "title": "Type", "to": "ann"}, {"arrows": "to", "from": "fr (anesth)", "title": "Conclusion", "to": "reanim"}, {"arrows": "to", "from": "fr (anesth)", "title": "References", "to": "1989"}, {"arrows": "to", "from": "use (in)", "title": "Class", "to": "one case report of"}, {"arrows": "to", "from": "use (in)", "title": "Type", "to": "uneventful"}, {"arrows": "to", "from": "use (in)", "title": "Conclusion", "to": "a"}, {"arrows": "to", "from": "use (in)", "title": "References", "to": "54"}, {"arrows": "to", "from": "clin (chim)", "title": "Class", "to": "probably"}, {"arrows": "to", "from": "clin (chim)", "title": "Type", "to": "unsafe"}, {"arrows": "to", "from": "clin (chim)", "title": "Conclusion", "to": "acta"}, {"arrows": "to", "from": "clin (chim)", "title": "References", "to": "1995"}, {"arrows": "to", "from": "ann (int)", "title": "Class", "to": "safe in"}, {"arrows": "to", "from": "ann (int)", "title": "Type", "to": "patients"}, {"arrows": "to", "from": "ann (int)", "title": "Conclusion", "to": "med"}, {"arrows": "to", "from": "ann (int)", "title": "References", "to": "2005"}, {"arrows": "to", "from": "blockers (metab)", "title": "Class", "to": "drug"}, {"arrows": "to", "from": "blockers (metab)", "title": "Type", "to": "agents"}, {"arrows": "to", "from": "blockers (metab)", "title": "Conclusion", "to": "disp"}, {"arrows": "to", "from": "blockers (metab)", "title": "References", "to": "34"}, {"arrows": "to", "from": "lose (dosages)", "title": "Class", "to": "porphyrogenic but safe"}, {"arrows": "to", "from": "lose (dosages)", "title": "Type", "to": "in"}, {"arrows": "to", "from": "lose (dosages)", "title": "Conclusion", "to": "neurology"}, {"arrows": "to", "from": "lose (dosages)", "title": "References", "to": "1982"}, {"arrows": "to", "from": "c (toxicol)", "title": "Class", "to": "possibly\nporphyrinogenic comp biochem"}, {"arrows": "to", "from": "c (toxicol)", "title": "Type", "to": "physiol"}, {"arrows": "to", "from": "c (toxicol)", "title": "Conclusion", "to": "pharmacol"}, {"arrows": "to", "from": "c (toxicol)", "title": "References", "to": "2005"}, {"arrows": "to", "from": "int (j)", "title": "Class", "to": "safe in"}, {"arrows": "to", "from": "int (j)", "title": "Type", "to": "patients"}, {"arrows": "to", "from": "int (j)", "title": "Conclusion", "to": "biochem"}, {"arrows": "to", "from": "int (j)", "title": "References", "to": "1985"}, {"arrows": "to", "from": "afr (med)", "title": "Class", "to": "unsafe in animals"}, {"arrows": "to", "from": "afr (med)", "title": "Type", "to": "s"}, {"arrows": "to", "from": "afr (med)", "title": "Conclusion", "to": "j"}, {"arrows": "to", "from": "afr (med)", "title": "References", "to": "1984"}, {"arrows": "to", "from": "afr (med)", "title": "Class", "to": "caution"}, {"arrows": "to", "from": "afr (med)", "title": "Class", "to": "safe in patients"}, {"arrows": "to", "from": "afr (med)", "title": "References", "to": "1988"}, {"arrows": "to", "from": "afr (med)", "title": "Class", "to": "use"}, {"arrows": "to", "from": "afr (med)", "title": "Class", "to": "probably safe in cell culture"}, {"arrows": "to", "from": "clin (endocrinol)", "title": "Class", "to": "unsafe"}, {"arrows": "to", "from": "clin (endocrinol)", "title": "Type", "to": "j"}, {"arrows": "to", "from": "clin (endocrinol)", "title": "Conclusion", "to": "metab"}, {"arrows": "to", "from": "clin (endocrinol)", "title": "References", "to": "1981"}, {"arrows": "to", "from": "clin (endocrinol)", "title": "Class", "to": "exacerbates acute porphyria"}, {"arrows": "to", "from": "clin (endocrinol)", "title": "References", "to": "1979"}, {"arrows": "to", "from": "eprosartan (teveten)", "title": "Class", "to": "safe\ncardiovascular"}, {"arrows": "to", "from": "eprosartan (teveten)", "title": "Type", "to": "angiotensin"}, {"arrows": "to", "from": "eprosartan (teveten)", "title": "Conclusion", "to": "ok!"}, {"arrows": "to", "from": "eprosartan (teveten)", "title": "References", "to": "98"}, {"arrows": "to", "from": "br (j)", "title": "Class", "to": "unsafe in"}, {"arrows": "to", "from": "br (j)", "title": "Type", "to": "animals"}, {"arrows": "to", "from": "br (j)", "title": "Conclusion", "to": "anaesth"}, {"arrows": "to", "from": "br (j)", "title": "References", "to": "1985"}, {"arrows": "to", "from": "br (j)", "title": "Class", "to": "probably"}, {"arrows": "to", "from": "br (j)", "title": "Type", "to": "safe"}, {"arrows": "to", "from": "neurology (system)", "title": "Class", "to": "unsafe in"}, {"arrows": "to", "from": "neurology (system)", "title": "Type", "to": "patients"}, {"arrows": "to", "from": "neurology (system)", "title": "Conclusion", "to": "agents"}, {"arrows": "to", "from": "neurology (system)", "title": "References", "to": "1981"}, {"arrows": "to", "from": "neurol (neurosurg)", "title": "Class", "to": "probably safe"}, {"arrows": "to", "from": "neurol (neurosurg)", "title": "Type", "to": "j"}, {"arrows": "to", "from": "neurol (neurosurg)", "title": "Conclusion", "to": "psychiat"}, {"arrows": "to", "from": "neurol (neurosurg)", "title": "References", "to": "1997"}, {"arrows": "to", "from": "patients (and)", "title": "Class", "to": "safe"}, {"arrows": "to", "from": "patients (and)", "title": "Type", "to": "in"}, {"arrows": "to", "from": "patients (and)", "title": "Conclusion", "to": "animals"}, {"arrows": "to", "from": "patients (and)", "title": "References", "to": "20"}, {"arrows": "to", "from": "weighing (at)", "title": "Class", "to": "years of age and"}, {"arrows": "to", "from": "weighing (at)", "title": "Type", "to": "older"}, {"arrows": "to", "from": "weighing (at)", "title": "Conclusion", "to": "least"}, {"arrows": "to", "from": "weighing (at)", "title": "References", "to": "40"}, {"arrows": "to", "from": "redox (agents)", "title": "Class", "to": "use with"}, {"arrows": "to", "from": "redox (agents)", "title": "Type", "to": "caution"}, {"arrows": "to", "from": "redox (agents)", "title": "Conclusion", "to": "rep"}, {"arrows": "to", "from": "redox (agents)", "title": "References", "to": "2004"}, {"arrows": "to", "from": "no (info)", "title": "Class", "to": "hormones progestins norethindrone"}, {"arrows": "to", "from": "no (info)", "title": "Type", "to": "loestrin"}, {"arrows": "to", "from": "no (info)", "title": "Conclusion", "to": "jama"}, {"arrows": "to", "from": "no (info)", "title": "References", "to": "1965"}, {"arrows": "to", "from": "j (appl)", "title": "Class", "to": "safe in cell"}, {"arrows": "to", "from": "j (appl)", "title": "Type", "to": "culture"}, {"arrows": "to", "from": "j (appl)", "title": "Conclusion", "to": "toxicol"}, {"arrows": "to", "from": "j (appl)", "title": "References", "to": "2005"}, {"arrows": "to", "from": "curr (drug)", "title": "Class", "to": "probably"}, {"arrows": "to", "from": "curr (drug)", "title": "Type", "to": "unsafe"}, {"arrows": "to", "from": "curr (drug)", "title": "Conclusion", "to": "metab"}, {"arrows": "to", "from": "curr (drug)", "title": "References", "to": "2003"}, {"arrows": "to", "from": "caution (pediat)", "title": "Class", "to": "use"}, {"arrows": "to", "from": "caution (pediat)", "title": "Type", "to": "with"}, {"arrows": "to", "from": "caution (pediat)", "title": "Conclusion", "to": "anesthes"}, {"arrows": "to", "from": "caution (pediat)", "title": "References", "to": "2005"}, {"arrows": "to", "from": "drug (metab)", "title": "Class", "to": "expert"}, {"arrows": "to", "from": "drug (metab)", "title": "Type", "to": "opin"}, {"arrows": "to", "from": "drug (metab)", "title": "Conclusion", "to": "toxicol"}, {"arrows": "to", "from": "drug (metab)", "title": "References", "to": "4"}, {"arrows": "to", "from": "agents (clin)", "title": "Class", "to": "possibly porphyrinogenic"}, {"arrows": "to", "from": "agents (clin)", "title": "Type", "to": "j"}, {"arrows": "to", "from": "agents (clin)", "title": "Conclusion", "to": "pharmacol"}, {"arrows": "to", "from": "agents (clin)", "title": "References", "to": "2001"}, {"arrows": "to", "from": "polish (j)", "title": "Class", "to": "safe in"}, {"arrows": "to", "from": "polish (j)", "title": "Type", "to": "patients"}, {"arrows": "to", "from": "polish (j)", "title": "Conclusion", "to": "pharmacol"}, {"arrows": "to", "from": "polish (j)", "title": "References", "to": "2001"}, {"arrows": "to", "from": "apf (is)", "title": "Class", "to": "evidence insufficient for deriving any conclusion\nabout apf"}, {"arrows": "to", "from": "apf (is)", "title": "Type", "to": "the"}, {"arrows": "to", "from": "apf (is)", "title": "Conclusion", "to": "a"}, {"arrows": "to", "from": "apf (is)", "title": "References", "to": "501"}, {"arrows": "to", "from": "fundraise (contact)", "title": "Class", "to": "join research\nwhat you can do\nget involved\ndonate"}, {"arrows": "to", "from": "fundraise (contact)", "title": "Type", "to": "volunteer"}, {"arrows": "to", "from": "fundraise (contact)", "title": "Conclusion", "to": "info"}, {"arrows": "to", "from": "fundraise (contact)", "title": "References", "to": "6605 33"}, {"arrows": "to", "from": "itching, skin_rash, nodal_skin_eruptions, dischromic _patches", "title": "Diagnosis", "to": "Fungal Infection"}, {"arrows": "to", "from": "skin_rash, nodal_skin_eruptions, dischromic _patches", "title": "Diagnosis", "to": "Fungal Infection"}, {"arrows": "to", "from": "itching, nodal_skin_eruptions, dischromic _patches", "title": "Diagnosis", "to": "Fungal Infection"}, {"arrows": "to", "from": "itching, skin_rash, dischromic _patches", "title": "Diagnosis", "to": "Fungal Infection"}, {"arrows": "to", "from": "itching, skin_rash, nodal_skin_eruptions", "title": "Diagnosis", "to": "Fungal Infection"}, {"arrows": "to", "from": "continuous_sneezing, shivering, chills, watering_from_eyes", "title": "Diagnosis", "to": "Allergy"}, {"arrows": "to", "from": "shivering, chills, watering_from_eyes", "title": "Diagnosis", "to": "Allergy"}, {"arrows": "to", "from": "continuous_sneezing, chills, watering_from_eyes", "title": "Diagnosis", "to": "Allergy"}, {"arrows": "to", "from": "continuous_sneezing, shivering, watering_from_eyes", "title": "Diagnosis", "to": "Allergy"}, {"arrows": "to", "from": "continuous_sneezing, shivering, chills", "title": "Diagnosis", "to": "Allergy"}, {"arrows": "to", "from": "stomach_pain, acidity, ulcers_on_tongue, vomiting, cough, chest_pain", "title": "Diagnosis", "to": "GERD"}, {"arrows": "to", "from": "stomach_pain, ulcers_on_tongue, vomiting, cough, chest_pain", "title": "Diagnosis", "to": "GERD"}, {"arrows": "to", "from": "stomach_pain, acidity, vomiting, cough, chest_pain", "title": "Diagnosis", "to": "GERD"}, {"arrows": "to", "from": "stomach_pain, acidity, ulcers_on_tongue, cough, chest_pain", "title": "Diagnosis", "to": "GERD"}, {"arrows": "to", "from": "stomach_pain, acidity, ulcers_on_tongue, vomiting, chest_pain", "title": "Diagnosis", "to": "GERD"}, {"arrows": "to", "from": "stomach_pain, acidity, ulcers_on_tongue, vomiting, cough", "title": "Diagnosis", "to": "GERD"}, {"arrows": "to", "from": "acidity, ulcers_on_tongue, vomiting, cough, chest_pain", "title": "Diagnosis", "to": "GERD"}, {"arrows": "to", "from": "itching, vomiting, yellowish_skin, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "title": "Diagnosis", "to": "Chronic Cholestasis"}, {"arrows": "to", "from": "vomiting, yellowish_skin, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "title": "Diagnosis", "to": "Chronic Cholestasis"}, {"arrows": "to", "from": "itching, yellowish_skin, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "title": "Diagnosis", "to": "Chronic Cholestasis"}, {"arrows": "to", "from": "itching, vomiting, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "title": "Diagnosis", "to": "Chronic Cholestasis"}, {"arrows": "to", "from": "itching, vomiting, yellowish_skin, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "title": "Diagnosis", "to": "Chronic Cholestasis"}, {"arrows": "to", "from": "itching, vomiting, yellowish_skin, nausea, abdominal_pain, yellowing_of_eyes", "title": "Diagnosis", "to": "Chronic Cholestasis"}, {"arrows": "to", "from": "itching, vomiting, yellowish_skin, nausea, loss_of_appetite, yellowing_of_eyes", "title": "Diagnosis", "to": "Chronic Cholestasis"}, {"arrows": "to", "from": "itching, vomiting, yellowish_skin, nausea, loss_of_appetite, abdominal_pain", "title": "Diagnosis", "to": "Chronic Cholestasis"}, {"arrows": "to", "from": "itching, skin_rash, stomach_pain, burning_micturition, spotting_ urination", "title": "Diagnosis", "to": "Drug Reaction"}, {"arrows": "to", "from": "itching, stomach_pain, burning_micturition, spotting_ urination", "title": "Diagnosis", "to": "Drug Reaction"}, {"arrows": "to", "from": "itching, skin_rash, burning_micturition, spotting_ urination", "title": "Diagnosis", "to": "Drug Reaction"}, {"arrows": "to", "from": "itching, skin_rash, stomach_pain, spotting_ urination", "title": "Diagnosis", "to": "Drug Reaction"}, {"arrows": "to", "from": "itching, skin_rash, stomach_pain, burning_micturition", "title": "Diagnosis", "to": "Drug Reaction"}, {"arrows": "to", "from": "skin_rash, stomach_pain, burning_micturition, spotting_ urination", "title": "Diagnosis", "to": "Drug Reaction"}, {"arrows": "to", "from": "vomiting, loss_of_appetite, abdominal_pain, passage_of_gases, internal_itching", "title": "Diagnosis", "to": "Peptic Ulcer Disease"}, {"arrows": "to", "from": "vomiting, indigestion, abdominal_pain, passage_of_gases, internal_itching", "title": "Diagnosis", "to": "Peptic Ulcer Disease"}, {"arrows": "to", "from": "indigestion, loss_of_appetite, abdominal_pain, passage_of_gases, internal_itching", "title": "Diagnosis", "to": "Peptic Ulcer Disease"}, {"arrows": "to", "from": "vomiting, indigestion, loss_of_appetite, passage_of_gases, internal_itching", "title": "Diagnosis", "to": "Peptic Ulcer Disease"}, {"arrows": "to", "from": "vomiting, indigestion, loss_of_appetite, abdominal_pain, internal_itching", "title": "Diagnosis", "to": "Peptic Ulcer Disease"}, {"arrows": "to", "from": "vomiting, indigestion, loss_of_appetite, abdominal_pain, passage_of_gases", "title": "Diagnosis", "to": "Peptic Ulcer Disease"}, {"arrows": "to", "from": "vomiting, indigestion, loss_of_appetite, abdominal_pain, passage_of_gases, internal_itching", "title": "Diagnosis", "to": "Peptic Ulcer Disease"}, {"arrows": "to", "from": "muscle_wasting, patches_in_throat, high_fever, extra_marital_contacts", "title": "Diagnosis", "to": "AIDS"}, {"arrows": "to", "from": "patches_in_throat, high_fever, extra_marital_contacts", "title": "Diagnosis", "to": "AIDS"}, {"arrows": "to", "from": "muscle_wasting, high_fever, extra_marital_contacts", "title": "Diagnosis", "to": "AIDS"}, {"arrows": "to", "from": "muscle_wasting, patches_in_throat, extra_marital_contacts", "title": "Diagnosis", "to": "AIDS"}, {"arrows": "to", "from": "muscle_wasting, patches_in_throat, high_fever", "title": "Diagnosis", "to": "AIDS"}, {"arrows": "to", "from": "fatigue, weight_loss, restlessness, lethargy, irregular_sugar_level, blurred_and_distorted_vision, obesity, excessive_hunger, increased_appetite, polyuria", "title": "Diagnosis", "to": "Diabetes"}, {"arrows": "to", "from": "weight_loss, restlessness, lethargy, irregular_sugar_level, blurred_and_distorted_vision, obesity, excessive_hunger, increased_appetite, polyuria", "title": "Diagnosis", "to": "Diabetes"}, {"arrows": "to", "from": "fatigue, restlessness, lethargy, irregular_sugar_level, blurred_and_distorted_vision, obesity, excessive_hunger, increased_appetite, polyuria", "title": "Diagnosis", "to": "Diabetes"}, {"arrows": "to", "from": "fatigue, weight_loss, lethargy, irregular_sugar_level, blurred_and_distorted_vision, obesity, excessive_hunger, increased_appetite, polyuria", "title": "Diagnosis", "to": "Diabetes"}, {"arrows": "to", "from": "fatigue, weight_loss, restlessness, irregular_sugar_level, blurred_and_distorted_vision, obesity, excessive_hunger, increased_appetite, polyuria", "title": "Diagnosis", "to": "Diabetes"}, {"arrows": "to", "from": "fatigue, weight_loss, restlessness, lethargy, blurred_and_distorted_vision, obesity, excessive_hunger, increased_appetite, polyuria", "title": "Diagnosis", "to": "Diabetes"}, {"arrows": "to", "from": "fatigue, weight_loss, restlessness, lethargy, irregular_sugar_level, obesity, excessive_hunger, increased_appetite, polyuria", "title": "Diagnosis", "to": "Diabetes"}, {"arrows": "to", "from": "fatigue, weight_loss, restlessness, lethargy, irregular_sugar_level, blurred_and_distorted_vision, excessive_hunger, increased_appetite, polyuria", "title": "Diagnosis", "to": "Diabetes"}, {"arrows": "to", "from": "fatigue, weight_loss, restlessness, lethargy, irregular_sugar_level, blurred_and_distorted_vision, obesity, increased_appetite, polyuria", "title": "Diagnosis", "to": "Diabetes"}, {"arrows": "to", "from": "vomiting, sunken_eyes, dehydration, diarrhoea", "title": "Diagnosis", "to": "Gastroenteritis"}, {"arrows": "to", "from": "sunken_eyes, dehydration, diarrhoea", "title": "Diagnosis", "to": "Gastroenteritis"}, {"arrows": "to", "from": "vomiting, dehydration, diarrhoea", "title": "Diagnosis", "to": "Gastroenteritis"}, {"arrows": "to", "from": "vomiting, sunken_eyes, diarrhoea", "title": "Diagnosis", "to": "Gastroenteritis"}, {"arrows": "to", "from": "vomiting, sunken_eyes, dehydration", "title": "Diagnosis", "to": "Gastroenteritis"}, {"arrows": "to", "from": "fatigue, cough, high_fever, breathlessness, family_history, mucoid_sputum", "title": "Diagnosis", "to": "Bronchial Asthma"}, {"arrows": "to", "from": "cough, high_fever, breathlessness, family_history, mucoid_sputum", "title": "Diagnosis", "to": "Bronchial Asthma"}, {"arrows": "to", "from": "fatigue, high_fever, breathlessness, family_history, mucoid_sputum", "title": "Diagnosis", "to": "Bronchial Asthma"}, {"arrows": "to", "from": "fatigue, cough, breathlessness, family_history, mucoid_sputum", "title": "Diagnosis", "to": "Bronchial Asthma"}, {"arrows": "to", "from": "fatigue, cough, high_fever, family_history, mucoid_sputum", "title": "Diagnosis", "to": "Bronchial Asthma"}, {"arrows": "to", "from": "fatigue, cough, high_fever, breathlessness, mucoid_sputum", "title": "Diagnosis", "to": "Bronchial Asthma"}, {"arrows": "to", "from": "fatigue, cough, high_fever, breathlessness, family_history", "title": "Diagnosis", "to": "Bronchial Asthma"}, {"arrows": "to", "from": "headache, chest_pain, dizziness, loss_of_balance, lack_of_concentration", "title": "Diagnosis", "to": "Hypertension"}, {"arrows": "to", "from": "chest_pain, dizziness, loss_of_balance, lack_of_concentration", "title": "Diagnosis", "to": "Hypertension"}, {"arrows": "to", "from": "headache, dizziness, loss_of_balance, lack_of_concentration", "title": "Diagnosis", "to": "Hypertension"}, {"arrows": "to", "from": "headache, chest_pain, loss_of_balance, lack_of_concentration", "title": "Diagnosis", "to": "Hypertension"}, {"arrows": "to", "from": "headache, chest_pain, dizziness, lack_of_concentration", "title": "Diagnosis", "to": "Hypertension"}, {"arrows": "to", "from": "headache, chest_pain, dizziness, loss_of_balance", "title": "Diagnosis", "to": "Hypertension"}, {"arrows": "to", "from": "acidity, indigestion, headache, blurred_and_distorted_vision, excessive_hunger, stiff_neck, depression, irritability, visual_disturbances", "title": "Diagnosis", "to": "Migraine"}, {"arrows": "to", "from": "indigestion, headache, blurred_and_distorted_vision, excessive_hunger, stiff_neck, depression, irritability, visual_disturbances", "title": "Diagnosis", "to": "Migraine"}, {"arrows": "to", "from": "acidity, headache, blurred_and_distorted_vision, excessive_hunger, stiff_neck, depression, irritability, visual_disturbances", "title": "Diagnosis", "to": "Migraine"}, {"arrows": "to", "from": "acidity, indigestion, blurred_and_distorted_vision, excessive_hunger, stiff_neck, depression, irritability, visual_disturbances", "title": "Diagnosis", "to": "Migraine"}, {"arrows": "to", "from": "acidity, indigestion, headache, excessive_hunger, stiff_neck, depression, irritability, visual_disturbances", "title": "Diagnosis", "to": "Migraine"}, {"arrows": "to", "from": "acidity, indigestion, headache, blurred_and_distorted_vision, stiff_neck, depression, irritability, visual_disturbances", "title": "Diagnosis", "to": "Migraine"}, {"arrows": "to", "from": "acidity, indigestion, headache, blurred_and_distorted_vision, excessive_hunger, depression, irritability, visual_disturbances", "title": "Diagnosis", "to": "Migraine"}, {"arrows": "to", "from": "acidity, indigestion, headache, blurred_and_distorted_vision, excessive_hunger, stiff_neck, irritability, visual_disturbances", "title": "Diagnosis", "to": "Migraine"}, {"arrows": "to", "from": "acidity, indigestion, headache, blurred_and_distorted_vision, excessive_hunger, stiff_neck, depression, visual_disturbances", "title": "Diagnosis", "to": "Migraine"}, {"arrows": "to", "from": "acidity, indigestion, headache, blurred_and_distorted_vision, excessive_hunger, stiff_neck, depression, irritability", "title": "Diagnosis", "to": "Migraine"}, {"arrows": "to", "from": "back_pain, weakness_in_limbs, neck_pain, dizziness, loss_of_balance", "title": "Diagnosis", "to": "Cervical Spondylosis"}, {"arrows": "to", "from": "weakness_in_limbs, neck_pain, dizziness, loss_of_balance", "title": "Diagnosis", "to": "Cervical Spondylosis"}, {"arrows": "to", "from": "back_pain, neck_pain, dizziness, loss_of_balance", "title": "Diagnosis", "to": "Cervical Spondylosis"}, {"arrows": "to", "from": "back_pain, weakness_in_limbs, dizziness, loss_of_balance", "title": "Diagnosis", "to": "Cervical Spondylosis"}, {"arrows": "to", "from": "back_pain, weakness_in_limbs, neck_pain, loss_of_balance", "title": "Diagnosis", "to": "Cervical Spondylosis"}, {"arrows": "to", "from": "back_pain, weakness_in_limbs, neck_pain, dizziness", "title": "Diagnosis", "to": "Cervical Spondylosis"}, {"arrows": "to", "from": "vomiting, headache, weakness_of_one_body_side, altered_sensorium", "title": "Diagnosis", "to": "Paralysis (brain hemorrhage)"}, {"arrows": "to", "from": "headache, weakness_of_one_body_side, altered_sensorium", "title": "Diagnosis", "to": "Paralysis (brain hemorrhage)"}, {"arrows": "to", "from": "vomiting, weakness_of_one_body_side, altered_sensorium", "title": "Diagnosis", "to": "Paralysis (brain hemorrhage)"}, {"arrows": "to", "from": "vomiting, headache, altered_sensorium", "title": "Diagnosis", "to": "Paralysis (brain hemorrhage)"}, {"arrows": "to", "from": "vomiting, headache, weakness_of_one_body_side", "title": "Diagnosis", "to": "Paralysis (brain hemorrhage)"}, {"arrows": "to", "from": "itching, vomiting, fatigue, weight_loss, high_fever, yellowish_skin, dark_urine, abdominal_pain", "title": "Diagnosis", "to": "Jaundice"}, {"arrows": "to", "from": "vomiting, fatigue, weight_loss, high_fever, yellowish_skin, dark_urine, abdominal_pain", "title": "Diagnosis", "to": "Jaundice"}, {"arrows": "to", "from": "itching, fatigue, weight_loss, high_fever, yellowish_skin, dark_urine, abdominal_pain", "title": "Diagnosis", "to": "Jaundice"}, {"arrows": "to", "from": "itching, vomiting, weight_loss, high_fever, yellowish_skin, dark_urine, abdominal_pain", "title": "Diagnosis", "to": "Jaundice"}, {"arrows": "to", "from": "itching, vomiting, fatigue, high_fever, yellowish_skin, dark_urine, abdominal_pain", "title": "Diagnosis", "to": "Jaundice"}, {"arrows": "to", "from": "itching, vomiting, fatigue, weight_loss, yellowish_skin, dark_urine, abdominal_pain", "title": "Diagnosis", "to": "Jaundice"}, {"arrows": "to", "from": "itching, vomiting, fatigue, weight_loss, high_fever, dark_urine, abdominal_pain", "title": "Diagnosis", "to": "Jaundice"}, {"arrows": "to", "from": "itching, vomiting, fatigue, weight_loss, high_fever, yellowish_skin, abdominal_pain", "title": "Diagnosis", "to": "Jaundice"}, {"arrows": "to", "from": "itching, vomiting, fatigue, weight_loss, high_fever, yellowish_skin, dark_urine", "title": "Diagnosis", "to": "Jaundice"}, {"arrows": "to", "from": "chills, vomiting, high_fever, sweating, headache, nausea, muscle_pain", "title": "Diagnosis", "to": "Malaria"}, {"arrows": "to", "from": "chills, vomiting, high_fever, sweating, headache, nausea, diarrhoea, muscle_pain", "title": "Diagnosis", "to": "Malaria"}, {"arrows": "to", "from": "vomiting, high_fever, sweating, headache, nausea, diarrhoea, muscle_pain", "title": "Diagnosis", "to": "Malaria"}, {"arrows": "to", "from": "chills, high_fever, sweating, headache, nausea, diarrhoea, muscle_pain", "title": "Diagnosis", "to": "Malaria"}, {"arrows": "to", "from": "chills, vomiting, sweating, headache, nausea, diarrhoea, muscle_pain", "title": "Diagnosis", "to": "Malaria"}, {"arrows": "to", "from": "chills, vomiting, high_fever, headache, nausea, diarrhoea, muscle_pain", "title": "Diagnosis", "to": "Malaria"}, {"arrows": "to", "from": "chills, vomiting, high_fever, sweating, nausea, diarrhoea, muscle_pain", "title": "Diagnosis", "to": "Malaria"}, {"arrows": "to", "from": "chills, vomiting, high_fever, sweating, headache, diarrhoea, muscle_pain", "title": "Diagnosis", "to": "Malaria"}, {"arrows": "to", "from": "itching, skin_rash, fatigue, lethargy, high_fever, headache, loss_of_appetite, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "title": "Diagnosis", "to": "Chickenpox"}, {"arrows": "to", "from": "skin_rash, fatigue, lethargy, high_fever, headache, loss_of_appetite, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "title": "Diagnosis", "to": "Chickenpox"}, {"arrows": "to", "from": "itching, fatigue, lethargy, high_fever, headache, loss_of_appetite, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "title": "Diagnosis", "to": "Chickenpox"}, {"arrows": "to", "from": "itching, skin_rash, lethargy, high_fever, headache, loss_of_appetite, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "title": "Diagnosis", "to": "Chickenpox"}, {"arrows": "to", "from": "itching, skin_rash, fatigue, high_fever, headache, loss_of_appetite, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "title": "Diagnosis", "to": "Chickenpox"}, {"arrows": "to", "from": "itching, skin_rash, fatigue, lethargy, headache, loss_of_appetite, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "title": "Diagnosis", "to": "Chickenpox"}, {"arrows": "to", "from": "itching, skin_rash, fatigue, lethargy, high_fever, loss_of_appetite, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "title": "Diagnosis", "to": "Chickenpox"}, {"arrows": "to", "from": "itching, skin_rash, fatigue, lethargy, high_fever, headache, mild_fever, swelled_lymph_nodes, malaise, red_spots_over_body", "title": "Diagnosis", "to": "Chickenpox"}, {"arrows": "to", "from": "itching, skin_rash, fatigue, lethargy, high_fever, headache, loss_of_appetite, swelled_lymph_nodes, malaise, red_spots_over_body", "title": "Diagnosis", "to": "Chickenpox"}, {"arrows": "to", "from": "itching, skin_rash, fatigue, lethargy, high_fever, headache, loss_of_appetite, mild_fever, malaise, red_spots_over_body", "title": "Diagnosis", "to": "Chickenpox"}, {"arrows": "to", "from": "skin_rash, chills, joint_pain, vomiting, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, muscle_pain, red_spots_over_body", "title": "Diagnosis", "to": "Dengue"}, {"arrows": "to", "from": "skin_rash, chills, joint_pain, vomiting, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, red_spots_over_body", "title": "Diagnosis", "to": "Dengue"}, {"arrows": "to", "from": "skin_rash, chills, joint_pain, vomiting, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain", "title": "Diagnosis", "to": "Dengue"}, {"arrows": "to", "from": "skin_rash, chills, joint_pain, vomiting, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain, red_spots_over_body", "title": "Diagnosis", "to": "Dengue"}, {"arrows": "to", "from": "chills, joint_pain, vomiting, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain, red_spots_over_body", "title": "Diagnosis", "to": "Dengue"}, {"arrows": "to", "from": "skin_rash, joint_pain, vomiting, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain, red_spots_over_body", "title": "Diagnosis", "to": "Dengue"}, {"arrows": "to", "from": "skin_rash, chills, vomiting, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain, red_spots_over_body", "title": "Diagnosis", "to": "Dengue"}, {"arrows": "to", "from": "skin_rash, chills, joint_pain, fatigue, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain, red_spots_over_body", "title": "Diagnosis", "to": "Dengue"}, {"arrows": "to", "from": "skin_rash, chills, joint_pain, vomiting, high_fever, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain, red_spots_over_body", "title": "Diagnosis", "to": "Dengue"}, {"arrows": "to", "from": "skin_rash, chills, joint_pain, vomiting, fatigue, headache, nausea, loss_of_appetite, pain_behind_the_eyes, back_pain, malaise, muscle_pain, red_spots_over_body", "title": "Diagnosis", "to": "Dengue"}, {"arrows": "to", "from": "chills, vomiting, fatigue, high_fever, nausea, constipation, abdominal_pain, diarrhoea, toxic_look_(typhos), belly_pain", "title": "Diagnosis", "to": "Typhoid"}, {"arrows": "to", "from": "chills, vomiting, fatigue, high_fever, headache, constipation, abdominal_pain, diarrhoea, toxic_look_(typhos), belly_pain", "title": "Diagnosis", "to": "Typhoid"}, {"arrows": "to", "from": "chills, vomiting, fatigue, high_fever, headache, nausea, abdominal_pain, diarrhoea, toxic_look_(typhos), belly_pain", "title": "Diagnosis", "to": "Typhoid"}, {"arrows": "to", "from": "chills, vomiting, fatigue, high_fever, headache, nausea, constipation, diarrhoea, toxic_look_(typhos), belly_pain", "title": "Diagnosis", "to": "Typhoid"}, {"arrows": "to", "from": "chills, vomiting, fatigue, high_fever, headache, nausea, constipation, abdominal_pain, toxic_look_(typhos), belly_pain", "title": "Diagnosis", "to": "Typhoid"}, {"arrows": "to", "from": "chills, vomiting, fatigue, high_fever, headache, nausea, constipation, abdominal_pain, diarrhoea, belly_pain", "title": "Diagnosis", "to": "Typhoid"}, {"arrows": "to", "from": "chills, vomiting, fatigue, high_fever, headache, nausea, constipation, abdominal_pain, diarrhoea, toxic_look_(typhos)", "title": "Diagnosis", "to": "Typhoid"}, {"arrows": "to", "from": "chills, vomiting, fatigue, high_fever, headache, nausea, constipation, abdominal_pain, diarrhoea, toxic_look_(typhos), belly_pain", "title": "Diagnosis", "to": "Typhoid"}, {"arrows": "to", "from": "chills, fatigue, high_fever, headache, nausea, constipation, abdominal_pain, diarrhoea, toxic_look_(typhos), belly_pain", "title": "Diagnosis", "to": "Typhoid"}, {"arrows": "to", "from": "joint_pain, vomiting, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "title": "Diagnosis", "to": "Hepatitis A"}, {"arrows": "to", "from": "vomiting, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "title": "Diagnosis", "to": "Hepatitis A"}, {"arrows": "to", "from": "joint_pain, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "title": "Diagnosis", "to": "Hepatitis A"}, {"arrows": "to", "from": "joint_pain, vomiting, dark_urine, nausea, loss_of_appetite, abdominal_pain, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "title": "Diagnosis", "to": "Hepatitis A"}, {"arrows": "to", "from": "joint_pain, vomiting, yellowish_skin, nausea, loss_of_appetite, abdominal_pain, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "title": "Diagnosis", "to": "Hepatitis A"}, {"arrows": "to", "from": "joint_pain, vomiting, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "title": "Diagnosis", "to": "Hepatitis A"}, {"arrows": "to", "from": "joint_pain, vomiting, yellowish_skin, dark_urine, nausea, abdominal_pain, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "title": "Diagnosis", "to": "Hepatitis A"}, {"arrows": "to", "from": "joint_pain, vomiting, yellowish_skin, dark_urine, nausea, loss_of_appetite, diarrhoea, mild_fever, yellowing_of_eyes, muscle_pain", "title": "Diagnosis", "to": "Hepatitis A"}, {"arrows": "to", "from": "joint_pain, vomiting, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, mild_fever, yellowing_of_eyes, muscle_pain", "title": "Diagnosis", "to": "Hepatitis A"}, {"arrows": "to", "from": "itching, fatigue, lethargy, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "title": "Diagnosis", "to": "Hepatitis B"}, {"arrows": "to", "from": "fatigue, lethargy, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "title": "Diagnosis", "to": "Hepatitis B"}, {"arrows": "to", "from": "itching, lethargy, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "title": "Diagnosis", "to": "Hepatitis B"}, {"arrows": "to", "from": "itching, fatigue, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "title": "Diagnosis", "to": "Hepatitis B"}, {"arrows": "to", "from": "itching, fatigue, lethargy, dark_urine, loss_of_appetite, abdominal_pain, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "title": "Diagnosis", "to": "Hepatitis B"}, {"arrows": "to", "from": "itching, fatigue, lethargy, yellowish_skin, loss_of_appetite, abdominal_pain, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "title": "Diagnosis", "to": "Hepatitis B"}, {"arrows": "to", "from": "itching, fatigue, lethargy, yellowish_skin, dark_urine, abdominal_pain, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "title": "Diagnosis", "to": "Hepatitis B"}, {"arrows": "to", "from": "itching, fatigue, lethargy, yellowish_skin, dark_urine, loss_of_appetite, yellow_urine, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "title": "Diagnosis", "to": "Hepatitis B"}, {"arrows": "to", "from": "itching, fatigue, lethargy, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, yellowing_of_eyes, malaise, receiving_blood_transfusion, receiving_unsterile_injections", "title": "Diagnosis", "to": "Hepatitis B"}, {"arrows": "to", "from": "fatigue, yellowish_skin, nausea, loss_of_appetite, family_history", "title": "Diagnosis", "to": "Hepatitis C"}, {"arrows": "to", "from": "fatigue, yellowish_skin, nausea, loss_of_appetite, yellowing_of_eyes, family_history", "title": "Diagnosis", "to": "Hepatitis C"}, {"arrows": "to", "from": "yellowish_skin, nausea, loss_of_appetite, yellowing_of_eyes, family_history", "title": "Diagnosis", "to": "Hepatitis C"}, {"arrows": "to", "from": "fatigue, nausea, loss_of_appetite, yellowing_of_eyes, family_history", "title": "Diagnosis", "to": "Hepatitis C"}, {"arrows": "to", "from": "fatigue, yellowish_skin, loss_of_appetite, yellowing_of_eyes, family_history", "title": "Diagnosis", "to": "Hepatitis C"}, {"arrows": "to", "from": "fatigue, yellowish_skin, nausea, yellowing_of_eyes, family_history", "title": "Diagnosis", "to": "Hepatitis C"}, {"arrows": "to", "from": "fatigue, yellowish_skin, nausea, loss_of_appetite, yellowing_of_eyes", "title": "Diagnosis", "to": "Hepatitis C"}, {"arrows": "to", "from": "joint_pain, vomiting, fatigue, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "title": "Diagnosis", "to": "Hepatitis D"}, {"arrows": "to", "from": "vomiting, fatigue, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "title": "Diagnosis", "to": "Hepatitis D"}, {"arrows": "to", "from": "joint_pain, fatigue, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "title": "Diagnosis", "to": "Hepatitis D"}, {"arrows": "to", "from": "joint_pain, vomiting, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "title": "Diagnosis", "to": "Hepatitis D"}, {"arrows": "to", "from": "joint_pain, vomiting, fatigue, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "title": "Diagnosis", "to": "Hepatitis D"}, {"arrows": "to", "from": "joint_pain, vomiting, fatigue, yellowish_skin, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "title": "Diagnosis", "to": "Hepatitis D"}, {"arrows": "to", "from": "joint_pain, vomiting, fatigue, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, yellowing_of_eyes", "title": "Diagnosis", "to": "Hepatitis D"}, {"arrows": "to", "from": "joint_pain, vomiting, fatigue, yellowish_skin, dark_urine, nausea, abdominal_pain, yellowing_of_eyes", "title": "Diagnosis", "to": "Hepatitis D"}, {"arrows": "to", "from": "joint_pain, vomiting, fatigue, yellowish_skin, dark_urine, nausea, loss_of_appetite, yellowing_of_eyes", "title": "Diagnosis", "to": "Hepatitis D"}, {"arrows": "to", "from": "joint_pain, vomiting, fatigue, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain", "title": "Diagnosis", "to": "Hepatitis D"}, {"arrows": "to", "from": "joint_pain, vomiting, fatigue, high_fever, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, coma, stomach_bleeding", "title": "Diagnosis", "to": "Hepatitis E"}, {"arrows": "to", "from": "joint_pain, vomiting, fatigue, high_fever, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "title": "Diagnosis", "to": "Hepatitis E"}, {"arrows": "to", "from": "vomiting, fatigue, high_fever, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "title": "Diagnosis", "to": "Hepatitis E"}, {"arrows": "to", "from": "joint_pain, fatigue, high_fever, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "title": "Diagnosis", "to": "Hepatitis E"}, {"arrows": "to", "from": "joint_pain, vomiting, high_fever, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "title": "Diagnosis", "to": "Hepatitis E"}, {"arrows": "to", "from": "joint_pain, vomiting, fatigue, yellowish_skin, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "title": "Diagnosis", "to": "Hepatitis E"}, {"arrows": "to", "from": "joint_pain, vomiting, fatigue, high_fever, dark_urine, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "title": "Diagnosis", "to": "Hepatitis E"}, {"arrows": "to", "from": "joint_pain, vomiting, fatigue, high_fever, yellowish_skin, nausea, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "title": "Diagnosis", "to": "Hepatitis E"}, {"arrows": "to", "from": "joint_pain, vomiting, fatigue, high_fever, yellowish_skin, dark_urine, loss_of_appetite, abdominal_pain, yellowing_of_eyes, acute_liver_failure, coma, stomach_bleeding", "title": "Diagnosis", "to": "Hepatitis E"}, {"arrows": "to", "from": "vomiting, yellowish_skin, abdominal_pain, swelling_of_stomach, distention_of_abdomen, history_of_alcohol_consumption, fluid_overload.1", "title": "Diagnosis", "to": "Alcoholic Hepatitis"}, {"arrows": "to", "from": "yellowish_skin, abdominal_pain, swelling_of_stomach, distention_of_abdomen, history_of_alcohol_consumption, fluid_overload.1", "title": "Diagnosis", "to": "Alcoholic Hepatitis"}, {"arrows": "to", "from": "vomiting, abdominal_pain, swelling_of_stomach, distention_of_abdomen, history_of_alcohol_consumption, fluid_overload.1", "title": "Diagnosis", "to": "Alcoholic Hepatitis"}, {"arrows": "to", "from": "vomiting, yellowish_skin, swelling_of_stomach, distention_of_abdomen, history_of_alcohol_consumption, fluid_overload.1", "title": "Diagnosis", "to": "Alcoholic Hepatitis"}, {"arrows": "to", "from": "vomiting, yellowish_skin, abdominal_pain, distention_of_abdomen, history_of_alcohol_consumption, fluid_overload.1", "title": "Diagnosis", "to": "Alcoholic Hepatitis"}, {"arrows": "to", "from": "vomiting, yellowish_skin, abdominal_pain, swelling_of_stomach, history_of_alcohol_consumption, fluid_overload.1", "title": "Diagnosis", "to": "Alcoholic Hepatitis"}, {"arrows": "to", "from": "vomiting, yellowish_skin, abdominal_pain, swelling_of_stomach, distention_of_abdomen, fluid_overload.1", "title": "Diagnosis", "to": "Alcoholic Hepatitis"}, {"arrows": "to", "from": "vomiting, yellowish_skin, abdominal_pain, swelling_of_stomach, distention_of_abdomen, history_of_alcohol_consumption", "title": "Diagnosis", "to": "Alcoholic Hepatitis"}, {"arrows": "to", "from": "chills, vomiting, fatigue, weight_loss, cough, high_fever, breathlessness, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "title": "Diagnosis", "to": "Tuberculosis"}, {"arrows": "to", "from": "vomiting, fatigue, weight_loss, cough, high_fever, breathlessness, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "title": "Diagnosis", "to": "Tuberculosis"}, {"arrows": "to", "from": "chills, fatigue, weight_loss, cough, high_fever, breathlessness, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "title": "Diagnosis", "to": "Tuberculosis"}, {"arrows": "to", "from": "chills, vomiting, weight_loss, cough, high_fever, breathlessness, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "title": "Diagnosis", "to": "Tuberculosis"}, {"arrows": "to", "from": "chills, vomiting, fatigue, cough, high_fever, breathlessness, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "title": "Diagnosis", "to": "Tuberculosis"}, {"arrows": "to", "from": "chills, vomiting, fatigue, weight_loss, high_fever, breathlessness, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "title": "Diagnosis", "to": "Tuberculosis"}, {"arrows": "to", "from": "chills, vomiting, fatigue, weight_loss, cough, breathlessness, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "title": "Diagnosis", "to": "Tuberculosis"}, {"arrows": "to", "from": "chills, vomiting, fatigue, weight_loss, cough, high_fever, sweating, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "title": "Diagnosis", "to": "Tuberculosis"}, {"arrows": "to", "from": "chills, vomiting, fatigue, weight_loss, cough, high_fever, breathlessness, loss_of_appetite, mild_fever, yellowing_of_eyes, swelled_lymph_nodes, malaise, phlegm, chest_pain, blood_in_sputum", "title": "Diagnosis", "to": "Tuberculosis"}, {"arrows": "to", "from": "continuous_sneezing, chills, fatigue, cough, high_fever, headache, swelled_lymph_nodes, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "title": "Diagnosis", "to": "Common Cold"}, {"arrows": "to", "from": "chills, fatigue, cough, high_fever, headache, swelled_lymph_nodes, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "title": "Diagnosis", "to": "Common Cold"}, {"arrows": "to", "from": "continuous_sneezing, fatigue, cough, high_fever, headache, swelled_lymph_nodes, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "title": "Diagnosis", "to": "Common Cold"}, {"arrows": "to", "from": "continuous_sneezing, chills, cough, high_fever, headache, swelled_lymph_nodes, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "title": "Diagnosis", "to": "Common Cold"}, {"arrows": "to", "from": "continuous_sneezing, chills, fatigue, high_fever, headache, swelled_lymph_nodes, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "title": "Diagnosis", "to": "Common Cold"}, {"arrows": "to", "from": "continuous_sneezing, chills, fatigue, cough, headache, swelled_lymph_nodes, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "title": "Diagnosis", "to": "Common Cold"}, {"arrows": "to", "from": "continuous_sneezing, chills, fatigue, cough, high_fever, swelled_lymph_nodes, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "title": "Diagnosis", "to": "Common Cold"}, {"arrows": "to", "from": "continuous_sneezing, chills, fatigue, cough, high_fever, headache, malaise, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "title": "Diagnosis", "to": "Common Cold"}, {"arrows": "to", "from": "continuous_sneezing, chills, fatigue, cough, high_fever, headache, swelled_lymph_nodes, phlegm, throat_irritation, redness_of_eyes, sinus_pressure, runny_nose, congestion, chest_pain, loss_of_smell, muscle_pain", "title": "Diagnosis", "to": "Common Cold"}, {"arrows": "to", "from": "chills, fatigue, cough, high_fever, breathlessness, sweating, malaise, chest_pain, fast_heart_rate, rusty_sputum", "title": "Diagnosis", "to": "Pneumonia"}, {"arrows": "to", "from": "chills, fatigue, cough, high_fever, breathlessness, sweating, malaise, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "title": "Diagnosis", "to": "Pneumonia"}, {"arrows": "to", "from": "fatigue, cough, high_fever, breathlessness, sweating, malaise, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "title": "Diagnosis", "to": "Pneumonia"}, {"arrows": "to", "from": "chills, cough, high_fever, breathlessness, sweating, malaise, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "title": "Diagnosis", "to": "Pneumonia"}, {"arrows": "to", "from": "chills, fatigue, high_fever, breathlessness, sweating, malaise, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "title": "Diagnosis", "to": "Pneumonia"}, {"arrows": "to", "from": "chills, fatigue, cough, breathlessness, sweating, malaise, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "title": "Diagnosis", "to": "Pneumonia"}, {"arrows": "to", "from": "chills, fatigue, cough, high_fever, sweating, malaise, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "title": "Diagnosis", "to": "Pneumonia"}, {"arrows": "to", "from": "chills, fatigue, cough, high_fever, breathlessness, malaise, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "title": "Diagnosis", "to": "Pneumonia"}, {"arrows": "to", "from": "chills, fatigue, cough, high_fever, breathlessness, sweating, phlegm, chest_pain, fast_heart_rate, rusty_sputum", "title": "Diagnosis", "to": "Pneumonia"}, {"arrows": "to", "from": "constipation, pain_during_bowel_movements, pain_in_anal_region, bloody_stool, irritation_in_anus", "title": "Diagnosis", "to": "Dimorphic Hemmorhoids (piles)"}, {"arrows": "to", "from": "pain_during_bowel_movements, pain_in_anal_region, bloody_stool, irritation_in_anus", "title": "Diagnosis", "to": "Dimorphic Hemmorhoids (piles)"}, {"arrows": "to", "from": "constipation, pain_in_anal_region, bloody_stool, irritation_in_anus", "title": "Diagnosis", "to": "Dimorphic Hemmorhoids (piles)"}, {"arrows": "to", "from": "constipation, pain_during_bowel_movements, bloody_stool, irritation_in_anus", "title": "Diagnosis", "to": "Dimorphic Hemmorhoids (piles)"}, {"arrows": "to", "from": "constipation, pain_during_bowel_movements, pain_in_anal_region, irritation_in_anus", "title": "Diagnosis", "to": "Dimorphic Hemmorhoids (piles)"}, {"arrows": "to", "from": "constipation, pain_during_bowel_movements, pain_in_anal_region, bloody_stool", "title": "Diagnosis", "to": "Dimorphic Hemmorhoids (piles)"}, {"arrows": "to", "from": "vomiting, breathlessness, sweating, chest_pain", "title": "Diagnosis", "to": "Heart Attack"}, {"arrows": "to", "from": "breathlessness, sweating, chest_pain", "title": "Diagnosis", "to": "Heart Attack"}, {"arrows": "to", "from": "vomiting, sweating, chest_pain", "title": "Diagnosis", "to": "Heart Attack"}, {"arrows": "to", "from": "vomiting, breathlessness, chest_pain", "title": "Diagnosis", "to": "Heart Attack"}, {"arrows": "to", "from": "vomiting, breathlessness, sweating", "title": "Diagnosis", "to": "Heart Attack"}, {"arrows": "to", "from": "fatigue, cramps, bruising, obesity, swollen_legs, swollen_blood_vessels, prominent_veins_on_calf", "title": "Diagnosis", "to": "Varicose Veins"}, {"arrows": "to", "from": "cramps, bruising, obesity, swollen_legs, swollen_blood_vessels, prominent_veins_on_calf", "title": "Diagnosis", "to": "Varicose Veins"}, {"arrows": "to", "from": "fatigue, bruising, obesity, swollen_legs, swollen_blood_vessels, prominent_veins_on_calf", "title": "Diagnosis", "to": "Varicose Veins"}, {"arrows": "to", "from": "fatigue, cramps, obesity, swollen_legs, swollen_blood_vessels, prominent_veins_on_calf", "title": "Diagnosis", "to": "Varicose Veins"}, {"arrows": "to", "from": "fatigue, cramps, bruising, swollen_legs, swollen_blood_vessels, prominent_veins_on_calf", "title": "Diagnosis", "to": "Varicose Veins"}, {"arrows": "to", "from": "fatigue, cramps, bruising, obesity, swollen_blood_vessels, prominent_veins_on_calf", "title": "Diagnosis", "to": "Varicose Veins"}, {"arrows": "to", "from": "fatigue, cramps, bruising, obesity, swollen_legs, prominent_veins_on_calf", "title": "Diagnosis", "to": "Varicose Veins"}, {"arrows": "to", "from": "fatigue, cramps, bruising, obesity, swollen_legs, swollen_blood_vessels", "title": "Diagnosis", "to": "Varicose Veins"}, {"arrows": "to", "from": "fatigue, weight_gain, cold_hands_and_feets, mood_swings, lethargy, dizziness, puffy_face_and_eyes, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "title": "Diagnosis", "to": "Hypothyroidism"}, {"arrows": "to", "from": "weight_gain, cold_hands_and_feets, mood_swings, lethargy, dizziness, puffy_face_and_eyes, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "title": "Diagnosis", "to": "Hypothyroidism"}, {"arrows": "to", "from": "fatigue, cold_hands_and_feets, mood_swings, lethargy, dizziness, puffy_face_and_eyes, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "title": "Diagnosis", "to": "Hypothyroidism"}, {"arrows": "to", "from": "fatigue, weight_gain, mood_swings, lethargy, dizziness, puffy_face_and_eyes, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "title": "Diagnosis", "to": "Hypothyroidism"}, {"arrows": "to", "from": "fatigue, weight_gain, cold_hands_and_feets, lethargy, dizziness, puffy_face_and_eyes, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "title": "Diagnosis", "to": "Hypothyroidism"}, {"arrows": "to", "from": "fatigue, weight_gain, cold_hands_and_feets, mood_swings, dizziness, puffy_face_and_eyes, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "title": "Diagnosis", "to": "Hypothyroidism"}, {"arrows": "to", "from": "fatigue, weight_gain, cold_hands_and_feets, mood_swings, lethargy, puffy_face_and_eyes, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "title": "Diagnosis", "to": "Hypothyroidism"}, {"arrows": "to", "from": "fatigue, weight_gain, cold_hands_and_feets, mood_swings, lethargy, dizziness, enlarged_thyroid, brittle_nails, swollen_extremeties, depression, irritability, abnormal_menstruation", "title": "Diagnosis", "to": "Hypothyroidism"}, {"arrows": "to", "from": "fatigue, mood_swings, weight_loss, restlessness, sweating, diarrhoea, fast_heart_rate, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "title": "Diagnosis", "to": "Hyperthyroidism"}, {"arrows": "to", "from": "mood_swings, weight_loss, restlessness, sweating, diarrhoea, fast_heart_rate, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "title": "Diagnosis", "to": "Hyperthyroidism"}, {"arrows": "to", "from": "fatigue, weight_loss, restlessness, sweating, diarrhoea, fast_heart_rate, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "title": "Diagnosis", "to": "Hyperthyroidism"}, {"arrows": "to", "from": "fatigue, mood_swings, restlessness, sweating, diarrhoea, fast_heart_rate, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "title": "Diagnosis", "to": "Hyperthyroidism"}, {"arrows": "to", "from": "fatigue, mood_swings, weight_loss, sweating, diarrhoea, fast_heart_rate, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "title": "Diagnosis", "to": "Hyperthyroidism"}, {"arrows": "to", "from": "fatigue, mood_swings, weight_loss, restlessness, diarrhoea, fast_heart_rate, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "title": "Diagnosis", "to": "Hyperthyroidism"}, {"arrows": "to", "from": "fatigue, mood_swings, weight_loss, restlessness, sweating, fast_heart_rate, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "title": "Diagnosis", "to": "Hyperthyroidism"}, {"arrows": "to", "from": "fatigue, mood_swings, weight_loss, restlessness, sweating, diarrhoea, excessive_hunger, muscle_weakness, irritability, abnormal_menstruation", "title": "Diagnosis", "to": "Hyperthyroidism"}, {"arrows": "to", "from": "fatigue, mood_swings, weight_loss, restlessness, sweating, diarrhoea, fast_heart_rate, muscle_weakness, irritability, abnormal_menstruation", "title": "Diagnosis", "to": "Hyperthyroidism"}, {"arrows": "to", "from": "vomiting, fatigue, anxiety, sweating, headache, nausea, blurred_and_distorted_vision, excessive_hunger, slurred_speech, irritability, palpitations", "title": "Diagnosis", "to": "Hypoglycemia"}, {"arrows": "to", "from": "vomiting, fatigue, anxiety, sweating, headache, nausea, blurred_and_distorted_vision, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "title": "Diagnosis", "to": "Hypoglycemia"}, {"arrows": "to", "from": "fatigue, anxiety, sweating, headache, nausea, blurred_and_distorted_vision, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "title": "Diagnosis", "to": "Hypoglycemia"}, {"arrows": "to", "from": "vomiting, anxiety, sweating, headache, nausea, blurred_and_distorted_vision, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "title": "Diagnosis", "to": "Hypoglycemia"}, {"arrows": "to", "from": "vomiting, fatigue, sweating, headache, nausea, blurred_and_distorted_vision, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "title": "Diagnosis", "to": "Hypoglycemia"}, {"arrows": "to", "from": "vomiting, fatigue, anxiety, headache, nausea, blurred_and_distorted_vision, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "title": "Diagnosis", "to": "Hypoglycemia"}, {"arrows": "to", "from": "vomiting, fatigue, anxiety, sweating, nausea, blurred_and_distorted_vision, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "title": "Diagnosis", "to": "Hypoglycemia"}, {"arrows": "to", "from": "vomiting, fatigue, anxiety, sweating, headache, blurred_and_distorted_vision, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "title": "Diagnosis", "to": "Hypoglycemia"}, {"arrows": "to", "from": "vomiting, fatigue, anxiety, sweating, headache, nausea, excessive_hunger, drying_and_tingling_lips, slurred_speech, irritability, palpitations", "title": "Diagnosis", "to": "Hypoglycemia"}, {"arrows": "to", "from": "joint_pain, neck_pain, knee_pain, hip_joint_pain, swelling_joints, painful_walking", "title": "Diagnosis", "to": "Osteoarthritis"}, {"arrows": "to", "from": "neck_pain, knee_pain, hip_joint_pain, swelling_joints, painful_walking", "title": "Diagnosis", "to": "Osteoarthritis"}, {"arrows": "to", "from": "joint_pain, knee_pain, hip_joint_pain, swelling_joints, painful_walking", "title": "Diagnosis", "to": "Osteoarthritis"}, {"arrows": "to", "from": "joint_pain, neck_pain, hip_joint_pain, swelling_joints, painful_walking", "title": "Diagnosis", "to": "Osteoarthritis"}, {"arrows": "to", "from": "joint_pain, neck_pain, knee_pain, swelling_joints, painful_walking", "title": "Diagnosis", "to": "Osteoarthritis"}, {"arrows": "to", "from": "joint_pain, neck_pain, knee_pain, hip_joint_pain, painful_walking", "title": "Diagnosis", "to": "Osteoarthritis"}, {"arrows": "to", "from": "joint_pain, neck_pain, knee_pain, hip_joint_pain, swelling_joints", "title": "Diagnosis", "to": "Osteoarthritis"}, {"arrows": "to", "from": "muscle_weakness, stiff_neck, swelling_joints, movement_stiffness, painful_walking", "title": "Diagnosis", "to": "Arthritis"}, {"arrows": "to", "from": "stiff_neck, swelling_joints, movement_stiffness, painful_walking", "title": "Diagnosis", "to": "Arthritis"}, {"arrows": "to", "from": "muscle_weakness, swelling_joints, movement_stiffness, painful_walking", "title": "Diagnosis", "to": "Arthritis"}, {"arrows": "to", "from": "muscle_weakness, stiff_neck, movement_stiffness, painful_walking", "title": "Diagnosis", "to": "Arthritis"}, {"arrows": "to", "from": "muscle_weakness, stiff_neck, swelling_joints, painful_walking", "title": "Diagnosis", "to": "Arthritis"}, {"arrows": "to", "from": "muscle_weakness, stiff_neck, swelling_joints, movement_stiffness", "title": "Diagnosis", "to": "Arthritis"}, {"arrows": "to", "from": "vomiting, headache, nausea, spinning_movements, loss_of_balance, unsteadiness", "title": "Diagnosis", "to": "Vertigo"}, {"arrows": "to", "from": "headache, nausea, spinning_movements, loss_of_balance, unsteadiness", "title": "Diagnosis", "to": "Vertigo"}, {"arrows": "to", "from": "vomiting, nausea, spinning_movements, loss_of_balance, unsteadiness", "title": "Diagnosis", "to": "Vertigo"}, {"arrows": "to", "from": "vomiting, headache, spinning_movements, loss_of_balance, unsteadiness", "title": "Diagnosis", "to": "Vertigo"}, {"arrows": "to", "from": "vomiting, headache, nausea, loss_of_balance, unsteadiness", "title": "Diagnosis", "to": "Vertigo"}, {"arrows": "to", "from": "vomiting, headache, nausea, spinning_movements, unsteadiness", "title": "Diagnosis", "to": "Vertigo"}, {"arrows": "to", "from": "vomiting, headache, nausea, spinning_movements, loss_of_balance", "title": "Diagnosis", "to": "Vertigo"}, {"arrows": "to", "from": "skin_rash, pus_filled_pimples, blackheads, scurring", "title": "Diagnosis", "to": "Acne"}, {"arrows": "to", "from": "pus_filled_pimples, blackheads, scurring", "title": "Diagnosis", "to": "Acne"}, {"arrows": "to", "from": "skin_rash, blackheads, scurring", "title": "Diagnosis", "to": "Acne"}, {"arrows": "to", "from": "skin_rash, pus_filled_pimples, scurring", "title": "Diagnosis", "to": "Acne"}, {"arrows": "to", "from": "skin_rash, pus_filled_pimples, blackheads", "title": "Diagnosis", "to": "Acne"}, {"arrows": "to", "from": "burning_micturition, bladder_discomfort, foul_smell_of urine, continuous_feel_of_urine", "title": "Diagnosis", "to": "Urinary Tract Infection"}, {"arrows": "to", "from": "bladder_discomfort, foul_smell_of urine, continuous_feel_of_urine", "title": "Diagnosis", "to": "Urinary Tract Infection"}, {"arrows": "to", "from": "burning_micturition, foul_smell_of urine, continuous_feel_of_urine", "title": "Diagnosis", "to": "Urinary Tract Infection"}, {"arrows": "to", "from": "burning_micturition, bladder_discomfort, continuous_feel_of_urine", "title": "Diagnosis", "to": "Urinary Tract Infection"}, {"arrows": "to", "from": "burning_micturition, bladder_discomfort, foul_smell_of urine", "title": "Diagnosis", "to": "Urinary Tract Infection"}, {"arrows": "to", "from": "skin_rash, joint_pain, skin_peeling, silver_like_dusting, small_dents_in_nails, inflammatory_nails", "title": "Diagnosis", "to": "Psoriasis"}, {"arrows": "to", "from": "joint_pain, skin_peeling, silver_like_dusting, small_dents_in_nails, inflammatory_nails", "title": "Diagnosis", "to": "Psoriasis"}, {"arrows": "to", "from": "skin_rash, skin_peeling, silver_like_dusting, small_dents_in_nails, inflammatory_nails", "title": "Diagnosis", "to": "Psoriasis"}, {"arrows": "to", "from": "skin_rash, joint_pain, silver_like_dusting, small_dents_in_nails, inflammatory_nails", "title": "Diagnosis", "to": "Psoriasis"}, {"arrows": "to", "from": "skin_rash, joint_pain, skin_peeling, small_dents_in_nails, inflammatory_nails", "title": "Diagnosis", "to": "Psoriasis"}, {"arrows": "to", "from": "skin_rash, joint_pain, skin_peeling, silver_like_dusting, inflammatory_nails", "title": "Diagnosis", "to": "Psoriasis"}, {"arrows": "to", "from": "skin_rash, joint_pain, skin_peeling, silver_like_dusting, small_dents_in_nails", "title": "Diagnosis", "to": "Psoriasis"}, {"arrows": "to", "from": "skin_rash, high_fever, blister, red_sore_around_nose, yellow_crust_ooze", "title": "Diagnosis", "to": "Impetigo"}, {"arrows": "to", "from": "high_fever, blister, red_sore_around_nose, yellow_crust_ooze", "title": "Diagnosis", "to": "Impetigo"}, {"arrows": "to", "from": "skin_rash, blister, red_sore_around_nose, yellow_crust_ooze", "title": "Diagnosis", "to": "Impetigo"}, {"arrows": "to", "from": "skin_rash, high_fever, red_sore_around_nose, yellow_crust_ooze", "title": "Diagnosis", "to": "Impetigo"}, {"arrows": "to", "from": "skin_rash, high_fever, blister, yellow_crust_ooze", "title": "Diagnosis", "to": "Impetigo"}, {"arrows": "to", "from": "skin_rash, high_fever, blister, red_sore_around_nose", "title": "Diagnosis", "to": "Impetigo"}, {"arrows": "to", "from": "Drug Name: abacavir and lamivudine, Active Ingredient: abacavir sulfate;lamivudine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: abacavir and lamivudine, Active Ingredient: abacavir sulfate;lamivudine", "title": "Last Updated", "to": "12/22/2023"}, {"arrows": "to", "from": "Drug Name: abacavir and lamivudine, Active Ingredient: abacavir sulfate;lamivudine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204311s000lbl.pdf#page=34"}, {"arrows": "to", "from": "Drug Name: abilify, Active Ingredient: aripiprazole", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: abilify, Active Ingredient: aripiprazole", "title": "Last Updated", "to": "02/05/2020"}, {"arrows": "to", "from": "Drug Name: abilify, Active Ingredient: aripiprazole", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf#page=77"}, {"arrows": "to", "from": "Drug Name: abilify, Active Ingredient: aripiprazole", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: abilify, Active Ingredient: aripiprazole", "title": "Other", "to": "ORALLY DISINTEGRATING;ORAL"}, {"arrows": "to", "from": "Drug Name: abilify, Active Ingredient: aripiprazole", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: abilify, Active Ingredient: aripiprazole", "title": "Last Updated", "to": "11/30/2022"}, {"arrows": "to", "from": "Drug Name: abilify, Active Ingredient: aripiprazole", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021436s048lbl.pdf#page=47"}, {"arrows": "to", "from": "Drug Name: abilify, Active Ingredient: aripiprazole", "title": "Form", "to": "INJECTABLE;INTRAMUSCULAR"}, {"arrows": "to", "from": "Drug Name: abilify maintena kit, Active Ingredient: aripiprazole", "title": "Form", "to": "FOR SUSPENSION"}, {"arrows": "to", "from": "Drug Name: abilify maintena kit, Active Ingredient: aripiprazole", "title": "Other", "to": "EXTENDED RELEASE;INTRAMUSCULAR"}, {"arrows": "to", "from": "Drug Name: abilify maintena kit, Active Ingredient: aripiprazole", "title": "Last Updated", "to": "02/05/2020"}, {"arrows": "to", "from": "Drug Name: abilify maintena kit, Active Ingredient: aripiprazole", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202971s013lbl.pdf#page=52"}, {"arrows": "to", "from": "Drug Name: abilify mycite kit, Active Ingredient: aripiprazole", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: abilify mycite kit, Active Ingredient: aripiprazole", "title": "Last Updated", "to": "11/30/2022"}, {"arrows": "to", "from": "Drug Name: abilify mycite kit, Active Ingredient: aripiprazole", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207202s006lbl.pdf#page=64"}, {"arrows": "to", "from": "Drug Name: abrilada, Active Ingredient: adalimumab-afzb", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: abrilada, Active Ingredient: adalimumab-afzb", "title": "Last Updated", "to": "10/04/2023"}, {"arrows": "to", "from": "Drug Name: abrilada, Active Ingredient: adalimumab-afzb", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761118s007lbl.pdf#page=47"}, {"arrows": "to", "from": "Drug Name: absorica, Active Ingredient: isotretinoin", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: absorica, Active Ingredient: isotretinoin", "title": "Last Updated", "to": "07/18/2023"}, {"arrows": "to", "from": "Drug Name: absorica, Active Ingredient: isotretinoin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021951s013lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: abstral, Active Ingredient: fentanyl citrate", "title": "Form", "to": "TABLET;SUBLINGUAL"}, {"arrows": "to", "from": "Drug Name: abstral, Active Ingredient: fentanyl citrate", "title": "Last Updated", "to": "10/07/2019"}, {"arrows": "to", "from": "Drug Name: abstral, Active Ingredient: fentanyl citrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022510s018lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: accutane, Active Ingredient: isotretinoin", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: accutane, Active Ingredient: isotretinoin", "title": "Last Updated", "to": "10/22/2010"}, {"arrows": "to", "from": "Drug Name: accutane, Active Ingredient: isotretinoin", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018662s061MedGuide.pdf"}, {"arrows": "to", "from": "Drug Name: aciphex, Active Ingredient: rabeprazole sodium", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: aciphex, Active Ingredient: rabeprazole sodium", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: aciphex, Active Ingredient: rabeprazole sodium", "title": "Last Updated", "to": "07/18/2023"}, {"arrows": "to", "from": "Drug Name: aciphex, Active Ingredient: rabeprazole sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020973s043lbl.pdf#page=34"}, {"arrows": "to", "from": "Drug Name: aciphex sprinkle, Active Ingredient: rabeprazole sodium", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: aciphex sprinkle, Active Ingredient: rabeprazole sodium", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: aciphex sprinkle, Active Ingredient: rabeprazole sodium", "title": "Last Updated", "to": "11/27/2020"}, {"arrows": "to", "from": "Drug Name: aciphex sprinkle, Active Ingredient: rabeprazole sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204736s012lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: actemra, Active Ingredient: tocilizumab", "title": "Form", "to": "INJECTABLE; INJECTION"}, {"arrows": "to", "from": "Drug Name: actemra, Active Ingredient: tocilizumab", "title": "Last Updated", "to": "09/20/2024"}, {"arrows": "to", "from": "Drug Name: actemra, Active Ingredient: tocilizumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125276s144,125472s056lbl.pdf#page=55"}, {"arrows": "to", "from": "Drug Name: actemra, Active Ingredient: tocilizumab", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: actemra, Active Ingredient: tocilizumab", "title": "Other", "to": "SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: acthar gel, Active Ingredient: corticotropin", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: acthar gel, Active Ingredient: corticotropin", "title": "Last Updated", "to": "02/29/2024"}, {"arrows": "to", "from": "Drug Name: acthar gel, Active Ingredient: corticotropin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/008372s071lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: actiq, Active Ingredient: fentanyl citrate", "title": "Form", "to": "TROCHE/LOZENGE;TRANSMUCOSAL"}, {"arrows": "to", "from": "Drug Name: actiq, Active Ingredient: fentanyl citrate", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: actiq, Active Ingredient: fentanyl citrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020747s062lbl.pdf#page=44"}, {"arrows": "to", "from": "Drug Name: actonel, Active Ingredient: risedronate sodium", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: actonel, Active Ingredient: risedronate sodium", "title": "Last Updated", "to": "11/05/2019"}, {"arrows": "to", "from": "Drug Name: actonel, Active Ingredient: risedronate sodium", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020835s052lbl.pdf#page=38"}, {"arrows": "to", "from": "Drug Name: actonel with calcium (copackaged), Active Ingredient: calcium carbonate; risedronate sodium", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: actonel with calcium (copackaged), Active Ingredient: calcium carbonate; risedronate sodium", "title": "Last Updated", "to": "04/08/2015"}, {"arrows": "to", "from": "Drug Name: actonel with calcium (copackaged), Active Ingredient: calcium carbonate; risedronate sodium", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021823s011lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: actoplus met, Active Ingredient: metformin hydrochloride; pioglitazone hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: actoplus met, Active Ingredient: metformin hydrochloride; pioglitazone hydrochloride", "title": "Last Updated", "to": "12/21/2017"}, {"arrows": "to", "from": "Drug Name: actoplus met, Active Ingredient: metformin hydrochloride; pioglitazone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021842s022lbl.pdf#page=41"}, {"arrows": "to", "from": "Drug Name: actoplus met xr, Active Ingredient: metformin hydrochloride; pioglitazone hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: actoplus met xr, Active Ingredient: metformin hydrochloride; pioglitazone hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: actoplus met xr, Active Ingredient: metformin hydrochloride; pioglitazone hydrochloride", "title": "Last Updated", "to": "12/21/2017"}, {"arrows": "to", "from": "Drug Name: actoplus met xr, Active Ingredient: metformin hydrochloride; pioglitazone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022024s014lbl.pdf#page=41"}, {"arrows": "to", "from": "Drug Name: actos, Active Ingredient: pioglitazone hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: actos, Active Ingredient: pioglitazone hydrochloride", "title": "Last Updated", "to": "12/21/2017"}, {"arrows": "to", "from": "Drug Name: actos, Active Ingredient: pioglitazone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021073s049lbl.pdf#page=35"}, {"arrows": "to", "from": "Drug Name: adasuve, Active Ingredient: loxapine", "title": "Form", "to": "POWDER;INHALATION"}, {"arrows": "to", "from": "Drug Name: adasuve, Active Ingredient: loxapine", "title": "Last Updated", "to": "02/01/2022"}, {"arrows": "to", "from": "Drug Name: adasuve, Active Ingredient: loxapine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022549s010lbl.pdf#page=28"}, {"arrows": "to", "from": "Drug Name: adderall 10, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: adderall 10, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: adderall 10, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: adderall 12.5, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: adderall 12.5, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: adderall 12.5, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: adderall 15, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: adderall 15, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: adderall 15, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: adderall 20, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: adderall 20, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: adderall 20, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: adderall 30, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: adderall 30, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Last Updated", "to": "02/25/2022"}, {"arrows": "to", "from": "Drug Name: adderall 30, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/011522s044lbl.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: adderall 5, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: adderall 5, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Last Updated", "to": "02/25/2022"}, {"arrows": "to", "from": "Drug Name: adderall 5, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/011522s044lbl.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: adderall 7.5, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: adderall 7.5, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Last Updated", "to": "02/25/2022"}, {"arrows": "to", "from": "Drug Name: adderall 7.5, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/011522s044lbl.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: adderall xr 10, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: adderall xr 10, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: adderall xr 10, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: adderall xr 10, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021303s038lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: adderall xr 15, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: adderall xr 15, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: adderall xr 15, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: adderall xr 15, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021303s038lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: adderall xr 20, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: adderall xr 20, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: adderall xr 20, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: adderall xr 20, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021303s038lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: adderall xr 25, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: adderall xr 25, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: adderall xr 25, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: adderall xr 25, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021303s038lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: adderall xr 30, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: adderall xr 30, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: adderall xr 30, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Last Updated", "to": "07/03/2019"}, {"arrows": "to", "from": "Drug Name: adderall xr 30, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021303s034lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: adderall xr 5, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: adderall xr 5, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: adderall xr 5, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Last Updated", "to": "07/03/2019"}, {"arrows": "to", "from": "Drug Name: adderall xr 5, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021303s034lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: addyi, Active Ingredient: flibanserin", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: addyi, Active Ingredient: flibanserin", "title": "Last Updated", "to": "09/29/2021"}, {"arrows": "to", "from": "Drug Name: addyi, Active Ingredient: flibanserin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022526s009lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: adempas, Active Ingredient: riociguat", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: adempas, Active Ingredient: riociguat", "title": "Last Updated", "to": "09/10/2021"}, {"arrows": "to", "from": "Drug Name: adempas, Active Ingredient: riociguat", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204819s015lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: adhansia xr, Active Ingredient: methylphenidate hydrochloride", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: adhansia xr, Active Ingredient: methylphenidate hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: adhansia xr, Active Ingredient: methylphenidate hydrochloride", "title": "Last Updated", "to": "06/28/2021"}, {"arrows": "to", "from": "Drug Name: adhansia xr, Active Ingredient: methylphenidate hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212038s002lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: adlyxin, Active Ingredient: lixisenatide", "title": "Form", "to": "SOLUTION;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: adlyxin, Active Ingredient: lixisenatide", "title": "Last Updated", "to": "09/28/2023"}, {"arrows": "to", "from": "Drug Name: adlyxin, Active Ingredient: lixisenatide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208471s007lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: aduhelm, Active Ingredient: aducanumab-avwa", "title": "Form", "to": "INJECTABLE; INJECTION"}, {"arrows": "to", "from": "Drug Name: aduhelm, Active Ingredient: aducanumab-avwa", "title": "Last Updated", "to": "08/30/2023"}, {"arrows": "to", "from": "Drug Name: aduhelm, Active Ingredient: aducanumab-avwa", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761178s011lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: adzenys er, Active Ingredient: amphetamine", "title": "Form", "to": "SUSPENSION"}, {"arrows": "to", "from": "Drug Name: adzenys er, Active Ingredient: amphetamine", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: adzenys er, Active Ingredient: amphetamine", "title": "Last Updated", "to": "02/25/2022"}, {"arrows": "to", "from": "Drug Name: adzenys er, Active Ingredient: amphetamine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204325s003lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: adzenys xr-odt, Active Ingredient: amphetamine", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: adzenys xr-odt, Active Ingredient: amphetamine", "title": "Other", "to": "ORALLY DISINTEGRATING"}, {"arrows": "to", "from": "Drug Name: adzenys xr-odt, Active Ingredient: amphetamine", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: adzenys xr-odt, Active Ingredient: amphetamine", "title": "Last Updated", "to": "03/12/2024"}, {"arrows": "to", "from": "Drug Name: adzenys xr-odt, Active Ingredient: amphetamine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204326s011lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: afrezza, Active Ingredient: insulin recombinant human", "title": "Form", "to": "POWDER;INHALATION"}, {"arrows": "to", "from": "Drug Name: afrezza, Active Ingredient: insulin recombinant human", "title": "Last Updated", "to": "02/03/2023"}, {"arrows": "to", "from": "Drug Name: afrezza, Active Ingredient: insulin recombinant human", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022472s023lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: alkindi sprinkle, Active Ingredient: hydrocortisone", "title": "Form", "to": "GRANULE;ORAL"}, {"arrows": "to", "from": "Drug Name: alkindi sprinkle, Active Ingredient: hydrocortisone", "title": "Last Updated", "to": "06/05/2024"}, {"arrows": "to", "from": "Drug Name: alkindi sprinkle, Active Ingredient: hydrocortisone", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213876s002lbl.pdf#page=14"}, {"arrows": "to", "from": "Drug Name: alvaiz, Active Ingredient: eltrombopag choline", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: alvaiz, Active Ingredient: eltrombopag choline", "title": "Last Updated", "to": "11/29/2023"}, {"arrows": "to", "from": "Drug Name: alvaiz, Active Ingredient: eltrombopag choline", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216774s000lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: ambien, Active Ingredient: zolpidem tartrate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: ambien, Active Ingredient: zolpidem tartrate", "title": "Last Updated", "to": "02/23/2022"}, {"arrows": "to", "from": "Drug Name: ambien, Active Ingredient: zolpidem tartrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019908s40s044s047lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: ambien cr, Active Ingredient: zolpidem tartrate", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: ambien cr, Active Ingredient: zolpidem tartrate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: ambien cr, Active Ingredient: zolpidem tartrate", "title": "Last Updated", "to": "02/23/2022"}, {"arrows": "to", "from": "Drug Name: ambien cr, Active Ingredient: zolpidem tartrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021774s021s025s028lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: amjevita, Active Ingredient: adalimumab-atto", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: amjevita, Active Ingredient: adalimumab-atto", "title": "Last Updated", "to": "08/14/2023"}, {"arrows": "to", "from": "Drug Name: amjevita, Active Ingredient: adalimumab-atto", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761024s015lbl.pdf#page=50"}, {"arrows": "to", "from": "Drug Name: ampyra, Active Ingredient: dalfampridine", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: ampyra, Active Ingredient: dalfampridine", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: ampyra, Active Ingredient: dalfampridine", "title": "Last Updated", "to": "11/18/2021"}, {"arrows": "to", "from": "Drug Name: ampyra, Active Ingredient: dalfampridine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022250s019lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: anafranil, Active Ingredient: clomipramine hydrochloride", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: anafranil, Active Ingredient: clomipramine hydrochloride", "title": "Last Updated", "to": "05/10/2019"}, {"arrows": "to", "from": "Drug Name: anafranil, Active Ingredient: clomipramine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019906s043lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: anaprox, Active Ingredient: naproxen sodium", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: anaprox, Active Ingredient: naproxen sodium", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: anaprox, Active Ingredient: naproxen sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017581s117,018164s067,020067s026lbl.pdf"}, {"arrows": "to", "from": "Drug Name: anaprox ds, Active Ingredient: naproxen sodium", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: anaprox ds, Active Ingredient: naproxen sodium", "title": "Last Updated", "to": "05/13/2024"}, {"arrows": "to", "from": "Drug Name: anaprox ds, Active Ingredient: naproxen sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017581s115,018164s065,020067s024lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: androgel, Active Ingredient: testosterone", "title": "Form", "to": "GEL"}, {"arrows": "to", "from": "Drug Name: androgel, Active Ingredient: testosterone", "title": "Other", "to": "METERED;TRANSDERMAL"}, {"arrows": "to", "from": "Drug Name: androgel, Active Ingredient: testosterone", "title": "Last Updated", "to": "05/30/2019"}, {"arrows": "to", "from": "Drug Name: androgel, Active Ingredient: testosterone", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022309s020lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: androgel, Active Ingredient: testosterone", "title": "Form", "to": "GEL;TRANSDERMAL"}, {"arrows": "to", "from": "Drug Name: androgel, Active Ingredient: testosterone", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021015s045lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: ansaid, Active Ingredient: flurbiprofen", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: ansaid, Active Ingredient: flurbiprofen", "title": "Last Updated", "to": "05/09/2016"}, {"arrows": "to", "from": "Drug Name: ansaid, Active Ingredient: flurbiprofen", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018766s015MedGuide.pdf"}, {"arrows": "to", "from": "Drug Name: apadaz, Active Ingredient: acetaminophen; benzhydrocodone hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: apadaz, Active Ingredient: acetaminophen; benzhydrocodone hydrochloride", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: apadaz, Active Ingredient: acetaminophen; benzhydrocodone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208653s008lbl.pdf#page=40"}, {"arrows": "to", "from": "Drug Name: aplenzin, Active Ingredient: bupropion hydrobromide", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: aplenzin, Active Ingredient: bupropion hydrobromide", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: aplenzin, Active Ingredient: bupropion hydrobromide", "title": "Last Updated", "to": "05/07/2024"}, {"arrows": "to", "from": "Drug Name: aplenzin, Active Ingredient: bupropion hydrobromide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022108s022lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: aptensio xr, Active Ingredient: methylphenidate hydrochloride", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: aptensio xr, Active Ingredient: methylphenidate hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: aptensio xr, Active Ingredient: methylphenidate hydrochloride", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: aptensio xr, Active Ingredient: methylphenidate hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205831s008lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: aptiom, Active Ingredient: eslicarbazepine acetate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: aptiom, Active Ingredient: eslicarbazepine acetate", "title": "Last Updated", "to": "03/15/2019"}, {"arrows": "to", "from": "Drug Name: aptiom, Active Ingredient: eslicarbazepine acetate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022416s011lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: aptryxol, Active Ingredient: desvenlafaxine", "title": "Form", "to": "TABLET,EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: aptryxol, Active Ingredient: desvenlafaxine", "title": "Last Updated", "to": "08/18/2023"}, {"arrows": "to", "from": "Drug Name: aptryxol, Active Ingredient: desvenlafaxine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205583s014lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: aranesp, Active Ingredient: darbepoetin alfa", "title": "Form", "to": "VIAL; INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: aranesp, Active Ingredient: darbepoetin alfa", "title": "Last Updated", "to": "01/30/2019"}, {"arrows": "to", "from": "Drug Name: aranesp, Active Ingredient: darbepoetin alfa", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103951s5377lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: aranesp, Active Ingredient: darbepoetin alfa", "title": "Form", "to": "VIAL; SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: arcapta neohaler, Active Ingredient: indacaterol maleate", "title": "Form", "to": "POWDER;INHALATION"}, {"arrows": "to", "from": "Drug Name: arcapta neohaler, Active Ingredient: indacaterol maleate", "title": "Last Updated", "to": "07/30/2021"}, {"arrows": "to", "from": "Drug Name: arcapta neohaler, Active Ingredient: indacaterol maleate", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022383s000MedG.pdf"}, {"arrows": "to", "from": "Drug Name: arikayce kit, Active Ingredient: amikacin sulfate", "title": "Form", "to": "SUSPENSION"}, {"arrows": "to", "from": "Drug Name: arikayce kit, Active Ingredient: amikacin sulfate", "title": "Other", "to": "LIPOSOMAL;INHALATION"}, {"arrows": "to", "from": "Drug Name: arikayce kit, Active Ingredient: amikacin sulfate", "title": "Last Updated", "to": "02/10/2023"}, {"arrows": "to", "from": "Drug Name: arikayce kit, Active Ingredient: amikacin sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207356s004lbl.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: aristada, Active Ingredient: aripiprazole lauroxil", "title": "Form", "to": "SUSPENSION"}, {"arrows": "to", "from": "Drug Name: aristada, Active Ingredient: aripiprazole lauroxil", "title": "Other", "to": "EXTENDED RELEASE;INTRAMUSCULAR"}, {"arrows": "to", "from": "Drug Name: aristada, Active Ingredient: aripiprazole lauroxil", "title": "Last Updated", "to": "03/30/2021"}, {"arrows": "to", "from": "Drug Name: aristada, Active Ingredient: aripiprazole lauroxil", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207533s017,209830s005lbl.pdf#page=36"}, {"arrows": "to", "from": "Drug Name: aristada initio kit, Active Ingredient: aripiprazole lauroxil", "title": "Form", "to": "SUSPENSION"}, {"arrows": "to", "from": "Drug Name: aristada initio kit, Active Ingredient: aripiprazole lauroxil", "title": "Other", "to": "EXTENDED RELEASE;INTRAMUSCULAR"}, {"arrows": "to", "from": "Drug Name: aristada initio kit, Active Ingredient: aripiprazole lauroxil", "title": "Last Updated", "to": "03/30/2021"}, {"arrows": "to", "from": "Drug Name: aristada initio kit, Active Ingredient: aripiprazole lauroxil", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207533s017,209830s005lbl.pdf#page=72"}, {"arrows": "to", "from": "Drug Name: arthrotec, Active Ingredient: diclofenac sodium; misoprostol", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: arthrotec, Active Ingredient: diclofenac sodium; misoprostol", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: arthrotec, Active Ingredient: diclofenac sodium; misoprostol", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: arthrotec, Active Ingredient: diclofenac sodium; misoprostol", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020607s043lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: arymo er, Active Ingredient: morphine sulfate", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: arymo er, Active Ingredient: morphine sulfate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: arymo er, Active Ingredient: morphine sulfate", "title": "Last Updated", "to": "10/07/2019"}, {"arrows": "to", "from": "Drug Name: arymo er, Active Ingredient: morphine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208603s005lbl.pdf#page=34"}, {"arrows": "to", "from": "Drug Name: astagraf xl, Active Ingredient: tacrolimus", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: astagraf xl, Active Ingredient: tacrolimus", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: astagraf xl, Active Ingredient: tacrolimus", "title": "Last Updated", "to": "11/22/2022"}, {"arrows": "to", "from": "Drug Name: astagraf xl, Active Ingredient: tacrolimus", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050708s054,050709s047,204096s010lbl.pdf#page=91"}, {"arrows": "to", "from": "Drug Name: astagraf xl, Active Ingredient: tacrolimus", "title": "Last Updated", "to": "09/14/2023"}, {"arrows": "to", "from": "Drug Name: astagraf xl, Active Ingredient: tacrolimus", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210115s006lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: astagraf xl, Active Ingredient: tacrolimus", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204096s011lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: atelvia, Active Ingredient: risedronate sodium", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: atelvia, Active Ingredient: risedronate sodium", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: atelvia, Active Ingredient: risedronate sodium", "title": "Last Updated", "to": "08/18/2020"}, {"arrows": "to", "from": "Drug Name: atelvia, Active Ingredient: risedronate sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022560s011lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: ativan, Active Ingredient: lorazepam", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: ativan, Active Ingredient: lorazepam", "title": "Last Updated", "to": "01/13/2023"}, {"arrows": "to", "from": "Drug Name: ativan, Active Ingredient: lorazepam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017794s049lbl.pdf#page=14"}, {"arrows": "to", "from": "Drug Name: aubagio, Active Ingredient: teriflunomide", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: aubagio, Active Ingredient: teriflunomide", "title": "Last Updated", "to": "06/10/2024"}, {"arrows": "to", "from": "Drug Name: aubagio, Active Ingredient: teriflunomide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202992s013s015lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: austedo, Active Ingredient: deutetrabenazine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: austedo, Active Ingredient: deutetrabenazine", "title": "Last Updated", "to": "05/29/2024"}, {"arrows": "to", "from": "Drug Name: austedo, Active Ingredient: deutetrabenazine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216354s000lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: austedo, Active Ingredient: deutetrabenazine", "title": "Last Updated", "to": "11/26/2024"}, {"arrows": "to", "from": "Drug Name: austedo, Active Ingredient: deutetrabenazine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/208082s016s017lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: auvelity, Active Ingredient: bupropion; dextromethorphan", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: auvelity, Active Ingredient: bupropion; dextromethorphan", "title": "Other", "to": "EXTENDED RELEASE; ORAL"}, {"arrows": "to", "from": "Drug Name: auvelity, Active Ingredient: bupropion; dextromethorphan", "title": "Last Updated", "to": "05/07/2024"}, {"arrows": "to", "from": "Drug Name: auvelity, Active Ingredient: bupropion; dextromethorphan", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215430s000lblCorrect3.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: avandamet, Active Ingredient: metformin hydrochloride; rosiglitazone maleate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: avandamet, Active Ingredient: metformin hydrochloride; rosiglitazone maleate", "title": "Last Updated", "to": "04/05/2017"}, {"arrows": "to", "from": "Drug Name: avandamet, Active Ingredient: metformin hydrochloride; rosiglitazone maleate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021410s040lbl.pdf#page=38"}, {"arrows": "to", "from": "Drug Name: avandaryl, Active Ingredient: glimepiride; rosiglitazone maleate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: avandaryl, Active Ingredient: glimepiride; rosiglitazone maleate", "title": "Last Updated", "to": "04/27/2023"}, {"arrows": "to", "from": "Drug Name: avandaryl, Active Ingredient: glimepiride; rosiglitazone maleate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217006s000lbl.pdf#page=39"}, {"arrows": "to", "from": "Drug Name: avandia, Active Ingredient: rosiglitazone maleate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: avandia, Active Ingredient: rosiglitazone maleate", "title": "Last Updated", "to": "02/05/2019"}, {"arrows": "to", "from": "Drug Name: avandia, Active Ingredient: rosiglitazone maleate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021071s052lbl.pdf#page=38"}, {"arrows": "to", "from": "Drug Name: aveed, Active Ingredient: testosterone undecanoate", "title": "Form", "to": "INJECTABLE;INTRAMUSCULAR"}, {"arrows": "to", "from": "Drug Name: aveed, Active Ingredient: testosterone undecanoate", "title": "Last Updated", "to": "08/16/2021"}, {"arrows": "to", "from": "Drug Name: aveed, Active Ingredient: testosterone undecanoate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022219s014lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: avelox, Active Ingredient: moxifloxacin hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: avelox, Active Ingredient: moxifloxacin hydrochloride", "title": "Last Updated", "to": "05/06/2020"}, {"arrows": "to", "from": "Drug Name: avelox, Active Ingredient: moxifloxacin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021085s066,021277s062lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: avelox in sodium chloride 0.8% in plastic container, Active Ingredient: moxifloxacin hydrochloride", "title": "Form", "to": "SOLUTION;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: avelox in sodium chloride 0.8% in plastic container, Active Ingredient: moxifloxacin hydrochloride", "title": "Last Updated", "to": "05/06/2020"}, {"arrows": "to", "from": "Drug Name: avelox in sodium chloride 0.8% in plastic container, Active Ingredient: moxifloxacin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021085s066,021277s062lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: avinza, Active Ingredient: morphine sulfate", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: avinza, Active Ingredient: morphine sulfate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: avinza, Active Ingredient: morphine sulfate", "title": "Last Updated", "to": "06/26/2015"}, {"arrows": "to", "from": "Drug Name: avinza, Active Ingredient: morphine sulfate", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM311346.pdf"}, {"arrows": "to", "from": "Drug Name: avonex, Active Ingredient: interferon beta-1a", "title": "Form", "to": "VIAL"}, {"arrows": "to", "from": "Drug Name: avonex, Active Ingredient: interferon beta-1a", "title": "Last Updated", "to": "07/28/2023"}, {"arrows": "to", "from": "Drug Name: avonex, Active Ingredient: interferon beta-1a", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103628s5269lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: avsola, Active Ingredient: infliximab-axxq", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: avsola, Active Ingredient: infliximab-axxq", "title": "Last Updated", "to": "09/09/2021"}, {"arrows": "to", "from": "Drug Name: avsola, Active Ingredient: infliximab-axxq", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761086s000lbl.pdf#page=48"}, {"arrows": "to", "from": "Drug Name: axiron, Active Ingredient: testosterone", "title": "Form", "to": "SOLUTION"}, {"arrows": "to", "from": "Drug Name: axiron, Active Ingredient: testosterone", "title": "Other", "to": "METERED;TRANSDERMAL"}, {"arrows": "to", "from": "Drug Name: axiron, Active Ingredient: testosterone", "title": "Last Updated", "to": "07/13/2017"}, {"arrows": "to", "from": "Drug Name: axiron, Active Ingredient: testosterone", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022504s016lbl.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: azstarys, Active Ingredient: dexmethylphenidate hydrochloride; serdexmethylphenidate chloride", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: azstarys, Active Ingredient: dexmethylphenidate hydrochloride; serdexmethylphenidate chloride", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: azstarys, Active Ingredient: dexmethylphenidate hydrochloride; serdexmethylphenidate chloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212994s000lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: banzel, Active Ingredient: rufinamide", "title": "Form", "to": "SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: banzel, Active Ingredient: rufinamide", "title": "Last Updated", "to": "05/30/2023"}, {"arrows": "to", "from": "Drug Name: banzel, Active Ingredient: rufinamide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201367Orig1s011lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: banzel, Active Ingredient: rufinamide", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: banzel, Active Ingredient: rufinamide", "title": "Last Updated", "to": "11/28/2019"}, {"arrows": "to", "from": "Drug Name: banzel, Active Ingredient: rufinamide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021911s017,201367s008lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: bavencio, Active Ingredient: avelumab", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: bavencio, Active Ingredient: avelumab", "title": "Last Updated", "to": "11/26/2024"}, {"arrows": "to", "from": "Drug Name: bavencio, Active Ingredient: avelumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761049s020lbl.pdf#page=36"}, {"arrows": "to", "from": "Drug Name: bavencio, Active Ingredient: avelumab", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: bavencio, Active Ingredient: avelumab", "title": "Last Updated", "to": "05/09/2017"}, {"arrows": "to", "from": "Drug Name: bavencio, Active Ingredient: avelumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761078s000lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: baxdela, Active Ingredient: delafloxacin meglumine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: baxdela, Active Ingredient: delafloxacin meglumine", "title": "Last Updated", "to": "06/19/2017"}, {"arrows": "to", "from": "Drug Name: baxdela, Active Ingredient: delafloxacin meglumine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208610s007,208611s006lbl.pdf#page=28"}, {"arrows": "to", "from": "Drug Name: baxdela, Active Ingredient: delafloxacin meglumine", "title": "Form", "to": "POWDER;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: baxdela, Active Ingredient: delafloxacin meglumine", "title": "Last Updated", "to": "12/01/2023"}, {"arrows": "to", "from": "Drug Name: baxdela, Active Ingredient: delafloxacin meglumine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208611s007lbl.pdf#page=28"}, {"arrows": "to", "from": "Drug Name: belbuca, Active Ingredient: buprenorphine hydrochloride", "title": "Form", "to": "FILM;BUCCAL"}, {"arrows": "to", "from": "Drug Name: belbuca, Active Ingredient: buprenorphine hydrochloride", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: belbuca, Active Ingredient: buprenorphine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207932s023lbl.pdf#page=40"}, {"arrows": "to", "from": "Drug Name: belsomra, Active Ingredient: suvorexant", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: belsomra, Active Ingredient: suvorexant", "title": "Last Updated", "to": "03/25/2021"}, {"arrows": "to", "from": "Drug Name: belsomra, Active Ingredient: suvorexant", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204569s008lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: benlysta, Active Ingredient: belimumab", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: benlysta, Active Ingredient: belimumab", "title": "Last Updated", "to": "05/16/2024"}, {"arrows": "to", "from": "Drug Name: benlysta, Active Ingredient: belimumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125370s079,761043s022lbl.pdf#page=41"}, {"arrows": "to", "from": "Drug Name: benlysta, Active Ingredient: belimumab", "title": "Form", "to": "INJECTABLE; INJECTION"}, {"arrows": "to", "from": "Drug Name: besremi, Active Ingredient: ropeginterferon alfa-2b-njft", "title": "Form", "to": "INJECTABLE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: besremi, Active Ingredient: ropeginterferon alfa-2b-njft", "title": "Last Updated", "to": "04/29/2024"}, {"arrows": "to", "from": "Drug Name: besremi, Active Ingredient: ropeginterferon alfa-2b-njft", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761166s000lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: betaseron, Active Ingredient: interferon beta-1b", "title": "Form", "to": "VIAL; SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: betaseron, Active Ingredient: interferon beta-1b", "title": "Last Updated", "to": "07/28/2023"}, {"arrows": "to", "from": "Drug Name: betaseron, Active Ingredient: interferon beta-1b", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103471s5202lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: bevyxxa, Active Ingredient: betrixaban", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: bevyxxa, Active Ingredient: betrixaban", "title": "Last Updated", "to": "08/24/2020"}, {"arrows": "to", "from": "Drug Name: bevyxxa, Active Ingredient: betrixaban", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208383s000lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: bimzelx, Active Ingredient: bimekizumab-bkzx", "title": "Form", "to": "INJECTABLE; SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: bimzelx, Active Ingredient: bimekizumab-bkzx", "title": "Last Updated", "to": "09/20/2024"}, {"arrows": "to", "from": "Drug Name: bimzelx, Active Ingredient: bimekizumab-bkzx", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761151s005s006s007lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: binosto, Active Ingredient: alendronate sodium", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: binosto, Active Ingredient: alendronate sodium", "title": "Other", "to": "EFFERVESCENT;ORAL"}, {"arrows": "to", "from": "Drug Name: binosto, Active Ingredient: alendronate sodium", "title": "Last Updated", "to": "10/13/2020"}, {"arrows": "to", "from": "Drug Name: binosto, Active Ingredient: alendronate sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202344s008lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: blenrep, Active Ingredient: belantamab mafodotin-blmf", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: blenrep, Active Ingredient: belantamab mafodotin-blmf", "title": "Last Updated", "to": "02/28/2022"}, {"arrows": "to", "from": "Drug Name: blenrep, Active Ingredient: belantamab mafodotin-blmf", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761158s006lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: blincyto, Active Ingredient: blinatumomab", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: blincyto, Active Ingredient: blinatumomab", "title": "Last Updated", "to": "06/14/2024"}, {"arrows": "to", "from": "Drug Name: blincyto, Active Ingredient: blinatumomab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125557s023s026lbl.pdf#page=41"}, {"arrows": "to", "from": "Drug Name: boniva, Active Ingredient: ibandronate sodium", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: boniva, Active Ingredient: ibandronate sodium", "title": "Last Updated", "to": "01/11/2022"}, {"arrows": "to", "from": "Drug Name: boniva, Active Ingredient: ibandronate sodium", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021858s022lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: boniva, Active Ingredient: ibandronate sodium", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: boniva, Active Ingredient: ibandronate sodium", "title": "Last Updated", "to": "12/07/2016"}, {"arrows": "to", "from": "Drug Name: boniva, Active Ingredient: ibandronate sodium", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021455s021lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: bonsity, Active Ingredient: teriparatide", "title": "Form", "to": "SOLUTION;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: bonsity, Active Ingredient: teriparatide", "title": "Last Updated", "to": "11/16/2023"}, {"arrows": "to", "from": "Drug Name: bonsity, Active Ingredient: teriparatide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211939s004lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: botox, Active Ingredient: onabotulinumtoxina", "title": "Form", "to": "VIAL; SINGLE-USE"}, {"arrows": "to", "from": "Drug Name: botox, Active Ingredient: onabotulinumtoxina", "title": "Last Updated", "to": "08/10/2023"}, {"arrows": "to", "from": "Drug Name: botox, Active Ingredient: onabotulinumtoxina", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103000s5327lbl.pdf#page=49"}, {"arrows": "to", "from": "Drug Name: botox cosmetic, Active Ingredient: onabotulinumtoxina", "title": "Form", "to": "VIAL; SINGLE-USE"}, {"arrows": "to", "from": "Drug Name: botox cosmetic, Active Ingredient: onabotulinumtoxina", "title": "Last Updated", "to": "08/10/2023"}, {"arrows": "to", "from": "Drug Name: botox cosmetic, Active Ingredient: onabotulinumtoxina", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103000s5327lbl.pdf#page=49"}, {"arrows": "to", "from": "Drug Name: braftovi, Active Ingredient: encorafenib", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: braftovi, Active Ingredient: encorafenib", "title": "Last Updated", "to": "09/12/2024"}, {"arrows": "to", "from": "Drug Name: braftovi, Active Ingredient: encorafenib", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210496s016lbl.pdf#page=31"}, {"arrows": "to", "from": "Drug Name: brenzavvy, Active Ingredient: bexagliflozin", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: brenzavvy, Active Ingredient: bexagliflozin", "title": "Last Updated", "to": "09/12/2023"}, {"arrows": "to", "from": "Drug Name: brenzavvy, Active Ingredient: bexagliflozin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214373s001lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: brexafemme, Active Ingredient: ibrexafungerp", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: brexafemme, Active Ingredient: ibrexafungerp", "title": "Last Updated", "to": "11/30/2022"}, {"arrows": "to", "from": "Drug Name: brexafemme, Active Ingredient: ibrexafungerp", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214900s002lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: brilinta, Active Ingredient: ticagrelor", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: brilinta, Active Ingredient: ticagrelor", "title": "Last Updated", "to": "03/22/2024"}, {"arrows": "to", "from": "Drug Name: brilinta, Active Ingredient: ticagrelor", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022433s034lbl.pdf#page=35"}, {"arrows": "to", "from": "Drug Name: brisdelle, Active Ingredient: paroxetine mesylate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: brisdelle, Active Ingredient: paroxetine mesylate", "title": "Last Updated", "to": "08/18/2023"}, {"arrows": "to", "from": "Drug Name: brisdelle, Active Ingredient: paroxetine mesylate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204516s013lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: briumvi, Active Ingredient: ublituximab-xiiy", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: briumvi, Active Ingredient: ublituximab-xiiy", "title": "Last Updated", "to": "12/28/2022"}, {"arrows": "to", "from": "Drug Name: briumvi, Active Ingredient: ublituximab-xiiy", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761238s000lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: briviact, Active Ingredient: brivaracetam", "title": "Form", "to": "SOLUTION;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: briviact, Active Ingredient: brivaracetam", "title": "Last Updated", "to": "05/17/2023"}, {"arrows": "to", "from": "Drug Name: briviact, Active Ingredient: brivaracetam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205836s014,205837s011,205838s011lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: briviact, Active Ingredient: brivaracetam", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: briviact, Active Ingredient: brivaracetam", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: brixadi, Active Ingredient: buprenorphine", "title": "Form", "to": "INJECTION"}, {"arrows": "to", "from": "Drug Name: brixadi, Active Ingredient: buprenorphine", "title": "Other", "to": "EXTENDED RELEASE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: brixadi, Active Ingredient: buprenorphine", "title": "Last Updated", "to": "05/23/2023"}, {"arrows": "to", "from": "Drug Name: brixadi, Active Ingredient: buprenorphine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210136s000lbl.pdf#page=52"}, {"arrows": "to", "from": "Drug Name: brovana, Active Ingredient: arformoterol tartrate", "title": "Form", "to": "SOLUTION;INHALATION"}, {"arrows": "to", "from": "Drug Name: brovana, Active Ingredient: arformoterol tartrate", "title": "Last Updated", "to": "05/29/2019"}, {"arrows": "to", "from": "Drug Name: brovana, Active Ingredient: arformoterol tartrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021912s013lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: bunavail, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "title": "Form", "to": "FILM;BUCCAL"}, {"arrows": "to", "from": "Drug Name: bunavail, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "title": "Last Updated", "to": "06/17/2022"}, {"arrows": "to", "from": "Drug Name: bunavail, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205637s023s024lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: butrans, Active Ingredient: buprenorphine", "title": "Form", "to": "FILM"}, {"arrows": "to", "from": "Drug Name: butrans, Active Ingredient: buprenorphine", "title": "Other", "to": "EXTENDED RELEASE;TRANSDERMAL"}, {"arrows": "to", "from": "Drug Name: butrans, Active Ingredient: buprenorphine", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: butrans, Active Ingredient: buprenorphine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021306s041lbl.pdf#page=45"}, {"arrows": "to", "from": "Drug Name: bydureon, Active Ingredient: exenatide synthetic", "title": "Form", "to": "FOR SUSPENSION"}, {"arrows": "to", "from": "Drug Name: bydureon, Active Ingredient: exenatide synthetic", "title": "Other", "to": "EXTENDED RELEASE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: bydureon, Active Ingredient: exenatide synthetic", "title": "Last Updated", "to": "12/21/2022"}, {"arrows": "to", "from": "Drug Name: bydureon, Active Ingredient: exenatide synthetic", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022200s034lbl.pdf#page=37"}, {"arrows": "to", "from": "Drug Name: bydureon bcise, Active Ingredient: exenatide synthetic", "title": "Form", "to": "SUSPENSION"}, {"arrows": "to", "from": "Drug Name: bydureon bcise, Active Ingredient: exenatide synthetic", "title": "Other", "to": "EXTENDED RELEASE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: bydureon bcise, Active Ingredient: exenatide synthetic", "title": "Last Updated", "to": "03/06/2024"}, {"arrows": "to", "from": "Drug Name: bydureon bcise, Active Ingredient: exenatide synthetic", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209210s022lbl.pdf#page=36"}, {"arrows": "to", "from": "Drug Name: bydureon pen, Active Ingredient: exenatide synthetic", "title": "Form", "to": "FOR SUSPENSION"}, {"arrows": "to", "from": "Drug Name: bydureon pen, Active Ingredient: exenatide synthetic", "title": "Other", "to": "EXTENDED RELEASE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: bydureon pen, Active Ingredient: exenatide synthetic", "title": "Last Updated", "to": "12/21/2022"}, {"arrows": "to", "from": "Drug Name: bydureon pen, Active Ingredient: exenatide synthetic", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022200s034lbl.pdf#page=37"}, {"arrows": "to", "from": "Drug Name: byetta, Active Ingredient: exenatide synthetic", "title": "Form", "to": "INJECTABLE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: byetta, Active Ingredient: exenatide synthetic", "title": "Last Updated", "to": "12/21/2022"}, {"arrows": "to", "from": "Drug Name: byetta, Active Ingredient: exenatide synthetic", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021773s048lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: byetta, Active Ingredient: exenatide synthetic", "title": "Form", "to": "INJECTABLE; SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: byetta, Active Ingredient: exenatide synthetic", "title": "Last Updated", "to": "10/30/2009"}, {"arrows": "to", "from": "Drug Name: byetta, Active Ingredient: exenatide synthetic", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM191084.pdf"}, {"arrows": "to", "from": "Drug Name: cambia, Active Ingredient: diclofenac potassium", "title": "Form", "to": "FOR SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: cambia, Active Ingredient: diclofenac potassium", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: cambia, Active Ingredient: diclofenac potassium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022165s016lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: camzyos, Active Ingredient: mavacamten", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: camzyos, Active Ingredient: mavacamten", "title": "Last Updated", "to": "06/15/2023"}, {"arrows": "to", "from": "Drug Name: camzyos, Active Ingredient: mavacamten", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214998s001lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: caplyta, Active Ingredient: lumateperone tosylate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: caplyta, Active Ingredient: lumateperone tosylate", "title": "Last Updated", "to": "06/28/2023"}, {"arrows": "to", "from": "Drug Name: caplyta, Active Ingredient: lumateperone tosylate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209500s011lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: caprelsa, Active Ingredient: vandetanib", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: caprelsa, Active Ingredient: vandetanib", "title": "Last Updated", "to": "03/28/2022"}, {"arrows": "to", "from": "Drug Name: caprelsa, Active Ingredient: vandetanib", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022405s019lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: carbatrol, Active Ingredient: carbamazepine", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: carbatrol, Active Ingredient: carbamazepine", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: carbatrol, Active Ingredient: carbamazepine", "title": "Last Updated", "to": "04/11/2023"}, {"arrows": "to", "from": "Drug Name: carbatrol, Active Ingredient: carbamazepine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020712s038lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: cassipa, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "title": "Form", "to": "FILM;SUBLINGUAL"}, {"arrows": "to", "from": "Drug Name: cassipa, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: cassipa, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208042s011lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: cataflam, Active Ingredient: diclofenac potassium", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: cataflam, Active Ingredient: diclofenac potassium", "title": "Last Updated", "to": "04/28/2021"}, {"arrows": "to", "from": "Drug Name: cataflam, Active Ingredient: diclofenac potassium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020142s029lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: celebrex, Active Ingredient: celecoxib", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: celebrex, Active Ingredient: celecoxib", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: celebrex, Active Ingredient: celecoxib", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020998s058lbl.pdf#page=41"}, {"arrows": "to", "from": "Drug Name: celebrex, Active Ingredient: celecoxib", "title": "Last Updated", "to": "02/04/2011"}, {"arrows": "to", "from": "Drug Name: celebrex, Active Ingredient: celecoxib", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020998s033,021156s003MedG.pdf"}, {"arrows": "to", "from": "Drug Name: celexa, Active Ingredient: citalopram hydrobromide", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: celexa, Active Ingredient: citalopram hydrobromide", "title": "Last Updated", "to": "12/03/2012"}, {"arrows": "to", "from": "Drug Name: celexa, Active Ingredient: citalopram hydrobromide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020822s042,021046s019lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: celexa, Active Ingredient: citalopram hydrobromide", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: celexa, Active Ingredient: citalopram hydrobromide", "title": "Last Updated", "to": "08/18/2023"}, {"arrows": "to", "from": "Drug Name: celexa, Active Ingredient: citalopram hydrobromide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020822s054lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: cellcept, Active Ingredient: mycophenolate mofetil", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: cellcept, Active Ingredient: mycophenolate mofetil", "title": "Last Updated", "to": "08/10/2022"}, {"arrows": "to", "from": "Drug Name: cellcept, Active Ingredient: mycophenolate mofetil", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050722s050,050723s050,050758s048,050759s055lbl.pdf#page=39"}, {"arrows": "to", "from": "Drug Name: cellcept, Active Ingredient: mycophenolate mofetil", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: cellcept, Active Ingredient: mycophenolate mofetil", "title": "Form", "to": "FOR SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: cellcept, Active Ingredient: mycophenolate mofetil hydrochloride", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: cellcept, Active Ingredient: mycophenolate mofetil hydrochloride", "title": "Last Updated", "to": "08/10/2022"}, {"arrows": "to", "from": "Drug Name: cellcept, Active Ingredient: mycophenolate mofetil hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050722s050,050723s050,050758s048,050759s055lbl.pdf#page=39"}, {"arrows": "to", "from": "Drug Name: celontin, Active Ingredient: methsuximide", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: celontin, Active Ingredient: methsuximide", "title": "Last Updated", "to": "06/15/2011"}, {"arrows": "to", "from": "Drug Name: celontin, Active Ingredient: methsuximide", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229201.pdf"}, {"arrows": "to", "from": "Drug Name: cerdelga, Active Ingredient: eliglustat tartrate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: cerdelga, Active Ingredient: eliglustat tartrate", "title": "Last Updated", "to": "08/29/2018"}, {"arrows": "to", "from": "Drug Name: cerdelga, Active Ingredient: eliglustat tartrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205494s003lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: chantix, Active Ingredient: varenicline tartrate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: chantix, Active Ingredient: varenicline tartrate", "title": "Last Updated", "to": "02/22/2019"}, {"arrows": "to", "from": "Drug Name: chantix, Active Ingredient: varenicline tartrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021928s048lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: chlordiazepoxide and amitriptyline hydrochloride, Active Ingredient: amitriptyline hydrochloride; chlordiazepoxide", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: chlordiazepoxide and amitriptyline hydrochloride, Active Ingredient: amitriptyline hydrochloride; chlordiazepoxide", "title": "Last Updated", "to": "02/05/2021"}, {"arrows": "to", "from": "Drug Name: chlordiazepoxide and amitriptyline hydrochloride, Active Ingredient: amitriptyline hydrochloride; chlordiazepoxide", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/071297Orig1s026MG.pdf"}, {"arrows": "to", "from": "Drug Name: cibinqo, Active Ingredient: abrocitinib", "title": "Form", "to": "TABLET; ORAL"}, {"arrows": "to", "from": "Drug Name: cibinqo, Active Ingredient: abrocitinib", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: cibinqo, Active Ingredient: abrocitinib", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213871s004lblcorrected.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: cimzia, Active Ingredient: certolizumab pegol", "title": "Form", "to": "INJECTABLE; INJECTION"}, {"arrows": "to", "from": "Drug Name: cimzia, Active Ingredient: certolizumab pegol", "title": "Last Updated", "to": "09/13/2024"}, {"arrows": "to", "from": "Drug Name: cimzia, Active Ingredient: certolizumab pegol", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125160s275lbl.pdf#page=42"}, {"arrows": "to", "from": "Drug Name: cipro, Active Ingredient: ciprofloxacin hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: cipro, Active Ingredient: ciprofloxacin hydrochloride", "title": "Last Updated", "to": "09/20/2024"}, {"arrows": "to", "from": "Drug Name: cipro, Active Ingredient: ciprofloxacin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/019537s095,020780s050lbl.pdf#page=40"}, {"arrows": "to", "from": "Drug Name: cipro, Active Ingredient: ciprofloxacin", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: cipro, Active Ingredient: ciprofloxacin", "title": "Last Updated", "to": "03/25/2022"}, {"arrows": "to", "from": "Drug Name: cipro, Active Ingredient: ciprofloxacin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019847s063lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: cipro, Active Ingredient: ciprofloxacin", "title": "Form", "to": "FOR SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: cipro, Active Ingredient: ciprofloxacin", "title": "Last Updated", "to": "09/20/2024"}, {"arrows": "to", "from": "Drug Name: cipro, Active Ingredient: ciprofloxacin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/019537s095,020780s050lbl.pdf#page=40"}, {"arrows": "to", "from": "Drug Name: cipro in dextrose 5% in plastic container, Active Ingredient: ciprofloxacin", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: cipro in dextrose 5% in plastic container, Active Ingredient: ciprofloxacin", "title": "Last Updated", "to": "03/25/2022"}, {"arrows": "to", "from": "Drug Name: cipro in dextrose 5% in plastic container, Active Ingredient: ciprofloxacin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019857s073lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: cipro xr, Active Ingredient: ciprofloxacin; ciprofloxacin hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: cipro xr, Active Ingredient: ciprofloxacin; ciprofloxacin hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: cipro xr, Active Ingredient: ciprofloxacin; ciprofloxacin hydrochloride", "title": "Last Updated", "to": "03/30/2021"}, {"arrows": "to", "from": "Drug Name: cipro xr, Active Ingredient: ciprofloxacin; ciprofloxacin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021473s043lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: citalopram, Active Ingredient: citalopram hydrobromide", "title": "Form", "to": "CAPSULE; ORAL"}, {"arrows": "to", "from": "Drug Name: citalopram, Active Ingredient: citalopram hydrobromide", "title": "Last Updated", "to": "08/18/2023"}, {"arrows": "to", "from": "Drug Name: citalopram, Active Ingredient: citalopram hydrobromide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215428s002lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: clenpiq, Active Ingredient: citric acid; magnesium oxide; sodium picosulfate", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: clenpiq, Active Ingredient: citric acid; magnesium oxide; sodium picosulfate", "title": "Last Updated", "to": "08/29/2023"}, {"arrows": "to", "from": "Drug Name: clenpiq, Active Ingredient: citric acid; magnesium oxide; sodium picosulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209589s015lbl.pdf#page=14"}, {"arrows": "to", "from": "Drug Name: clinoril, Active Ingredient: sulindac", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: clinoril, Active Ingredient: sulindac", "title": "Last Updated", "to": "12/23/2010"}, {"arrows": "to", "from": "Drug Name: clinoril, Active Ingredient: sulindac", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088573.pdf"}, {"arrows": "to", "from": "Drug Name: codeine sulfate, Active Ingredient: codeine sulfate", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: codeine sulfate, Active Ingredient: codeine sulfate", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: codeine sulfate, Active Ingredient: codeine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202245s010lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: codeine sulfate, Active Ingredient: codeine sulfate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: codeine sulfate, Active Ingredient: codeine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022402s015lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: colcrys, Active Ingredient: colchicine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: colcrys, Active Ingredient: colchicine", "title": "Last Updated", "to": "05/14/2020"}, {"arrows": "to", "from": "Drug Name: colcrys, Active Ingredient: colchicine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022352s026lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: colcrys, Active Ingredient: colchicine", "title": "Form", "to": "TABLET; ORAL"}, {"arrows": "to", "from": "Drug Name: colcrys, Active Ingredient: colchicine", "title": "Last Updated", "to": "10/16/2019"}, {"arrows": "to", "from": "Drug Name: colcrys, Active Ingredient: colchicine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022353lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: columvi, Active Ingredient: glofitamab-gxbm", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: columvi, Active Ingredient: glofitamab-gxbm", "title": "Last Updated", "to": "06/15/2023"}, {"arrows": "to", "from": "Drug Name: columvi, Active Ingredient: glofitamab-gxbm", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761309s000lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: combogesic, Active Ingredient: acetaminophen; ibuprofen", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: combogesic, Active Ingredient: acetaminophen; ibuprofen", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: combogesic, Active Ingredient: acetaminophen; ibuprofen", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209471s001lbl.pdf#page=28"}, {"arrows": "to", "from": "Drug Name: combunox, Active Ingredient: ibuprofen; oxycodone hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: combunox, Active Ingredient: ibuprofen; oxycodone hydrochloride", "title": "Last Updated", "to": "09/02/2010"}, {"arrows": "to", "from": "Drug Name: combunox, Active Ingredient: ibuprofen; oxycodone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021378s006lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: concerta, Active Ingredient: methylphenidate hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: concerta, Active Ingredient: methylphenidate hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: concerta, Active Ingredient: methylphenidate hydrochloride", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: concerta, Active Ingredient: methylphenidate hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021121s049lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: consensi, Active Ingredient: amlodipine besylate; celecoxib", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: consensi, Active Ingredient: amlodipine besylate; celecoxib", "title": "Last Updated", "to": "04/28/2021"}, {"arrows": "to", "from": "Drug Name: consensi, Active Ingredient: amlodipine besylate; celecoxib", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210045s009lbl.pdf#page=10"}, {"arrows": "to", "from": "Drug Name: contrave, Active Ingredient: bupropion hydrochloride; naltrexone hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: contrave, Active Ingredient: bupropion hydrochloride; naltrexone hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: contrave, Active Ingredient: bupropion hydrochloride; naltrexone hydrochloride", "title": "Last Updated", "to": "05/07/2024"}, {"arrows": "to", "from": "Drug Name: contrave, Active Ingredient: bupropion hydrochloride; naltrexone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200063s021lbl.pdf#page=40"}, {"arrows": "to", "from": "Drug Name: conzip, Active Ingredient: tramadol hydrochloride", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: conzip, Active Ingredient: tramadol hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: conzip, Active Ingredient: tramadol hydrochloride", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: conzip, Active Ingredient: tramadol hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022370s025lbl.pdf#page=37"}, {"arrows": "to", "from": "Drug Name: copegus, Active Ingredient: ribavirin", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: copegus, Active Ingredient: ribavirin", "title": "Last Updated", "to": "08/11/2015"}, {"arrows": "to", "from": "Drug Name: copegus, Active Ingredient: ribavirin", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021511s029lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: copiktra, Active Ingredient: duvelisib", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: copiktra, Active Ingredient: duvelisib", "title": "Last Updated", "to": "12/17/2021"}, {"arrows": "to", "from": "Drug Name: copiktra, Active Ingredient: duvelisib", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211155s005lbl.pdf#page=28"}, {"arrows": "to", "from": "Drug Name: cordarone, Active Ingredient: amiodarone hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: cordarone, Active Ingredient: amiodarone hydrochloride", "title": "Last Updated", "to": "10/17/2018"}, {"arrows": "to", "from": "Drug Name: cordarone, Active Ingredient: amiodarone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018972s054lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: corlanor, Active Ingredient: ivabradine hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: corlanor, Active Ingredient: ivabradine hydrochloride", "title": "Last Updated", "to": "08/04/2021"}, {"arrows": "to", "from": "Drug Name: corlanor, Active Ingredient: ivabradine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206143s008,209964s002lblrpl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: corlanor, Active Ingredient: ivabradine", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: corlanor, Active Ingredient: ivabradine", "title": "Last Updated", "to": "08/04/2021"}, {"arrows": "to", "from": "Drug Name: corlanor, Active Ingredient: ivabradine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206143s008,209964s002lblrpl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: cosentyx, Active Ingredient: secukinumab", "title": "Form", "to": "INJECTABLE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: cosentyx, Active Ingredient: secukinumab", "title": "Other", "to": "INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: cosentyx, Active Ingredient: secukinumab", "title": "Last Updated", "to": "10/06/2023"}, {"arrows": "to", "from": "Drug Name: cosentyx, Active Ingredient: secukinumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761349s000lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: cosentyx, Active Ingredient: secukinumab", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: cosentyx, Active Ingredient: secukinumab", "title": "Last Updated", "to": "08/16/2024"}, {"arrows": "to", "from": "Drug Name: cosentyx, Active Ingredient: secukinumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125504s082lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: cotempla xr-odt, Active Ingredient: methylphenidate", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: cotempla xr-odt, Active Ingredient: methylphenidate", "title": "Other", "to": "ORALLY DISINTEGRATING"}, {"arrows": "to", "from": "Drug Name: cotempla xr-odt, Active Ingredient: methylphenidate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: cotempla xr-odt, Active Ingredient: methylphenidate", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: cotempla xr-odt, Active Ingredient: methylphenidate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205489s012lbl.pdf##page=24"}, {"arrows": "to", "from": "Drug Name: coumadin, Active Ingredient: warfarin sodium", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: coumadin, Active Ingredient: warfarin sodium", "title": "Last Updated", "to": "08/14/2017"}, {"arrows": "to", "from": "Drug Name: coumadin, Active Ingredient: warfarin sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009218s118lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: coumadin, Active Ingredient: warfarin sodium", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: coxanto, Active Ingredient: oxaprozin", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: coxanto, Active Ingredient: oxaprozin", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: coxanto, Active Ingredient: oxaprozin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217927s002lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: creon, Active Ingredient: pancrelipase (amylase;lipase;protease)", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: creon, Active Ingredient: pancrelipase (amylase;lipase;protease)", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: creon, Active Ingredient: pancrelipase (amylase;lipase;protease)", "title": "Last Updated", "to": "06/02/2024"}, {"arrows": "to", "from": "Drug Name: creon, Active Ingredient: pancrelipase (amylase;lipase;protease)", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020725s028lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: cyltezo, Active Ingredient: adalimumab-adbm", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: cyltezo, Active Ingredient: adalimumab-adbm", "title": "Last Updated", "to": "04/30/2024"}, {"arrows": "to", "from": "Drug Name: cyltezo, Active Ingredient: adalimumab-adbm", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761058s018lbl.pdf#page=38"}, {"arrows": "to", "from": "Drug Name: cymbalta, Active Ingredient: duloxetine hydrochloride", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: cymbalta, Active Ingredient: duloxetine hydrochloride", "title": "Other", "to": "DELAYED REL PELLETS;ORAL"}, {"arrows": "to", "from": "Drug Name: cymbalta, Active Ingredient: duloxetine hydrochloride", "title": "Last Updated", "to": "08/18/2023"}, {"arrows": "to", "from": "Drug Name: cymbalta, Active Ingredient: duloxetine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021427s055s057lbl.pdf#page=38"}, {"arrows": "to", "from": "Drug Name: daliresp, Active Ingredient: roflumilast", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: daliresp, Active Ingredient: roflumilast", "title": "Last Updated", "to": "01/23/2018"}, {"arrows": "to", "from": "Drug Name: daliresp, Active Ingredient: roflumilast", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022522s009lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: dalmane, Active Ingredient: flurazepam hydrochloride", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: dalmane, Active Ingredient: flurazepam hydrochloride", "title": "Last Updated", "to": "03/27/2009"}, {"arrows": "to", "from": "Drug Name: dalmane, Active Ingredient: flurazepam hydrochloride", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/016721s077lbl.pdf"}, {"arrows": "to", "from": "Drug Name: darvocet-n 100, Active Ingredient: acetaminophen; propoxyphene napsylate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: darvocet-n 100, Active Ingredient: acetaminophen; propoxyphene napsylate", "title": "Last Updated", "to": "09/25/2009"}, {"arrows": "to", "from": "Drug Name: darvocet-n 100, Active Ingredient: acetaminophen; propoxyphene napsylate", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187067.pdf"}, {"arrows": "to", "from": "Drug Name: darvocet-n 50, Active Ingredient: acetaminophen; propoxyphene napsylate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: darvocet-n 50, Active Ingredient: acetaminophen; propoxyphene napsylate", "title": "Last Updated", "to": "09/25/2009"}, {"arrows": "to", "from": "Drug Name: darvocet-n 50, Active Ingredient: acetaminophen; propoxyphene napsylate", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187067.pdf"}, {"arrows": "to", "from": "Drug Name: darvon, Active Ingredient: propoxyphene hydrochloride", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: darvon, Active Ingredient: propoxyphene hydrochloride", "title": "Last Updated", "to": "09/25/2009"}, {"arrows": "to", "from": "Drug Name: darvon, Active Ingredient: propoxyphene hydrochloride", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187068.pdf"}, {"arrows": "to", "from": "Drug Name: darvon-n, Active Ingredient: propoxyphene napsylate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: darvon-n, Active Ingredient: propoxyphene napsylate", "title": "Last Updated", "to": "09/25/2009"}, {"arrows": "to", "from": "Drug Name: darvon-n, Active Ingredient: propoxyphene napsylate", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187068.pdf"}, {"arrows": "to", "from": "Drug Name: daurismo, Active Ingredient: glasdegib maleate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: daurismo, Active Ingredient: glasdegib maleate", "title": "Last Updated", "to": "03/27/2023"}, {"arrows": "to", "from": "Drug Name: daurismo, Active Ingredient: glasdegib maleate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210656s005lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: daxxify, Active Ingredient: daxibotulinumtoxina-lanm", "title": "Form", "to": "INJECTABLE;INTRAMUSCULAR"}, {"arrows": "to", "from": "Drug Name: daxxify, Active Ingredient: daxibotulinumtoxina-lanm", "title": "Last Updated", "to": "08/11/2023"}, {"arrows": "to", "from": "Drug Name: daxxify, Active Ingredient: daxibotulinumtoxina-lanm", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761127s002lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: daypro, Active Ingredient: oxaprozin", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: daypro, Active Ingredient: oxaprozin", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: daypro, Active Ingredient: oxaprozin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018841s036lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: daypro alta, Active Ingredient: oxaprozin potassium", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: daypro alta, Active Ingredient: oxaprozin potassium", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: daypro alta, Active Ingredient: oxaprozin potassium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020776s013lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: daytrana, Active Ingredient: methylphenidate", "title": "Form", "to": "SYSTEM;TRANSDERMAL"}, {"arrows": "to", "from": "Drug Name: daytrana, Active Ingredient: methylphenidate", "title": "Last Updated", "to": "11/29/2024"}, {"arrows": "to", "from": "Drug Name: daytrana, Active Ingredient: methylphenidate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021514s039lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: daytrana, Active Ingredient: methylphenidate", "title": "Form", "to": "FILM"}, {"arrows": "to", "from": "Drug Name: daytrana, Active Ingredient: methylphenidate", "title": "Other", "to": "EXTENDED RELEASE;TRANSDERMAL"}, {"arrows": "to", "from": "Drug Name: daytrana, Active Ingredient: methylphenidate", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: daytrana, Active Ingredient: methylphenidate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021514s036lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: dayvigo, Active Ingredient: lemborexant", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: dayvigo, Active Ingredient: lemborexant", "title": "Last Updated", "to": "04/20/2023"}, {"arrows": "to", "from": "Drug Name: dayvigo, Active Ingredient: lemborexant", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212028s008lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: demerol, Active Ingredient: meperidine hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: demerol, Active Ingredient: meperidine hydrochloride", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: demerol, Active Ingredient: meperidine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005010s060lbl.pdf#page=31"}, {"arrows": "to", "from": "Drug Name: demerol, Active Ingredient: meperidine hydrochloride", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: demerol, Active Ingredient: meperidine hydrochloride", "title": "Form", "to": "SYRUP;ORAL"}, {"arrows": "to", "from": "Drug Name: depakene, Active Ingredient: valproic acid", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: depakene, Active Ingredient: valproic acid", "title": "Last Updated", "to": "05/19/2020"}, {"arrows": "to", "from": "Drug Name: depakene, Active Ingredient: valproic acid", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018081s070,018082s053lbl.pdf#page=41"}, {"arrows": "to", "from": "Drug Name: depakene, Active Ingredient: valproic acid", "title": "Form", "to": "SYRUP;ORAL"}, {"arrows": "to", "from": "Drug Name: depakene, Active Ingredient: valproic acid", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018081Orig1s068%20018082Orig1s051lbl.pdf#page=38"}, {"arrows": "to", "from": "Drug Name: depakote, Active Ingredient: divalproex sodium", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: depakote, Active Ingredient: divalproex sodium", "title": "Other", "to": "DELAYED REL PELLETS;ORAL"}, {"arrows": "to", "from": "Drug Name: depakote, Active Ingredient: divalproex sodium", "title": "Last Updated", "to": "03/18/2024"}, {"arrows": "to", "from": "Drug Name: depakote, Active Ingredient: divalproex sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019680s052lbl.pdf#page=42"}, {"arrows": "to", "from": "Drug Name: depakote, Active Ingredient: divalproex sodium", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: depakote, Active Ingredient: divalproex sodium", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: depakote, Active Ingredient: divalproex sodium", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018723s066lbledt.pdf#page=48"}, {"arrows": "to", "from": "Drug Name: depakote er, Active Ingredient: divalproex sodium", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: depakote er, Active Ingredient: divalproex sodium", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: depakote er, Active Ingredient: divalproex sodium", "title": "Last Updated", "to": "03/18/2024"}, {"arrows": "to", "from": "Drug Name: depakote er, Active Ingredient: divalproex sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021168s044lbl.pdf#page=48"}, {"arrows": "to", "from": "Drug Name: descovy, Active Ingredient: emtricitabine; tenofovir alafenamide fumarate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: descovy, Active Ingredient: emtricitabine; tenofovir alafenamide fumarate", "title": "Last Updated", "to": "01/07/2022"}, {"arrows": "to", "from": "Drug Name: descovy, Active Ingredient: emtricitabine; tenofovir alafenamide fumarate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208215s019lbl.pdf#page=37"}, {"arrows": "to", "from": "Drug Name: desoxyn, Active Ingredient: methamphetamine hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: desoxyn, Active Ingredient: methamphetamine hydrochloride", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: desoxyn, Active Ingredient: methamphetamine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005378s038lbl.pdf#page=12"}, {"arrows": "to", "from": "Drug Name: desoxyn, Active Ingredient: methamphetamine hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: desoxyn, Active Ingredient: methamphetamine hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: desoxyn, Active Ingredient: methamphetamine hydrochloride", "title": "Last Updated", "to": "09/24/2024"}, {"arrows": "to", "from": "Drug Name: desoxyn, Active Ingredient: methamphetamine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/005378s032lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: desvenlafaxine, Active Ingredient: desvenlafaxine fumarate", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: desvenlafaxine, Active Ingredient: desvenlafaxine fumarate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: desvenlafaxine, Active Ingredient: desvenlafaxine fumarate", "title": "Last Updated", "to": "07/18/2014"}, {"arrows": "to", "from": "Drug Name: desvenlafaxine, Active Ingredient: desvenlafaxine fumarate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205208Orig1s001lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: desvenlafaxine, Active Ingredient: desvenlafaxine", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: desvenlafaxine, Active Ingredient: desvenlafaxine", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: desvenlafaxine, Active Ingredient: desvenlafaxine", "title": "Last Updated", "to": "08/18/2023"}, {"arrows": "to", "from": "Drug Name: desvenlafaxine, Active Ingredient: desvenlafaxine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204150s020lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: desyrel, Active Ingredient: trazodone hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: desyrel, Active Ingredient: trazodone hydrochloride", "title": "Last Updated", "to": "10/18/2018"}, {"arrows": "to", "from": "Drug Name: desyrel, Active Ingredient: trazodone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018207s032lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: desyrel, Active Ingredient: trazodone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018207s033lbl.pdf#page=14"}, {"arrows": "to", "from": "Drug Name: dexedrine, Active Ingredient: dextroamphetamine sulfate", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: dexedrine, Active Ingredient: dextroamphetamine sulfate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: dexedrine, Active Ingredient: dextroamphetamine sulfate", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: dexedrine, Active Ingredient: dextroamphetamine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017078s055lbl.pdf#page=14"}, {"arrows": "to", "from": "Drug Name: dexilant, Active Ingredient: dexlansoprazole", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: dexilant, Active Ingredient: dexlansoprazole", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: dexilant, Active Ingredient: dexlansoprazole", "title": "Last Updated", "to": "07/18/2023"}, {"arrows": "to", "from": "Drug Name: dexilant, Active Ingredient: dexlansoprazole", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022287s038lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: dextroamphetamine sulfate, Active Ingredient: dextroamphetamine sulfate", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: dextroamphetamine sulfate, Active Ingredient: dextroamphetamine sulfate", "title": "Last Updated", "to": "01/04/2017"}, {"arrows": "to", "from": "Drug Name: dextroamphetamine sulfate, Active Ingredient: dextroamphetamine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/40776MG.pdf#page=7"}, {"arrows": "to", "from": "Drug Name: diacomit, Active Ingredient: stiripentol", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: diacomit, Active Ingredient: stiripentol", "title": "Last Updated", "to": "08/20/2018"}, {"arrows": "to", "from": "Drug Name: diacomit, Active Ingredient: stiripentol", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206709s000,207223s000lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: diacomit, Active Ingredient: stiripentol", "title": "Form", "to": "FOR SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: dilantin, Active Ingredient: phenytoin sodium", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: dilantin, Active Ingredient: phenytoin sodium", "title": "Last Updated", "to": "09/07/2022"}, {"arrows": "to", "from": "Drug Name: dilantin, Active Ingredient: phenytoin sodium", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/084349s088lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: dilantin, Active Ingredient: phenytoin", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: dilantin, Active Ingredient: phenytoin", "title": "Other", "to": "CHEWABLE;ORAL"}, {"arrows": "to", "from": "Drug Name: dilantin, Active Ingredient: phenytoin", "title": "Last Updated", "to": "10/22/2021"}, {"arrows": "to", "from": "Drug Name: dilantin, Active Ingredient: phenytoin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/084427s039s041lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: dilantin-125, Active Ingredient: phenytoin", "title": "Form", "to": "SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: dilantin-125, Active Ingredient: phenytoin", "title": "Last Updated", "to": "03/03/2022"}, {"arrows": "to", "from": "Drug Name: dilantin-125, Active Ingredient: phenytoin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/008762s066lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: dilantin-30, Active Ingredient: phenytoin", "title": "Form", "to": "SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: dilantin-30, Active Ingredient: phenytoin", "title": "Last Updated", "to": "03/03/2022"}, {"arrows": "to", "from": "Drug Name: dilantin-30, Active Ingredient: phenytoin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/008762s066lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: dilaudid, Active Ingredient: hydromorphone hydrochloride", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: dilaudid, Active Ingredient: hydromorphone hydrochloride", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: dilaudid, Active Ingredient: hydromorphone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019891s031,019892s041lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: dilaudid, Active Ingredient: hydromorphone hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: dolophine hydrochloride, Active Ingredient: methadone hydrochloride", "title": "Form", "to": "SYRUP;ORAL"}, {"arrows": "to", "from": "Drug Name: dolophine hydrochloride, Active Ingredient: methadone hydrochloride", "title": "Last Updated", "to": "06/02/2021"}, {"arrows": "to", "from": "Drug Name: dolophine hydrochloride, Active Ingredient: methadone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/006134s050lbl.pdf#page=36"}, {"arrows": "to", "from": "Drug Name: dolophine hydrochloride, Active Ingredient: methadone hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: doral, Active Ingredient: quazepam", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: doral, Active Ingredient: quazepam", "title": "Last Updated", "to": "01/13/2023"}, {"arrows": "to", "from": "Drug Name: doral, Active Ingredient: quazepam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018708s029lbl.pdf#page=11"}, {"arrows": "to", "from": "Drug Name: dotarem, Active Ingredient: gadoterate meglumine", "title": "Form", "to": "SOLUTION;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: dotarem, Active Ingredient: gadoterate meglumine", "title": "Last Updated", "to": "01/26/2024"}, {"arrows": "to", "from": "Drug Name: dotarem, Active Ingredient: gadoterate meglumine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204781s012lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: drizalma sprinkle, Active Ingredient: duloxetine hydrochloride", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: drizalma sprinkle, Active Ingredient: duloxetine hydrochloride", "title": "Other", "to": "DELAYED REL PELLETS;ORAL"}, {"arrows": "to", "from": "Drug Name: drizalma sprinkle, Active Ingredient: duloxetine hydrochloride", "title": "Last Updated", "to": "08/18/2023"}, {"arrows": "to", "from": "Drug Name: drizalma sprinkle, Active Ingredient: duloxetine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212516s005lbl.pdf#page=45"}, {"arrows": "to", "from": "Drug Name: droxia, Active Ingredient: hydroxyurea", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: droxia, Active Ingredient: hydroxyurea", "title": "Last Updated", "to": "11/28/2023"}, {"arrows": "to", "from": "Drug Name: droxia, Active Ingredient: hydroxyurea", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016295s058lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: duetact, Active Ingredient: glimepiride; pioglitazone hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: duetact, Active Ingredient: glimepiride; pioglitazone hydrochloride", "title": "Last Updated", "to": "12/21/2017"}, {"arrows": "to", "from": "Drug Name: duetact, Active Ingredient: glimepiride; pioglitazone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021925s017lbl.pdf#page=39"}, {"arrows": "to", "from": "Drug Name: duexis, Active Ingredient: famotidine; ibuprofen", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: duexis, Active Ingredient: famotidine; ibuprofen", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: duexis, Active Ingredient: famotidine; ibuprofen", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022519s014lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: duragesic-100, Active Ingredient: fentanyl", "title": "Form", "to": "FILM"}, {"arrows": "to", "from": "Drug Name: duragesic-100, Active Ingredient: fentanyl", "title": "Other", "to": "EXTENDED RELEASE;TRANSDERMAL"}, {"arrows": "to", "from": "Drug Name: duragesic-100, Active Ingredient: fentanyl", "title": "Last Updated", "to": "03/04/2021"}, {"arrows": "to", "from": "Drug Name: duragesic-100, Active Ingredient: fentanyl", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52"}, {"arrows": "to", "from": "Drug Name: duragesic-12, Active Ingredient: fentanyl", "title": "Form", "to": "FILM"}, {"arrows": "to", "from": "Drug Name: duragesic-12, Active Ingredient: fentanyl", "title": "Other", "to": "EXTENDED RELEASE;TRANSDERMAL"}, {"arrows": "to", "from": "Drug Name: duragesic-12, Active Ingredient: fentanyl", "title": "Last Updated", "to": "03/04/2021"}, {"arrows": "to", "from": "Drug Name: duragesic-12, Active Ingredient: fentanyl", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52"}, {"arrows": "to", "from": "Drug Name: duragesic-25, Active Ingredient: fentanyl", "title": "Form", "to": "FILM"}, {"arrows": "to", "from": "Drug Name: duragesic-25, Active Ingredient: fentanyl", "title": "Other", "to": "EXTENDED RELEASE;TRANSDERMAL"}, {"arrows": "to", "from": "Drug Name: duragesic-25, Active Ingredient: fentanyl", "title": "Last Updated", "to": "03/04/2021"}, {"arrows": "to", "from": "Drug Name: duragesic-25, Active Ingredient: fentanyl", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52"}, {"arrows": "to", "from": "Drug Name: duragesic-37, Active Ingredient: fentanyl", "title": "Form", "to": "FILM"}, {"arrows": "to", "from": "Drug Name: duragesic-37, Active Ingredient: fentanyl", "title": "Other", "to": "EXTENDED RELEASE;TRANSDERMAL"}, {"arrows": "to", "from": "Drug Name: duragesic-37, Active Ingredient: fentanyl", "title": "Last Updated", "to": "03/04/2021"}, {"arrows": "to", "from": "Drug Name: duragesic-37, Active Ingredient: fentanyl", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52"}, {"arrows": "to", "from": "Drug Name: duragesic-50, Active Ingredient: fentanyl", "title": "Form", "to": "FILM"}, {"arrows": "to", "from": "Drug Name: duragesic-50, Active Ingredient: fentanyl", "title": "Other", "to": "EXTENDED RELEASE;TRANSDERMAL"}, {"arrows": "to", "from": "Drug Name: duragesic-50, Active Ingredient: fentanyl", "title": "Last Updated", "to": "03/04/2021"}, {"arrows": "to", "from": "Drug Name: duragesic-50, Active Ingredient: fentanyl", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52"}, {"arrows": "to", "from": "Drug Name: duragesic-75, Active Ingredient: fentanyl", "title": "Form", "to": "FILM"}, {"arrows": "to", "from": "Drug Name: duragesic-75, Active Ingredient: fentanyl", "title": "Other", "to": "EXTENDED RELEASE;TRANSDERMAL"}, {"arrows": "to", "from": "Drug Name: duragesic-75, Active Ingredient: fentanyl", "title": "Last Updated", "to": "03/04/2021"}, {"arrows": "to", "from": "Drug Name: duragesic-75, Active Ingredient: fentanyl", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52"}, {"arrows": "to", "from": "Drug Name: duzallo, Active Ingredient: allopurinol; lesinurad", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: duzallo, Active Ingredient: allopurinol; lesinurad", "title": "Last Updated", "to": "08/18/2017"}, {"arrows": "to", "from": "Drug Name: duzallo, Active Ingredient: allopurinol; lesinurad", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209203s000lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: dyanavel xr, Active Ingredient: amphetamine", "title": "Form", "to": "SUSPENSION"}, {"arrows": "to", "from": "Drug Name: dyanavel xr, Active Ingredient: amphetamine", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: dyanavel xr, Active Ingredient: amphetamine", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: dyanavel xr, Active Ingredient: amphetamine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208147s016,210526s008lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: dyanavel xr 10, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: dyanavel xr 10, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: dyanavel xr 10, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: dyanavel xr 10, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208147s016,210526s008lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: dyanavel xr 15, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: dyanavel xr 15, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: dyanavel xr 15, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: dyanavel xr 15, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208147s016,210526s008lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: dyanavel xr 20, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: dyanavel xr 20, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: dyanavel xr 20, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: dyanavel xr 20, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208147s016,210526s008lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: dyanavel xr 5, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: dyanavel xr 5, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: dyanavel xr 5, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: dyanavel xr 5, Active Ingredient: amphetamine; amphetamine aspartate/dextroamphetamine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208147s016,210526s008lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: dysport, Active Ingredient: abobotulinumtoxina", "title": "Form", "to": "INJECTABLE; INJECTION"}, {"arrows": "to", "from": "Drug Name: dysport, Active Ingredient: abobotulinumtoxina", "title": "Last Updated", "to": "09/21/2023"}, {"arrows": "to", "from": "Drug Name: dysport, Active Ingredient: abobotulinumtoxina", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125274s125lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: ec-naprosyn, Active Ingredient: naproxen", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: ec-naprosyn, Active Ingredient: naproxen", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: ec-naprosyn, Active Ingredient: naproxen", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: ec-naprosyn, Active Ingredient: naproxen", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017581s117,018164s067,020067s026lbl.pdf"}, {"arrows": "to", "from": "Drug Name: edluar, Active Ingredient: zolpidem tartrate", "title": "Form", "to": "TABLET;SUBLINGUAL"}, {"arrows": "to", "from": "Drug Name: edluar, Active Ingredient: zolpidem tartrate", "title": "Last Updated", "to": "08/18/2019"}, {"arrows": "to", "from": "Drug Name: edluar, Active Ingredient: zolpidem tartrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021997s011lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: effexor, Active Ingredient: venlafaxine hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: effexor, Active Ingredient: venlafaxine hydrochloride", "title": "Last Updated", "to": "12/12/2012"}, {"arrows": "to", "from": "Drug Name: effexor, Active Ingredient: venlafaxine hydrochloride", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020151s031s055s058s060lbl.pdf#page=34"}, {"arrows": "to", "from": "Drug Name: effexor xr, Active Ingredient: venlafaxine hydrochloride", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: effexor xr, Active Ingredient: venlafaxine hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: effexor xr, Active Ingredient: venlafaxine hydrochloride", "title": "Last Updated", "to": "08/18/2023"}, {"arrows": "to", "from": "Drug Name: effexor xr, Active Ingredient: venlafaxine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020699s118lbl.pdf#page=41"}, {"arrows": "to", "from": "Drug Name: effient, Active Ingredient: prasugrel hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: effient, Active Ingredient: prasugrel hydrochloride", "title": "Last Updated", "to": "12/22/2020"}, {"arrows": "to", "from": "Drug Name: effient, Active Ingredient: prasugrel hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022307s018lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: elepsia xr, Active Ingredient: levetiracetam", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: elepsia xr, Active Ingredient: levetiracetam", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: elepsia xr, Active Ingredient: levetiracetam", "title": "Last Updated", "to": "03/12/2024"}, {"arrows": "to", "from": "Drug Name: elepsia xr, Active Ingredient: levetiracetam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204417s004lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: elidel, Active Ingredient: pimecrolimus", "title": "Form", "to": "CREAM;TOPICAL"}, {"arrows": "to", "from": "Drug Name: elidel, Active Ingredient: pimecrolimus", "title": "Last Updated", "to": "06/09/2016"}, {"arrows": "to", "from": "Drug Name: elidel, Active Ingredient: pimecrolimus", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088587.pdf"}, {"arrows": "to", "from": "Drug Name: eliquis, Active Ingredient: apixaban", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: eliquis, Active Ingredient: apixaban", "title": "Last Updated", "to": "10/12/2021"}, {"arrows": "to", "from": "Drug Name: eliquis, Active Ingredient: apixaban", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202155s034lbl.pdf#page=38"}, {"arrows": "to", "from": "Drug Name: elmiron, Active Ingredient: pentosan polysulfate sodium", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: elmiron, Active Ingredient: pentosan polysulfate sodium", "title": "Last Updated", "to": "03/12/2021"}, {"arrows": "to", "from": "Drug Name: elmiron, Active Ingredient: pentosan polysulfate sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020193s015lbl.pdf#page=11"}, {"arrows": "to", "from": "Drug Name: elrexfio, Active Ingredient: elranatamab-bcmm", "title": "Form", "to": "INJECTABLE; SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: elrexfio, Active Ingredient: elranatamab-bcmm", "title": "Last Updated", "to": "08/14/2023"}, {"arrows": "to", "from": "Drug Name: elrexfio, Active Ingredient: elranatamab-bcmm", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761345s000lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: elucirem, Active Ingredient: gadopiclenol", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: elucirem, Active Ingredient: gadopiclenol", "title": "Last Updated", "to": "01/26/2024"}, {"arrows": "to", "from": "Drug Name: elucirem, Active Ingredient: gadopiclenol", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216986s000lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: elyxyb, Active Ingredient: celecoxib", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: elyxyb, Active Ingredient: celecoxib", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: elyxyb, Active Ingredient: celecoxib", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/212157s003lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: embeda, Active Ingredient: morphine sulfate; naltrexone hydrochloride", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: embeda, Active Ingredient: morphine sulfate; naltrexone hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: embeda, Active Ingredient: morphine sulfate; naltrexone hydrochloride", "title": "Last Updated", "to": "10/07/2019"}, {"arrows": "to", "from": "Drug Name: embeda, Active Ingredient: morphine sulfate; naltrexone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022321s030lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: empavel, Active Ingredient: pegcetacoplan", "title": "Form", "to": "INJECTABLE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: empavel, Active Ingredient: pegcetacoplan", "title": "Last Updated", "to": "02/08/2024"}, {"arrows": "to", "from": "Drug Name: empavel, Active Ingredient: pegcetacoplan", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215014s003lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: emsam, Active Ingredient: selegiline", "title": "Form", "to": "FILM"}, {"arrows": "to", "from": "Drug Name: emsam, Active Ingredient: selegiline", "title": "Other", "to": "EXTENDED RELEASE;TRANSDERMAL"}, {"arrows": "to", "from": "Drug Name: emsam, Active Ingredient: selegiline", "title": "Last Updated", "to": "07/14/2017"}, {"arrows": "to", "from": "Drug Name: emsam, Active Ingredient: selegiline", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021336s014lbl.pdf#page=34"}, {"arrows": "to", "from": "Drug Name: enbrel, Active Ingredient: etanercept", "title": "Form", "to": "VIAL; SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: enbrel, Active Ingredient: etanercept", "title": "Last Updated", "to": "09/12/2024"}, {"arrows": "to", "from": "Drug Name: enbrel, Active Ingredient: etanercept", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/103795s5600lbl.pdf#page=36"}, {"arrows": "to", "from": "Drug Name: enbrel, Active Ingredient: etanercept", "title": "Form", "to": "SYRINGE"}, {"arrows": "to", "from": "Drug Name: enbrel, Active Ingredient: etanercept", "title": "Last Updated", "to": "06/09/2023"}, {"arrows": "to", "from": "Drug Name: enbrel, Active Ingredient: etanercept", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103795s5594lbl.pdf#page=35"}, {"arrows": "to", "from": "Drug Name: enhertu, Active Ingredient: fam-trastuzumab deruxtecan-nxki", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: enhertu, Active Ingredient: fam-trastuzumab deruxtecan-nxki", "title": "Last Updated", "to": "04/05/2024"}, {"arrows": "to", "from": "Drug Name: enhertu, Active Ingredient: fam-trastuzumab deruxtecan-nxki", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761139s022lbl.pdf#page=31"}, {"arrows": "to", "from": "Drug Name: enjaymo, Active Ingredient: sutimlimab-jome", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: enjaymo, Active Ingredient: sutimlimab-jome", "title": "Last Updated", "to": "02/08/2024"}, {"arrows": "to", "from": "Drug Name: enjaymo, Active Ingredient: sutimlimab-jome", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761164s000lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: enspryng, Active Ingredient: satralizumab-mwge", "title": "Form", "to": "INJECTABLE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: enspryng, Active Ingredient: satralizumab-mwge", "title": "Last Updated", "to": "09/14/2022"}, {"arrows": "to", "from": "Drug Name: enspryng, Active Ingredient: satralizumab-mwge", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761149s005lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: entyvio, Active Ingredient: vedolizumab", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: entyvio, Active Ingredient: vedolizumab", "title": "Last Updated", "to": "04/18/2024"}, {"arrows": "to", "from": "Drug Name: entyvio, Active Ingredient: vedolizumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761133s000lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: entyvio, Active Ingredient: vedolizumab", "title": "Form", "to": "INJECTABLE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: entyvio, Active Ingredient: vedolizumab", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: entyvio, Active Ingredient: vedolizumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125476s038s039lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: entyvio pen, Active Ingredient: vedolizumab", "title": "Form", "to": "INJECTABLE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: entyvio pen, Active Ingredient: vedolizumab", "title": "Last Updated", "to": "04/18/2024"}, {"arrows": "to", "from": "Drug Name: entyvio pen, Active Ingredient: vedolizumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761133s000lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: envarsus xr, Active Ingredient: tacrolimus", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: envarsus xr, Active Ingredient: tacrolimus", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: envarsus xr, Active Ingredient: tacrolimus", "title": "Last Updated", "to": "04/08/2024"}, {"arrows": "to", "from": "Drug Name: envarsus xr, Active Ingredient: tacrolimus", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206406s010lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: eovist, Active Ingredient: gadoxetate disodium", "title": "Form", "to": "SOLUTION;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: eovist, Active Ingredient: gadoxetate disodium", "title": "Last Updated", "to": "01/30/2024"}, {"arrows": "to", "from": "Drug Name: eovist, Active Ingredient: gadoxetate disodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022090s020lbledt.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: epidiolex, Active Ingredient: cannabidiol", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: epidiolex, Active Ingredient: cannabidiol", "title": "Last Updated", "to": "03/04/2024"}, {"arrows": "to", "from": "Drug Name: epidiolex, Active Ingredient: cannabidiol", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210365s020lbl.pdf#page=31"}, {"arrows": "to", "from": "Drug Name: epkinly, Active Ingredient: epcoritamab-bysp", "title": "Form", "to": "INJECTABLE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: epkinly, Active Ingredient: epcoritamab-bysp", "title": "Last Updated", "to": "06/26/2024"}, {"arrows": "to", "from": "Drug Name: epkinly, Active Ingredient: epcoritamab-bysp", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761324s000lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: epogen, Active Ingredient: epoetin alfa", "title": "Form", "to": "VIAL; SINGLE-USE"}, {"arrows": "to", "from": "Drug Name: epogen, Active Ingredient: epoetin alfa", "title": "Last Updated", "to": "04/30/2024"}, {"arrows": "to", "from": "Drug Name: epogen, Active Ingredient: epoetin alfa", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103234s5363s5366lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: epzicom, Active Ingredient: abacavir sulfate; lamivudine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: epzicom, Active Ingredient: abacavir sulfate; lamivudine", "title": "Last Updated", "to": "12/10/2021"}, {"arrows": "to", "from": "Drug Name: epzicom, Active Ingredient: abacavir sulfate; lamivudine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021652s029lbl.pdf#page=28"}, {"arrows": "to", "from": "Drug Name: equetro, Active Ingredient: carbamazepine", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: equetro, Active Ingredient: carbamazepine", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: equetro, Active Ingredient: carbamazepine", "title": "Last Updated", "to": "10/14/2022"}, {"arrows": "to", "from": "Drug Name: equetro, Active Ingredient: carbamazepine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021710s018lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: erelzi, Active Ingredient: etanercept-szzs", "title": "Form", "to": "INJECTABLE; INJECTION"}, {"arrows": "to", "from": "Drug Name: erelzi, Active Ingredient: etanercept-szzs", "title": "Last Updated", "to": "11/10/2022"}, {"arrows": "to", "from": "Drug Name: erelzi, Active Ingredient: etanercept-szzs", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761042s018lbl.pdf#page=41"}, {"arrows": "to", "from": "Drug Name: erivedge, Active Ingredient: vismodegib", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: erivedge, Active Ingredient: vismodegib", "title": "Last Updated", "to": "03/27/2023"}, {"arrows": "to", "from": "Drug Name: erivedge, Active Ingredient: vismodegib", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203388s017lbl.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: esomeprazole strontium, Active Ingredient: esomeprazole strontium", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: esomeprazole strontium, Active Ingredient: esomeprazole strontium", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: esomeprazole strontium, Active Ingredient: esomeprazole strontium", "title": "Last Updated", "to": "03/04/2022"}, {"arrows": "to", "from": "Drug Name: esomeprazole strontium, Active Ingredient: esomeprazole strontium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202342s007lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: estazolam, Active Ingredient: estazolam", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: estazolam, Active Ingredient: estazolam", "title": "Last Updated", "to": "02/05/2021"}, {"arrows": "to", "from": "Drug Name: estazolam, Active Ingredient: estazolam", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM359235.pdf"}, {"arrows": "to", "from": "Drug Name: eticovo, Active Ingredient: etanercept-ykro", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: eticovo, Active Ingredient: etanercept-ykro", "title": "Last Updated", "to": "05/03/2024"}, {"arrows": "to", "from": "Drug Name: eticovo, Active Ingredient: etanercept-ykro", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761066s000lbl.pdf#page=31"}, {"arrows": "to", "from": "Drug Name: evekeo odt, Active Ingredient: amphetamine sulfate", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: evekeo odt, Active Ingredient: amphetamine sulfate", "title": "Other", "to": "ORALLY DISINTEGRATING;ORAL"}, {"arrows": "to", "from": "Drug Name: evekeo odt, Active Ingredient: amphetamine sulfate", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: evekeo odt, Active Ingredient: amphetamine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209905s004lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: evenity, Active Ingredient: romosozumab-aqqg", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: evenity, Active Ingredient: romosozumab-aqqg", "title": "Last Updated", "to": "12/20/2019"}, {"arrows": "to", "from": "Drug Name: evenity, Active Ingredient: romosozumab-aqqg", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761062s000lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: evista, Active Ingredient: raloxifene hydrochloride", "title": "Form", "to": "TABLET; ORAL"}, {"arrows": "to", "from": "Drug Name: evista, Active Ingredient: raloxifene hydrochloride", "title": "Last Updated", "to": "09/13/2007"}, {"arrows": "to", "from": "Drug Name: evista, Active Ingredient: raloxifene hydrochloride", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088593.pdf"}, {"arrows": "to", "from": "Drug Name: evista, Active Ingredient: raloxifene hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: evista, Active Ingredient: raloxifene hydrochloride", "title": "Last Updated", "to": "06/27/2018"}, {"arrows": "to", "from": "Drug Name: exalgo, Active Ingredient: hydromorphone hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: exalgo, Active Ingredient: hydromorphone hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: exalgo, Active Ingredient: hydromorphone hydrochloride", "title": "Last Updated", "to": "10/07/2019"}, {"arrows": "to", "from": "Drug Name: exalgo, Active Ingredient: hydromorphone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021217s025lbl.pdf#page=31"}, {"arrows": "to", "from": "Drug Name: exjade, Active Ingredient: deferasirox", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: exjade, Active Ingredient: deferasirox", "title": "Other", "to": "FOR SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: exjade, Active Ingredient: deferasirox", "title": "Last Updated", "to": "07/23/2020"}, {"arrows": "to", "from": "Drug Name: exjade, Active Ingredient: deferasirox", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021882s033lbl.pdf#page=28"}, {"arrows": "to", "from": "Drug Name: extavia, Active Ingredient: interferon beta-1b", "title": "Form", "to": "INJECTABLE; SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: extavia, Active Ingredient: interferon beta-1b", "title": "Last Updated", "to": "07/28/2023"}, {"arrows": "to", "from": "Drug Name: extavia, Active Ingredient: interferon beta-1b", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125290s074lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: fabhalta, Active Ingredient: iptacopan", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: fabhalta, Active Ingredient: iptacopan", "title": "Last Updated", "to": "08/07/2024"}, {"arrows": "to", "from": "Drug Name: fabhalta, Active Ingredient: iptacopan", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218276s001lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: factive, Active Ingredient: gemifloxacin mesylate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: factive, Active Ingredient: gemifloxacin mesylate", "title": "Last Updated", "to": "07/26/2016"}, {"arrows": "to", "from": "Drug Name: factive, Active Ingredient: gemifloxacin mesylate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021158s026lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: farxiga, Active Ingredient: dapagliflozin", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: farxiga, Active Ingredient: dapagliflozin", "title": "Last Updated", "to": "06/12/2024"}, {"arrows": "to", "from": "Drug Name: farxiga, Active Ingredient: dapagliflozin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202293s030lbl.pdf#page=53"}, {"arrows": "to", "from": "Drug Name: farydak, Active Ingredient: panobinostat lactate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: farydak, Active Ingredient: panobinostat lactate", "title": "Last Updated", "to": "06/06/2016"}, {"arrows": "to", "from": "Drug Name: farydak, Active Ingredient: panobinostat lactate", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM436377.pdf"}, {"arrows": "to", "from": "Drug Name: felbatol, Active Ingredient: felbamate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: felbatol, Active Ingredient: felbamate", "title": "Last Updated", "to": "08/31/2012"}, {"arrows": "to", "from": "Drug Name: felbatol, Active Ingredient: felbamate", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020189s027mg.pdf"}, {"arrows": "to", "from": "Drug Name: felbatol, Active Ingredient: felbamate", "title": "Form", "to": "SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: feldene, Active Ingredient: piroxicam", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: feldene, Active Ingredient: piroxicam", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: feldene, Active Ingredient: piroxicam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018147s050lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: fensolvi kit, Active Ingredient: leuprolide acetate", "title": "Form", "to": "POWDER;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: fensolvi kit, Active Ingredient: leuprolide acetate", "title": "Last Updated", "to": "04/22/2022"}, {"arrows": "to", "from": "Drug Name: fensolvi kit, Active Ingredient: leuprolide acetate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213150s002lbl.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: fentanyl citrate, Active Ingredient: fentanyl citrate", "title": "Form", "to": "TROCHE/LOZENGE;TRANSMUCOSAL"}, {"arrows": "to", "from": "Drug Name: fentanyl citrate, Active Ingredient: fentanyl citrate", "title": "Last Updated", "to": "09/07/2017"}, {"arrows": "to", "from": "Drug Name: fentanyl citrate, Active Ingredient: fentanyl citrate", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/077312MedGuide.pdf"}, {"arrows": "to", "from": "Drug Name: fentanyl citrate, Active Ingredient: fentanyl citrate", "title": "Last Updated", "to": "12/03/2021"}, {"arrows": "to", "from": "Drug Name: fentanyl citrate, Active Ingredient: fentanyl citrate", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/078907MedGuide.pdf"}, {"arrows": "to", "from": "Drug Name: fentora, Active Ingredient: fentanyl citrate", "title": "Form", "to": "TABLET;BUCCAL"}, {"arrows": "to", "from": "Drug Name: fentora, Active Ingredient: fentanyl citrate", "title": "Other", "to": "SUBLINGUAL"}, {"arrows": "to", "from": "Drug Name: fentora, Active Ingredient: fentanyl citrate", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: fentora, Active Ingredient: fentanyl citrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021947s043lbl.pdf#page=43"}, {"arrows": "to", "from": "Drug Name: ferriprox, Active Ingredient: deferiprone", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: ferriprox, Active Ingredient: deferiprone", "title": "Last Updated", "to": "11/30/2021"}, {"arrows": "to", "from": "Drug Name: ferriprox, Active Ingredient: deferiprone", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212269s003lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: ferriprox, Active Ingredient: deferiprone", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021825s010lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: ferriprox, Active Ingredient: deferiprone", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: ferriprox, Active Ingredient: deferiprone", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208030s007lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: fetzima, Active Ingredient: levomilnacipran hydrochloride", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: fetzima, Active Ingredient: levomilnacipran hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: fetzima, Active Ingredient: levomilnacipran hydrochloride", "title": "Last Updated", "to": "04/19/2024"}, {"arrows": "to", "from": "Drug Name: fetzima, Active Ingredient: levomilnacipran hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204168s011lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: filspari, Active Ingredient: sparsentan", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: filspari, Active Ingredient: sparsentan", "title": "Last Updated", "to": "02/17/2023"}, {"arrows": "to", "from": "Drug Name: filspari, Active Ingredient: sparsentan", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216403s000lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: fintepla, Active Ingredient: fenfluramine hydrochloride", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: fintepla, Active Ingredient: fenfluramine hydrochloride", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: fintepla, Active Ingredient: fenfluramine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212102s013lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: fioricet w/ codeine, Active Ingredient: acetaminophen; butalbital; caffeine; codeine phosphate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: fioricet w/ codeine, Active Ingredient: acetaminophen; butalbital; caffeine; codeine phosphate", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: fioricet w/ codeine, Active Ingredient: acetaminophen; butalbital; caffeine; codeine phosphate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020232s047lbl.pdf#page=44"}, {"arrows": "to", "from": "Drug Name: fiorinal w/codeine, Active Ingredient: aspirin; butalbital; caffeine; codeine phosphate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: fiorinal w/codeine, Active Ingredient: aspirin; butalbital; caffeine; codeine phosphate", "title": "Last Updated", "to": "04/28/2021"}, {"arrows": "to", "from": "Drug Name: fiorinal w/codeine, Active Ingredient: aspirin; butalbital; caffeine; codeine phosphate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019429s043lbl.pdf#page=39"}, {"arrows": "to", "from": "Drug Name: firdapse, Active Ingredient: amifampridine phosphate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: firdapse, Active Ingredient: amifampridine phosphate", "title": "Last Updated", "to": "05/30/2024"}, {"arrows": "to", "from": "Drug Name: firdapse, Active Ingredient: amifampridine phosphate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208078s009lbl.pdf#page=12"}, {"arrows": "to", "from": "Drug Name: flector, Active Ingredient: diclofenac epolamine", "title": "Form", "to": "SYSTEM;TOPICAL"}, {"arrows": "to", "from": "Drug Name: flector, Active Ingredient: diclofenac epolamine", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: flector, Active Ingredient: diclofenac epolamine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021234s024lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: flowtuss, Active Ingredient: guaifenesin; hydrocodone bitartrate", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: flowtuss, Active Ingredient: guaifenesin; hydrocodone bitartrate", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: flowtuss, Active Ingredient: guaifenesin; hydrocodone bitartrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022424s003lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: floxin, Active Ingredient: ofloxacin", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: floxin, Active Ingredient: ofloxacin", "title": "Last Updated", "to": "02/25/2011"}, {"arrows": "to", "from": "Drug Name: floxin, Active Ingredient: ofloxacin", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019735s061MedG.pdf"}, {"arrows": "to", "from": "Drug Name: fluoxetine hydrochloride, Active Ingredient: fluoxetine hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: fluoxetine hydrochloride, Active Ingredient: fluoxetine hydrochloride", "title": "Last Updated", "to": "08/18/2023"}, {"arrows": "to", "from": "Drug Name: fluoxetine hydrochloride, Active Ingredient: fluoxetine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202133s009s016lbl.pdf#page=36"}, {"arrows": "to", "from": "Drug Name: focalin, Active Ingredient: dexmethylphenidate hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: focalin, Active Ingredient: dexmethylphenidate hydrochloride", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: focalin, Active Ingredient: dexmethylphenidate hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021278s028s031lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: focalin xr, Active Ingredient: dexmethylphenidate hydrochloride", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: focalin xr, Active Ingredient: dexmethylphenidate hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: focalin xr, Active Ingredient: dexmethylphenidate hydrochloride", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: focalin xr, Active Ingredient: dexmethylphenidate hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021802s038s041lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: foradil, Active Ingredient: formoterol fumarate", "title": "Form", "to": "POWDER;INHALATION"}, {"arrows": "to", "from": "Drug Name: foradil, Active Ingredient: formoterol fumarate", "title": "Last Updated", "to": "03/02/2016"}, {"arrows": "to", "from": "Drug Name: foradil, Active Ingredient: formoterol fumarate", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088602.pdf"}, {"arrows": "to", "from": "Drug Name: foradil certihaler, Active Ingredient: formoterol fumarate", "title": "Form", "to": "POWDER;INHALATION"}, {"arrows": "to", "from": "Drug Name: foradil certihaler, Active Ingredient: formoterol fumarate", "title": "Last Updated", "to": "06/02/2010"}, {"arrows": "to", "from": "Drug Name: foradil certihaler, Active Ingredient: formoterol fumarate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021592s003lbl.pdf#page=35"}, {"arrows": "to", "from": "Drug Name: forfivo xl, Active Ingredient: bupropion hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: forfivo xl, Active Ingredient: bupropion hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: forfivo xl, Active Ingredient: bupropion hydrochloride", "title": "Last Updated", "to": "05/07/2024"}, {"arrows": "to", "from": "Drug Name: forfivo xl, Active Ingredient: bupropion hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022497s008lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: forteo, Active Ingredient: teriparatide", "title": "Form", "to": "SOLUTION;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: forteo, Active Ingredient: teriparatide", "title": "Last Updated", "to": "09/07/2021"}, {"arrows": "to", "from": "Drug Name: forteo, Active Ingredient: teriparatide", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021318Orig1s054lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: fortesta, Active Ingredient: testosterone", "title": "Form", "to": "GEL"}, {"arrows": "to", "from": "Drug Name: fortesta, Active Ingredient: testosterone", "title": "Other", "to": "METERED;TRANSDERMAL"}, {"arrows": "to", "from": "Drug Name: fortesta, Active Ingredient: testosterone", "title": "Last Updated", "to": "06/30/2020"}, {"arrows": "to", "from": "Drug Name: fortesta, Active Ingredient: testosterone", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021463s025lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: fosamax, Active Ingredient: alendronate sodium", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: fosamax, Active Ingredient: alendronate sodium", "title": "Last Updated", "to": "11/30/2015"}, {"arrows": "to", "from": "Drug Name: fosamax, Active Ingredient: alendronate sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020560s068,021575s024lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: fosamax, Active Ingredient: alendronate sodium", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: fosamax, Active Ingredient: alendronate sodium", "title": "Last Updated", "to": "08/16/2019"}, {"arrows": "to", "from": "Drug Name: fosamax plus d, Active Ingredient: alendronate sodium; cholecalciferol", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: fosamax plus d, Active Ingredient: alendronate sodium; cholecalciferol", "title": "Last Updated", "to": "08/16/2019"}, {"arrows": "to", "from": "Drug Name: fosamax plus d, Active Ingredient: alendronate sodium; cholecalciferol", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM241521.pdf"}, {"arrows": "to", "from": "Drug Name: fosamax plus d, Active Ingredient: alendronate sodium; cholecalciferol", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021762s022lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: fosrenol, Active Ingredient: lanthanum carbonate", "title": "Form", "to": "POWDER;ORAL"}, {"arrows": "to", "from": "Drug Name: fosrenol, Active Ingredient: lanthanum carbonate", "title": "Last Updated", "to": "08/29/2024"}, {"arrows": "to", "from": "Drug Name: fosrenol, Active Ingredient: lanthanum carbonate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204734s007,021468s025lbl.pdf#page=12"}, {"arrows": "to", "from": "Drug Name: fosrenol, Active Ingredient: lanthanum carbonate", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: fosrenol, Active Ingredient: lanthanum carbonate", "title": "Other", "to": "CHEWABLE;ORAL"}, {"arrows": "to", "from": "Drug Name: fycompa, Active Ingredient: perampanel", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: fycompa, Active Ingredient: perampanel", "title": "Last Updated", "to": "05/30/2019"}, {"arrows": "to", "from": "Drug Name: fycompa, Active Ingredient: perampanel", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202834s016,208277s004lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: fycompa, Active Ingredient: perampanel", "title": "Form", "to": "SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: fycompa, Active Ingredient: perampanel", "title": "Last Updated", "to": "02/23/2021"}, {"arrows": "to", "from": "Drug Name: fycompa, Active Ingredient: perampanel", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208277s005lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: gabitril, Active Ingredient: tiagabine hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: gabitril, Active Ingredient: tiagabine hydrochloride", "title": "Last Updated", "to": "08/09/2016"}, {"arrows": "to", "from": "Drug Name: gabitril, Active Ingredient: tiagabine hydrochloride", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229203.pdf"}, {"arrows": "to", "from": "Drug Name: gadavist, Active Ingredient: gadobutrol", "title": "Form", "to": "SOLUTION;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: gadavist, Active Ingredient: gadobutrol", "title": "Last Updated", "to": "01/26/2024"}, {"arrows": "to", "from": "Drug Name: gadavist, Active Ingredient: gadobutrol", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201277s020lbl.pdf#page=42"}, {"arrows": "to", "from": "Drug Name: gattex kit, Active Ingredient: teduglutide recombinant", "title": "Form", "to": "POWDER;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: gattex kit, Active Ingredient: teduglutide recombinant", "title": "Last Updated", "to": "09/19/2024"}, {"arrows": "to", "from": "Drug Name: gattex kit, Active Ingredient: teduglutide recombinant", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203441s022lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: gilenya, Active Ingredient: fingolimod hydrochloride", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: gilenya, Active Ingredient: fingolimod hydrochloride", "title": "Last Updated", "to": "06/05/2024"}, {"arrows": "to", "from": "Drug Name: gilenya, Active Ingredient: fingolimod hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022527s038lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: gimoti, Active Ingredient: metoclopramide hydrochloride", "title": "Form", "to": "SPRAY"}, {"arrows": "to", "from": "Drug Name: gimoti, Active Ingredient: metoclopramide hydrochloride", "title": "Other", "to": "METERED;NASAL"}, {"arrows": "to", "from": "Drug Name: gimoti, Active Ingredient: metoclopramide hydrochloride", "title": "Last Updated", "to": "01/14/2021"}, {"arrows": "to", "from": "Drug Name: gimoti, Active Ingredient: metoclopramide hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209388s001lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: gloperba, Active Ingredient: colchicine", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: gloperba, Active Ingredient: colchicine", "title": "Last Updated", "to": "08/28/2024"}, {"arrows": "to", "from": "Drug Name: gloperba, Active Ingredient: colchicine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210942s002lbl.pdf#page=14"}, {"arrows": "to", "from": "Drug Name: glyxambi, Active Ingredient: empagliflozin; linagliptin", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: glyxambi, Active Ingredient: empagliflozin; linagliptin", "title": "Last Updated", "to": "10/30/2023"}, {"arrows": "to", "from": "Drug Name: glyxambi, Active Ingredient: empagliflozin; linagliptin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206073s036lbl.pdf#page=34"}, {"arrows": "to", "from": "Drug Name: golytely, Active Ingredient: polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous", "title": "Form", "to": "FOR SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: golytely, Active Ingredient: polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous", "title": "Last Updated", "to": "05/14/2021"}, {"arrows": "to", "from": "Drug Name: golytely, Active Ingredient: polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019011s033lbl.pdf#page=9"}, {"arrows": "to", "from": "Drug Name: gralise, Active Ingredient: gabapentin", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: gralise, Active Ingredient: gabapentin", "title": "Last Updated", "to": "04/18/2023"}, {"arrows": "to", "from": "Drug Name: gralise, Active Ingredient: gabapentin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022544Orig1s029lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: h.p. acthar gel, Active Ingredient: repository corticotropin", "title": "Form", "to": "INJECTABLE; INJECTION"}, {"arrows": "to", "from": "Drug Name: h.p. acthar gel, Active Ingredient: repository corticotropin", "title": "Last Updated", "to": "10/15/2010"}, {"arrows": "to", "from": "Drug Name: h.p. acthar gel, Active Ingredient: repository corticotropin", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM231714.pdf"}, {"arrows": "to", "from": "Drug Name: hadlima, Active Ingredient: adalimumab-bwwd", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: hadlima, Active Ingredient: adalimumab-bwwd", "title": "Last Updated", "to": "06/28/2024"}, {"arrows": "to", "from": "Drug Name: hadlima, Active Ingredient: adalimumab-bwwd", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761059s008lbl.pdf#page=46"}, {"arrows": "to", "from": "Drug Name: halcion, Active Ingredient: triazolam", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: halcion, Active Ingredient: triazolam", "title": "Last Updated", "to": "01/13/2023"}, {"arrows": "to", "from": "Drug Name: halcion, Active Ingredient: triazolam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017892s057lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: halflytely, Active Ingredient: bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride", "title": "Form", "to": "FOR SOLUTION"}, {"arrows": "to", "from": "Drug Name: halflytely, Active Ingredient: bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride", "title": "Other", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: halflytely, Active Ingredient: bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: halflytely, Active Ingredient: bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride", "title": "Last Updated", "to": "06/03/2013"}, {"arrows": "to", "from": "Drug Name: halflytely, Active Ingredient: bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM220644.pdf"}, {"arrows": "to", "from": "Drug Name: hemangeol, Active Ingredient: propranolol hydrochloride", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: hemangeol, Active Ingredient: propranolol hydrochloride", "title": "Last Updated", "to": "06/22/2021"}, {"arrows": "to", "from": "Drug Name: hemangeol, Active Ingredient: propranolol hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205410s006lbl.pdf#page=11"}, {"arrows": "to", "from": "Drug Name: hemlibra, Active Ingredient: emicizumab", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: hemlibra, Active Ingredient: emicizumab", "title": "Last Updated", "to": "01/31/2024"}, {"arrows": "to", "from": "Drug Name: hemlibra, Active Ingredient: emicizumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761083s015lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: horizant, Active Ingredient: gabapentin enacarbil", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: horizant, Active Ingredient: gabapentin enacarbil", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: horizant, Active Ingredient: gabapentin enacarbil", "title": "Last Updated", "to": "04/17/2020"}, {"arrows": "to", "from": "Drug Name: horizant, Active Ingredient: gabapentin enacarbil", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022399s010lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: hulio, Active Ingredient: adalimumab-fkjp", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: hulio, Active Ingredient: adalimumab-fkjp", "title": "Last Updated", "to": "08/25/2023"}, {"arrows": "to", "from": "Drug Name: hulio, Active Ingredient: adalimumab-fkjp", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761154s005lbl.pdf#page=57"}, {"arrows": "to", "from": "Drug Name: humira, Active Ingredient: adalimumab", "title": "Form", "to": "SYRINGE"}, {"arrows": "to", "from": "Drug Name: humira, Active Ingredient: adalimumab", "title": "Last Updated", "to": "11/03/2023"}, {"arrows": "to", "from": "Drug Name: humira, Active Ingredient: adalimumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125057s423lbl.pdf#page=57"}, {"arrows": "to", "from": "Drug Name: humira, Active Ingredient: adalimumab", "title": "Form", "to": "VIAL"}, {"arrows": "to", "from": "Drug Name: humira, Active Ingredient: adalimumab", "title": "Last Updated", "to": "02/24/2021"}, {"arrows": "to", "from": "Drug Name: humira, Active Ingredient: adalimumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125057s417lbl.pdf#page=60"}, {"arrows": "to", "from": "Drug Name: hycodan, Active Ingredient: homatropine methylbromide; hydrocodone bitartrate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: hycodan, Active Ingredient: homatropine methylbromide; hydrocodone bitartrate", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: hycodan, Active Ingredient: homatropine methylbromide; hydrocodone bitartrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005213s046lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: hycodan, Active Ingredient: homatropine methylbromide; hydrocodone bitartrate", "title": "Form", "to": "SYRUP;ORAL"}, {"arrows": "to", "from": "Drug Name: hycofenix, Active Ingredient: hydrocodone bitartrate;pseudoephedrine hydrochloride;guaifenesin", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: hycofenix, Active Ingredient: hydrocodone bitartrate;pseudoephedrine hydrochloride;guaifenesin", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: hycofenix, Active Ingredient: hydrocodone bitartrate;pseudoephedrine hydrochloride;guaifenesin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022279s003lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: hydromorphone hydrochloride, Active Ingredient: hydromorphone hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: hydromorphone hydrochloride, Active Ingredient: hydromorphone hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: hydromorphone hydrochloride, Active Ingredient: hydromorphone hydrochloride", "title": "Last Updated", "to": "03/04/2021"}, {"arrows": "to", "from": "Drug Name: hydromorphone hydrochloride, Active Ingredient: hydromorphone hydrochloride", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204278Orig1s000MG.pdf"}, {"arrows": "to", "from": "Drug Name: hyrimoz, Active Ingredient: adalimumab-adaz", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: hyrimoz, Active Ingredient: adalimumab-adaz", "title": "Last Updated", "to": "06/12/2024"}, {"arrows": "to", "from": "Drug Name: hyrimoz, Active Ingredient: adalimumab-adaz", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761071s016lbl.pdf#page=60"}, {"arrows": "to", "from": "Drug Name: hysingla er, Active Ingredient: hydrocodone bitartrate", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: hysingla er, Active Ingredient: hydrocodone bitartrate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: hysingla er, Active Ingredient: hydrocodone bitartrate", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: hysingla er, Active Ingredient: hydrocodone bitartrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206627s015lbl.pdf#page=40"}, {"arrows": "to", "from": "Drug Name: ibsrela, Active Ingredient: tenapanor hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: ibsrela, Active Ingredient: tenapanor hydrochloride", "title": "Last Updated", "to": "04/05/2022"}, {"arrows": "to", "from": "Drug Name: ibsrela, Active Ingredient: tenapanor hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211801s004lbl.pdf#page=14"}, {"arrows": "to", "from": "Drug Name: iclusig, Active Ingredient: ponatinib hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: iclusig, Active Ingredient: ponatinib hydrochloride", "title": "Last Updated", "to": "03/19/2024"}, {"arrows": "to", "from": "Drug Name: iclusig, Active Ingredient: ponatinib hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203469s035lbl.pdf#page=34"}, {"arrows": "to", "from": "Drug Name: idacio, Active Ingredient: adalimumab-aacf", "title": "Form", "to": "INJECTABLE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: idacio, Active Ingredient: adalimumab-aacf", "title": "Last Updated", "to": "06/04/2024"}, {"arrows": "to", "from": "Drug Name: idacio, Active Ingredient: adalimumab-aacf", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761255s004lbl.pdf#page=48"}, {"arrows": "to", "from": "Drug Name: idhifa, Active Ingredient: enasidenib mesylate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: idhifa, Active Ingredient: enasidenib mesylate", "title": "Last Updated", "to": "12/21/2023"}, {"arrows": "to", "from": "Drug Name: idhifa, Active Ingredient: enasidenib mesylate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209606s006lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: ilaris, Active Ingredient: canakinumab", "title": "Form", "to": "INJECTABLE; SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: ilaris, Active Ingredient: canakinumab", "title": "Last Updated", "to": "08/25/2023"}, {"arrows": "to", "from": "Drug Name: ilaris, Active Ingredient: canakinumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125319s107lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: ilumya, Active Ingredient: tildrakizumab-asmn", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: ilumya, Active Ingredient: tildrakizumab-asmn", "title": "Last Updated", "to": "04/03/2024"}, {"arrows": "to", "from": "Drug Name: ilumya, Active Ingredient: tildrakizumab-asmn", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761067s000lbl.pdf#page=10"}, {"arrows": "to", "from": "Drug Name: imfinzi, Active Ingredient: durvalumab", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: imfinzi, Active Ingredient: durvalumab", "title": "Last Updated", "to": "12/04/2024"}, {"arrows": "to", "from": "Drug Name: imfinzi, Active Ingredient: durvalumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761069s049lbl.pdf#page=68"}, {"arrows": "to", "from": "Drug Name: imipramine hydrochloride, Active Ingredient: imipramine hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: imipramine hydrochloride, Active Ingredient: imipramine hydrochloride", "title": "Last Updated", "to": "06/29/2017"}, {"arrows": "to", "from": "Drug Name: imipramine hydrochloride, Active Ingredient: imipramine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/087846s028,087844s027,087845s027lbl.pdf#page=3"}, {"arrows": "to", "from": "Drug Name: imjudo, Active Ingredient: tremelimumab-actl", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: imjudo, Active Ingredient: tremelimumab-actl", "title": "Other", "to": "SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: imjudo, Active Ingredient: tremelimumab-actl", "title": "Last Updated", "to": "11/10/2022"}, {"arrows": "to", "from": "Drug Name: imjudo, Active Ingredient: tremelimumab-actl", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761270s000lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: imjudo, Active Ingredient: tremelimumab-actl", "title": "Last Updated", "to": "01/25/2024"}, {"arrows": "to", "from": "Drug Name: imjudo, Active Ingredient: tremelimumab-actl", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761289s002lbl.pdf#page=31"}, {"arrows": "to", "from": "Drug Name: incivek, Active Ingredient: telaprevir", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: incivek, Active Ingredient: telaprevir", "title": "Last Updated", "to": "03/25/2014"}, {"arrows": "to", "from": "Drug Name: incivek, Active Ingredient: telaprevir", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM256383.pdf"}, {"arrows": "to", "from": "Drug Name: indocin, Active Ingredient: indomethacin", "title": "Form", "to": "SUPPOSITORY;RECTAL"}, {"arrows": "to", "from": "Drug Name: indocin, Active Ingredient: indomethacin", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: indocin, Active Ingredient: indomethacin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017814s045lbl.pdf"}, {"arrows": "to", "from": "Drug Name: indocin, Active Ingredient: indomethacin", "title": "Form", "to": "SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: indocin, Active Ingredient: indomethacin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018332s043lbl.pdf"}, {"arrows": "to", "from": "Drug Name: indocin, Active Ingredient: indomethacin", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: indocin, Active Ingredient: indomethacin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/016059s102lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: indocin sr, Active Ingredient: indomethacin", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: indocin sr, Active Ingredient: indomethacin", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: indocin sr, Active Ingredient: indomethacin", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: indocin sr, Active Ingredient: indomethacin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018185s059lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: indomethacin, Active Ingredient: indomethacin", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: indomethacin, Active Ingredient: indomethacin", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: indomethacin, Active Ingredient: indomethacin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018829s025lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: indomethacin, Active Ingredient: indomethacin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018851s028lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: indomethacin, Active Ingredient: indomethacin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018858s049lbl.pdf"}, {"arrows": "to", "from": "Drug Name: inflectra, Active Ingredient: infliximab-dyyb", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: inflectra, Active Ingredient: infliximab-dyyb", "title": "Last Updated", "to": "06/17/2021"}, {"arrows": "to", "from": "Drug Name: inflectra, Active Ingredient: infliximab-dyyb", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125544s018lbl.pdf#page=61"}, {"arrows": "to", "from": "Drug Name: inpefa, Active Ingredient: sotagliflozin", "title": "Form", "to": "TABLET; ORAL"}, {"arrows": "to", "from": "Drug Name: inpefa, Active Ingredient: sotagliflozin", "title": "Last Updated", "to": "05/26/2023"}, {"arrows": "to", "from": "Drug Name: inpefa, Active Ingredient: sotagliflozin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216203s000lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: inrebic, Active Ingredient: fedratinib hydrochloride", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: inrebic, Active Ingredient: fedratinib hydrochloride", "title": "Last Updated", "to": "05/15/2023"}, {"arrows": "to", "from": "Drug Name: inrebic, Active Ingredient: fedratinib hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212327s005lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: intermezzo, Active Ingredient: zolpidem tartrate", "title": "Form", "to": "TABLET;SUBLINGUAL"}, {"arrows": "to", "from": "Drug Name: intermezzo, Active Ingredient: zolpidem tartrate", "title": "Last Updated", "to": "08/18/2019"}, {"arrows": "to", "from": "Drug Name: intermezzo, Active Ingredient: zolpidem tartrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022328s008lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: intron a, Active Ingredient: interferon alfa-2b", "title": "Form", "to": "VIAL"}, {"arrows": "to", "from": "Drug Name: intron a, Active Ingredient: interferon alfa-2b", "title": "Last Updated", "to": "11/26/2021"}, {"arrows": "to", "from": "Drug Name: intron a, Active Ingredient: interferon alfa-2b", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103132s5196lbl.pdf#page=40"}, {"arrows": "to", "from": "Drug Name: invirase, Active Ingredient: saquinavir mesylate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: invirase, Active Ingredient: saquinavir mesylate", "title": "Last Updated", "to": "03/28/2019"}, {"arrows": "to", "from": "Drug Name: invirase, Active Ingredient: saquinavir mesylate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020628s047,021785s023lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: invirase, Active Ingredient: saquinavir mesylate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: invirase, Active Ingredient: saquinavir mesylate", "title": "Last Updated", "to": "09/18/2020"}, {"arrows": "to", "from": "Drug Name: invirase, Active Ingredient: saquinavir mesylate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021785s025lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: invokamet, Active Ingredient: canagliflozin; metformin hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: invokamet, Active Ingredient: canagliflozin; metformin hydrochloride", "title": "Last Updated", "to": "08/23/2024"}, {"arrows": "to", "from": "Drug Name: invokamet, Active Ingredient: canagliflozin; metformin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204353s045,205879s022lbl.pdf#page=58"}, {"arrows": "to", "from": "Drug Name: invokamet xr, Active Ingredient: canagliflozin; metformin hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: invokamet xr, Active Ingredient: canagliflozin; metformin hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: invokamet xr, Active Ingredient: canagliflozin; metformin hydrochloride", "title": "Last Updated", "to": "08/23/2024"}, {"arrows": "to", "from": "Drug Name: invokamet xr, Active Ingredient: canagliflozin; metformin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204353s045,205879s022lbl.pdf#page=58"}, {"arrows": "to", "from": "Drug Name: invokana, Active Ingredient: canagliflozin", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: invokana, Active Ingredient: canagliflozin", "title": "Last Updated", "to": "08/23/2024"}, {"arrows": "to", "from": "Drug Name: invokana, Active Ingredient: canagliflozin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204042s041s042lbl.pdf#page=48"}, {"arrows": "to", "from": "Drug Name: ixifi, Active Ingredient: infliximab-qbtx", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: ixifi, Active Ingredient: infliximab-qbtx", "title": "Last Updated", "to": "12/26/2023"}, {"arrows": "to", "from": "Drug Name: ixifi, Active Ingredient: infliximab-qbtx", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761072s009lbl.pdf#page=46"}, {"arrows": "to", "from": "Drug Name: jadenu, Active Ingredient: deferasirox", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: jadenu, Active Ingredient: deferasirox", "title": "Last Updated", "to": "07/23/2020"}, {"arrows": "to", "from": "Drug Name: jadenu, Active Ingredient: deferasirox", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206910s015lbl.pdf#page=31"}, {"arrows": "to", "from": "Drug Name: jadenu sprinkle, Active Ingredient: deferasirox", "title": "Form", "to": "GRANULE;ORAL"}, {"arrows": "to", "from": "Drug Name: jadenu sprinkle, Active Ingredient: deferasirox", "title": "Last Updated", "to": "07/23/2020"}, {"arrows": "to", "from": "Drug Name: jadenu sprinkle, Active Ingredient: deferasirox", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207968s009lbl.pdf#page=31"}, {"arrows": "to", "from": "Drug Name: janumet, Active Ingredient: metformin hydrochloride; sitagliptin phosphate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: janumet, Active Ingredient: metformin hydrochloride; sitagliptin phosphate", "title": "Last Updated", "to": "06/21/2022"}, {"arrows": "to", "from": "Drug Name: janumet, Active Ingredient: metformin hydrochloride; sitagliptin phosphate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022044s052lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: janumet xr, Active Ingredient: metformin hydrochloride; sitagliptin phosphate", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: janumet xr, Active Ingredient: metformin hydrochloride; sitagliptin phosphate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: janumet xr, Active Ingredient: metformin hydrochloride; sitagliptin phosphate", "title": "Last Updated", "to": "06/21/2022"}, {"arrows": "to", "from": "Drug Name: janumet xr, Active Ingredient: metformin hydrochloride; sitagliptin phosphate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202270s026lbl.pdf#page=34"}, {"arrows": "to", "from": "Drug Name: januvia, Active Ingredient: sitagliptin phosphate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: januvia, Active Ingredient: sitagliptin phosphate", "title": "Last Updated", "to": "06/21/2022"}, {"arrows": "to", "from": "Drug Name: januvia, Active Ingredient: sitagliptin phosphate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021995s050lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: jardiance, Active Ingredient: empagliflozin", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: jardiance, Active Ingredient: empagliflozin", "title": "Last Updated", "to": "09/21/2023"}, {"arrows": "to", "from": "Drug Name: jardiance, Active Ingredient: empagliflozin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204629s040lbl.pdf#page=47"}, {"arrows": "to", "from": "Drug Name: jemperli, Active Ingredient: dostarlimab-gxly", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: jemperli, Active Ingredient: dostarlimab-gxly", "title": "Last Updated", "to": "08/01/2024"}, {"arrows": "to", "from": "Drug Name: jemperli, Active Ingredient: dostarlimab-gxly", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761174s009lbl.pdf#page=37"}, {"arrows": "to", "from": "Drug Name: jemperli, Active Ingredient: dostarlimab-gxly", "title": "Last Updated", "to": "08/17/2021"}, {"arrows": "to", "from": "Drug Name: jemperli, Active Ingredient: dostarlimab-gxly", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761223s000lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: jentadueto, Active Ingredient: linagliptin; metformin hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: jentadueto, Active Ingredient: linagliptin; metformin hydrochloride", "title": "Last Updated", "to": "06/20/2023"}, {"arrows": "to", "from": "Drug Name: jentadueto, Active Ingredient: linagliptin; metformin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201281s035lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: jentadueto xr, Active Ingredient: linagliptin; metformin hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: jentadueto xr, Active Ingredient: linagliptin; metformin hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: jentadueto xr, Active Ingredient: linagliptin; metformin hydrochloride", "title": "Last Updated", "to": "06/20/2023"}, {"arrows": "to", "from": "Drug Name: jentadueto xr, Active Ingredient: linagliptin; metformin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208026s024lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: jesduvroq, Active Ingredient: daprodustat", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: jesduvroq, Active Ingredient: daprodustat", "title": "Last Updated", "to": "02/01/2023"}, {"arrows": "to", "from": "Drug Name: jesduvroq, Active Ingredient: daprodustat", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216951s000lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: jeuveau, Active Ingredient: prabotulinumtoxina-xvfs", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: jeuveau, Active Ingredient: prabotulinumtoxina-xvfs", "title": "Last Updated", "to": "07/12/2019"}, {"arrows": "to", "from": "Drug Name: jeuveau, Active Ingredient: prabotulinumtoxina-xvfs", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761085s000lbl.pdf#page=9"}, {"arrows": "to", "from": "Drug Name: jornay pm, Active Ingredient: methylphenidate hydrochloride", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: jornay pm, Active Ingredient: methylphenidate hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: jornay pm, Active Ingredient: methylphenidate hydrochloride", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: jornay pm, Active Ingredient: methylphenidate hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209311s010lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: juvisync, Active Ingredient: simvastatin; sitagliptin phosphate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: juvisync, Active Ingredient: simvastatin; sitagliptin phosphate", "title": "Last Updated", "to": "02/24/2014"}, {"arrows": "to", "from": "Drug Name: juvisync, Active Ingredient: simvastatin; sitagliptin phosphate", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM275945.pdf"}, {"arrows": "to", "from": "Drug Name: juxtapid, Active Ingredient: lomitapide mesylate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: juxtapid, Active Ingredient: lomitapide mesylate", "title": "Last Updated", "to": "05/27/2021"}, {"arrows": "to", "from": "Drug Name: juxtapid, Active Ingredient: lomitapide mesylate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203858s017lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: jynarque, Active Ingredient: tolvaptan", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: jynarque, Active Ingredient: tolvaptan", "title": "Last Updated", "to": "11/25/2020"}, {"arrows": "to", "from": "Drug Name: jynarque, Active Ingredient: tolvaptan", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204441lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: kadian, Active Ingredient: morphine sulfate", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: kadian, Active Ingredient: morphine sulfate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: kadian, Active Ingredient: morphine sulfate", "title": "Last Updated", "to": "03/04/2021"}, {"arrows": "to", "from": "Drug Name: kadian, Active Ingredient: morphine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020616s065lbl.pdf#page=36"}, {"arrows": "to", "from": "Drug Name: kalbitor, Active Ingredient: ecallantide", "title": "Form", "to": "INJECTABLE; INJECTION"}, {"arrows": "to", "from": "Drug Name: kalbitor, Active Ingredient: ecallantide", "title": "Last Updated", "to": "12/28/2020"}, {"arrows": "to", "from": "Drug Name: kalbitor, Active Ingredient: ecallantide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125277s081lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: kaletra, Active Ingredient: lopinavir; ritonavir", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: kaletra, Active Ingredient: lopinavir; ritonavir", "title": "Last Updated", "to": "10/21/2020"}, {"arrows": "to", "from": "Drug Name: kaletra, Active Ingredient: lopinavir; ritonavir", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021251s059,021906s054lbl.pdf#page=53"}, {"arrows": "to", "from": "Drug Name: kaletra, Active Ingredient: lopinavir; ritonavir", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: kaletra, Active Ingredient: lopinavir; ritonavir", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021226s049lbl.pdf#page=53"}, {"arrows": "to", "from": "Drug Name: kaletra, Active Ingredient: lopinavir; ritonavir", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: kazano, Active Ingredient: alogliptin benzoate; metformin hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: kazano, Active Ingredient: alogliptin benzoate; metformin hydrochloride", "title": "Last Updated", "to": "07/27/2023"}, {"arrows": "to", "from": "Drug Name: kazano, Active Ingredient: alogliptin benzoate; metformin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203414s016lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: keppra, Active Ingredient: levetiracetam", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: keppra, Active Ingredient: levetiracetam", "title": "Last Updated", "to": "03/12/2024"}, {"arrows": "to", "from": "Drug Name: keppra, Active Ingredient: levetiracetam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021035s113,021505s052lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: keppra, Active Ingredient: levetiracetam", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: keppra xr, Active Ingredient: levetiracetam", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: keppra xr, Active Ingredient: levetiracetam", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: keppra xr, Active Ingredient: levetiracetam", "title": "Last Updated", "to": "03/12/2024"}, {"arrows": "to", "from": "Drug Name: keppra xr, Active Ingredient: levetiracetam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022285s034lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: kesimpta, Active Ingredient: ofatumumab", "title": "Form", "to": "SOLUTION;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: kesimpta, Active Ingredient: ofatumumab", "title": "Last Updated", "to": "04/12/2024"}, {"arrows": "to", "from": "Drug Name: kesimpta, Active Ingredient: ofatumumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125326s075lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: ketek, Active Ingredient: telithromycin", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: ketek, Active Ingredient: telithromycin", "title": "Last Updated", "to": "11/04/2015"}, {"arrows": "to", "from": "Drug Name: ketek, Active Ingredient: telithromycin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021144s019lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: kevzara, Active Ingredient: sarilumab", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: kevzara, Active Ingredient: sarilumab", "title": "Last Updated", "to": "06/10/2024"}, {"arrows": "to", "from": "Drug Name: kevzara, Active Ingredient: sarilumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761037s013lbl.pdf#page=31"}, {"arrows": "to", "from": "Drug Name: keytruda, Active Ingredient: pembrolizumab", "title": "Form", "to": "SOLUTION;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: keytruda, Active Ingredient: pembrolizumab", "title": "Last Updated", "to": "09/17/2024"}, {"arrows": "to", "from": "Drug Name: keytruda, Active Ingredient: pembrolizumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125514s161lbl.pdf#page=165"}, {"arrows": "to", "from": "Drug Name: khedezla, Active Ingredient: desvenlafaxine", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: khedezla, Active Ingredient: desvenlafaxine", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: khedezla, Active Ingredient: desvenlafaxine", "title": "Last Updated", "to": "09/20/2021"}, {"arrows": "to", "from": "Drug Name: khedezla, Active Ingredient: desvenlafaxine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204683s007lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: klonopin, Active Ingredient: clonazepam", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: klonopin, Active Ingredient: clonazepam", "title": "Last Updated", "to": "01/13/2023"}, {"arrows": "to", "from": "Drug Name: klonopin, Active Ingredient: clonazepam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017533s062lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: kombiglyze xr, Active Ingredient: metformin hydrochloride; saxagliptin hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: kombiglyze xr, Active Ingredient: metformin hydrochloride; saxagliptin hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: kombiglyze xr, Active Ingredient: metformin hydrochloride; saxagliptin hydrochloride", "title": "Last Updated", "to": "07/01/2019"}, {"arrows": "to", "from": "Drug Name: kombiglyze xr, Active Ingredient: metformin hydrochloride; saxagliptin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200678s024lbl.pdf#page=47"}, {"arrows": "to", "from": "Drug Name: konvomep, Active Ingredient: omeprazole; sodium bicarbonate", "title": "Form", "to": "SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: konvomep, Active Ingredient: omeprazole; sodium bicarbonate", "title": "Last Updated", "to": "08/30/2022"}, {"arrows": "to", "from": "Drug Name: konvomep, Active Ingredient: omeprazole; sodium bicarbonate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213593s000lbl.pdf#page=28"}, {"arrows": "to", "from": "Drug Name: korlym, Active Ingredient: mifepristone", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: korlym, Active Ingredient: mifepristone", "title": "Last Updated", "to": "11/05/2019"}, {"arrows": "to", "from": "Drug Name: korlym, Active Ingredient: mifepristone", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202107s008lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: krystexxa, Active Ingredient: pegloticase", "title": "Form", "to": "INJECTABLE; INJECTION"}, {"arrows": "to", "from": "Drug Name: krystexxa, Active Ingredient: pegloticase", "title": "Last Updated", "to": "07/07/2022"}, {"arrows": "to", "from": "Drug Name: krystexxa, Active Ingredient: pegloticase", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125293s104lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: kynamro, Active Ingredient: mipomersen sodium", "title": "Form", "to": "SOLUTION;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: kynamro, Active Ingredient: mipomersen sodium", "title": "Last Updated", "to": "03/18/2019"}, {"arrows": "to", "from": "Drug Name: kynamro, Active Ingredient: mipomersen sodium", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM337730.pdf"}, {"arrows": "to", "from": "Drug Name: lacosamide, Active Ingredient: lacosamide", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: lacosamide, Active Ingredient: lacosamide", "title": "Last Updated", "to": "10/27/2017"}, {"arrows": "to", "from": "Drug Name: lacosamide, Active Ingredient: lacosamide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LacosamideTabletsCVMedGuide.pdf"}, {"arrows": "to", "from": "Drug Name: lacosamide, Active Ingredient: lacosamide", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: lacosamide, Active Ingredient: lacosamide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LACOSAMIDE TABLETSMedGuide.pdf"}, {"arrows": "to", "from": "Drug Name: lacosamide, Active Ingredient: lacosamide", "title": "Last Updated", "to": "08/10/2021"}, {"arrows": "to", "from": "Drug Name: lacosamide, Active Ingredient: lacosamide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LACOSAMIDE ORAL SOLUTIONMed Guide.pdf"}, {"arrows": "to", "from": "Drug Name: lamictal, Active Ingredient: lamotrigine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: lamictal, Active Ingredient: lamotrigine", "title": "Last Updated", "to": "03/31/2021"}, {"arrows": "to", "from": "Drug Name: lamictal, Active Ingredient: lamotrigine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020241s064,020764s057,022251s028lbl.pdf#page=65"}, {"arrows": "to", "from": "Drug Name: lamictal cd, Active Ingredient: lamotrigine", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: lamictal cd, Active Ingredient: lamotrigine", "title": "Other", "to": "FOR SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: lamictal cd, Active Ingredient: lamotrigine", "title": "Last Updated", "to": "03/31/2021"}, {"arrows": "to", "from": "Drug Name: lamictal cd, Active Ingredient: lamotrigine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020241s064,020764s057,022251s028lbl.pdf#page=65"}, {"arrows": "to", "from": "Drug Name: lamictal odt, Active Ingredient: lamotrigine", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: lamictal odt, Active Ingredient: lamotrigine", "title": "Other", "to": "ORALLY DISINTEGRATING;ORAL"}, {"arrows": "to", "from": "Drug Name: lamictal odt, Active Ingredient: lamotrigine", "title": "Last Updated", "to": "03/31/2021"}, {"arrows": "to", "from": "Drug Name: lamictal odt, Active Ingredient: lamotrigine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020241s064,020764s057,022251s028lbl.pdf#page=65"}, {"arrows": "to", "from": "Drug Name: lamictal xr, Active Ingredient: lamotrigine", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: lamictal xr, Active Ingredient: lamotrigine", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: lamictal xr, Active Ingredient: lamotrigine", "title": "Last Updated", "to": "03/31/2021"}, {"arrows": "to", "from": "Drug Name: lamictal xr, Active Ingredient: lamotrigine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022115s029lbl.pdf#page=51"}, {"arrows": "to", "from": "Drug Name: lamictal xr, Active Ingredient: lamotrigine", "title": "Other", "to": "EXTENDED RELEASE; ORAL"}, {"arrows": "to", "from": "Drug Name: lamictal xr, Active Ingredient: lamotrigine", "title": "Last Updated", "to": "01/29/2010"}, {"arrows": "to", "from": "Drug Name: lamictal xr, Active Ingredient: lamotrigine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022509lbl.pdf#page=39"}, {"arrows": "to", "from": "Drug Name: lamisil, Active Ingredient: terbinafine hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: lamisil, Active Ingredient: terbinafine hydrochloride", "title": "Last Updated", "to": "03/29/2019"}, {"arrows": "to", "from": "Drug Name: lamisil, Active Ingredient: terbinafine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020539s033lbl.pdf#page=11"}, {"arrows": "to", "from": "Drug Name: lamisil, Active Ingredient: terbinafine hydrochloride", "title": "Form", "to": "GRANULE;ORAL"}, {"arrows": "to", "from": "Drug Name: lamisil, Active Ingredient: terbinafine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020539s029,022071s013lbl.pdf#page=10"}, {"arrows": "to", "from": "Drug Name: lamivudine, nevirapine and zidovudine, Active Ingredient: lamivudine; nevirapine; zidovudine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: lamivudine, nevirapine and zidovudine, Active Ingredient: lamivudine; nevirapine; zidovudine", "title": "Last Updated", "to": "08/13/2018"}, {"arrows": "to", "from": "Drug Name: lamivudine, nevirapine and zidovudine, Active Ingredient: lamivudine; nevirapine; zidovudine", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205626s000lbl.pdf#page=50"}, {"arrows": "to", "from": "Drug Name: lariam, Active Ingredient: mefloquine hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: lariam, Active Ingredient: mefloquine hydrochloride", "title": "Last Updated", "to": "04/29/2011"}, {"arrows": "to", "from": "Drug Name: lariam, Active Ingredient: mefloquine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019591s026s028lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: latuda, Active Ingredient: lurasidone hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: latuda, Active Ingredient: lurasidone hydrochloride", "title": "Last Updated", "to": "12/04/2019"}, {"arrows": "to", "from": "Drug Name: latuda, Active Ingredient: lurasidone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200603s035lbl.pdf#page=62"}, {"arrows": "to", "from": "Drug Name: lazanda, Active Ingredient: fentanyl citrate", "title": "Form", "to": "SPRAY"}, {"arrows": "to", "from": "Drug Name: lazanda, Active Ingredient: fentanyl citrate", "title": "Other", "to": "METERED;NASAL"}, {"arrows": "to", "from": "Drug Name: lazanda, Active Ingredient: fentanyl citrate", "title": "Last Updated", "to": "12/03/2021"}, {"arrows": "to", "from": "Drug Name: lazanda, Active Ingredient: fentanyl citrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022569s030lbl.pdf#page=35"}, {"arrows": "to", "from": "Drug Name: lemtrada, Active Ingredient: alemtuzumab", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: lemtrada, Active Ingredient: alemtuzumab", "title": "Last Updated", "to": "05/20/2024"}, {"arrows": "to", "from": "Drug Name: lemtrada, Active Ingredient: alemtuzumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/103948s5185lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: leqembi, Active Ingredient: ecanemab-irmb", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: leqembi, Active Ingredient: ecanemab-irmb", "title": "Last Updated", "to": "07/06/2023"}, {"arrows": "to", "from": "Drug Name: leqembi, Active Ingredient: ecanemab-irmb", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761269Orig1s001lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: letairis, Active Ingredient: ambrisentan", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: letairis, Active Ingredient: ambrisentan", "title": "Last Updated", "to": "06/08/2021"}, {"arrows": "to", "from": "Drug Name: letairis, Active Ingredient: ambrisentan", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022081s041lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: levaquin, Active Ingredient: levofloxacin", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: levaquin, Active Ingredient: levofloxacin", "title": "Last Updated", "to": "02/08/2017"}, {"arrows": "to", "from": "Drug Name: levaquin, Active Ingredient: levofloxacin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020634s068,020635s074,021721s035lbl.pdf#page=59"}, {"arrows": "to", "from": "Drug Name: levaquin, Active Ingredient: levofloxacin", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: levaquin, Active Ingredient: levofloxacin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020634s073lbl.pdf#page=54"}, {"arrows": "to", "from": "Drug Name: levaquin, Active Ingredient: levofloxacin", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: lexapro, Active Ingredient: escitalopram oxalate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: lexapro, Active Ingredient: escitalopram oxalate", "title": "Last Updated", "to": "04/19/2024"}, {"arrows": "to", "from": "Drug Name: lexapro, Active Ingredient: escitalopram oxalate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021323s057,021365s040lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: lexapro, Active Ingredient: escitalopram oxalate", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: librax, Active Ingredient: chlordiazepoxide hydrochloride; clidinium bromide", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: librax, Active Ingredient: chlordiazepoxide hydrochloride; clidinium bromide", "title": "Last Updated", "to": "01/13/2023"}, {"arrows": "to", "from": "Drug Name: librax, Active Ingredient: chlordiazepoxide hydrochloride; clidinium bromide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/012750s068lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: librium, Active Ingredient: chlordiazepoxide hydrochloride", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: librium, Active Ingredient: chlordiazepoxide hydrochloride", "title": "Last Updated", "to": "12/16/2016"}, {"arrows": "to", "from": "Drug Name: librium, Active Ingredient: chlordiazepoxide hydrochloride", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/012249s049lbl.pdf#page=8"}, {"arrows": "to", "from": "Drug Name: libtayo, Active Ingredient: cemiplimab-rwlc", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: libtayo, Active Ingredient: cemiplimab-rwlc", "title": "Last Updated", "to": "04/05/2024"}, {"arrows": "to", "from": "Drug Name: libtayo, Active Ingredient: cemiplimab-rwlc", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761097s016lbl.pdf#page=36"}, {"arrows": "to", "from": "Drug Name: licart, Active Ingredient: diclofenac epolamine", "title": "Form", "to": "SYSTEM;TOPICAL"}, {"arrows": "to", "from": "Drug Name: licart, Active Ingredient: diclofenac epolamine", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: licart, Active Ingredient: diclofenac epolamine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/206976s016lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: limbitrol, Active Ingredient: amitriptyline hydrochloride; chlordiazepoxide", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: limbitrol, Active Ingredient: amitriptyline hydrochloride; chlordiazepoxide", "title": "Last Updated", "to": "02/05/2021"}, {"arrows": "to", "from": "Drug Name: limbitrol, Active Ingredient: amitriptyline hydrochloride; chlordiazepoxide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016949s041lbl.pdf#page=14"}, {"arrows": "to", "from": "Drug Name: limbitrol ds, Active Ingredient: amitriptyline hydrochloride; chlordiazepoxide", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: limbitrol ds, Active Ingredient: amitriptyline hydrochloride; chlordiazepoxide", "title": "Last Updated", "to": "02/05/2021"}, {"arrows": "to", "from": "Drug Name: limbitrol ds, Active Ingredient: amitriptyline hydrochloride; chlordiazepoxide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016949s041lbl.pdf#page=14"}, {"arrows": "to", "from": "Drug Name: lindane, Active Ingredient: lindane", "title": "Form", "to": "SHAMPOO;TOPICAL"}, {"arrows": "to", "from": "Drug Name: lindane, Active Ingredient: lindane", "title": "Last Updated", "to": "04/05/2004"}, {"arrows": "to", "from": "Drug Name: lindane, Active Ingredient: lindane", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LindaneLotionMedGuide.pdf"}, {"arrows": "to", "from": "Drug Name: lindane, Active Ingredient: lindane", "title": "Form", "to": "LOTION;TOPICAL"}, {"arrows": "to", "from": "Drug Name: lindane, Active Ingredient: lindane", "title": "Last Updated", "to": "09/04/2001"}, {"arrows": "to", "from": "Drug Name: lindane, Active Ingredient: lindane", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LindaneShampooMedGuide.pdf"}, {"arrows": "to", "from": "Drug Name: linzess, Active Ingredient: linaclotide", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: linzess, Active Ingredient: linaclotide", "title": "Last Updated", "to": "06/12/2023"}, {"arrows": "to", "from": "Drug Name: linzess, Active Ingredient: linaclotide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202811s021lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: lithium carbonate, Active Ingredient: lithium carbonate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: lithium carbonate, Active Ingredient: lithium carbonate", "title": "Last Updated", "to": "10/13/2022"}, {"arrows": "to", "from": "Drug Name: lithium carbonate, Active Ingredient: lithium carbonate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017812s036,018421s035,018558s030lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: lithium carbonate, Active Ingredient: lithium carbonate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: lithium citrate, Active Ingredient: lithium citrate", "title": "Form", "to": "SYRUP;ORAL"}, {"arrows": "to", "from": "Drug Name: lithium citrate, Active Ingredient: lithium citrate", "title": "Last Updated", "to": "10/13/2022"}, {"arrows": "to", "from": "Drug Name: lithium citrate, Active Ingredient: lithium citrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017812s036,018421s035,018558s030lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: loqtorzi, Active Ingredient: toripalimab-tpzi", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: loqtorzi, Active Ingredient: toripalimab-tpzi", "title": "Last Updated", "to": "04/22/2024"}, {"arrows": "to", "from": "Drug Name: loqtorzi, Active Ingredient: toripalimab-tpzi", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761240s000lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: loreev xr, Active Ingredient: lorazepam", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: loreev xr, Active Ingredient: lorazepam", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: loreev xr, Active Ingredient: lorazepam", "title": "Last Updated", "to": "01/13/2023"}, {"arrows": "to", "from": "Drug Name: loreev xr, Active Ingredient: lorazepam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214826s003lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: lotronex, Active Ingredient: alosetron hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: lotronex, Active Ingredient: alosetron hydrochloride", "title": "Last Updated", "to": "04/03/2019"}, {"arrows": "to", "from": "Drug Name: lotronex, Active Ingredient: alosetron hydrochloride", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088624.pdf"}, {"arrows": "to", "from": "Drug Name: lumoxiti, Active Ingredient: moxetumomab pasudotox-tdfk", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: lumoxiti, Active Ingredient: moxetumomab pasudotox-tdfk", "title": "Last Updated", "to": "08/20/2020"}, {"arrows": "to", "from": "Drug Name: lumoxiti, Active Ingredient: moxetumomab pasudotox-tdfk", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761104s003lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: lunesta, Active Ingredient: eszopiclone", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: lunesta, Active Ingredient: eszopiclone", "title": "Last Updated", "to": "08/18/2019"}, {"arrows": "to", "from": "Drug Name: lunesta, Active Ingredient: eszopiclone", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021476Orig1s038rplLBL.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: lunsumio, Active Ingredient: mosunetuzumab-axgb", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: lunsumio, Active Ingredient: mosunetuzumab-axgb", "title": "Last Updated", "to": "11/22/2024"}, {"arrows": "to", "from": "Drug Name: lunsumio, Active Ingredient: mosunetuzumab-axgb", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761263s005lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: lupaneta pack, Active Ingredient: leuprolide acetate for depot suspension, norethindrone acetate usp", "title": "Form", "to": "INJECTABLE;INTRAMUSCULAR; TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: lupaneta pack, Active Ingredient: leuprolide acetate for depot suspension, norethindrone acetate usp", "title": "Last Updated", "to": "08/09/2023"}, {"arrows": "to", "from": "Drug Name: lupaneta pack, Active Ingredient: leuprolide acetate for depot suspension, norethindrone acetate usp", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203696s005s006lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: lupkynis, Active Ingredient: voclosporin", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: lupkynis, Active Ingredient: voclosporin", "title": "Last Updated", "to": "04/29/2024"}, {"arrows": "to", "from": "Drug Name: lupkynis, Active Ingredient: voclosporin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213716s000lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: lupron, Active Ingredient: leuprolide acetate", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: lupron, Active Ingredient: leuprolide acetate", "title": "Last Updated", "to": "12/10/2018"}, {"arrows": "to", "from": "Drug Name: lupron, Active Ingredient: leuprolide acetate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019010s038lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: lupron depot-ped kit, Active Ingredient: leuprolide acetate", "title": "Form", "to": "POWDER;INTRAMUSCULAR"}, {"arrows": "to", "from": "Drug Name: lupron depot-ped kit, Active Ingredient: leuprolide acetate", "title": "Last Updated", "to": "04/14/2023"}, {"arrows": "to", "from": "Drug Name: lupron depot-ped kit, Active Ingredient: leuprolide acetate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020263s053lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: luvox, Active Ingredient: fluvoxamine maleate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: luvox, Active Ingredient: fluvoxamine maleate", "title": "Last Updated", "to": "08/18/2023"}, {"arrows": "to", "from": "Drug Name: luvox, Active Ingredient: fluvoxamine maleate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021519s026lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: luvox cr, Active Ingredient: fluvoxamine maleate", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: luvox cr, Active Ingredient: fluvoxamine maleate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: luvox cr, Active Ingredient: fluvoxamine maleate", "title": "Last Updated", "to": "01/04/2017"}, {"arrows": "to", "from": "Drug Name: luvox cr, Active Ingredient: fluvoxamine maleate", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022033s011lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: lybalvi, Active Ingredient: olanzapine; samidorphan l-malate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: lybalvi, Active Ingredient: olanzapine; samidorphan l-malate", "title": "Last Updated", "to": "01/30/2024"}, {"arrows": "to", "from": "Drug Name: lybalvi, Active Ingredient: olanzapine; samidorphan l-malate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213378s000lbl.pdf#page=40"}, {"arrows": "to", "from": "Drug Name: lynparza, Active Ingredient: olaparib", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: lynparza, Active Ingredient: olaparib", "title": "Last Updated", "to": "09/27/2018"}, {"arrows": "to", "from": "Drug Name: lynparza, Active Ingredient: olaparib", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206162s011lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: lynparza, Active Ingredient: olaparib", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: lynparza, Active Ingredient: olaparib", "title": "Last Updated", "to": "11/06/2023"}, {"arrows": "to", "from": "Drug Name: lynparza, Active Ingredient: olaparib", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208558s028lbl.pdf#page=58"}, {"arrows": "to", "from": "Drug Name: lyrica, Active Ingredient: pregabalin", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: lyrica, Active Ingredient: pregabalin", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: lyrica, Active Ingredient: pregabalin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021446s041,022488s018lbl.pdf#page=57"}, {"arrows": "to", "from": "Drug Name: lyrica, Active Ingredient: pregabalin", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: lyrica, Active Ingredient: pregabalin", "title": "Last Updated", "to": "12/13/2023"}, {"arrows": "to", "from": "Drug Name: lyrica cr, Active Ingredient: pregabalin", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: lyrica cr, Active Ingredient: pregabalin", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: lyrica cr, Active Ingredient: pregabalin", "title": "Last Updated", "to": "12/13/2023"}, {"arrows": "to", "from": "Drug Name: lyrica cr, Active Ingredient: pregabalin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209501s005lbl.pdf#page=31"}, {"arrows": "to", "from": "Drug Name: magnevist, Active Ingredient: gadopentetate dimeglumine", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: magnevist, Active Ingredient: gadopentetate dimeglumine", "title": "Last Updated", "to": "07/25/2018"}, {"arrows": "to", "from": "Drug Name: magnevist, Active Ingredient: gadopentetate dimeglumine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019596s064s065lbl.pdf#page=12"}, {"arrows": "to", "from": "Drug Name: magnevist, Active Ingredient: gadopentetate dimeglumine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021037s037s038lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: marplan, Active Ingredient: isocarboxazid", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: marplan, Active Ingredient: isocarboxazid", "title": "Last Updated", "to": "11/08/2018"}, {"arrows": "to", "from": "Drug Name: marplan, Active Ingredient: isocarboxazid", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/011961s045lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: mavenclad, Active Ingredient: cladribine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: mavenclad, Active Ingredient: cladribine", "title": "Last Updated", "to": "09/19/2022"}, {"arrows": "to", "from": "Drug Name: mavenclad, Active Ingredient: cladribine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022561s006lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: mayzent, Active Ingredient: siponimod fumaric acid", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: mayzent, Active Ingredient: siponimod fumaric acid", "title": "Last Updated", "to": "06/05/2024"}, {"arrows": "to", "from": "Drug Name: mayzent, Active Ingredient: siponimod fumaric acid", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209884s016s018lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: mektov, Active Ingredient: binimetinib", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: mektov, Active Ingredient: binimetinib", "title": "Last Updated", "to": "09/12/2024"}, {"arrows": "to", "from": "Drug Name: mektov, Active Ingredient: binimetinib", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210498s010lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: meridia, Active Ingredient: sibutramine hydrochloride", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: meridia, Active Ingredient: sibutramine hydrochloride", "title": "Last Updated", "to": "08/04/2010"}, {"arrows": "to", "from": "Drug Name: meridia, Active Ingredient: sibutramine hydrochloride", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020632s034s035MedGuide.pdf"}, {"arrows": "to", "from": "Drug Name: metadate cd, Active Ingredient: methylphenidate hydrochloride", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: metadate cd, Active Ingredient: methylphenidate hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: metadate cd, Active Ingredient: methylphenidate hydrochloride", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: metadate cd, Active Ingredient: methylphenidate hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021259s034lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: methylin, Active Ingredient: methylphenidate hydrochloride", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: methylin, Active Ingredient: methylphenidate hydrochloride", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: methylin, Active Ingredient: methylphenidate hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021419s023lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: methylin, Active Ingredient: methylphenidate hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: methylin, Active Ingredient: methylphenidate hydrochloride", "title": "Other", "to": "CHEWABLE;ORAL"}, {"arrows": "to", "from": "Drug Name: methylin, Active Ingredient: methylphenidate hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021475s012lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: metoclopramide hydrochloride, Active Ingredient: metoclopramide hydrochloride", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: metoclopramide hydrochloride, Active Ingredient: metoclopramide hydrochloride", "title": "Last Updated", "to": "04/08/2014"}, {"arrows": "to", "from": "Drug Name: metoclopramide hydrochloride, Active Ingredient: metoclopramide hydrochloride", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM244086.pdf"}, {"arrows": "to", "from": "Drug Name: metozolv odt, Active Ingredient: metoclopramide hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: metozolv odt, Active Ingredient: metoclopramide hydrochloride", "title": "Other", "to": "ORALLY DISINTEGRATING;ORAL"}, {"arrows": "to", "from": "Drug Name: metozolv odt, Active Ingredient: metoclopramide hydrochloride", "title": "Last Updated", "to": "02/28/2019"}, {"arrows": "to", "from": "Drug Name: metozolv odt, Active Ingredient: metoclopramide hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022246s009lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: mifeprex, Active Ingredient: mifepristone", "title": "Form", "to": "TABLET; ORAL"}, {"arrows": "to", "from": "Drug Name: mifeprex, Active Ingredient: mifepristone", "title": "Last Updated", "to": "03/23/2023"}, {"arrows": "to", "from": "Drug Name: mifeprex, Active Ingredient: mifepristone", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020687Orig1s026lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: mircera, Active Ingredient: methoxy polyethylene glycol-epoetin beta", "title": "Form", "to": "SOLUTION; INJECTION"}, {"arrows": "to", "from": "Drug Name: mircera, Active Ingredient: methoxy polyethylene glycol-epoetin beta", "title": "Last Updated", "to": "06/04/2024"}, {"arrows": "to", "from": "Drug Name: mircera, Active Ingredient: methoxy polyethylene glycol-epoetin beta", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125164s087lblcorretion.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: mircera, Active Ingredient: methoxy polyethylene glycol-epoetin beta", "title": "Form", "to": "INJECTABLE; SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: mircera, Active Ingredient: methoxy polyethylene glycol-epoetin beta", "title": "Last Updated", "to": "04/13/2023"}, {"arrows": "to", "from": "Drug Name: mircera, Active Ingredient: methoxy polyethylene glycol-epoetin beta", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/126164s087lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: mitigare, Active Ingredient: colchicine", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: mitigare, Active Ingredient: colchicine", "title": "Last Updated", "to": "09/26/2014"}, {"arrows": "to", "from": "Drug Name: mitigare, Active Ingredient: colchicine", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204820s000lbl.pdf#page=11"}, {"arrows": "to", "from": "Drug Name: mitigare, Active Ingredient: colchicine", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM417495.pdf"}, {"arrows": "to", "from": "Drug Name: mobic, Active Ingredient: meloxicam", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: mobic, Active Ingredient: meloxicam", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: mobic, Active Ingredient: meloxicam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020938s030lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: mobic, Active Ingredient: meloxicam", "title": "Form", "to": "SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: mobic, Active Ingredient: meloxicam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021530s020lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: morphabond er, Active Ingredient: morphine sulfate", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: morphabond er, Active Ingredient: morphine sulfate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: morphabond er, Active Ingredient: morphine sulfate", "title": "Last Updated", "to": "10/07/2019"}, {"arrows": "to", "from": "Drug Name: morphabond er, Active Ingredient: morphine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206544s012lbl.pdf#page=38"}, {"arrows": "to", "from": "Drug Name: morphine sulfate, Active Ingredient: morphine sulfate", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: morphine sulfate, Active Ingredient: morphine sulfate", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: morphine sulfate, Active Ingredient: morphine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201517s018lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: morphine sulfate, Active Ingredient: morphine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022195s021lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: morphine sulfate, Active Ingredient: morphine sulfate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: morphine sulfate, Active Ingredient: morphine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022207s011lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: motpoly xr, Active Ingredient: lacosamide", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: motpoly xr, Active Ingredient: lacosamide", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: motpoly xr, Active Ingredient: lacosamide", "title": "Last Updated", "to": "06/07/2024"}, {"arrows": "to", "from": "Drug Name: motpoly xr, Active Ingredient: lacosamide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216185s000lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: motrin, Active Ingredient: ibuprofen", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: motrin, Active Ingredient: ibuprofen", "title": "Last Updated", "to": "09/10/2007"}, {"arrows": "to", "from": "Drug Name: motrin, Active Ingredient: ibuprofen", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/017463s104lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: mounjaro, Active Ingredient: tirzepatide", "title": "Form", "to": "INJECTABLE; SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: mounjaro, Active Ingredient: tirzepatide", "title": "Last Updated", "to": "07/28/2023"}, {"arrows": "to", "from": "Drug Name: mounjaro, Active Ingredient: tirzepatide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215866s002s006lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: movantik, Active Ingredient: naloxegol oxalate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: movantik, Active Ingredient: naloxegol oxalate", "title": "Last Updated", "to": "04/13/2020"}, {"arrows": "to", "from": "Drug Name: movantik, Active Ingredient: naloxegol oxalate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204760s009lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: moviprep, Active Ingredient: ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate", "title": "Form", "to": "FOR SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: moviprep, Active Ingredient: ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate", "title": "Last Updated", "to": "05/14/2021"}, {"arrows": "to", "from": "Drug Name: moviprep, Active Ingredient: ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021881s023lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: moxifloxacin hydrochloride, Active Ingredient: moxifloxacin hydrochloride", "title": "Form", "to": "SOLUTION;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: moxifloxacin hydrochloride, Active Ingredient: moxifloxacin hydrochloride", "title": "Last Updated", "to": "07/26/2016"}, {"arrows": "to", "from": "Drug Name: moxifloxacin hydrochloride, Active Ingredient: moxifloxacin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205572s007lbl.pdf#page=49"}, {"arrows": "to", "from": "Drug Name: ms contin, Active Ingredient: morphine sulfate", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: ms contin, Active Ingredient: morphine sulfate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: ms contin, Active Ingredient: morphine sulfate", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: ms contin, Active Ingredient: morphine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019516s058lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: multaq, Active Ingredient: dronedarone hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: multaq, Active Ingredient: dronedarone hydrochloride", "title": "Last Updated", "to": "10/23/2023"}, {"arrows": "to", "from": "Drug Name: multaq, Active Ingredient: dronedarone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022425s028s030lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: multihance, Active Ingredient: gadobenate dimeglumine", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: multihance, Active Ingredient: gadobenate dimeglumine", "title": "Last Updated", "to": "08/14/2024"}, {"arrows": "to", "from": "Drug Name: multihance, Active Ingredient: gadobenate dimeglumine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021357s026,021358s024lbl.pdf#page=36"}, {"arrows": "to", "from": "Drug Name: multihance multipack, Active Ingredient: gadobenate dimeglumine", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: multihance multipack, Active Ingredient: gadobenate dimeglumine", "title": "Last Updated", "to": "08/14/2024"}, {"arrows": "to", "from": "Drug Name: multihance multipack, Active Ingredient: gadobenate dimeglumine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021357s026,021358s024lbl.pdf#page=36"}, {"arrows": "to", "from": "Drug Name: myalept, Active Ingredient: metreleptin", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: myalept, Active Ingredient: metreleptin", "title": "Last Updated", "to": "02/28/2022"}, {"arrows": "to", "from": "Drug Name: myalept, Active Ingredient: metreleptin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125390s024lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: mydayis, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: mydayis, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: mydayis, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: mydayis, Active Ingredient: amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022063s005lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: myfortic, Active Ingredient: mycophenolic sodium", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: myfortic, Active Ingredient: mycophenolic sodium", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: myfortic, Active Ingredient: mycophenolic sodium", "title": "Last Updated", "to": "03/15/2022"}, {"arrows": "to", "from": "Drug Name: myfortic, Active Ingredient: mycophenolic sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050791s035lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: myobloc, Active Ingredient: botulinum toxin type b", "title": "Form", "to": "VIAL"}, {"arrows": "to", "from": "Drug Name: myobloc, Active Ingredient: botulinum toxin type b", "title": "Last Updated", "to": "03/10/2021"}, {"arrows": "to", "from": "Drug Name: myobloc, Active Ingredient: botulinum toxin type b", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103846s5195lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: mysoline, Active Ingredient: primidone", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: mysoline, Active Ingredient: primidone", "title": "Last Updated", "to": "06/10/2020"}, {"arrows": "to", "from": "Drug Name: mysoline, Active Ingredient: primidone", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/009170Orig1s040lbl.pdf#page=7"}, {"arrows": "to", "from": "Drug Name: nalfon, Active Ingredient: fenoprofen calcium", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: nalfon, Active Ingredient: fenoprofen calcium", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: nalfon, Active Ingredient: fenoprofen calcium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017604s054lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: naprelan, Active Ingredient: naproxen sodium", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: naprelan, Active Ingredient: naproxen sodium", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: naprelan, Active Ingredient: naproxen sodium", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: naprelan, Active Ingredient: naproxen sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020353s041lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: naprosyn, Active Ingredient: naproxen", "title": "Form", "to": "SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: naprosyn, Active Ingredient: naproxen", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: naprosyn, Active Ingredient: naproxen", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018965s028lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: naprosyn, Active Ingredient: naproxen", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: naprosyn, Active Ingredient: naproxen", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017581s117,018164s067,020067s026lbl.pdf"}, {"arrows": "to", "from": "Drug Name: nardil, Active Ingredient: phenelzine sulfate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: nardil, Active Ingredient: phenelzine sulfate", "title": "Last Updated", "to": "08/02/2007"}, {"arrows": "to", "from": "Drug Name: nardil, Active Ingredient: phenelzine sulfate", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088660.pdf"}, {"arrows": "to", "from": "Drug Name: natpara, Active Ingredient: parathyroid hormone", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: natpara, Active Ingredient: parathyroid hormone", "title": "Last Updated", "to": "07/01/2020"}, {"arrows": "to", "from": "Drug Name: natpara, Active Ingredient: parathyroid hormone", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125511s016lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: nayzilam, Active Ingredient: midazolam", "title": "Form", "to": "SPRAY;NASAL"}, {"arrows": "to", "from": "Drug Name: nayzilam, Active Ingredient: midazolam", "title": "Last Updated", "to": "01/13/2023"}, {"arrows": "to", "from": "Drug Name: nayzilam, Active Ingredient: midazolam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211321s008lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: nesina, Active Ingredient: alogliptin benzoate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: nesina, Active Ingredient: alogliptin benzoate", "title": "Last Updated", "to": "07/27/2023"}, {"arrows": "to", "from": "Drug Name: nesina, Active Ingredient: alogliptin benzoate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022271s015lbl.pdf#page=28"}, {"arrows": "to", "from": "Drug Name: neurontin, Active Ingredient: gabapentin", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: neurontin, Active Ingredient: gabapentin", "title": "Last Updated", "to": "12/16/2020"}, {"arrows": "to", "from": "Drug Name: neurontin, Active Ingredient: gabapentin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020235s069,020882s050,021129s050lbl.pdf#Page=28"}, {"arrows": "to", "from": "Drug Name: neurontin, Active Ingredient: gabapentin", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: neurontin, Active Ingredient: gabapentin", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: nexium, Active Ingredient: esomeprazole magnesium", "title": "Form", "to": "FOR SUSPENSION"}, {"arrows": "to", "from": "Drug Name: nexium, Active Ingredient: esomeprazole magnesium", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: nexium, Active Ingredient: esomeprazole magnesium", "title": "Last Updated", "to": "07/18/2023"}, {"arrows": "to", "from": "Drug Name: nexium, Active Ingredient: esomeprazole magnesium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021153s060,021957s027,022101s024lbl.pdf#page=40"}, {"arrows": "to", "from": "Drug Name: nexium, Active Ingredient: esomeprazole magnesium", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: nexium, Active Ingredient: esomeprazole magnesium", "title": "Other", "to": "DELAYED REL PELLETS;ORAL"}, {"arrows": "to", "from": "Drug Name: nizoral, Active Ingredient: ketoconazole", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: nizoral, Active Ingredient: ketoconazole", "title": "Last Updated", "to": "07/30/2013"}, {"arrows": "to", "from": "Drug Name: nizoral, Active Ingredient: ketoconazole", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018533s040lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: nocdurna, Active Ingredient: desmopressin acetate", "title": "Form", "to": "TABLET;SUBLINGUAL"}, {"arrows": "to", "from": "Drug Name: nocdurna, Active Ingredient: desmopressin acetate", "title": "Last Updated", "to": "06/21/2018"}, {"arrows": "to", "from": "Drug Name: nocdurna, Active Ingredient: desmopressin acetate", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022517s000lbl.pdf#page=14"}, {"arrows": "to", "from": "Drug Name: noctiva, Active Ingredient: desmopressin acetate", "title": "Form", "to": "SPRAY"}, {"arrows": "to", "from": "Drug Name: noctiva, Active Ingredient: desmopressin acetate", "title": "Other", "to": "METERED;NASAL"}, {"arrows": "to", "from": "Drug Name: noctiva, Active Ingredient: desmopressin acetate", "title": "Last Updated", "to": "03/03/2017"}, {"arrows": "to", "from": "Drug Name: noctiva, Active Ingredient: desmopressin acetate", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/201656lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: nolvadex, Active Ingredient: tamoxifen citrate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: nolvadex, Active Ingredient: tamoxifen citrate", "title": "Last Updated", "to": "03/13/2009"}, {"arrows": "to", "from": "Drug Name: nolvadex, Active Ingredient: tamoxifen citrate", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088661.pdf"}, {"arrows": "to", "from": "Drug Name: norco, Active Ingredient: acetaminophen; hydrocodone bitartrate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: norco, Active Ingredient: acetaminophen; hydrocodone bitartrate", "title": "Last Updated", "to": "03/04/2021"}, {"arrows": "to", "from": "Drug Name: norco, Active Ingredient: acetaminophen; hydrocodone bitartrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/040099s023lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: noroxin, Active Ingredient: norfloxacin", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: noroxin, Active Ingredient: norfloxacin", "title": "Last Updated", "to": "07/26/2016"}, {"arrows": "to", "from": "Drug Name: noroxin, Active Ingredient: norfloxacin", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM246795.pdf"}, {"arrows": "to", "from": "Drug Name: norpramin, Active Ingredient: desipramine hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: norpramin, Active Ingredient: desipramine hydrochloride", "title": "Last Updated", "to": "11/09/2018"}, {"arrows": "to", "from": "Drug Name: norpramin, Active Ingredient: desipramine hydrochloride", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/014399s066s067mg.pdf"}, {"arrows": "to", "from": "Drug Name: novantrone, Active Ingredient: mitoxantrone hydrochloride", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: novantrone, Active Ingredient: mitoxantrone hydrochloride", "title": "Last Updated", "to": "03/23/2012"}, {"arrows": "to", "from": "Drug Name: novantrone, Active Ingredient: mitoxantrone hydrochloride", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019297s035mg.pdf"}, {"arrows": "to", "from": "Drug Name: nplate, Active Ingredient: romiplostim", "title": "Form", "to": "INJECTABLE; SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: nplate, Active Ingredient: romiplostim", "title": "Last Updated", "to": "02/10/2021"}, {"arrows": "to", "from": "Drug Name: nplate, Active Ingredient: romiplostim", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125268s167lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: nucynta, Active Ingredient: tapentadol hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: nucynta, Active Ingredient: tapentadol hydrochloride", "title": "Last Updated", "to": "06/14/2024"}, {"arrows": "to", "from": "Drug Name: nucynta, Active Ingredient: tapentadol hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022304s026lbl.pdf#page=40"}, {"arrows": "to", "from": "Drug Name: nucynta, Active Ingredient: tapentadol hydrochloride", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: nucynta, Active Ingredient: tapentadol hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203794s011lbl.pdf#page=37"}, {"arrows": "to", "from": "Drug Name: nucynta er, Active Ingredient: tapentadol hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: nucynta er, Active Ingredient: tapentadol hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: nucynta er, Active Ingredient: tapentadol hydrochloride", "title": "Last Updated", "to": "06/14/2024"}, {"arrows": "to", "from": "Drug Name: nucynta er, Active Ingredient: tapentadol hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200533s027lbl.pdf#page=40"}, {"arrows": "to", "from": "Drug Name: nulojix, Active Ingredient: belatacept", "title": "Form", "to": "INJECTABLE; INJECTION"}, {"arrows": "to", "from": "Drug Name: nulojix, Active Ingredient: belatacept", "title": "Last Updated", "to": "07/28/2021"}, {"arrows": "to", "from": "Drug Name: nulojix, Active Ingredient: belatacept", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125288s075lbl.pdf#page=49"}, {"arrows": "to", "from": "Drug Name: nulytely, Active Ingredient: polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride", "title": "Form", "to": "FOR SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: nulytely, Active Ingredient: polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride", "title": "Last Updated", "to": "05/14/2021"}, {"arrows": "to", "from": "Drug Name: nulytely, Active Ingredient: polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM370636.pdf"}, {"arrows": "to", "from": "Drug Name: nulytely-flavored, Active Ingredient: polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride", "title": "Form", "to": "FOR SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: nulytely-flavored, Active Ingredient: polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride", "title": "Last Updated", "to": "05/14/2021"}, {"arrows": "to", "from": "Drug Name: nulytely-flavored, Active Ingredient: polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM370636.pdf"}, {"arrows": "to", "from": "Drug Name: nuvigil, Active Ingredient: armodafinil", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: nuvigil, Active Ingredient: armodafinil", "title": "Last Updated", "to": "02/07/2017"}, {"arrows": "to", "from": "Drug Name: nuvigil, Active Ingredient: armodafinil", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021875s023lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: obredon, Active Ingredient: guaifenesin; hydrocodone bitartrate", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: obredon, Active Ingredient: guaifenesin; hydrocodone bitartrate", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: obredon, Active Ingredient: guaifenesin; hydrocodone bitartrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205474s008lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: ocaliva, Active Ingredient: obeticholic acid", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: ocaliva, Active Ingredient: obeticholic acid", "title": "Last Updated", "to": "05/26/2021"}, {"arrows": "to", "from": "Drug Name: ocaliva, Active Ingredient: obeticholic acid", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207999s007lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: ocrevus, Active Ingredient: ocrelizumab", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: ocrevus, Active Ingredient: ocrelizumab", "title": "Last Updated", "to": "06/21/2024"}, {"arrows": "to", "from": "Drug Name: ocrevus, Active Ingredient: ocrelizumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761053s031lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: ocrevus zunovo, Active Ingredient: ocrelizumab and hyaluronidazse-ocsq", "title": "Form", "to": "INJECTABLE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: ocrevus zunovo, Active Ingredient: ocrelizumab and hyaluronidazse-ocsq", "title": "Last Updated", "to": "09/13/2024"}, {"arrows": "to", "from": "Drug Name: ocrevus zunovo, Active Ingredient: ocrelizumab and hyaluronidazse-ocsq", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761371s000lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: odomzo, Active Ingredient: sonidegib phosphate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: odomzo, Active Ingredient: sonidegib phosphate", "title": "Last Updated", "to": "08/22/2023"}, {"arrows": "to", "from": "Drug Name: odomzo, Active Ingredient: sonidegib phosphate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205266s009lbl.pdf#page=14"}, {"arrows": "to", "from": "Drug Name: oleptro, Active Ingredient: trazodone hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: oleptro, Active Ingredient: trazodone hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: oleptro, Active Ingredient: trazodone hydrochloride", "title": "Last Updated", "to": "07/17/2014"}, {"arrows": "to", "from": "Drug Name: oleptro, Active Ingredient: trazodone hydrochloride", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM202202.pdf"}, {"arrows": "to", "from": "Drug Name: olumiant, Active Ingredient: baricitinib", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: olumiant, Active Ingredient: baricitinib", "title": "Last Updated", "to": "05/10/2022"}, {"arrows": "to", "from": "Drug Name: olumiant, Active Ingredient: baricitinib", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207924s006lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: omniscan, Active Ingredient: gadodiamide", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: omniscan, Active Ingredient: gadodiamide", "title": "Last Updated", "to": "01/26/2024"}, {"arrows": "to", "from": "Drug Name: omniscan, Active Ingredient: gadodiamide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022066s008lbl.pdf#page=1"}, {"arrows": "to", "from": "Drug Name: omniscan, Active Ingredient: gadodiamide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020123s046lbl.pdf#page=1"}, {"arrows": "to", "from": "Drug Name: omontys, Active Ingredient: peginesatide acetate", "title": "Form", "to": "SOLUTION;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: omontys, Active Ingredient: peginesatide acetate", "title": "Other", "to": "SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: omontys, Active Ingredient: peginesatide acetate", "title": "Last Updated", "to": "12/04/2012"}, {"arrows": "to", "from": "Drug Name: omontys, Active Ingredient: peginesatide acetate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202799s001lbl.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: omvoh, Active Ingredient: mirikizumab-mrkz", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: omvoh, Active Ingredient: mirikizumab-mrkz", "title": "Other", "to": "SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: omvoh, Active Ingredient: mirikizumab-mrkz", "title": "Last Updated", "to": "04/29/2024"}, {"arrows": "to", "from": "Drug Name: omvoh, Active Ingredient: mirikizumab-mrkz", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761279s000lbl.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: onfi, Active Ingredient: clobazam", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: onfi, Active Ingredient: clobazam", "title": "Last Updated", "to": "03/12/2024"}, {"arrows": "to", "from": "Drug Name: onfi, Active Ingredient: clobazam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202067s007,203993s009lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: onfi, Active Ingredient: clobazam", "title": "Form", "to": "SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: onglyza, Active Ingredient: saxagliptin hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: onglyza, Active Ingredient: saxagliptin hydrochloride", "title": "Last Updated", "to": "07/01/2019"}, {"arrows": "to", "from": "Drug Name: onglyza, Active Ingredient: saxagliptin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022350s023lbl.pdf#page=31"}, {"arrows": "to", "from": "Drug Name: onsolis, Active Ingredient: fentanyl citrate", "title": "Form", "to": "FILM;BUCCAL"}, {"arrows": "to", "from": "Drug Name: onsolis, Active Ingredient: fentanyl citrate", "title": "Last Updated", "to": "12/03/2021"}, {"arrows": "to", "from": "Drug Name: onsolis, Active Ingredient: fentanyl citrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022266s025lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: opana, Active Ingredient: oxymorphone hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: opana, Active Ingredient: oxymorphone hydrochloride", "title": "Last Updated", "to": "10/25/2019"}, {"arrows": "to", "from": "Drug Name: opana, Active Ingredient: oxymorphone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021611s016lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: opana er, Active Ingredient: oxymorphone hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: opana er, Active Ingredient: oxymorphone hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: opana er, Active Ingredient: oxymorphone hydrochloride", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: opana er, Active Ingredient: oxymorphone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021610s031lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: opana er, Active Ingredient: oxymorphone hydrochloride", "title": "Last Updated", "to": "10/07/2019"}, {"arrows": "to", "from": "Drug Name: opana er, Active Ingredient: oxymorphone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201655s026lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: opdivo, Active Ingredient: nivolumab", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: opdivo, Active Ingredient: nivolumab", "title": "Last Updated", "to": "10/03/2024"}, {"arrows": "to", "from": "Drug Name: opdivo, Active Ingredient: nivolumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125554s127lbl.pdf#page=166"}, {"arrows": "to", "from": "Drug Name: opsumit, Active Ingredient: macitentan", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: opsumit, Active Ingredient: macitentan", "title": "Last Updated", "to": "05/26/2023"}, {"arrows": "to", "from": "Drug Name: opsumit, Active Ingredient: macitentan", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204410s024lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: optimark, Active Ingredient: gadoversetamide", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: optimark, Active Ingredient: gadoversetamide", "title": "Last Updated", "to": "11/02/2018"}, {"arrows": "to", "from": "Drug Name: optimark, Active Ingredient: gadoversetamide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020937s028,020975s029,020976s030lbl.pdf#page=14"}, {"arrows": "to", "from": "Drug Name: optimark, Active Ingredient: gadoversetamide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020975s028lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: optimark in plastic container, Active Ingredient: gadoversetamide", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: optimark in plastic container, Active Ingredient: gadoversetamide", "title": "Last Updated", "to": "11/02/2018"}, {"arrows": "to", "from": "Drug Name: optimark in plastic container, Active Ingredient: gadoversetamide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020976s029lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: opzelura, Active Ingredient: ruxolitinib phosphate", "title": "Form", "to": "CREAM;TOPICAL"}, {"arrows": "to", "from": "Drug Name: opzelura, Active Ingredient: ruxolitinib phosphate", "title": "Last Updated", "to": "03/13/2023"}, {"arrows": "to", "from": "Drug Name: opzelura, Active Ingredient: ruxolitinib phosphate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215309s004lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: oriahnn (copackaged), Active Ingredient: elagolix sodium,estradiol,norethindrone acetate; elagolix sodium", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: oriahnn (copackaged), Active Ingredient: elagolix sodium,estradiol,norethindrone acetate; elagolix sodium", "title": "Last Updated", "to": "05/29/2023"}, {"arrows": "to", "from": "Drug Name: oriahnn (copackaged), Active Ingredient: elagolix sodium,estradiol,norethindrone acetate; elagolix sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213388s003lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: orilissa, Active Ingredient: elagolix sodium", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: orilissa, Active Ingredient: elagolix sodium", "title": "Last Updated", "to": "06/05/2023"}, {"arrows": "to", "from": "Drug Name: orilissa, Active Ingredient: elagolix sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210450s009lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: oseni, Active Ingredient: alogliptin benzoate; pioglitazone hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: oseni, Active Ingredient: alogliptin benzoate; pioglitazone hydrochloride", "title": "Last Updated", "to": "06/28/2024"}, {"arrows": "to", "from": "Drug Name: oseni, Active Ingredient: alogliptin benzoate; pioglitazone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022426s012lbl.pdf#page=43"}, {"arrows": "to", "from": "Drug Name: osmoprep, Active Ingredient: sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: osmoprep, Active Ingredient: sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate", "title": "Last Updated", "to": "11/29/2018"}, {"arrows": "to", "from": "Drug Name: osmoprep, Active Ingredient: sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021892s014lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: otulfi, Active Ingredient: ustekinumab-aauz", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: otulfi, Active Ingredient: ustekinumab-aauz", "title": "Last Updated", "to": "09/27/2024"}, {"arrows": "to", "from": "Drug Name: otulfi, Active Ingredient: ustekinumab-aauz", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761379s000lbl.pdf#page=36"}, {"arrows": "to", "from": "Drug Name: oxaydo, Active Ingredient: oxycodone hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: oxaydo, Active Ingredient: oxycodone hydrochloride", "title": "Last Updated", "to": "04/19/2024"}, {"arrows": "to", "from": "Drug Name: oxaydo, Active Ingredient: oxycodone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202080s013lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: oxtellar xr, Active Ingredient: oxcarbazepine", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: oxtellar xr, Active Ingredient: oxcarbazepine", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: oxtellar xr, Active Ingredient: oxcarbazepine", "title": "Last Updated", "to": "08/14/2024"}, {"arrows": "to", "from": "Drug Name: oxtellar xr, Active Ingredient: oxcarbazepine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202810s020lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: oxycodone hydrochloride, Active Ingredient: oxycodone hydrochloride", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: oxycodone hydrochloride, Active Ingredient: oxycodone hydrochloride", "title": "Last Updated", "to": "04/19/2024"}, {"arrows": "to", "from": "Drug Name: oxycodone hydrochloride, Active Ingredient: oxycodone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200535s022lbl.pdf#page=35"}, {"arrows": "to", "from": "Drug Name: oxycodone hydrochloride, Active Ingredient: oxycodone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201194s017lbl.pdf#page=34"}, {"arrows": "to", "from": "Drug Name: oxycodone hydrochloride capsules, Active Ingredient: oxycodone hydrochloride", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: oxycodone hydrochloride capsules, Active Ingredient: oxycodone hydrochloride", "title": "Last Updated", "to": "04/19/2024"}, {"arrows": "to", "from": "Drug Name: oxycodone hydrochloride capsules, Active Ingredient: oxycodone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200534s013lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: oxycontin, Active Ingredient: oxycodone hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: oxycontin, Active Ingredient: oxycodone hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: oxycontin, Active Ingredient: oxycodone hydrochloride", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: oxycontin, Active Ingredient: oxycodone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022272s048lbl.pdf#page=49"}, {"arrows": "to", "from": "Drug Name: oxymorphone hydrochloride, Active Ingredient: oxymorphone hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: oxymorphone hydrochloride, Active Ingredient: oxymorphone hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: oxymorphone hydrochloride, Active Ingredient: oxymorphone hydrochloride", "title": "Last Updated", "to": "03/04/2021"}, {"arrows": "to", "from": "Drug Name: oxymorphone hydrochloride, Active Ingredient: oxymorphone hydrochloride", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/079046s000mg.pdf"}, {"arrows": "to", "from": "Drug Name: ozempic, Active Ingredient: semaglutide", "title": "Form", "to": "SOLUTION;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: ozempic, Active Ingredient: semaglutide", "title": "Last Updated", "to": "10/06/2022"}, {"arrows": "to", "from": "Drug Name: ozempic, Active Ingredient: semaglutide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209637s012lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: pacerone, Active Ingredient: amiodarone hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: pacerone, Active Ingredient: amiodarone hydrochloride", "title": "Last Updated", "to": "11/01/2019"}, {"arrows": "to", "from": "Drug Name: pacerone, Active Ingredient: amiodarone hydrochloride", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088668.pdf"}, {"arrows": "to", "from": "Drug Name: palladone, Active Ingredient: hydromorphone hydrochloride", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: palladone, Active Ingredient: hydromorphone hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: palladone, Active Ingredient: hydromorphone hydrochloride", "title": "Last Updated", "to": "04/16/2014"}, {"arrows": "to", "from": "Drug Name: palladone, Active Ingredient: hydromorphone hydrochloride", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088670.pdf"}, {"arrows": "to", "from": "Drug Name: palynziq, Active Ingredient: pegvaliase-pqpz", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: palynziq, Active Ingredient: pegvaliase-pqpz", "title": "Last Updated", "to": "11/20/2020"}, {"arrows": "to", "from": "Drug Name: palynziq, Active Ingredient: pegvaliase-pqpz", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761079s000lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: pamelor, Active Ingredient: nortriptyline hydrochloride", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: pamelor, Active Ingredient: nortriptyline hydrochloride", "title": "Last Updated", "to": "07/28/2014"}, {"arrows": "to", "from": "Drug Name: pamelor, Active Ingredient: nortriptyline hydrochloride", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088671.pdf"}, {"arrows": "to", "from": "Drug Name: pamelor, Active Ingredient: nortriptyline hydrochloride", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: pamelor, Active Ingredient: nortriptyline hydrochloride", "title": "Last Updated", "to": "04/09/2019"}, {"arrows": "to", "from": "Drug Name: pamelor, Active Ingredient: nortriptyline hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018013s064lbl.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: pancreaze, Active Ingredient: pancrelipase (amylase;lipase;protease)", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: pancreaze, Active Ingredient: pancrelipase (amylase;lipase;protease)", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: pancreaze, Active Ingredient: pancrelipase (amylase;lipase;protease)", "title": "Last Updated", "to": "02/28/2024"}, {"arrows": "to", "from": "Drug Name: pancreaze, Active Ingredient: pancrelipase (amylase;lipase;protease)", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022523s013lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: parnate, Active Ingredient: tranylcypromine sulfate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: parnate, Active Ingredient: tranylcypromine sulfate", "title": "Last Updated", "to": "01/04/2018"}, {"arrows": "to", "from": "Drug Name: parnate, Active Ingredient: tranylcypromine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012342s064lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: paxil, Active Ingredient: paroxetine hydrochloride", "title": "Form", "to": "SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: paxil, Active Ingredient: paroxetine hydrochloride", "title": "Last Updated", "to": "11/26/2024"}, {"arrows": "to", "from": "Drug Name: paxil, Active Ingredient: paroxetine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020031s083,020710s051lbl.pdf#page=39"}, {"arrows": "to", "from": "Drug Name: paxil, Active Ingredient: paroxetine hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: paxil cr, Active Ingredient: paroxetine hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: paxil cr, Active Ingredient: paroxetine hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: paxil cr, Active Ingredient: paroxetine hydrochloride", "title": "Last Updated", "to": "02/23/2024"}, {"arrows": "to", "from": "Drug Name: paxil cr, Active Ingredient: paroxetine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020936s057s064lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: peganone, Active Ingredient: ethotoin", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: peganone, Active Ingredient: ethotoin", "title": "Last Updated", "to": "02/27/2017"}, {"arrows": "to", "from": "Drug Name: peganone, Active Ingredient: ethotoin", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/010841s022MedGuide.pdf"}, {"arrows": "to", "from": "Drug Name: pegasys, Active Ingredient: peginterferon alfa-2a", "title": "Form", "to": "VIAL; SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: pegasys, Active Ingredient: peginterferon alfa-2a", "title": "Last Updated", "to": "12/11/2023"}, {"arrows": "to", "from": "Drug Name: pegasys, Active Ingredient: peginterferon alfa-2a", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103964s5276lbl.pdf#page=37"}, {"arrows": "to", "from": "Drug Name: pegasys, Active Ingredient: peginterferon alfa-2a", "title": "Form", "to": "SYRINGE"}, {"arrows": "to", "from": "Drug Name: pegintron, Active Ingredient: peginterferon alfa-2b", "title": "Form", "to": "SYRINGE"}, {"arrows": "to", "from": "Drug Name: pegintron, Active Ingredient: peginterferon alfa-2b", "title": "Last Updated", "to": "12/21/2018"}, {"arrows": "to", "from": "Drug Name: pegintron, Active Ingredient: peginterferon alfa-2b", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103949s5313lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: pennsaid, Active Ingredient: diclofenac sodium", "title": "Form", "to": "SOLUTION;TOPICAL"}, {"arrows": "to", "from": "Drug Name: pennsaid, Active Ingredient: diclofenac sodium", "title": "Last Updated", "to": "05/09/2016"}, {"arrows": "to", "from": "Drug Name: pennsaid, Active Ingredient: diclofenac sodium", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM191085.pdf"}, {"arrows": "to", "from": "Drug Name: pennsaid, Active Ingredient: diclofenac sodium", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: pennsaid, Active Ingredient: diclofenac sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204623s013lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: percocet, Active Ingredient: acetaminophen; oxycodone hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: percocet, Active Ingredient: acetaminophen; oxycodone hydrochloride", "title": "Last Updated", "to": "03/04/2021"}, {"arrows": "to", "from": "Drug Name: percocet, Active Ingredient: acetaminophen; oxycodone hydrochloride", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/040330s052lbl.pdf"}, {"arrows": "to", "from": "Drug Name: percodan, Active Ingredient: aspirin; oxycodone hydrochloride; oxycodone terephthalate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: percodan, Active Ingredient: aspirin; oxycodone hydrochloride; oxycodone terephthalate", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: percodan, Active Ingredient: aspirin; oxycodone hydrochloride; oxycodone terephthalate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/007337s057lbl.pdf"}, {"arrows": "to", "from": "Drug Name: percodan, Active Ingredient: aspirin; oxycodone hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: percodan, Active Ingredient: aspirin; oxycodone hydrochloride", "title": "Last Updated", "to": "04/19/2024"}, {"arrows": "to", "from": "Drug Name: percodan, Active Ingredient: aspirin; oxycodone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/007337s053lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: perforomist, Active Ingredient: formoterol fumarate", "title": "Form", "to": "SOLUTION;INHALATION"}, {"arrows": "to", "from": "Drug Name: perforomist, Active Ingredient: formoterol fumarate", "title": "Last Updated", "to": "05/29/2019"}, {"arrows": "to", "from": "Drug Name: perforomist, Active Ingredient: formoterol fumarate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022007s014lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: pertzye, Active Ingredient: pancrelipase (amylase;lipase;protease)", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: pertzye, Active Ingredient: pancrelipase (amylase;lipase;protease)", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: pertzye, Active Ingredient: pancrelipase (amylase;lipase;protease)", "title": "Last Updated", "to": "02/28/2024"}, {"arrows": "to", "from": "Drug Name: pertzye, Active Ingredient: pancrelipase (amylase;lipase;protease)", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022175s008lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: pexeva, Active Ingredient: paroxetine mesylate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: pexeva, Active Ingredient: paroxetine mesylate", "title": "Last Updated", "to": "08/18/2023"}, {"arrows": "to", "from": "Drug Name: pexeva, Active Ingredient: paroxetine mesylate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021299s035s038lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: phenergan vc w/ codeine, Active Ingredient: codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride", "title": "Form", "to": "SYRUP;ORAL"}, {"arrows": "to", "from": "Drug Name: phenergan vc w/ codeine, Active Ingredient: codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: phenergan vc w/ codeine, Active Ingredient: codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/008306s035lbl.pdf#page=66"}, {"arrows": "to", "from": "Drug Name: phenergan w/ codeine, Active Ingredient: codeine phosphate; promethazine hydrochloride", "title": "Form", "to": "SYRUP;ORAL"}, {"arrows": "to", "from": "Drug Name: phenergan w/ codeine, Active Ingredient: codeine phosphate; promethazine hydrochloride", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: phenergan w/ codeine, Active Ingredient: codeine phosphate; promethazine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/008306s035lbl.pdf#page=66"}, {"arrows": "to", "from": "Drug Name: plavix, Active Ingredient: clopidogrel bisulfate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: plavix, Active Ingredient: clopidogrel bisulfate", "title": "Last Updated", "to": "03/01/2021"}, {"arrows": "to", "from": "Drug Name: plavix, Active Ingredient: clopidogrel bisulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020839s074lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: plegridy, Active Ingredient: peginterferon beta-1a", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: plegridy, Active Ingredient: peginterferon beta-1a", "title": "Last Updated", "to": "07/28/2023"}, {"arrows": "to", "from": "Drug Name: plegridy, Active Ingredient: peginterferon beta-1a", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125499s028lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: plenvu, Active Ingredient: ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate", "title": "Form", "to": "FOR SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: plenvu, Active Ingredient: ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate", "title": "Last Updated", "to": "09/08/2023"}, {"arrows": "to", "from": "Drug Name: plenvu, Active Ingredient: ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209381s013lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: pomalyst, Active Ingredient: pomalidomide", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: pomalyst, Active Ingredient: pomalidomide", "title": "Last Updated", "to": "03/24/2023"}, {"arrows": "to", "from": "Drug Name: pomalyst, Active Ingredient: pomalidomide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204026s031lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: ponstel, Active Ingredient: mefenamic acid", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: ponstel, Active Ingredient: mefenamic acid", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: ponstel, Active Ingredient: mefenamic acid", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/015034s046lbl.pdf"}, {"arrows": "to", "from": "Drug Name: ponvory, Active Ingredient: ponesimod", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: ponvory, Active Ingredient: ponesimod", "title": "Last Updated", "to": "06/05/2024"}, {"arrows": "to", "from": "Drug Name: ponvory, Active Ingredient: ponesimod", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213498s004lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: potiga, Active Ingredient: ezogabine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: potiga, Active Ingredient: ezogabine", "title": "Last Updated", "to": "05/20/2016"}, {"arrows": "to", "from": "Drug Name: potiga, Active Ingredient: ezogabine", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM259619.pdf"}, {"arrows": "to", "from": "Drug Name: pradaxa, Active Ingredient: dabigatran etexilate mesylate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: pradaxa, Active Ingredient: dabigatran etexilate mesylate", "title": "Last Updated", "to": "11/17/2023"}, {"arrows": "to", "from": "Drug Name: pradaxa, Active Ingredient: dabigatran etexilate mesylate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022512s047lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: pradaxa, Active Ingredient: dabigatran etexilate mesylate", "title": "Form", "to": "PELLETS;ORAL"}, {"arrows": "to", "from": "Drug Name: pradaxa, Active Ingredient: dabigatran etexilate mesylate", "title": "Last Updated", "to": "11/14/2023"}, {"arrows": "to", "from": "Drug Name: pradaxa, Active Ingredient: dabigatran etexilate mesylate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214358s007lbl.pdf#page=14"}, {"arrows": "to", "from": "Drug Name: prepopik, Active Ingredient: citric acid; magnesium oxide; sodium picosulfate", "title": "Form", "to": "FOR SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: prepopik, Active Ingredient: citric acid; magnesium oxide; sodium picosulfate", "title": "Last Updated", "to": "08/29/2023"}, {"arrows": "to", "from": "Drug Name: prepopik, Active Ingredient: citric acid; magnesium oxide; sodium picosulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202535s006lbl.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: pretomanid, Active Ingredient: pretomanid", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: pretomanid, Active Ingredient: pretomanid", "title": "Last Updated", "to": "11/22/2024"}, {"arrows": "to", "from": "Drug Name: pretomanid, Active Ingredient: pretomanid", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/212862s008lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: prevacid, Active Ingredient: lansoprazole", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: prevacid, Active Ingredient: lansoprazole", "title": "Other", "to": "DELAYED REL PELLETS;ORAL"}, {"arrows": "to", "from": "Drug Name: prevacid, Active Ingredient: lansoprazole", "title": "Last Updated", "to": "08/08/2023"}, {"arrows": "to", "from": "Drug Name: prevacid, Active Ingredient: lansoprazole", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020406s095,021428s042lbl.pdf#page=45"}, {"arrows": "to", "from": "Drug Name: prevacid, Active Ingredient: lansoprazole", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: prevacid, Active Ingredient: lansoprazole", "title": "Other", "to": "ORALLY DISINTEGRATING"}, {"arrows": "to", "from": "Drug Name: prevacid, Active Ingredient: lansoprazole", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: prevacid naprapac 250 (copackaged), Active Ingredient: lansoprazole; naproxen", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: prevacid naprapac 250 (copackaged), Active Ingredient: lansoprazole; naproxen", "title": "Other", "to": "DELAYED REL PELLETS"}, {"arrows": "to", "from": "Drug Name: prevacid naprapac 250 (copackaged), Active Ingredient: lansoprazole; naproxen", "title": "Other", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: prevacid naprapac 250 (copackaged), Active Ingredient: lansoprazole; naproxen", "title": "Last Updated", "to": "07/31/2009"}, {"arrows": "to", "from": "Drug Name: prevacid naprapac 250 (copackaged), Active Ingredient: lansoprazole; naproxen", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088694.pdf"}, {"arrows": "to", "from": "Drug Name: prevacid naprapac 375 (copackaged), Active Ingredient: lansoprazole; naproxen", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: prevacid naprapac 375 (copackaged), Active Ingredient: lansoprazole; naproxen", "title": "Other", "to": "DELAYED REL PELLETS"}, {"arrows": "to", "from": "Drug Name: prevacid naprapac 375 (copackaged), Active Ingredient: lansoprazole; naproxen", "title": "Other", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: prevacid naprapac 375 (copackaged), Active Ingredient: lansoprazole; naproxen", "title": "Last Updated", "to": "07/31/2009"}, {"arrows": "to", "from": "Drug Name: prevacid naprapac 375 (copackaged), Active Ingredient: lansoprazole; naproxen", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088694.pdf"}, {"arrows": "to", "from": "Drug Name: prevacid naprapac 500 (copackaged), Active Ingredient: lansoprazole; naproxen", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: prevacid naprapac 500 (copackaged), Active Ingredient: lansoprazole; naproxen", "title": "Other", "to": "DELAYED REL PELLETS"}, {"arrows": "to", "from": "Drug Name: prevacid naprapac 500 (copackaged), Active Ingredient: lansoprazole; naproxen", "title": "Other", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: prevacid naprapac 500 (copackaged), Active Ingredient: lansoprazole; naproxen", "title": "Last Updated", "to": "07/31/2009"}, {"arrows": "to", "from": "Drug Name: prevacid naprapac 500 (copackaged), Active Ingredient: lansoprazole; naproxen", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088694.pdf"}, {"arrows": "to", "from": "Drug Name: priftin, Active Ingredient: rifapentine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: priftin, Active Ingredient: rifapentine", "title": "Last Updated", "to": "07/01/2015"}, {"arrows": "to", "from": "Drug Name: priftin, Active Ingredient: rifapentine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021024s017s018lbl.pdf#page=28"}, {"arrows": "to", "from": "Drug Name: prilosec, Active Ingredient: omeprazole magnesium", "title": "Form", "to": "FOR SUSPENSION"}, {"arrows": "to", "from": "Drug Name: prilosec, Active Ingredient: omeprazole magnesium", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: prilosec, Active Ingredient: omeprazole magnesium", "title": "Last Updated", "to": "07/18/2023"}, {"arrows": "to", "from": "Drug Name: prilosec, Active Ingredient: omeprazole magnesium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022056s026lbl.pdf#page=34"}, {"arrows": "to", "from": "Drug Name: prilosec, Active Ingredient: omeprazole", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: prilosec, Active Ingredient: omeprazole", "title": "Other", "to": "DELAYED REL PELLETS;ORAL"}, {"arrows": "to", "from": "Drug Name: prilosec, Active Ingredient: omeprazole", "title": "Last Updated", "to": "12/19/2016"}, {"arrows": "to", "from": "Drug Name: prilosec, Active Ingredient: omeprazole", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019810s103,022056s020lbl.pdf#page=34"}, {"arrows": "to", "from": "Drug Name: pristiq, Active Ingredient: desvenlafaxine succinate", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: pristiq, Active Ingredient: desvenlafaxine succinate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: pristiq, Active Ingredient: desvenlafaxine succinate", "title": "Last Updated", "to": "11/10/2021"}, {"arrows": "to", "from": "Drug Name: pristiq, Active Ingredient: desvenlafaxine succinate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021992s047lbl.pdf#page=36"}, {"arrows": "to", "from": "Drug Name: probuphine, Active Ingredient: buprenorphine hydrochloride", "title": "Form", "to": "IMPLANT;IMPLANTATION"}, {"arrows": "to", "from": "Drug Name: probuphine, Active Ingredient: buprenorphine hydrochloride", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: probuphine, Active Ingredient: buprenorphine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204442s014lbl.pdf#page=47"}, {"arrows": "to", "from": "Drug Name: procrit, Active Ingredient: epoetin alfa", "title": "Form", "to": "VIAL; SINGLE-USE"}, {"arrows": "to", "from": "Drug Name: procrit, Active Ingredient: epoetin alfa", "title": "Last Updated", "to": "04/30/2024"}, {"arrows": "to", "from": "Drug Name: procrit, Active Ingredient: epoetin alfa", "title": "More Info", "to": "https://www.fda.gov/media/73511/download"}, {"arrows": "to", "from": "Drug Name: prohance, Active Ingredient: gadoteridol", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: prohance, Active Ingredient: gadoteridol", "title": "Last Updated", "to": "08/14/2024"}, {"arrows": "to", "from": "Drug Name: prohance, Active Ingredient: gadoteridol", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020131s042,021489s023lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: prohance multipack, Active Ingredient: gadoteridol", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: prohance multipack, Active Ingredient: gadoteridol", "title": "Last Updated", "to": "08/14/2024"}, {"arrows": "to", "from": "Drug Name: prohance multipack, Active Ingredient: gadoteridol", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020131s042,021489s023lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: prolia, Active Ingredient: denosumab", "title": "Form", "to": "INJECTABLE; SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: prolia, Active Ingredient: denosumab", "title": "Last Updated", "to": "01/03/2023"}, {"arrows": "to", "from": "Drug Name: prolia, Active Ingredient: denosumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125320s211lbl.pdf#page=31"}, {"arrows": "to", "from": "Drug Name: promacta, Active Ingredient: eltrombopag olamine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: promacta, Active Ingredient: eltrombopag olamine", "title": "Last Updated", "to": "03/09/2023"}, {"arrows": "to", "from": "Drug Name: promacta, Active Ingredient: eltrombopag olamine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022291s037,207027s017lbl.pdf#page=35"}, {"arrows": "to", "from": "Drug Name: promacta kit, Active Ingredient: eltrombopag olamine", "title": "Form", "to": "FOR SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: promacta kit, Active Ingredient: eltrombopag olamine", "title": "Last Updated", "to": "03/09/2023"}, {"arrows": "to", "from": "Drug Name: promacta kit, Active Ingredient: eltrombopag olamine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022291s037,207027s017lbl.pdf#page=35"}, {"arrows": "to", "from": "Drug Name: propulsid, Active Ingredient: cisapride monohydrate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: propulsid, Active Ingredient: cisapride monohydrate", "title": "Last Updated", "to": "03/06/2000"}, {"arrows": "to", "from": "Drug Name: propulsid, Active Ingredient: cisapride monohydrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Propulsid.pdf"}, {"arrows": "to", "from": "Drug Name: propylthiouracil, Active Ingredient: propylthiouracil", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: propylthiouracil, Active Ingredient: propylthiouracil", "title": "Last Updated", "to": "09/19/2018"}, {"arrows": "to", "from": "Drug Name: propylthiouracil, Active Ingredient: propylthiouracil", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/006188s026lbl.pdf#page=7"}, {"arrows": "to", "from": "Drug Name: proquin xr, Active Ingredient: ciprofloxacin hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: proquin xr, Active Ingredient: ciprofloxacin hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: proquin xr, Active Ingredient: ciprofloxacin hydrochloride", "title": "Last Updated", "to": "08/15/2011"}, {"arrows": "to", "from": "Drug Name: proquin xr, Active Ingredient: ciprofloxacin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Proquin XR.pdf"}, {"arrows": "to", "from": "Drug Name: protonix, Active Ingredient: pantoprazole sodium", "title": "Form", "to": "FOR SUSPENSION"}, {"arrows": "to", "from": "Drug Name: protonix, Active Ingredient: pantoprazole sodium", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: protonix, Active Ingredient: pantoprazole sodium", "title": "Last Updated", "to": "07/18/2023"}, {"arrows": "to", "from": "Drug Name: protonix, Active Ingredient: pantoprazole sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020987s060,022020s023lbl.pdf#page=31"}, {"arrows": "to", "from": "Drug Name: protonix, Active Ingredient: pantoprazole sodium", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: protopic, Active Ingredient: tacrolimus", "title": "Form", "to": "OINTMENT;TOPICAL"}, {"arrows": "to", "from": "Drug Name: protopic, Active Ingredient: tacrolimus", "title": "Last Updated", "to": "02/25/2019"}, {"arrows": "to", "from": "Drug Name: protopic, Active Ingredient: tacrolimus", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088996.pdf"}, {"arrows": "to", "from": "Drug Name: provigil, Active Ingredient: modafinil", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: provigil, Active Ingredient: modafinil", "title": "Last Updated", "to": "01/15/2015"}, {"arrows": "to", "from": "Drug Name: provigil, Active Ingredient: modafinil", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020717s030s034s036MedGuide.pdf"}, {"arrows": "to", "from": "Drug Name: prozac, Active Ingredient: fluoxetine hydrochloride", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: prozac, Active Ingredient: fluoxetine hydrochloride", "title": "Last Updated", "to": "08/18/2023"}, {"arrows": "to", "from": "Drug Name: prozac, Active Ingredient: fluoxetine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018936 s112lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: prozac weekly, Active Ingredient: fluoxetine hydrochloride", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: prozac weekly, Active Ingredient: fluoxetine hydrochloride", "title": "Other", "to": "DELAYED REL PELLETS;ORAL"}, {"arrows": "to", "from": "Drug Name: prozac weekly, Active Ingredient: fluoxetine hydrochloride", "title": "Last Updated", "to": "03/24/2017"}, {"arrows": "to", "from": "Drug Name: prozac weekly, Active Ingredient: fluoxetine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018936s103,021235s023lbl.pdf#page=28"}, {"arrows": "to", "from": "Drug Name: qdolo, Active Ingredient: tramadol hydrochloride", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: qdolo, Active Ingredient: tramadol hydrochloride", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: qdolo, Active Ingredient: tramadol hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214044s002lbl.pdf#page=28"}, {"arrows": "to", "from": "Drug Name: qelbree, Active Ingredient: viloxazine hydrochloride", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: qelbree, Active Ingredient: viloxazine hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: qelbree, Active Ingredient: viloxazine hydrochloride", "title": "Last Updated", "to": "04/29/2022"}, {"arrows": "to", "from": "Drug Name: qelbree, Active Ingredient: viloxazine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211964s003lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: qmiiz odt, Active Ingredient: meloxicam", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: qmiiz odt, Active Ingredient: meloxicam", "title": "Other", "to": "ORALLY DISINTEGRATING;ORAL"}, {"arrows": "to", "from": "Drug Name: qmiiz odt, Active Ingredient: meloxicam", "title": "Last Updated", "to": "04/28/2021"}, {"arrows": "to", "from": "Drug Name: qmiiz odt, Active Ingredient: meloxicam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211210s002lbl.pdf#page=37"}, {"arrows": "to", "from": "Drug Name: qsymia, Active Ingredient: phentermine hydrochloride; topiramate", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: qsymia, Active Ingredient: phentermine hydrochloride; topiramate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: qsymia, Active Ingredient: phentermine hydrochloride; topiramate", "title": "Last Updated", "to": "09/13/2024"}, {"arrows": "to", "from": "Drug Name: qsymia, Active Ingredient: phentermine hydrochloride; topiramate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022580s025lbl.pdf#page=43"}, {"arrows": "to", "from": "Drug Name: qtern, Active Ingredient: dapagliflozin; saxagliptin hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: qtern, Active Ingredient: dapagliflozin; saxagliptin hydrochloride", "title": "Last Updated", "to": "09/12/2023"}, {"arrows": "to", "from": "Drug Name: qtern, Active Ingredient: dapagliflozin; saxagliptin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209091s008lbl.pdf#page=37"}, {"arrows": "to", "from": "Drug Name: qternmet xr, Active Ingredient: dapagliflozin; metformin hydrochloride; saxagliptin hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: qternmet xr, Active Ingredient: dapagliflozin; metformin hydrochloride; saxagliptin hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: qternmet xr, Active Ingredient: dapagliflozin; metformin hydrochloride; saxagliptin hydrochloride", "title": "Last Updated", "to": "01/24/2020"}, {"arrows": "to", "from": "Drug Name: qternmet xr, Active Ingredient: dapagliflozin; metformin hydrochloride; saxagliptin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210874s003lbl.pdf#page=47"}, {"arrows": "to", "from": "Drug Name: qualaquin, Active Ingredient: quinine sulfate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: qualaquin, Active Ingredient: quinine sulfate", "title": "Last Updated", "to": "06/19/2019"}, {"arrows": "to", "from": "Drug Name: qualaquin, Active Ingredient: quinine sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021799s029lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: qudexy xr, Active Ingredient: topiramate", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: qudexy xr, Active Ingredient: topiramate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: qudexy xr, Active Ingredient: topiramate", "title": "Last Updated", "to": "03/28/2024"}, {"arrows": "to", "from": "Drug Name: qudexy xr, Active Ingredient: topiramate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205122s014lbl.pdf#page=54"}, {"arrows": "to", "from": "Drug Name: quillichew er, Active Ingredient: methylphenidate hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: quillichew er, Active Ingredient: methylphenidate hydrochloride", "title": "Other", "to": "EXTENDED RELEASE"}, {"arrows": "to", "from": "Drug Name: quillichew er, Active Ingredient: methylphenidate hydrochloride", "title": "Other", "to": "CHEWABLE;ORAL"}, {"arrows": "to", "from": "Drug Name: quillichew er, Active Ingredient: methylphenidate hydrochloride", "title": "Last Updated", "to": "06/25/2021"}, {"arrows": "to", "from": "Drug Name: quillichew er, Active Ingredient: methylphenidate hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207960s012lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: quillivant xr, Active Ingredient: methylphenidate hydrochloride", "title": "Form", "to": "FOR SUSPENSION"}, {"arrows": "to", "from": "Drug Name: quillivant xr, Active Ingredient: methylphenidate hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: quillivant xr, Active Ingredient: methylphenidate hydrochloride", "title": "Last Updated", "to": "06/25/2021"}, {"arrows": "to", "from": "Drug Name: quillivant xr, Active Ingredient: methylphenidate hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202100s018lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: quviviq, Active Ingredient: daridorexant", "title": "Form", "to": "TABLET; ORAL"}, {"arrows": "to", "from": "Drug Name: quviviq, Active Ingredient: daridorexant", "title": "Last Updated", "to": "09/30/2024"}, {"arrows": "to", "from": "Drug Name: quviviq, Active Ingredient: daridorexant", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214985s010s012lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: raldesy, Active Ingredient: trazodone hydrochloride, usp", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: raldesy, Active Ingredient: trazodone hydrochloride, usp", "title": "Last Updated", "to": "11/26/2024"}, {"arrows": "to", "from": "Drug Name: raldesy, Active Ingredient: trazodone hydrochloride, usp", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218637s000lbl.pdf#page=12"}, {"arrows": "to", "from": "Drug Name: rapamune, Active Ingredient: sirolimus", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: rapamune, Active Ingredient: sirolimus", "title": "Last Updated", "to": "01/02/2020"}, {"arrows": "to", "from": "Drug Name: rapamune, Active Ingredient: sirolimus", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021083s067,021110s085lbl.pdf#page=43"}, {"arrows": "to", "from": "Drug Name: rapamune, Active Ingredient: sirolimus", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: rapamune, Active Ingredient: sirolimus", "title": "Last Updated", "to": "08/09/2021"}, {"arrows": "to", "from": "Drug Name: rapamune, Active Ingredient: sirolimus", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021110s086lbl.pdf#page=43"}, {"arrows": "to", "from": "Drug Name: ravicti, Active Ingredient: glycerol phenylbutyrate", "title": "Form", "to": "LIQUID;ORAL"}, {"arrows": "to", "from": "Drug Name: ravicti, Active Ingredient: glycerol phenylbutyrate", "title": "Last Updated", "to": "09/03/2021"}, {"arrows": "to", "from": "Drug Name: ravicti, Active Ingredient: glycerol phenylbutyrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203284s012lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: rebetol, Active Ingredient: ribavirin", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: rebetol, Active Ingredient: ribavirin", "title": "Last Updated", "to": "03/16/2022"}, {"arrows": "to", "from": "Drug Name: rebetol, Active Ingredient: ribavirin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020903s057,021546s013lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: rebetol, Active Ingredient: ribavirin", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: rebif, Active Ingredient: interferon beta-1a", "title": "Form", "to": "SYRINGE"}, {"arrows": "to", "from": "Drug Name: rebif, Active Ingredient: interferon beta-1a", "title": "Last Updated", "to": "07/28/2023"}, {"arrows": "to", "from": "Drug Name: rebif, Active Ingredient: interferon beta-1a", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103780s5214lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: reclast, Active Ingredient: zoledronic acid", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: reclast, Active Ingredient: zoledronic acid", "title": "Last Updated", "to": "04/29/2020"}, {"arrows": "to", "from": "Drug Name: reclast, Active Ingredient: zoledronic acid", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021817s028lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: recorlev, Active Ingredient: levoketoconazole", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: recorlev, Active Ingredient: levoketoconazole", "title": "Last Updated", "to": "08/16/2023"}, {"arrows": "to", "from": "Drug Name: recorlev, Active Ingredient: levoketoconazole", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214133s003lbl.pdf#page=3"}, {"arrows": "to", "from": "Drug Name: reglan, Active Ingredient: metoclopramide hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: reglan, Active Ingredient: metoclopramide hydrochloride", "title": "Last Updated", "to": "08/29/2017"}, {"arrows": "to", "from": "Drug Name: reglan, Active Ingredient: metoclopramide hydrochloride", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM235574.pdf"}, {"arrows": "to", "from": "Drug Name: reglan, Active Ingredient: metoclopramide hydrochloride", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: reglan, Active Ingredient: metoclopramide hydrochloride", "title": "Last Updated", "to": "11/18/2010"}, {"arrows": "to", "from": "Drug Name: reglan, Active Ingredient: metoclopramide hydrochloride", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/017862s063MedGuide.pdf"}, {"arrows": "to", "from": "Drug Name: reglan odt, Active Ingredient: metoclopramide hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: reglan odt, Active Ingredient: metoclopramide hydrochloride", "title": "Other", "to": "ORALLY DISINTEGRATING;ORAL"}, {"arrows": "to", "from": "Drug Name: reglan odt, Active Ingredient: metoclopramide hydrochloride", "title": "Last Updated", "to": "11/30/2011"}, {"arrows": "to", "from": "Drug Name: reglan odt, Active Ingredient: metoclopramide hydrochloride", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021793s011mg.pdf"}, {"arrows": "to", "from": "Drug Name: regranex, Active Ingredient: becaplermin", "title": "Form", "to": "GEL; TOPICAL"}, {"arrows": "to", "from": "Drug Name: regranex, Active Ingredient: becaplermin", "title": "Last Updated", "to": "08/26/2019"}, {"arrows": "to", "from": "Drug Name: regranex, Active Ingredient: becaplermin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103691s5138lbl.pdf#page=8"}, {"arrows": "to", "from": "Drug Name: relexxii, Active Ingredient: methylphenidate hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: relexxii, Active Ingredient: methylphenidate hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: relexxii, Active Ingredient: methylphenidate hydrochloride", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: relexxii, Active Ingredient: methylphenidate hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216117s001lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: relistor, Active Ingredient: methylnaltrexone bromide", "title": "Form", "to": "SOLUTION;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: relistor, Active Ingredient: methylnaltrexone bromide", "title": "Last Updated", "to": "03/14/2018"}, {"arrows": "to", "from": "Drug Name: relistor, Active Ingredient: methylnaltrexone bromide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021964s019,208271s003lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: relistor, Active Ingredient: methylnaltrexone bromide", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: remeron, Active Ingredient: mirtazapine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: remeron, Active Ingredient: mirtazapine", "title": "Last Updated", "to": "11/18/2021"}, {"arrows": "to", "from": "Drug Name: remeron, Active Ingredient: mirtazapine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020415s038,021208s028lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: remeron soltab, Active Ingredient: mirtazapine", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: remeron soltab, Active Ingredient: mirtazapine", "title": "Other", "to": "ORALLY DISINTEGRATING;ORAL"}, {"arrows": "to", "from": "Drug Name: remeron soltab, Active Ingredient: mirtazapine", "title": "Last Updated", "to": "11/18/2021"}, {"arrows": "to", "from": "Drug Name: remeron soltab, Active Ingredient: mirtazapine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020415s038,021208s028lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: remicade, Active Ingredient: infliximab", "title": "Form", "to": "VIAL"}, {"arrows": "to", "from": "Drug Name: remicade, Active Ingredient: infliximab", "title": "Last Updated", "to": "10/05/2021"}, {"arrows": "to", "from": "Drug Name: remicade, Active Ingredient: infliximab", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103772s5401lbl.pdf#page=50"}, {"arrows": "to", "from": "Drug Name: renflexis, Active Ingredient: infliximab-abda", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: renflexis, Active Ingredient: infliximab-abda", "title": "Last Updated", "to": "12/26/2023"}, {"arrows": "to", "from": "Drug Name: renflexis, Active Ingredient: infliximab-abda", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761054s021lbl.pdf#page=55"}, {"arrows": "to", "from": "Drug Name: restoril, Active Ingredient: temazepam", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: restoril, Active Ingredient: temazepam", "title": "Last Updated", "to": "01/13/2023"}, {"arrows": "to", "from": "Drug Name: restoril, Active Ingredient: temazepam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018163s071lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: retacrit, Active Ingredient: epoetin alfa-epbx", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: retacrit, Active Ingredient: epoetin alfa-epbx", "title": "Last Updated", "to": "06/04/2024"}, {"arrows": "to", "from": "Drug Name: retacrit, Active Ingredient: epoetin alfa-epbx", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125545s005lbl.pdf#page=31"}, {"arrows": "to", "from": "Drug Name: revlimid, Active Ingredient: lenalidomide", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: revlimid, Active Ingredient: lenalidomide", "title": "Last Updated", "to": "03/24/2023"}, {"arrows": "to", "from": "Drug Name: revlimid, Active Ingredient: lenalidomide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021880s067lbl.pdf#page=48"}, {"arrows": "to", "from": "Drug Name: rexulti, Active Ingredient: brexpiprazole", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: rexulti, Active Ingredient: brexpiprazole", "title": "Last Updated", "to": "05/07/2024"}, {"arrows": "to", "from": "Drug Name: rexulti, Active Ingredient: brexpiprazole", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205422s009lbl.pdf#page=36"}, {"arrows": "to", "from": "Drug Name: reyvow, Active Ingredient: lasmiditan succinate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: reyvow, Active Ingredient: lasmiditan succinate", "title": "Last Updated", "to": "09/15/2022"}, {"arrows": "to", "from": "Drug Name: reyvow, Active Ingredient: lasmiditan succinate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211280s008lbl.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: rezira, Active Ingredient: hydrocodone bitartrate; pseudoephedrine hydrochloride", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: rezira, Active Ingredient: hydrocodone bitartrate; pseudoephedrine hydrochloride", "title": "Last Updated", "to": "06/28/2018"}, {"arrows": "to", "from": "Drug Name: rezira, Active Ingredient: hydrocodone bitartrate; pseudoephedrine hydrochloride", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022442s010lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: riabni, Active Ingredient: rituximab-arrx", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: riabni, Active Ingredient: rituximab-arrx", "title": "Last Updated", "to": "06/03/2022"}, {"arrows": "to", "from": "Drug Name: riabni, Active Ingredient: rituximab-arrx", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761140s001lbl.pdf#page=41"}, {"arrows": "to", "from": "Drug Name: rinvoq, Active Ingredient: upadacitinib", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: rinvoq, Active Ingredient: upadacitinib", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: rinvoq, Active Ingredient: upadacitinib", "title": "Last Updated", "to": "04/26/2024"}, {"arrows": "to", "from": "Drug Name: rinvoq, Active Ingredient: upadacitinib", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211675s019lbl.pdf#page=72"}, {"arrows": "to", "from": "Drug Name: ritalin, Active Ingredient: methylphenidate hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: ritalin, Active Ingredient: methylphenidate hydrochloride", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: ritalin, Active Ingredient: methylphenidate hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/010187s092s096lbl.pdf#page18"}, {"arrows": "to", "from": "Drug Name: ritalin la, Active Ingredient: methylphenidate hydrochloride", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: ritalin la, Active Ingredient: methylphenidate hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: ritalin la, Active Ingredient: methylphenidate hydrochloride", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: ritalin la, Active Ingredient: methylphenidate hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021284s042s046lbl.pdf#page18"}, {"arrows": "to", "from": "Drug Name: ritalin-sr, Active Ingredient: methylphenidate hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: ritalin-sr, Active Ingredient: methylphenidate hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: ritalin-sr, Active Ingredient: methylphenidate hydrochloride", "title": "Last Updated", "to": "11/19/2019"}, {"arrows": "to", "from": "Drug Name: ritalin-sr, Active Ingredient: methylphenidate hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010187s091,018029s059lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: rituxan, Active Ingredient: rituximab", "title": "Form", "to": "SOLUTION;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: rituxan, Active Ingredient: rituximab", "title": "Last Updated", "to": "12/17/2021"}, {"arrows": "to", "from": "Drug Name: rituxan, Active Ingredient: rituximab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103705s5465lbl.pdf#page=56"}, {"arrows": "to", "from": "Drug Name: rituxan hycela, Active Ingredient: rituximab; hyaluronidase (human recombinant)", "title": "Form", "to": "SOLUTION;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: rituxan hycela, Active Ingredient: rituximab; hyaluronidase (human recombinant)", "title": "Last Updated", "to": "06/10/2021"}, {"arrows": "to", "from": "Drug Name: rituxan hycela, Active Ingredient: rituximab; hyaluronidase (human recombinant)", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761064s013lbl.pdf#page=28"}, {"arrows": "to", "from": "Drug Name: roxicodone, Active Ingredient: oxycodone hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: roxicodone, Active Ingredient: oxycodone hydrochloride", "title": "Last Updated", "to": "04/19/2024"}, {"arrows": "to", "from": "Drug Name: roxicodone, Active Ingredient: oxycodone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021011s013lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: roxybond, Active Ingredient: oxycodone hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: roxybond, Active Ingredient: oxycodone hydrochloride", "title": "Last Updated", "to": "04/19/2024"}, {"arrows": "to", "from": "Drug Name: roxybond, Active Ingredient: oxycodone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209777s008lbl.pdf#page=38"}, {"arrows": "to", "from": "Drug Name: rozerem, Active Ingredient: ramelteon", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: rozerem, Active Ingredient: ramelteon", "title": "Last Updated", "to": "11/03/2021"}, {"arrows": "to", "from": "Drug Name: rozerem, Active Ingredient: ramelteon", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021782s022lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: ruxience, Active Ingredient: rituximab-pvvr", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: ruxience, Active Ingredient: rituximab-pvvr", "title": "Last Updated", "to": "10/16/2023"}, {"arrows": "to", "from": "Drug Name: ruxience, Active Ingredient: rituximab-pvvr", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761103s011lbl.pdf#page=42"}, {"arrows": "to", "from": "Drug Name: ruzurgi, Active Ingredient: amifampridine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: ruzurgi, Active Ingredient: amifampridine", "title": "Last Updated", "to": "08/21/2020"}, {"arrows": "to", "from": "Drug Name: ruzurgi, Active Ingredient: amifampridine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209321s000lbl.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: rybelsus, Active Ingredient: semaglutide", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: rybelsus, Active Ingredient: semaglutide", "title": "Last Updated", "to": "01/24/2024"}, {"arrows": "to", "from": "Drug Name: rybelsus, Active Ingredient: semaglutide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213051s012lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: rybelsus, Active Ingredient: semaglutide", "title": "Last Updated", "to": "01/16/2020"}, {"arrows": "to", "from": "Drug Name: rybelsus, Active Ingredient: semaglutide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213182s000,213051s001lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: sabril, Active Ingredient: vigabatrin", "title": "Form", "to": "FOR SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: sabril, Active Ingredient: vigabatrin", "title": "Last Updated", "to": "10/20/2021"}, {"arrows": "to", "from": "Drug Name: sabril, Active Ingredient: vigabatrin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020427s025,022006s026lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: sabril, Active Ingredient: vigabatrin", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: samsca, Active Ingredient: tolvaptan", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: samsca, Active Ingredient: tolvaptan", "title": "Last Updated", "to": "04/22/2021"}, {"arrows": "to", "from": "Drug Name: samsca, Active Ingredient: tolvaptan", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022275s017lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: sarafem, Active Ingredient: fluoxetine hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: sarafem, Active Ingredient: fluoxetine hydrochloride", "title": "Last Updated", "to": "09/20/2021"}, {"arrows": "to", "from": "Drug Name: sarafem, Active Ingredient: fluoxetine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021860s015lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: savaysa, Active Ingredient: edoxaban tosylate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: savaysa, Active Ingredient: edoxaban tosylate", "title": "Last Updated", "to": "10/18/2023"}, {"arrows": "to", "from": "Drug Name: savaysa, Active Ingredient: edoxaban tosylate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206316s019lbl.pdf#page=35"}, {"arrows": "to", "from": "Drug Name: savella, Active Ingredient: milnacipran hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: savella, Active Ingredient: milnacipran hydrochloride", "title": "Last Updated", "to": "05/22/2024"}, {"arrows": "to", "from": "Drug Name: savella, Active Ingredient: milnacipran hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022256s028lbl.pdf#page=31"}, {"arrows": "to", "from": "Drug Name: saxenda, Active Ingredient: liraglutide recombinant", "title": "Form", "to": "SOLUTION;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: saxenda, Active Ingredient: liraglutide recombinant", "title": "Last Updated", "to": "04/20/2023"}, {"arrows": "to", "from": "Drug Name: saxenda, Active Ingredient: liraglutide recombinant", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206321s016lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: seglentis, Active Ingredient: celecoxib; tramadol hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: seglentis, Active Ingredient: celecoxib; tramadol hydrochloride", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: seglentis, Active Ingredient: celecoxib; tramadol hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213426s003lbl.pdf#page=57"}, {"arrows": "to", "from": "Drug Name: segluromet, Active Ingredient: ertugliflozin; metformin hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: segluromet, Active Ingredient: ertugliflozin; metformin hydrochloride", "title": "Last Updated", "to": "09/12/2023"}, {"arrows": "to", "from": "Drug Name: segluromet, Active Ingredient: ertugliflozin; metformin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209806s010lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: selzentry, Active Ingredient: maraviroc", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: selzentry, Active Ingredient: maraviroc", "title": "Last Updated", "to": "10/30/2020"}, {"arrows": "to", "from": "Drug Name: selzentry, Active Ingredient: maraviroc", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022128s019,208984s002lbl.pdf#page=43"}, {"arrows": "to", "from": "Drug Name: selzentry, Active Ingredient: maraviroc", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: serevent, Active Ingredient: salmeterol xinafoate", "title": "Form", "to": "POWDER;INHALATION"}, {"arrows": "to", "from": "Drug Name: serevent, Active Ingredient: salmeterol xinafoate", "title": "Last Updated", "to": "07/22/2019"}, {"arrows": "to", "from": "Drug Name: serevent, Active Ingredient: salmeterol xinafoate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020692s047lbl.pdf#page=35"}, {"arrows": "to", "from": "Drug Name: seroquel, Active Ingredient: quetiapine fumarate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: seroquel, Active Ingredient: quetiapine fumarate", "title": "Last Updated", "to": "01/31/2022"}, {"arrows": "to", "from": "Drug Name: seroquel, Active Ingredient: quetiapine fumarate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020639s072lbl.pdf#page=49"}, {"arrows": "to", "from": "Drug Name: seroquel xr, Active Ingredient: quetiapine fumarate", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: seroquel xr, Active Ingredient: quetiapine fumarate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: seroquel xr, Active Ingredient: quetiapine fumarate", "title": "Last Updated", "to": "01/28/2022"}, {"arrows": "to", "from": "Drug Name: seroquel xr, Active Ingredient: quetiapine fumarate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022047s046lbl.pdf#page=53"}, {"arrows": "to", "from": "Drug Name: sertraline, Active Ingredient: sertraline hydrochloride", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: sertraline, Active Ingredient: sertraline hydrochloride", "title": "Last Updated", "to": "08/18/2023"}, {"arrows": "to", "from": "Drug Name: sertraline, Active Ingredient: sertraline hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215133s001lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: signifor, Active Ingredient: pasireotide diaspartate", "title": "Form", "to": "SOLUTION;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: signifor, Active Ingredient: pasireotide diaspartate", "title": "Last Updated", "to": "01/15/2020"}, {"arrows": "to", "from": "Drug Name: signifor, Active Ingredient: pasireotide diaspartate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/200677s006lbl.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: siklos, Active Ingredient: hydroxyurea", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: siklos, Active Ingredient: hydroxyurea", "title": "Last Updated", "to": "11/28/2023"}, {"arrows": "to", "from": "Drug Name: siklos, Active Ingredient: hydroxyurea", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208843s004lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: silenor, Active Ingredient: doxepin hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: silenor, Active Ingredient: doxepin hydrochloride", "title": "Last Updated", "to": "10/29/2020"}, {"arrows": "to", "from": "Drug Name: silenor, Active Ingredient: doxepin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022036s006lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: siliq, Active Ingredient: brodalumab", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: siliq, Active Ingredient: brodalumab", "title": "Last Updated", "to": "08/12/2024"}, {"arrows": "to", "from": "Drug Name: siliq, Active Ingredient: brodalumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761032s014lbl.pdf#page=14"}, {"arrows": "to", "from": "Drug Name: simponi, Active Ingredient: golimumab", "title": "Form", "to": "INJECTABLE; INJECTION"}, {"arrows": "to", "from": "Drug Name: simponi, Active Ingredient: golimumab", "title": "Last Updated", "to": "09/24/2019"}, {"arrows": "to", "from": "Drug Name: simponi, Active Ingredient: golimumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125289s146lbl.pdf#page=38"}, {"arrows": "to", "from": "Drug Name: simponi aria, Active Ingredient: golimumab", "title": "Form", "to": "INJECTABLE; INJECTION"}, {"arrows": "to", "from": "Drug Name: simponi aria, Active Ingredient: golimumab", "title": "Last Updated", "to": "02/01/2021"}, {"arrows": "to", "from": "Drug Name: simponi aria, Active Ingredient: golimumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125433s032lbl.pdf#page=34"}, {"arrows": "to", "from": "Drug Name: sinequan, Active Ingredient: doxepin hydrochloride", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: sinequan, Active Ingredient: doxepin hydrochloride", "title": "Last Updated", "to": "07/14/2014"}, {"arrows": "to", "from": "Drug Name: sinequan, Active Ingredient: doxepin hydrochloride", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089129.pdf"}, {"arrows": "to", "from": "Drug Name: singulair, Active Ingredient: montelukast sodium", "title": "Form", "to": "GRANULE;ORAL"}, {"arrows": "to", "from": "Drug Name: singulair, Active Ingredient: montelukast sodium", "title": "Last Updated", "to": "02/22/2021"}, {"arrows": "to", "from": "Drug Name: singulair, Active Ingredient: montelukast sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s0760,021409s052lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: singulair, Active Ingredient: montelukast sodium", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: singulair, Active Ingredient: montelukast sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s076,021409s052lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: singulair, Active Ingredient: montelukast sodium", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: singulair, Active Ingredient: montelukast sodium", "title": "Other", "to": "CHEWABLE;ORAL"}, {"arrows": "to", "from": "Drug Name: sirturo, Active Ingredient: bedaquiline fumarate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: sirturo, Active Ingredient: bedaquiline fumarate", "title": "Last Updated", "to": "06/21/2024"}, {"arrows": "to", "from": "Drug Name: sirturo, Active Ingredient: bedaquiline fumarate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204384s017lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: skyrizi, Active Ingredient: risankizumab-rzaa", "title": "Form", "to": "INJECTABLE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: skyrizi, Active Ingredient: risankizumab-rzaa", "title": "Last Updated", "to": "06/18/2024"}, {"arrows": "to", "from": "Drug Name: skyrizi, Active Ingredient: risankizumab-rzaa", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761262s001lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: skyrizi, Active Ingredient: risankizumab-rzaa", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: skyrizi, Active Ingredient: risankizumab-rzaa", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761105s018lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: sodium oxybate, Active Ingredient: sodium oxybate", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: sodium oxybate, Active Ingredient: sodium oxybate", "title": "Last Updated", "to": "01/03/2022"}, {"arrows": "to", "from": "Drug Name: sodium oxybate, Active Ingredient: sodium oxybate", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202090lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: sohonos, Active Ingredient: paloverotene", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: sohonos, Active Ingredient: paloverotene", "title": "Last Updated", "to": "08/16/2023"}, {"arrows": "to", "from": "Drug Name: sohonos, Active Ingredient: paloverotene", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215559s000lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: solaraze, Active Ingredient: diclofenac sodium", "title": "Form", "to": "GEL;TOPICAL"}, {"arrows": "to", "from": "Drug Name: solaraze, Active Ingredient: diclofenac sodium", "title": "Last Updated", "to": "11/14/2022"}, {"arrows": "to", "from": "Drug Name: solaraze, Active Ingredient: diclofenac sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021005s024lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: solaraze, Active Ingredient: diclofenac sodium", "title": "Last Updated", "to": "04/28/2021"}, {"arrows": "to", "from": "Drug Name: solaraze, Active Ingredient: diclofenac sodium", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM501655.pdf"}, {"arrows": "to", "from": "Drug Name: soliqua 100/33, Active Ingredient: insulin glargine; lixisenatide", "title": "Form", "to": "SOLUTION;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: soliqua 100/33, Active Ingredient: insulin glargine; lixisenatide", "title": "Last Updated", "to": "09/28/2023"}, {"arrows": "to", "from": "Drug Name: soliqua 100/33, Active Ingredient: insulin glargine; lixisenatide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208673s013lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: soliris, Active Ingredient: eculizumab", "title": "Form", "to": "INJECTABLE; IV (INFUSION)"}, {"arrows": "to", "from": "Drug Name: soliris, Active Ingredient: eculizumab", "title": "Last Updated", "to": "06/28/2024"}, {"arrows": "to", "from": "Drug Name: soliris, Active Ingredient: eculizumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125166s431lbl.pdf#page=40"}, {"arrows": "to", "from": "Drug Name: soltamox, Active Ingredient: tamoxifen citrate", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: soltamox, Active Ingredient: tamoxifen citrate", "title": "Last Updated", "to": "04/08/2019"}, {"arrows": "to", "from": "Drug Name: soltamox, Active Ingredient: tamoxifen citrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021807s006lbl.pdf#page=36"}, {"arrows": "to", "from": "Drug Name: sonata, Active Ingredient: zaleplon", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: sonata, Active Ingredient: zaleplon", "title": "Last Updated", "to": "08/18/2019"}, {"arrows": "to", "from": "Drug Name: sonata, Active Ingredient: zaleplon", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020859s016lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: soriatane, Active Ingredient: acitretin", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: soriatane, Active Ingredient: acitretin", "title": "Last Updated", "to": "02/22/2023"}, {"arrows": "to", "from": "Drug Name: soriatane, Active Ingredient: acitretin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019821s029lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: sotret, Active Ingredient: isotretinoin", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: sotret, Active Ingredient: isotretinoin", "title": "Last Updated", "to": "04/12/2012"}, {"arrows": "to", "from": "Drug Name: sotret, Active Ingredient: isotretinoin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Sotret.pdf"}, {"arrows": "to", "from": "Drug Name: sotyktu, Active Ingredient: deucravacitinib", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: sotyktu, Active Ingredient: deucravacitinib", "title": "Last Updated", "to": "09/09/2022"}, {"arrows": "to", "from": "Drug Name: sotyktu, Active Ingredient: deucravacitinib", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214958s000lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: spevigo, Active Ingredient: spesolimab-sbzo", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: spevigo, Active Ingredient: spesolimab-sbzo", "title": "Last Updated", "to": "03/18/2024"}, {"arrows": "to", "from": "Drug Name: spevigo, Active Ingredient: spesolimab-sbzo", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761244s000lbl.pdf#page=11"}, {"arrows": "to", "from": "Drug Name: spravato, Active Ingredient: esketamine hydrochloride", "title": "Form", "to": "SPRAY;NASAL"}, {"arrows": "to", "from": "Drug Name: spravato, Active Ingredient: esketamine hydrochloride", "title": "Last Updated", "to": "10/18/2023"}, {"arrows": "to", "from": "Drug Name: spravato, Active Ingredient: esketamine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211243s012lbl.pdf#page=43"}, {"arrows": "to", "from": "Drug Name: spritam, Active Ingredient: levetiracetam", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: spritam, Active Ingredient: levetiracetam", "title": "Other", "to": "FOR SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: spritam, Active Ingredient: levetiracetam", "title": "Last Updated", "to": "06/14/2024"}, {"arrows": "to", "from": "Drug Name: spritam, Active Ingredient: levetiracetam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207958s023lbl.pdf#page=36"}, {"arrows": "to", "from": "Drug Name: sprix, Active Ingredient: ketorolac tromethamine", "title": "Form", "to": "SPRAY"}, {"arrows": "to", "from": "Drug Name: sprix, Active Ingredient: ketorolac tromethamine", "title": "Other", "to": "METERED;NASAL"}, {"arrows": "to", "from": "Drug Name: sprix, Active Ingredient: ketorolac tromethamine", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: sprix, Active Ingredient: ketorolac tromethamine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022382s022lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: stavzor, Active Ingredient: valproic acid", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: stavzor, Active Ingredient: valproic acid", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: stavzor, Active Ingredient: valproic acid", "title": "Last Updated", "to": "11/30/2021"}, {"arrows": "to", "from": "Drug Name: stavzor, Active Ingredient: valproic acid", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022152s009lbl.pdf#page=42"}, {"arrows": "to", "from": "Drug Name: steglatro, Active Ingredient: ertugliflozin", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: steglatro, Active Ingredient: ertugliflozin", "title": "Last Updated", "to": "09/12/2023"}, {"arrows": "to", "from": "Drug Name: steglatro, Active Ingredient: ertugliflozin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209803s007lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: steglujan, Active Ingredient: ertugliflozin; sitagliptin phosphate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: steglujan, Active Ingredient: ertugliflozin; sitagliptin phosphate", "title": "Last Updated", "to": "09/12/2023"}, {"arrows": "to", "from": "Drug Name: steglujan, Active Ingredient: ertugliflozin; sitagliptin phosphate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209805s016lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: stelara, Active Ingredient: ustekinumab", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: stelara, Active Ingredient: ustekinumab", "title": "Last Updated", "to": "03/18/2024"}, {"arrows": "to", "from": "Drug Name: stelara, Active Ingredient: ustekinumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761044s009lbl.pdf#page=37"}, {"arrows": "to", "from": "Drug Name: stelara, Active Ingredient: ustekinumab", "title": "Form", "to": "INJECTABLE; INJECTION"}, {"arrows": "to", "from": "Drug Name: stelara, Active Ingredient: ustekinumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125261s158,761044s009lbl.pdf#page=36"}, {"arrows": "to", "from": "Drug Name: strattera, Active Ingredient: atomoxetine hydrochloride", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: strattera, Active Ingredient: atomoxetine hydrochloride", "title": "Last Updated", "to": "01/06/2022"}, {"arrows": "to", "from": "Drug Name: strattera, Active Ingredient: atomoxetine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021411s050lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: striverdi respimat, Active Ingredient: olodaterol hydrochloride", "title": "Form", "to": "SPRAY"}, {"arrows": "to", "from": "Drug Name: striverdi respimat, Active Ingredient: olodaterol hydrochloride", "title": "Other", "to": "METERED;INHALATION"}, {"arrows": "to", "from": "Drug Name: striverdi respimat, Active Ingredient: olodaterol hydrochloride", "title": "Last Updated", "to": "05/29/2019"}, {"arrows": "to", "from": "Drug Name: striverdi respimat, Active Ingredient: olodaterol hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/striverdi respimatMedGuide2016.pdf"}, {"arrows": "to", "from": "Drug Name: sublocade, Active Ingredient: buprenorphine", "title": "Form", "to": "SOLUTION"}, {"arrows": "to", "from": "Drug Name: sublocade, Active Ingredient: buprenorphine", "title": "Other", "to": "EXTENDED RELEASE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: sublocade, Active Ingredient: buprenorphine", "title": "Last Updated", "to": "09/22/2021"}, {"arrows": "to", "from": "Drug Name: sublocade, Active Ingredient: buprenorphine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209819s018lbl.pdf#page=45"}, {"arrows": "to", "from": "Drug Name: suboxone, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "title": "Form", "to": "FILM;BUCCAL"}, {"arrows": "to", "from": "Drug Name: suboxone, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "title": "Other", "to": "SUBLINGUAL"}, {"arrows": "to", "from": "Drug Name: suboxone, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "title": "Last Updated", "to": "06/17/2022"}, {"arrows": "to", "from": "Drug Name: suboxone, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022410s046s047lbl.pdf#page=35"}, {"arrows": "to", "from": "Drug Name: suboxone, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "title": "Form", "to": "TABLET;SUBLINGUAL"}, {"arrows": "to", "from": "Drug Name: suboxone, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020733s031s032lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: subsys, Active Ingredient: fentanyl", "title": "Form", "to": "SPRAY;SUBLINGUAL"}, {"arrows": "to", "from": "Drug Name: subsys, Active Ingredient: fentanyl", "title": "Last Updated", "to": "12/03/2021"}, {"arrows": "to", "from": "Drug Name: subsys, Active Ingredient: fentanyl", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202788s023lbl.pdf#page=40"}, {"arrows": "to", "from": "Drug Name: subutex, Active Ingredient: buprenorphine hydrochloride", "title": "Form", "to": "TABLET;SUBLINGUAL"}, {"arrows": "to", "from": "Drug Name: subutex, Active Ingredient: buprenorphine hydrochloride", "title": "Last Updated", "to": "06/17/2022"}, {"arrows": "to", "from": "Drug Name: subutex, Active Ingredient: buprenorphine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020732s027s028lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: suclear, Active Ingredient: magnesium sulfate; polyethylene glycol 3350; potassium chloride; potassium sulfate; sodium bicarbonate; sodium chloride; sodium sulfate", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: suclear, Active Ingredient: magnesium sulfate; polyethylene glycol 3350; potassium chloride; potassium sulfate; sodium bicarbonate; sodium chloride; sodium sulfate", "title": "Last Updated", "to": "08/15/2013"}, {"arrows": "to", "from": "Drug Name: suclear, Active Ingredient: magnesium sulfate; polyethylene glycol 3350; potassium chloride; potassium sulfate; sodium bicarbonate; sodium chloride; sodium sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203595s000lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: suflave, Active Ingredient: polyethylene glycol 3350; sodium sulfate; potassium chloride; magnesium sulfate; sodium chloride", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: suflave, Active Ingredient: polyethylene glycol 3350; sodium sulfate; potassium chloride; magnesium sulfate; sodium chloride", "title": "Last Updated", "to": "06/15/2023"}, {"arrows": "to", "from": "Drug Name: suflave, Active Ingredient: polyethylene glycol 3350; sodium sulfate; potassium chloride; magnesium sulfate; sodium chloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215344s000lbl.pdf#page=14"}, {"arrows": "to", "from": "Drug Name: sunosi, Active Ingredient: solriamfetol hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: sunosi, Active Ingredient: solriamfetol hydrochloride", "title": "Last Updated", "to": "06/28/2023"}, {"arrows": "to", "from": "Drug Name: sunosi, Active Ingredient: solriamfetol hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211230s009lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: supprelin la, Active Ingredient: histrelin acetate", "title": "Form", "to": "IMPLANT;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: supprelin la, Active Ingredient: histrelin acetate", "title": "Last Updated", "to": "04/22/2022"}, {"arrows": "to", "from": "Drug Name: supprelin la, Active Ingredient: histrelin acetate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022058s017lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: suprep bowel prep kit, Active Ingredient: magnesium sulfate; potassium sulfate; sodium sulfate", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: suprep bowel prep kit, Active Ingredient: magnesium sulfate; potassium sulfate; sodium sulfate", "title": "Last Updated", "to": "08/05/2020"}, {"arrows": "to", "from": "Drug Name: suprep bowel prep kit, Active Ingredient: magnesium sulfate; potassium sulfate; sodium sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022372s013lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: surmontil, Active Ingredient: trimipramine maleate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: surmontil, Active Ingredient: trimipramine maleate", "title": "Last Updated", "to": "09/30/2014"}, {"arrows": "to", "from": "Drug Name: surmontil, Active Ingredient: trimipramine maleate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/016792s037lbl.pdf#page=12"}, {"arrows": "to", "from": "Drug Name: sustol, Active Ingredient: granisetron", "title": "Form", "to": "INJECTION"}, {"arrows": "to", "from": "Drug Name: sustol, Active Ingredient: granisetron", "title": "Other", "to": "EXTENDED RELEASE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: sustol, Active Ingredient: granisetron", "title": "Last Updated", "to": "05/25/2023"}, {"arrows": "to", "from": "Drug Name: sustol, Active Ingredient: granisetron", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022445s010lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: sutab, Active Ingredient: magnesium sulfate; potassium chloride; sodium sulfate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: sutab, Active Ingredient: magnesium sulfate; potassium chloride; sodium sulfate", "title": "Last Updated", "to": "10/24/2023"}, {"arrows": "to", "from": "Drug Name: sutab, Active Ingredient: magnesium sulfate; potassium chloride; sodium sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213135s004lbl.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: sutent, Active Ingredient: sunitinib malate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: sutent, Active Ingredient: sunitinib malate", "title": "Last Updated", "to": "08/30/2021"}, {"arrows": "to", "from": "Drug Name: sutent, Active Ingredient: sunitinib malate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021938s039lbledt.pdf#page=34"}, {"arrows": "to", "from": "Drug Name: sylatron, Active Ingredient: peginterferon alfa-2b", "title": "Form", "to": "VIAL"}, {"arrows": "to", "from": "Drug Name: sylatron, Active Ingredient: peginterferon alfa-2b", "title": "Last Updated", "to": "12/21/2018"}, {"arrows": "to", "from": "Drug Name: sylatron, Active Ingredient: peginterferon alfa-2b", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103949s5312lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: symbyax, Active Ingredient: fluoxetine hydrochloride; olanzapine", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: symbyax, Active Ingredient: fluoxetine hydrochloride; olanzapine", "title": "Last Updated", "to": "08/18/2023"}, {"arrows": "to", "from": "Drug Name: symbyax, Active Ingredient: fluoxetine hydrochloride; olanzapine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021520s055lbl.pdf#page=42"}, {"arrows": "to", "from": "Drug Name: symlin, Active Ingredient: pramlintide acetate", "title": "Form", "to": "INJECTABLE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: symlin, Active Ingredient: pramlintide acetate", "title": "Last Updated", "to": "12/18/2019"}, {"arrows": "to", "from": "Drug Name: symlin, Active Ingredient: pramlintide acetate", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089141.pdf"}, {"arrows": "to", "from": "Drug Name: sympazan, Active Ingredient: clobazam", "title": "Form", "to": "FILM;ORAL"}, {"arrows": "to", "from": "Drug Name: sympazan, Active Ingredient: clobazam", "title": "Last Updated", "to": "03/12/2024"}, {"arrows": "to", "from": "Drug Name: sympazan, Active Ingredient: clobazam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210833s004lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: symproic, Active Ingredient: naldemedine tosylate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: symproic, Active Ingredient: naldemedine tosylate", "title": "Last Updated", "to": "01/24/2018"}, {"arrows": "to", "from": "Drug Name: symproic, Active Ingredient: naldemedine tosylate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208854s002lbl.pdf#page=13"}, {"arrows": "to", "from": "Drug Name: synalgos-dc, Active Ingredient: aspirin; caffeine; dihydrocodeine bitartrate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: synalgos-dc, Active Ingredient: aspirin; caffeine; dihydrocodeine bitartrate", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: synalgos-dc, Active Ingredient: aspirin; caffeine; dihydrocodeine bitartrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/011483s037lbl.pdf"}, {"arrows": "to", "from": "Drug Name: synarel, Active Ingredient: nafarelin acetate", "title": "Form", "to": "SPRAY"}, {"arrows": "to", "from": "Drug Name: synarel, Active Ingredient: nafarelin acetate", "title": "Other", "to": "METERED;NASAL"}, {"arrows": "to", "from": "Drug Name: synarel, Active Ingredient: nafarelin acetate", "title": "Last Updated", "to": "01/31/2023"}, {"arrows": "to", "from": "Drug Name: synarel, Active Ingredient: nafarelin acetate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019886s039lbl.pdf#page=28"}, {"arrows": "to", "from": "Drug Name: synjardy, Active Ingredient: empagliflozin; metformin hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: synjardy, Active Ingredient: empagliflozin; metformin hydrochloride", "title": "Last Updated", "to": "10/30/2023"}, {"arrows": "to", "from": "Drug Name: synjardy, Active Ingredient: empagliflozin; metformin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206111s042,208658s028lbl.pdf#page=44"}, {"arrows": "to", "from": "Drug Name: synjardy xr, Active Ingredient: empagliflozin; metformin hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: synjardy xr, Active Ingredient: empagliflozin; metformin hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: synjardy xr, Active Ingredient: empagliflozin; metformin hydrochloride", "title": "Last Updated", "to": "10/30/2023"}, {"arrows": "to", "from": "Drug Name: synjardy xr, Active Ingredient: empagliflozin; metformin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206111s042,208658s028lbl.pdf#page=44"}, {"arrows": "to", "from": "Drug Name: synribo, Active Ingredient: omacetaxine mepesuccinate", "title": "Form", "to": "POWDER;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: synribo, Active Ingredient: omacetaxine mepesuccinate", "title": "Last Updated", "to": "05/12/2021"}, {"arrows": "to", "from": "Drug Name: synribo, Active Ingredient: omacetaxine mepesuccinate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203585Orig1s008lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: tafinlar, Active Ingredient: dabrafenib mesylate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: tafinlar, Active Ingredient: dabrafenib mesylate", "title": "Last Updated", "to": "03/29/2024"}, {"arrows": "to", "from": "Drug Name: tafinlar, Active Ingredient: dabrafenib mesylate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202806s027lbl.pdf#page=46"}, {"arrows": "to", "from": "Drug Name: tafinlar, Active Ingredient: dabrafenib", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: tafinlar, Active Ingredient: dabrafenib", "title": "Last Updated", "to": "03/29/2024"}, {"arrows": "to", "from": "Drug Name: tafinlar, Active Ingredient: dabrafenib", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217514s000lbl.pdf#page=46"}, {"arrows": "to", "from": "Drug Name: taltz, Active Ingredient: ixekizumab", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: taltz, Active Ingredient: ixekizumab", "title": "Last Updated", "to": "07/27/2022"}, {"arrows": "to", "from": "Drug Name: taltz, Active Ingredient: ixekizumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125521s024lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: talvey, Active Ingredient: talquetamab-tgvs", "title": "Form", "to": "INJECTABLE; SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: talvey, Active Ingredient: talquetamab-tgvs", "title": "Last Updated", "to": "08/09/2023"}, {"arrows": "to", "from": "Drug Name: talvey, Active Ingredient: talquetamab-tgvs", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761342s000lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: tanzeum, Active Ingredient: albiglutide", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: tanzeum, Active Ingredient: albiglutide", "title": "Last Updated", "to": "12/20/2017"}, {"arrows": "to", "from": "Drug Name: tanzeum, Active Ingredient: albiglutide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125431s019lbl.pdf#page=36"}, {"arrows": "to", "from": "Drug Name: targiniq, Active Ingredient: naloxone hydrochloride; oxycodone hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: targiniq, Active Ingredient: naloxone hydrochloride; oxycodone hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: targiniq, Active Ingredient: naloxone hydrochloride; oxycodone hydrochloride", "title": "Last Updated", "to": "09/18/2018"}, {"arrows": "to", "from": "Drug Name: targiniq, Active Ingredient: naloxone hydrochloride; oxycodone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205777s010s011lbl.pdf#page=47"}, {"arrows": "to", "from": "Drug Name: tasigna, Active Ingredient: nilotinib hydrochloride", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: tasigna, Active Ingredient: nilotinib hydrochloride", "title": "Last Updated", "to": "02/08/2024"}, {"arrows": "to", "from": "Drug Name: tasigna, Active Ingredient: nilotinib hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022068s035s036lbl.pdf#page=36"}, {"arrows": "to", "from": "Drug Name: tavneos, Active Ingredient: avacopan", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: tavneos, Active Ingredient: avacopan", "title": "Last Updated", "to": "06/03/2024"}, {"arrows": "to", "from": "Drug Name: tavneos, Active Ingredient: avacopan", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214487s000lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: tazverik, Active Ingredient: tazemetostat hydrobromide", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: tazverik, Active Ingredient: tazemetostat hydrobromide", "title": "Last Updated", "to": "11/16/2023"}, {"arrows": "to", "from": "Drug Name: tazverik, Active Ingredient: tazemetostat hydrobromide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211723s004lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: tazverik, Active Ingredient: tazemetostat hydrobromide", "title": "Last Updated", "to": "06/18/2020"}, {"arrows": "to", "from": "Drug Name: tazverik, Active Ingredient: tazemetostat hydrobromide", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213400s000lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: tecentriq, Active Ingredient: atezolizumab", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: tecentriq, Active Ingredient: atezolizumab", "title": "Last Updated", "to": "04/22/2024"}, {"arrows": "to", "from": "Drug Name: tecentriq, Active Ingredient: atezolizumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761034s049s051lbl.pdf#page=62"}, {"arrows": "to", "from": "Drug Name: tecentriq, Active Ingredient: atezolizumab", "title": "Form", "to": "INJECTABLE; INJECTION"}, {"arrows": "to", "from": "Drug Name: tecentriq, Active Ingredient: atezolizumab", "title": "Last Updated", "to": "10/18/2016"}, {"arrows": "to", "from": "Drug Name: tecentriq, Active Ingredient: atezolizumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761041s000lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: technivie, Active Ingredient: ombitasvir; paritaprevir; ritonavir", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: technivie, Active Ingredient: ombitasvir; paritaprevir; ritonavir", "title": "Last Updated", "to": "12/06/2019"}, {"arrows": "to", "from": "Drug Name: technivie, Active Ingredient: ombitasvir; paritaprevir; ritonavir", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207931s013lbl.pdf#page=39"}, {"arrows": "to", "from": "Drug Name: tecvayli, Active Ingredient: teclistamab-cqyv", "title": "Form", "to": "INJECTABLE; SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: tecvayli, Active Ingredient: teclistamab-cqyv", "title": "Last Updated", "to": "11/22/2024"}, {"arrows": "to", "from": "Drug Name: tecvayli, Active Ingredient: teclistamab-cqyv", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761291s009lbl.pdf#page=28"}, {"arrows": "to", "from": "Drug Name: tegretol, Active Ingredient: carbamazepine", "title": "Form", "to": "SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: tegretol, Active Ingredient: carbamazepine", "title": "Last Updated", "to": "09/13/2023"}, {"arrows": "to", "from": "Drug Name: tegretol, Active Ingredient: carbamazepine", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016608s121_018927s60_020234s054lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: tegretol, Active Ingredient: carbamazepine", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: tegretol, Active Ingredient: carbamazepine", "title": "Other", "to": "CHEWABLE;ORAL"}, {"arrows": "to", "from": "Drug Name: tegretol, Active Ingredient: carbamazepine", "title": "Last Updated", "to": "03/20/2018"}, {"arrows": "to", "from": "Drug Name: tegretol, Active Ingredient: carbamazepine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016608s115_018281_s058_018927s055_020234_s047.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: tegretol, Active Ingredient: carbamazepine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: tegretol-xr, Active Ingredient: carbamazepine", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: tegretol-xr, Active Ingredient: carbamazepine", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: tegretol-xr, Active Ingredient: carbamazepine", "title": "Last Updated", "to": "09/13/2023"}, {"arrows": "to", "from": "Drug Name: tegretol-xr, Active Ingredient: carbamazepine", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016608s121_018927s60_020234s054lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: tegsedi, Active Ingredient: inotersen sodium", "title": "Form", "to": "SOLUTION;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: tegsedi, Active Ingredient: inotersen sodium", "title": "Last Updated", "to": "01/12/2024"}, {"arrows": "to", "from": "Drug Name: tegsedi, Active Ingredient: inotersen sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211172s010lbl.pdf#page=28"}, {"arrows": "to", "from": "Drug Name: testim, Active Ingredient: testosterone", "title": "Form", "to": "GEL;TRANSDERMAL"}, {"arrows": "to", "from": "Drug Name: testim, Active Ingredient: testosterone", "title": "Last Updated", "to": "08/20/2021"}, {"arrows": "to", "from": "Drug Name: testim, Active Ingredient: testosterone", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021454s030s031lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: testosterone, Active Ingredient: testosterone", "title": "Form", "to": "GEL;TRANSDERMAL"}, {"arrows": "to", "from": "Drug Name: testosterone, Active Ingredient: testosterone", "title": "Last Updated", "to": "10/25/2016"}, {"arrows": "to", "from": "Drug Name: testosterone, Active Ingredient: testosterone", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202763s000mg.pdf"}, {"arrows": "to", "from": "Drug Name: testosterone cypionate injection, Active Ingredient: testosterone cypionate", "title": "Form", "to": "INJECTABLE;INTRAMUSCULAR"}, {"arrows": "to", "from": "Drug Name: testosterone cypionate injection, Active Ingredient: testosterone cypionate", "title": "Last Updated", "to": "02/01/2024"}, {"arrows": "to", "from": "Drug Name: testosterone cypionate injection, Active Ingredient: testosterone cypionate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216318Orig1s002lbl.pdf#page=14"}, {"arrows": "to", "from": "Drug Name: thalomid, Active Ingredient: thalidomide", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: thalomid, Active Ingredient: thalidomide", "title": "Last Updated", "to": "03/24/2023"}, {"arrows": "to", "from": "Drug Name: thalomid, Active Ingredient: thalidomide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020785s071lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: tibsovo, Active Ingredient: ivosidenib", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: tibsovo, Active Ingredient: ivosidenib", "title": "Last Updated", "to": "10/24/2023"}, {"arrows": "to", "from": "Drug Name: tibsovo, Active Ingredient: ivosidenib", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211192s011lbl.pdf#page=38"}, {"arrows": "to", "from": "Drug Name: tikosyn, Active Ingredient: dofetilide", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: tikosyn, Active Ingredient: dofetilide", "title": "Last Updated", "to": "08/08/2019"}, {"arrows": "to", "from": "Drug Name: tikosyn, Active Ingredient: dofetilide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020931s017lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: tivdak, Active Ingredient: tisotumab vedotin-tftv", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: tivdak, Active Ingredient: tisotumab vedotin-tftv", "title": "Last Updated", "to": "04/29/2024"}, {"arrows": "to", "from": "Drug Name: tivdak, Active Ingredient: tisotumab vedotin-tftv", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761208s005lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: tivorbex, Active Ingredient: indomethacin", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: tivorbex, Active Ingredient: indomethacin", "title": "Last Updated", "to": "04/28/2021"}, {"arrows": "to", "from": "Drug Name: tivorbex, Active Ingredient: indomethacin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204768s008lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: tofidence, Active Ingredient: tocilizumab-bavi", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: tofidence, Active Ingredient: tocilizumab-bavi", "title": "Last Updated", "to": "12/03/2024"}, {"arrows": "to", "from": "Drug Name: tofidence, Active Ingredient: tocilizumab-bavi", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761354s004lbl.pdf#page=55"}, {"arrows": "to", "from": "Drug Name: tofranil, Active Ingredient: imipramine hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: tofranil, Active Ingredient: imipramine hydrochloride", "title": "Last Updated", "to": "06/29/2017"}, {"arrows": "to", "from": "Drug Name: tofranil, Active Ingredient: imipramine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/087846s028,087844s027,087845s027lbl.pdf#page=3"}, {"arrows": "to", "from": "Drug Name: tofranil-pm, Active Ingredient: imipramine pamoate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: tofranil-pm, Active Ingredient: imipramine pamoate", "title": "Last Updated", "to": "07/28/2014"}, {"arrows": "to", "from": "Drug Name: tofranil-pm, Active Ingredient: imipramine pamoate", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM326090.pdf"}, {"arrows": "to", "from": "Drug Name: tolectin, Active Ingredient: tolmetin sodium", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: tolectin, Active Ingredient: tolmetin sodium", "title": "Last Updated", "to": "01/22/2008"}, {"arrows": "to", "from": "Drug Name: tolectin, Active Ingredient: tolmetin sodium", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089162.pdf"}, {"arrows": "to", "from": "Drug Name: tolectin 600, Active Ingredient: tolmetin sodium", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: tolectin 600, Active Ingredient: tolmetin sodium", "title": "Last Updated", "to": "01/22/2008"}, {"arrows": "to", "from": "Drug Name: tolectin 600, Active Ingredient: tolmetin sodium", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089162.pdf"}, {"arrows": "to", "from": "Drug Name: tolectin ds, Active Ingredient: tolmetin sodium", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: tolectin ds, Active Ingredient: tolmetin sodium", "title": "Last Updated", "to": "01/22/2008"}, {"arrows": "to", "from": "Drug Name: tolectin ds, Active Ingredient: tolmetin sodium", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089162.pdf"}, {"arrows": "to", "from": "Drug Name: topamax, Active Ingredient: topiramate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: topamax, Active Ingredient: topiramate", "title": "Last Updated", "to": "05/03/2023"}, {"arrows": "to", "from": "Drug Name: topamax, Active Ingredient: topiramate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020505s065,020844s056lbl.pdf#page=56"}, {"arrows": "to", "from": "Drug Name: topamax, Active Ingredient: topiramate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: topamax sprinkle, Active Ingredient: topiramate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: topamax sprinkle, Active Ingredient: topiramate", "title": "Last Updated", "to": "05/03/2023"}, {"arrows": "to", "from": "Drug Name: topamax sprinkle, Active Ingredient: topiramate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020505s065,020844s056lbl.pdf#page=56"}, {"arrows": "to", "from": "Drug Name: toradol, Active Ingredient: ketorolac tromethamine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: toradol, Active Ingredient: ketorolac tromethamine", "title": "Last Updated", "to": "03/26/2013"}, {"arrows": "to", "from": "Drug Name: toradol, Active Ingredient: ketorolac tromethamine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019645s019lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: tracleer, Active Ingredient: bosentan", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: tracleer, Active Ingredient: bosentan", "title": "Last Updated", "to": "02/08/2024"}, {"arrows": "to", "from": "Drug Name: tracleer, Active Ingredient: bosentan", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021290s039,209279s005lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: tracleer, Active Ingredient: bosentan", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: tracleer, Active Ingredient: bosentan", "title": "Other", "to": "FOR SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: tradjenta, Active Ingredient: linagliptin", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: tradjenta, Active Ingredient: linagliptin", "title": "Last Updated", "to": "06/20/2023"}, {"arrows": "to", "from": "Drug Name: tradjenta, Active Ingredient: linagliptin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201280s027lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: tranxene, Active Ingredient: clorazepate dipotassium", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: tranxene, Active Ingredient: clorazepate dipotassium", "title": "Last Updated", "to": "01/13/2023"}, {"arrows": "to", "from": "Drug Name: tranxene, Active Ingredient: clorazepate dipotassium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017105s085lbl.pdf#page=14"}, {"arrows": "to", "from": "Drug Name: tranxene, Active Ingredient: clorazepate dipotassium", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: tranxene sd, Active Ingredient: clorazepate dipotassium", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: tranxene sd, Active Ingredient: clorazepate dipotassium", "title": "Last Updated", "to": "01/13/2023"}, {"arrows": "to", "from": "Drug Name: tranxene sd, Active Ingredient: clorazepate dipotassium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017105s085lbl.pdf#page=14"}, {"arrows": "to", "from": "Drug Name: trazodone hydrochloride, Active Ingredient: trazodone hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: trazodone hydrochloride, Active Ingredient: trazodone hydrochloride", "title": "Last Updated", "to": "04/20/2020"}, {"arrows": "to", "from": "Drug Name: trazodone hydrochloride, Active Ingredient: trazodone hydrochloride", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/071196s062lbl.pdf#page=3"}, {"arrows": "to", "from": "Drug Name: trelegy ellipta, Active Ingredient: fluticasone furoate; umeclidinium bromide; vilanterol trifenatate", "title": "Form", "to": "POWDER;INHALATION"}, {"arrows": "to", "from": "Drug Name: trelegy ellipta, Active Ingredient: fluticasone furoate; umeclidinium bromide; vilanterol trifenatate", "title": "Last Updated", "to": "06/02/2023"}, {"arrows": "to", "from": "Drug Name: trelegy ellipta, Active Ingredient: fluticasone furoate; umeclidinium bromide; vilanterol trifenatate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209482s000lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: tremfya, Active Ingredient: guselkumab", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: tremfya, Active Ingredient: guselkumab", "title": "Last Updated", "to": "06/29/2023"}, {"arrows": "to", "from": "Drug Name: tremfya, Active Ingredient: guselkumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761061s009lbl.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: treximet, Active Ingredient: naproxen sodium; sumatriptan succinate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: treximet, Active Ingredient: naproxen sodium; sumatriptan succinate", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: treximet, Active Ingredient: naproxen sodium; sumatriptan succinate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021926s019lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: tridione, Active Ingredient: trimethadione", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: tridione, Active Ingredient: trimethadione", "title": "Last Updated", "to": "06/07/2016"}, {"arrows": "to", "from": "Drug Name: tridione, Active Ingredient: trimethadione", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM308402.pdf"}, {"arrows": "to", "from": "Drug Name: tridione, Active Ingredient: trimethadione", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: tridione, Active Ingredient: trimethadione", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: trijardy xr, Active Ingredient: empagliflozin; linagliptin; metformin hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: trijardy xr, Active Ingredient: empagliflozin; linagliptin; metformin hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: trijardy xr, Active Ingredient: empagliflozin; linagliptin; metformin hydrochloride", "title": "Last Updated", "to": "10/30/2023"}, {"arrows": "to", "from": "Drug Name: trijardy xr, Active Ingredient: empagliflozin; linagliptin; metformin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212614s020lbl.pdf#page=44"}, {"arrows": "to", "from": "Drug Name: trileptal, Active Ingredient: oxcarbazepine", "title": "Form", "to": "SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: trileptal, Active Ingredient: oxcarbazepine", "title": "Last Updated", "to": "01/04/2019"}, {"arrows": "to", "from": "Drug Name: trileptal, Active Ingredient: oxcarbazepine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021014s042,021285s035lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: trileptal, Active Ingredient: oxcarbazepine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: trintellix, Active Ingredient: vortioxetine hydrobromide", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: trintellix, Active Ingredient: vortioxetine hydrobromide", "title": "Last Updated", "to": "08/23/2023"}, {"arrows": "to", "from": "Drug Name: trintellix, Active Ingredient: vortioxetine hydrobromide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204447s026lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: triptodur kit, Active Ingredient: triptorelin pamoate", "title": "Form", "to": "FOR SUSPENSION"}, {"arrows": "to", "from": "Drug Name: triptodur kit, Active Ingredient: triptorelin pamoate", "title": "Other", "to": "EXTENDED RELEASE;INTRAMUSCULAR"}, {"arrows": "to", "from": "Drug Name: triptodur kit, Active Ingredient: triptorelin pamoate", "title": "Last Updated", "to": "12/07/2022"}, {"arrows": "to", "from": "Drug Name: triptodur kit, Active Ingredient: triptorelin pamoate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208956s010lbl.pdf#page=12"}, {"arrows": "to", "from": "Drug Name: triumeq, Active Ingredient: abacavir sulfate; dolutegravir sodium; lamivudine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: triumeq, Active Ingredient: abacavir sulfate; dolutegravir sodium; lamivudine", "title": "Last Updated", "to": "04/18/2024"}, {"arrows": "to", "from": "Drug Name: triumeq, Active Ingredient: abacavir sulfate; dolutegravir sodium; lamivudine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205551s31,215413s02lbl.pdf#page=56"}, {"arrows": "to", "from": "Drug Name: triumeq pd, Active Ingredient: abacavir sulfate; dolutegravir sodium; lamivudine", "title": "Form", "to": "SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: triumeq pd, Active Ingredient: abacavir sulfate; dolutegravir sodium; lamivudine", "title": "Last Updated", "to": "04/18/2024"}, {"arrows": "to", "from": "Drug Name: triumeq pd, Active Ingredient: abacavir sulfate; dolutegravir sodium; lamivudine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205551s31,215413s02lbl.pdf#page=56"}, {"arrows": "to", "from": "Drug Name: trizivir, Active Ingredient: abacavir sulfate; lamivudine; zidovudine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: trizivir, Active Ingredient: abacavir sulfate; lamivudine; zidovudine", "title": "Last Updated", "to": "02/17/2021"}, {"arrows": "to", "from": "Drug Name: trizivir, Active Ingredient: abacavir sulfate; lamivudine; zidovudine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021205s038lbl.pdf#page=34"}, {"arrows": "to", "from": "Drug Name: trokendi xr, Active Ingredient: topiramate", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: trokendi xr, Active Ingredient: topiramate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: trokendi xr, Active Ingredient: topiramate", "title": "Last Updated", "to": "01/04/2024"}, {"arrows": "to", "from": "Drug Name: trokendi xr, Active Ingredient: topiramate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201635s030lbl.pdf#page=52"}, {"arrows": "to", "from": "Drug Name: troxyca er, Active Ingredient: naltrexone hydrochloride; oxycodone hydrochloride", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: troxyca er, Active Ingredient: naltrexone hydrochloride; oxycodone hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: troxyca er, Active Ingredient: naltrexone hydrochloride; oxycodone hydrochloride", "title": "Last Updated", "to": "05/26/2017"}, {"arrows": "to", "from": "Drug Name: troxyca er, Active Ingredient: naltrexone hydrochloride; oxycodone hydrochloride", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207621s004lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: trudhesa, Active Ingredient: dihydroergotamine mesylate", "title": "Form", "to": "SPRAY"}, {"arrows": "to", "from": "Drug Name: trudhesa, Active Ingredient: dihydroergotamine mesylate", "title": "Other", "to": "METERED;NASAL"}, {"arrows": "to", "from": "Drug Name: trudhesa, Active Ingredient: dihydroergotamine mesylate", "title": "Last Updated", "to": "09/02/2021"}, {"arrows": "to", "from": "Drug Name: trudhesa, Active Ingredient: dihydroergotamine mesylate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213436s000lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: trulance, Active Ingredient: plecanatide", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: trulance, Active Ingredient: plecanatide", "title": "Last Updated", "to": "04/13/2021"}, {"arrows": "to", "from": "Drug Name: trulance, Active Ingredient: plecanatide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208745s011lbl.pdf#page=15"}, {"arrows": "to", "from": "Drug Name: trulicity, Active Ingredient: dulaglutide", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: trulicity, Active Ingredient: dulaglutide", "title": "Last Updated", "to": "11/17/2022"}, {"arrows": "to", "from": "Drug Name: trulicity, Active Ingredient: dulaglutide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125469s051lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: truvada, Active Ingredient: emtricitabine; tenofovir disoproxil fumarate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: truvada, Active Ingredient: emtricitabine; tenofovir disoproxil fumarate", "title": "Last Updated", "to": "04/29/2024"}, {"arrows": "to", "from": "Drug Name: truvada, Active Ingredient: emtricitabine; tenofovir disoproxil fumarate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021752Orig1s063lbl.pdf#page=35"}, {"arrows": "to", "from": "Drug Name: truxima, Active Ingredient: rituximab-abbs", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: truxima, Active Ingredient: rituximab-abbs", "title": "Last Updated", "to": "02/04/2022"}, {"arrows": "to", "from": "Drug Name: truxima, Active Ingredient: rituximab-abbs", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761088s018lbl.pdf#page=49"}, {"arrows": "to", "from": "Drug Name: turalio, Active Ingredient: pexidartinib hydrochloride", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: turalio, Active Ingredient: pexidartinib hydrochloride", "title": "Last Updated", "to": "11/16/2023"}, {"arrows": "to", "from": "Drug Name: turalio, Active Ingredient: pexidartinib hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211810s012lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: tussionex pennkinetic, Active Ingredient: chlorpheniramine polistirex; hydrocodone polistirex", "title": "Form", "to": "SUSPENSION"}, {"arrows": "to", "from": "Drug Name: tussionex pennkinetic, Active Ingredient: chlorpheniramine polistirex; hydrocodone polistirex", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: tussionex pennkinetic, Active Ingredient: chlorpheniramine polistirex; hydrocodone polistirex", "title": "Last Updated", "to": "06/28/2018"}, {"arrows": "to", "from": "Drug Name: tussionex pennkinetic, Active Ingredient: chlorpheniramine polistirex; hydrocodone polistirex", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019111s022lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: tuxarin er, Active Ingredient: chlorpheniramine maleate; codeine phosphate", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: tuxarin er, Active Ingredient: chlorpheniramine maleate; codeine phosphate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: tuxarin er, Active Ingredient: chlorpheniramine maleate; codeine phosphate", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: tuxarin er, Active Ingredient: chlorpheniramine maleate; codeine phosphate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206323s008lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: tuzistra xr, Active Ingredient: chlorpheniramine polistirex; codeine polistirex", "title": "Form", "to": "SUSPENSION"}, {"arrows": "to", "from": "Drug Name: tuzistra xr, Active Ingredient: chlorpheniramine polistirex; codeine polistirex", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: tuzistra xr, Active Ingredient: chlorpheniramine polistirex; codeine polistirex", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: tuzistra xr, Active Ingredient: chlorpheniramine polistirex; codeine polistirex", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207768s013lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: tyenne, Active Ingredient: tocilizumab--aazg", "title": "Form", "to": "INJECTABLE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: tyenne, Active Ingredient: tocilizumab--aazg", "title": "Last Updated", "to": "12/03/2024"}, {"arrows": "to", "from": "Drug Name: tyenne, Active Ingredient: tocilizumab--aazg", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761275s011lbl.pdf#page=46"}, {"arrows": "to", "from": "Drug Name: tymlos, Active Ingredient: abaloparatide", "title": "Form", "to": "SOLUTION;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: tymlos, Active Ingredient: abaloparatide", "title": "Last Updated", "to": "12/21/2023"}, {"arrows": "to", "from": "Drug Name: tymlos, Active Ingredient: abaloparatide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208743s009lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: tysabri, Active Ingredient: natalizumab", "title": "Form", "to": "VIAL; SINGLE-USE"}, {"arrows": "to", "from": "Drug Name: tysabri, Active Ingredient: natalizumab", "title": "Last Updated", "to": "10/30/2023"}, {"arrows": "to", "from": "Drug Name: tysabri, Active Ingredient: natalizumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125104s976s979lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: tyzeka, Active Ingredient: telbivudine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: tyzeka, Active Ingredient: telbivudine", "title": "Last Updated", "to": "12/27/2018"}, {"arrows": "to", "from": "Drug Name: tyzeka, Active Ingredient: telbivudine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022011s022,022154s019lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: tyzeka, Active Ingredient: telbivudine", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: ukoniq, Active Ingredient: umbralisib tosylate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: ukoniq, Active Ingredient: umbralisib tosylate", "title": "Last Updated", "to": "02/05/2021"}, {"arrows": "to", "from": "Drug Name: ukoniq, Active Ingredient: umbralisib tosylate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213176s000lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: uloric, Active Ingredient: febuxostat", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: uloric, Active Ingredient: febuxostat", "title": "Last Updated", "to": "04/17/2023"}, {"arrows": "to", "from": "Drug Name: uloric, Active Ingredient: febuxostat", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021856s015lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: ultomiris, Active Ingredient: ravulizumab-cwvz", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: ultomiris, Active Ingredient: ravulizumab-cwvz", "title": "Last Updated", "to": "06/28/2024"}, {"arrows": "to", "from": "Drug Name: ultomiris, Active Ingredient: ravulizumab-cwvz", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761108s023lbl.pdf#page=41"}, {"arrows": "to", "from": "Drug Name: ultracet, Active Ingredient: acetaminophen; tramadol hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: ultracet, Active Ingredient: acetaminophen; tramadol hydrochloride", "title": "Last Updated", "to": "02/13/2023"}, {"arrows": "to", "from": "Drug Name: ultracet, Active Ingredient: acetaminophen; tramadol hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021123s015lbl.pdf#page=46"}, {"arrows": "to", "from": "Drug Name: ultram, Active Ingredient: tramadol hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: ultram, Active Ingredient: tramadol hydrochloride", "title": "Last Updated", "to": "02/13/2023"}, {"arrows": "to", "from": "Drug Name: ultram, Active Ingredient: tramadol hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020281s040lbl.pdf#page=42"}, {"arrows": "to", "from": "Drug Name: ultram er, Active Ingredient: tramadol hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: ultram er, Active Ingredient: tramadol hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: ultram er, Active Ingredient: tramadol hydrochloride", "title": "Last Updated", "to": "08/29/2017"}, {"arrows": "to", "from": "Drug Name: ultram er, Active Ingredient: tramadol hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021692s015lbl.pdf#page=36"}, {"arrows": "to", "from": "Drug Name: uplizna, Active Ingredient: inebilizumab-cdon", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: uplizna, Active Ingredient: inebilizumab-cdon", "title": "Last Updated", "to": "06/11/2020"}, {"arrows": "to", "from": "Drug Name: uplizna, Active Ingredient: inebilizumab-cdon", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761142s000lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: valchlor, Active Ingredient: mechlorethamine hydrochloride", "title": "Form", "to": "GEL;TOPICAL"}, {"arrows": "to", "from": "Drug Name: valchlor, Active Ingredient: mechlorethamine hydrochloride", "title": "Last Updated", "to": "05/01/2020"}, {"arrows": "to", "from": "Drug Name: valchlor, Active Ingredient: mechlorethamine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202317s009lbl.pdf#page=10"}, {"arrows": "to", "from": "Drug Name: valium, Active Ingredient: diazepam", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: valium, Active Ingredient: diazepam", "title": "Last Updated", "to": "03/19/2024"}, {"arrows": "to", "from": "Drug Name: valium, Active Ingredient: diazepam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/013263Orig1s100lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: valtoco, Active Ingredient: diazepam", "title": "Form", "to": "SPRAY;NASAL"}, {"arrows": "to", "from": "Drug Name: valtoco, Active Ingredient: diazepam", "title": "Last Updated", "to": "01/13/2023"}, {"arrows": "to", "from": "Drug Name: valtoco, Active Ingredient: diazepam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211635s008lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: vanflyta, Active Ingredient: quizartinib", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: vanflyta, Active Ingredient: quizartinib", "title": "Last Updated", "to": "06/25/2024"}, {"arrows": "to", "from": "Drug Name: vanflyta, Active Ingredient: quizartinib", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216993s000lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: vantrela er, Active Ingredient: hydrocodone bitartrate", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: vantrela er, Active Ingredient: hydrocodone bitartrate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: vantrela er, Active Ingredient: hydrocodone bitartrate", "title": "Last Updated", "to": "05/26/2017"}, {"arrows": "to", "from": "Drug Name: vantrela er, Active Ingredient: hydrocodone bitartrate", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207975s000lbl.pdf#page=39"}, {"arrows": "to", "from": "Drug Name: velsipity, Active Ingredient: etrasimod arganine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: velsipity, Active Ingredient: etrasimod arganine", "title": "Last Updated", "to": "06/05/2024"}, {"arrows": "to", "from": "Drug Name: velsipity, Active Ingredient: etrasimod arganine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216956s000lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: venbysi xr, Active Ingredient: venlafaxine besylate", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: venbysi xr, Active Ingredient: venlafaxine besylate", "title": "Other", "to": "EXTENDED RELEASE; ORAL"}, {"arrows": "to", "from": "Drug Name: venbysi xr, Active Ingredient: venlafaxine besylate", "title": "Last Updated", "to": "08/18/2023"}, {"arrows": "to", "from": "Drug Name: venbysi xr, Active Ingredient: venlafaxine besylate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215429s001lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: venclexta, Active Ingredient: venetoclax", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: venclexta, Active Ingredient: venetoclax", "title": "Last Updated", "to": "06/15/2022"}, {"arrows": "to", "from": "Drug Name: venclexta, Active Ingredient: venetoclax", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208573s026lbl.pdf#page=54"}, {"arrows": "to", "from": "Drug Name: venlafaxine hydrochloride, Active Ingredient: venlafaxine hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: venlafaxine hydrochloride, Active Ingredient: venlafaxine hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: venlafaxine hydrochloride, Active Ingredient: venlafaxine hydrochloride", "title": "Last Updated", "to": "08/18/2023"}, {"arrows": "to", "from": "Drug Name: venlafaxine hydrochloride, Active Ingredient: venlafaxine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022104s023lbl.pdf#page=35"}, {"arrows": "to", "from": "Drug Name: veopoz, Active Ingredient: pozelimab-bbfg", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: veopoz, Active Ingredient: pozelimab-bbfg", "title": "Other", "to": "SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: veopoz, Active Ingredient: pozelimab-bbfg", "title": "Last Updated", "to": "08/18/2023"}, {"arrows": "to", "from": "Drug Name: veopoz, Active Ingredient: pozelimab-bbfg", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761339s000lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: verquvo, Active Ingredient: vericiguat", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: verquvo, Active Ingredient: vericiguat", "title": "Last Updated", "to": "05/10/2023"}, {"arrows": "to", "from": "Drug Name: verquvo, Active Ingredient: vericiguat", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214377s002lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: vibativ, Active Ingredient: telavancin", "title": "Form", "to": "INJECTABLE; INJECTION"}, {"arrows": "to", "from": "Drug Name: vibativ, Active Ingredient: telavancin", "title": "Last Updated", "to": "06/21/2013"}, {"arrows": "to", "from": "Drug Name: vibativ, Active Ingredient: telavancin", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM183838.pdf"}, {"arrows": "to", "from": "Drug Name: vibativ, Active Ingredient: telavancin hydrochloride", "title": "Form", "to": "POWDER;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: vibativ, Active Ingredient: telavancin hydrochloride", "title": "Last Updated", "to": "07/07/2020"}, {"arrows": "to", "from": "Drug Name: vibativ, Active Ingredient: telavancin hydrochloride", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM183838.pdf"}, {"arrows": "to", "from": "Drug Name: viberzi, Active Ingredient: eluxadoline", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: viberzi, Active Ingredient: eluxadoline", "title": "Last Updated", "to": "06/17/2020"}, {"arrows": "to", "from": "Drug Name: viberzi, Active Ingredient: eluxadoline", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206940s007lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: vicoprofen, Active Ingredient: hydrocodone bitartrate; ibuprofen", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: vicoprofen, Active Ingredient: hydrocodone bitartrate; ibuprofen", "title": "Last Updated", "to": "12/16/2016"}, {"arrows": "to", "from": "Drug Name: vicoprofen, Active Ingredient: hydrocodone bitartrate; ibuprofen", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020716s012s013s014s015s016lbl.pdf#page=36"}, {"arrows": "to", "from": "Drug Name: victoza, Active Ingredient: liraglutide recombinant", "title": "Form", "to": "SOLUTION;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: victoza, Active Ingredient: liraglutide recombinant", "title": "Last Updated", "to": "07/05/2023"}, {"arrows": "to", "from": "Drug Name: victoza, Active Ingredient: liraglutide recombinant", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022341s039lbl.pdf#page=31"}, {"arrows": "to", "from": "Drug Name: victrelis, Active Ingredient: boceprevir", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: victrelis, Active Ingredient: boceprevir", "title": "Last Updated", "to": "01/30/2017"}, {"arrows": "to", "from": "Drug Name: victrelis, Active Ingredient: boceprevir", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202258MG.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: videx, Active Ingredient: didanosine", "title": "Form", "to": "FOR SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: videx, Active Ingredient: didanosine", "title": "Last Updated", "to": "12/17/2018"}, {"arrows": "to", "from": "Drug Name: videx, Active Ingredient: didanosine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020156s054lbl.pdf#page=34"}, {"arrows": "to", "from": "Drug Name: videx ec, Active Ingredient: didanosine", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: videx ec, Active Ingredient: didanosine", "title": "Other", "to": "DELAYED REL PELLETS;ORAL"}, {"arrows": "to", "from": "Drug Name: videx ec, Active Ingredient: didanosine", "title": "Last Updated", "to": "12/17/2018"}, {"arrows": "to", "from": "Drug Name: videx ec, Active Ingredient: didanosine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021183s029lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: viekira pak (copackaged), Active Ingredient: dasabuvir sodium; ombitasvir, paritaprevir, ritonavir", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: viekira pak (copackaged), Active Ingredient: dasabuvir sodium; ombitasvir, paritaprevir, ritonavir", "title": "Last Updated", "to": "12/06/2019"}, {"arrows": "to", "from": "Drug Name: viekira pak (copackaged), Active Ingredient: dasabuvir sodium; ombitasvir, paritaprevir, ritonavir", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206619s020lbl.pdf#page=49"}, {"arrows": "to", "from": "Drug Name: viekira xr, Active Ingredient: dasabuvir sodium; ombitasvir; paritaprevir; ritonavir", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: viekira xr, Active Ingredient: dasabuvir sodium; ombitasvir; paritaprevir; ritonavir", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: viekira xr, Active Ingredient: dasabuvir sodium; ombitasvir; paritaprevir; ritonavir", "title": "Last Updated", "to": "12/06/2019"}, {"arrows": "to", "from": "Drug Name: viekira xr, Active Ingredient: dasabuvir sodium; ombitasvir; paritaprevir; ritonavir", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208624s008lbl.pdf#page=49"}, {"arrows": "to", "from": "Drug Name: viibryd, Active Ingredient: vilazodone hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: viibryd, Active Ingredient: vilazodone hydrochloride", "title": "Last Updated", "to": "04/19/2024"}, {"arrows": "to", "from": "Drug Name: viibryd, Active Ingredient: vilazodone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022567s024lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: vimovo, Active Ingredient: esomeprazole magnesium; naproxen", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: vimovo, Active Ingredient: esomeprazole magnesium; naproxen", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: vimovo, Active Ingredient: esomeprazole magnesium; naproxen", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: vimovo, Active Ingredient: esomeprazole magnesium; naproxen", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022511s030lbl.pdf#page=40"}, {"arrows": "to", "from": "Drug Name: vimpat, Active Ingredient: lacosamide", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: vimpat, Active Ingredient: lacosamide", "title": "Last Updated", "to": "10/16/2023"}, {"arrows": "to", "from": "Drug Name: vimpat, Active Ingredient: lacosamide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022253s057,022254s047,022255s039lbl.pdf#page=31"}, {"arrows": "to", "from": "Drug Name: vimpat, Active Ingredient: lacosamide", "title": "Form", "to": "SOLUTION;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: vimpat, Active Ingredient: lacosamide", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: viokace, Active Ingredient: pancrelipase (amylase;lipase;protease)", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: viokace, Active Ingredient: pancrelipase (amylase;lipase;protease)", "title": "Last Updated", "to": "02/28/2024"}, {"arrows": "to", "from": "Drug Name: viokace, Active Ingredient: pancrelipase (amylase;lipase;protease)", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022542s007lbl.pdf#page=12"}, {"arrows": "to", "from": "Drug Name: viramune, Active Ingredient: nevirapine", "title": "Form", "to": "SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: viramune, Active Ingredient: nevirapine", "title": "Last Updated", "to": "06/10/2022"}, {"arrows": "to", "from": "Drug Name: viramune, Active Ingredient: nevirapine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020636s052,020933s043lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: viramune, Active Ingredient: nevirapine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: viramune xr, Active Ingredient: nevirapine", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: viramune xr, Active Ingredient: nevirapine", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: viramune xr, Active Ingredient: nevirapine", "title": "Last Updated", "to": "06/10/2022"}, {"arrows": "to", "from": "Drug Name: viramune xr, Active Ingredient: nevirapine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201152s014lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: visicol, Active Ingredient: sodium phosphate, dibasic anhydrous; sodium phosphate, monobasic, monohydrate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: visicol, Active Ingredient: sodium phosphate, dibasic anhydrous; sodium phosphate, monobasic, monohydrate", "title": "Last Updated", "to": "03/07/2013"}, {"arrows": "to", "from": "Drug Name: visicol, Active Ingredient: sodium phosphate, dibasic anhydrous; sodium phosphate, monobasic, monohydrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021097s016lbl.pdf#page=11"}, {"arrows": "to", "from": "Drug Name: vituz, Active Ingredient: chlorpheniramine maleate; hydrocodone bitartrate", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: vituz, Active Ingredient: chlorpheniramine maleate; hydrocodone bitartrate", "title": "Last Updated", "to": "06/28/2018"}, {"arrows": "to", "from": "Drug Name: vituz, Active Ingredient: chlorpheniramine maleate; hydrocodone bitartrate", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204307s004lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: vivactil, Active Ingredient: protriptyline hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: vivactil, Active Ingredient: protriptyline hydrochloride", "title": "Last Updated", "to": "07/17/2014"}, {"arrows": "to", "from": "Drug Name: vivactil, Active Ingredient: protriptyline hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Vivactil.pdf"}, {"arrows": "to", "from": "Drug Name: vivitrol, Active Ingredient: naltrexone", "title": "Form", "to": "FOR SUSPENSION"}, {"arrows": "to", "from": "Drug Name: vivitrol, Active Ingredient: naltrexone", "title": "Other", "to": "EXTENDED RELEASE;INTRAMUSCULAR"}, {"arrows": "to", "from": "Drug Name: vivitrol, Active Ingredient: naltrexone", "title": "Last Updated", "to": "09/30/2022"}, {"arrows": "to", "from": "Drug Name: vivitrol, Active Ingredient: naltrexone", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021897s052lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: vivlodex, Active Ingredient: meloxicam", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: vivlodex, Active Ingredient: meloxicam", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: vivlodex, Active Ingredient: meloxicam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/207233s005lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: vogelxo, Active Ingredient: testosterone", "title": "Form", "to": "GEL;TRANSDERMAL"}, {"arrows": "to", "from": "Drug Name: vogelxo, Active Ingredient: testosterone", "title": "Last Updated", "to": "04/30/2020"}, {"arrows": "to", "from": "Drug Name: vogelxo, Active Ingredient: testosterone", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204399s012lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: vogelxo, Active Ingredient: testosterone", "title": "Form", "to": "GEL"}, {"arrows": "to", "from": "Drug Name: vogelxo, Active Ingredient: testosterone", "title": "Other", "to": "METERED;TRANSDERMAL"}, {"arrows": "to", "from": "Drug Name: voltaren, Active Ingredient: diclofenac sodium", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: voltaren, Active Ingredient: diclofenac sodium", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: voltaren, Active Ingredient: diclofenac sodium", "title": "Last Updated", "to": "04/28/2021"}, {"arrows": "to", "from": "Drug Name: voltaren, Active Ingredient: diclofenac sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019201s048lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: voltaren arthritis pain, Active Ingredient: diclofenac sodium", "title": "Form", "to": "GEL;TOPICAL"}, {"arrows": "to", "from": "Drug Name: voltaren arthritis pain, Active Ingredient: diclofenac sodium", "title": "Last Updated", "to": "11/29/2023"}, {"arrows": "to", "from": "Drug Name: voltaren arthritis pain, Active Ingredient: diclofenac sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022122s011lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: voltaren-xr, Active Ingredient: diclofenac sodium", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: voltaren-xr, Active Ingredient: diclofenac sodium", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: voltaren-xr, Active Ingredient: diclofenac sodium", "title": "Last Updated", "to": "04/28/2021"}, {"arrows": "to", "from": "Drug Name: voltaren-xr, Active Ingredient: diclofenac sodium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020254s030lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: votrient, Active Ingredient: pazopanib hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: votrient, Active Ingredient: pazopanib hydrochloride", "title": "Last Updated", "to": "01/25/2024"}, {"arrows": "to", "from": "Drug Name: votrient, Active Ingredient: pazopanib hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022465s031s032lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: vraylar, Active Ingredient: cariprazine hydrochloride", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: vraylar, Active Ingredient: cariprazine hydrochloride", "title": "Last Updated", "to": "11/22/2024"}, {"arrows": "to", "from": "Drug Name: vraylar, Active Ingredient: cariprazine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204370s012lbl.pdf#page=46"}, {"arrows": "to", "from": "Drug Name: vyvanse, Active Ingredient: lisdexamfetamine dimesylate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: vyvanse, Active Ingredient: lisdexamfetamine dimesylate", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: vyvanse, Active Ingredient: lisdexamfetamine dimesylate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021977s050,208510s007lbl.pdf#page=38"}, {"arrows": "to", "from": "Drug Name: vyvanse, Active Ingredient: lisdexamfetamine dimesylate", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: vyvanse, Active Ingredient: lisdexamfetamine dimesylate", "title": "Other", "to": "CHEWABLE;ORAL"}, {"arrows": "to", "from": "Drug Name: wegovy, Active Ingredient: semaglutide", "title": "Form", "to": "SOLUTION;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: wegovy, Active Ingredient: semaglutide", "title": "Last Updated", "to": "11/27/2024"}, {"arrows": "to", "from": "Drug Name: wegovy, Active Ingredient: semaglutide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215256s015lbl.pdf#page=35"}, {"arrows": "to", "from": "Drug Name: welireg, Active Ingredient: belzutifan", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: welireg, Active Ingredient: belzutifan", "title": "Last Updated", "to": "02/26/2024"}, {"arrows": "to", "from": "Drug Name: welireg, Active Ingredient: belzutifan", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215383s006lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: wellbutrin, Active Ingredient: bupropion hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: wellbutrin, Active Ingredient: bupropion hydrochloride", "title": "Last Updated", "to": "05/07/2024"}, {"arrows": "to", "from": "Drug Name: wellbutrin, Active Ingredient: bupropion hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018644s057lbl.pdf#page=32"}, {"arrows": "to", "from": "Drug Name: wellbutrin sr, Active Ingredient: bupropion hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: wellbutrin sr, Active Ingredient: bupropion hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: wellbutrin sr, Active Ingredient: bupropion hydrochloride", "title": "Last Updated", "to": "05/07/2024"}, {"arrows": "to", "from": "Drug Name: wellbutrin sr, Active Ingredient: bupropion hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020358s064lbl.pdf#page=34"}, {"arrows": "to", "from": "Drug Name: wellbutrin xl, Active Ingredient: bupropion hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: wellbutrin xl, Active Ingredient: bupropion hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: wellbutrin xl, Active Ingredient: bupropion hydrochloride", "title": "Last Updated", "to": "05/07/2024"}, {"arrows": "to", "from": "Drug Name: wellbutrin xl, Active Ingredient: bupropion hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021515s044lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: wezlana, Active Ingredient: ustekinumab-auub", "title": "Form", "to": "INJECTABLE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: wezlana, Active Ingredient: ustekinumab-auub", "title": "Other", "to": "INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: wezlana, Active Ingredient: ustekinumab-auub", "title": "Last Updated", "to": "10/31/2023"}, {"arrows": "to", "from": "Drug Name: wezlana, Active Ingredient: ustekinumab-auub", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761285s000,761331s000lbl.pdf#page=36"}, {"arrows": "to", "from": "Drug Name: xalkori, Active Ingredient: crizotinib", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: xalkori, Active Ingredient: crizotinib", "title": "Last Updated", "to": "09/07/2023"}, {"arrows": "to", "from": "Drug Name: xalkori, Active Ingredient: crizotinib", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202570s036lbl.pdf#page=46"}, {"arrows": "to", "from": "Drug Name: xanax, Active Ingredient: alprazolam", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: xanax, Active Ingredient: alprazolam", "title": "Last Updated", "to": "01/13/2023"}, {"arrows": "to", "from": "Drug Name: xanax, Active Ingredient: alprazolam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018276s059lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: xanax xr, Active Ingredient: alprazolam", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: xanax xr, Active Ingredient: alprazolam", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: xanax xr, Active Ingredient: alprazolam", "title": "Last Updated", "to": "01/13/2023"}, {"arrows": "to", "from": "Drug Name: xanax xr, Active Ingredient: alprazolam", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021434s022lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: xarelto, Active Ingredient: rivaroxaban", "title": "Form", "to": "FOR SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: xarelto, Active Ingredient: rivaroxaban", "title": "Last Updated", "to": "02/08/2023"}, {"arrows": "to", "from": "Drug Name: xarelto, Active Ingredient: rivaroxaban", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215859s000lbl.pdf#page=77"}, {"arrows": "to", "from": "Drug Name: xarelto, Active Ingredient: rivaroxaban", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: xarelto, Active Ingredient: rivaroxaban", "title": "Last Updated", "to": "03/01/2022"}, {"arrows": "to", "from": "Drug Name: xarelto, Active Ingredient: rivaroxaban", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022406s039,202439s038lbl.pdf#page=77"}, {"arrows": "to", "from": "Drug Name: xartemis xr, Active Ingredient: acetaminophen; oxycodone hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: xartemis xr, Active Ingredient: acetaminophen; oxycodone hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: xartemis xr, Active Ingredient: acetaminophen; oxycodone hydrochloride", "title": "Last Updated", "to": "09/18/2018"}, {"arrows": "to", "from": "Drug Name: xartemis xr, Active Ingredient: acetaminophen; oxycodone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204031s004s005lbl.pdf#page=34"}, {"arrows": "to", "from": "Drug Name: xcopri, Active Ingredient: cenobamate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: xcopri, Active Ingredient: cenobamate", "title": "Last Updated", "to": "04/05/2024"}, {"arrows": "to", "from": "Drug Name: xcopri, Active Ingredient: cenobamate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212839s006s007lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: xeljanz, Active Ingredient: tofacitinib citrate", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: xeljanz, Active Ingredient: tofacitinib citrate", "title": "Last Updated", "to": "09/27/2024"}, {"arrows": "to", "from": "Drug Name: xeljanz, Active Ingredient: tofacitinib citrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203214s036,208246s023,213082s008lbl.pdf#page=65"}, {"arrows": "to", "from": "Drug Name: xeljanz, Active Ingredient: tofacitinib citrate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: xeljanz xr, Active Ingredient: tofacitinib citrate", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: xeljanz xr, Active Ingredient: tofacitinib citrate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: xeljanz xr, Active Ingredient: tofacitinib citrate", "title": "Last Updated", "to": "09/27/2024"}, {"arrows": "to", "from": "Drug Name: xeljanz xr, Active Ingredient: tofacitinib citrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203214s036,208246s023,213082s008lbl.pdf#page=65"}, {"arrows": "to", "from": "Drug Name: xelstrym, Active Ingredient: dextroamphetamine", "title": "Form", "to": "SYSTEM;TRANSDERMAL"}, {"arrows": "to", "from": "Drug Name: xelstrym, Active Ingredient: dextroamphetamine", "title": "Last Updated", "to": "10/13/2023"}, {"arrows": "to", "from": "Drug Name: xelstrym, Active Ingredient: dextroamphetamine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215401s008lbl.pdf#page=28"}, {"arrows": "to", "from": "Drug Name: xenazine, Active Ingredient: tetrabenazine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: xenazine, Active Ingredient: tetrabenazine", "title": "Last Updated", "to": "09/13/2017"}, {"arrows": "to", "from": "Drug Name: xenazine, Active Ingredient: tetrabenazine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021894s013lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: xeomin, Active Ingredient: incobotulinumtoxina", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: xeomin, Active Ingredient: incobotulinumtoxina", "title": "Last Updated", "to": "09/08/2023"}, {"arrows": "to", "from": "Drug Name: xeomin, Active Ingredient: incobotulinumtoxina", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125360s097lbl.pdf#page=23"}, {"arrows": "to", "from": "Drug Name: xiaflex, Active Ingredient: collagenase clostridium histolyticum", "title": "Form", "to": "SOLUTION; INJECTION"}, {"arrows": "to", "from": "Drug Name: xiaflex, Active Ingredient: collagenase clostridium histolyticum", "title": "Last Updated", "to": "07/12/2023"}, {"arrows": "to", "from": "Drug Name: xiaflex, Active Ingredient: collagenase clostridium histolyticum", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125338s111lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: xigduo xr, Active Ingredient: dapagliflozin; metformin hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: xigduo xr, Active Ingredient: dapagliflozin; metformin hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: xigduo xr, Active Ingredient: dapagliflozin; metformin hydrochloride", "title": "Last Updated", "to": "06/12/2024"}, {"arrows": "to", "from": "Drug Name: xigduo xr, Active Ingredient: dapagliflozin; metformin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205649s021lbl.pdf#page=59"}, {"arrows": "to", "from": "Drug Name: xolair, Active Ingredient: omalizumab", "title": "Form", "to": "VIAL"}, {"arrows": "to", "from": "Drug Name: xolair, Active Ingredient: omalizumab", "title": "Last Updated", "to": "02/16/2024"}, {"arrows": "to", "from": "Drug Name: xolair, Active Ingredient: omalizumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103976s5242lbl.pdf#page=37"}, {"arrows": "to", "from": "Drug Name: xospata, Active Ingredient: gilteritinib fumarate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: xospata, Active Ingredient: gilteritinib fumarate", "title": "Last Updated", "to": "01/12/2022"}, {"arrows": "to", "from": "Drug Name: xospata, Active Ingredient: gilteritinib fumarate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211349s003lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: xpovio, Active Ingredient: selinexor", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: xpovio, Active Ingredient: selinexor", "title": "Last Updated", "to": "07/15/2022"}, {"arrows": "to", "from": "Drug Name: xpovio, Active Ingredient: selinexor", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212306s010lbl.pdf#page=31"}, {"arrows": "to", "from": "Drug Name: xtampza er, Active Ingredient: oxycodone", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: xtampza er, Active Ingredient: oxycodone", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: xtampza er, Active Ingredient: oxycodone", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: xtampza er, Active Ingredient: oxycodone", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208090s021lbl.pdf#page=40"}, {"arrows": "to", "from": "Drug Name: xtrelus, Active Ingredient: hydrocodone bitartrate;guaifenesin", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: xtrelus, Active Ingredient: hydrocodone bitartrate;guaifenesin", "title": "Last Updated", "to": "12/15/2023"}, {"arrows": "to", "from": "Drug Name: xtrelus, Active Ingredient: hydrocodone bitartrate;guaifenesin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208085s002lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: xultophy 100/3.6, Active Ingredient: insulin degludec; liraglutide", "title": "Form", "to": "SOLUTION;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: xultophy 100/3.6, Active Ingredient: insulin degludec; liraglutide", "title": "Last Updated", "to": "07/10/2023"}, {"arrows": "to", "from": "Drug Name: xultophy 100/3.6, Active Ingredient: insulin degludec; liraglutide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208583s021lbl.pdf#page=42"}, {"arrows": "to", "from": "Drug Name: xyosted (autoinjector), Active Ingredient: testosterone enanthate", "title": "Form", "to": "SOLUTION;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: xyosted (autoinjector), Active Ingredient: testosterone enanthate", "title": "Last Updated", "to": "11/19/2019"}, {"arrows": "to", "from": "Drug Name: xyosted (autoinjector), Active Ingredient: testosterone enanthate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209863s000lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: xyrem, Active Ingredient: sodium oxybate", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: xyrem, Active Ingredient: sodium oxybate", "title": "Last Updated", "to": "05/22/2024"}, {"arrows": "to", "from": "Drug Name: xyrem, Active Ingredient: sodium oxybate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021196s042lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: xywav, Active Ingredient: calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: xywav, Active Ingredient: calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate", "title": "Last Updated", "to": "05/22/2024"}, {"arrows": "to", "from": "Drug Name: xywav, Active Ingredient: calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212690s011lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: yervoy, Active Ingredient: ipilimumab", "title": "Form", "to": "INJECTABLE; INJECTION"}, {"arrows": "to", "from": "Drug Name: yervoy, Active Ingredient: ipilimumab", "title": "Last Updated", "to": "02/15/2023"}, {"arrows": "to", "from": "Drug Name: yervoy, Active Ingredient: ipilimumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125377s129lbl.pdf#page=72"}, {"arrows": "to", "from": "Drug Name: yesintek, Active Ingredient: ustekinumab-kfce", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: yesintek, Active Ingredient: ustekinumab-kfce", "title": "Other", "to": "SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: yesintek, Active Ingredient: ustekinumab-kfce", "title": "Last Updated", "to": "Invalid date"}, {"arrows": "to", "from": "Drug Name: yesintek, Active Ingredient: ustekinumab-kfce", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761406s000lbl.pdf#page=37"}, {"arrows": "to", "from": "Drug Name: yosprala, Active Ingredient: aspirin; omeprazole", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: yosprala, Active Ingredient: aspirin; omeprazole", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: yosprala, Active Ingredient: aspirin; omeprazole", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: yosprala, Active Ingredient: aspirin; omeprazole", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205103s010lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: yuflyma, Active Ingredient: adalimumab-aaty", "title": "Form", "to": "INJECTABLE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: yuflyma, Active Ingredient: adalimumab-aaty", "title": "Last Updated", "to": "08/16/2024"}, {"arrows": "to", "from": "Drug Name: yuflyma, Active Ingredient: adalimumab-aaty", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761219s011lbl.pdf#page=43"}, {"arrows": "to", "from": "Drug Name: yusimry, Active Ingredient: adalimumab-aqvh", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: yusimry, Active Ingredient: adalimumab-aqvh", "title": "Last Updated", "to": "09/13/2023"}, {"arrows": "to", "from": "Drug Name: yusimry, Active Ingredient: adalimumab-aqvh", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761216s004lbl.pdf#page=56"}, {"arrows": "to", "from": "Drug Name: zarontin, Active Ingredient: ethosuximide", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: zarontin, Active Ingredient: ethosuximide", "title": "Last Updated", "to": "10/28/2021"}, {"arrows": "to", "from": "Drug Name: zarontin, Active Ingredient: ethosuximide", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/012380s034mg.pdf"}, {"arrows": "to", "from": "Drug Name: zegerid, Active Ingredient: omeprazole; sodium bicarbonate", "title": "Form", "to": "FOR SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: zegerid, Active Ingredient: omeprazole; sodium bicarbonate", "title": "Last Updated", "to": "07/18/2023"}, {"arrows": "to", "from": "Drug Name: zegerid, Active Ingredient: omeprazole; sodium bicarbonate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021849s020,021636s025lbl.pdf#page=31"}, {"arrows": "to", "from": "Drug Name: zegerid, Active Ingredient: omeprazole; sodium bicarbonate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: zelboraf, Active Ingredient: vemurafenib", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: zelboraf, Active Ingredient: vemurafenib", "title": "Last Updated", "to": "05/18/2020"}, {"arrows": "to", "from": "Drug Name: zelboraf, Active Ingredient: vemurafenib", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202429s016lbl.pdf#page=21"}, {"arrows": "to", "from": "Drug Name: zenpep, Active Ingredient: pancrelipase;lipase;protease;amylase", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: zenpep, Active Ingredient: pancrelipase;lipase;protease;amylase", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: zenpep, Active Ingredient: pancrelipase;lipase;protease;amylase", "title": "Last Updated", "to": "02/28/2024"}, {"arrows": "to", "from": "Drug Name: zenpep, Active Ingredient: pancrelipase;lipase;protease;amylase", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022210s024lbl.pdf#page=14"}, {"arrows": "to", "from": "Drug Name: zenpep, Active Ingredient: pancrelipase (amylase;lipase;protease)", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: zenpep, Active Ingredient: pancrelipase (amylase;lipase;protease)", "title": "Other", "to": "DELAYED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: zenpep, Active Ingredient: pancrelipase (amylase;lipase;protease)", "title": "Last Updated", "to": "02/28/2024"}, {"arrows": "to", "from": "Drug Name: zenpep, Active Ingredient: pancrelipase (amylase;lipase;protease)", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM180714.pdf"}, {"arrows": "to", "from": "Drug Name: zeposia, Active Ingredient: ozanimod hydrochloride", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: zeposia, Active Ingredient: ozanimod hydrochloride", "title": "Last Updated", "to": "06/05/2024"}, {"arrows": "to", "from": "Drug Name: zeposia, Active Ingredient: ozanimod hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209899s006s009lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: zerit, Active Ingredient: stavudine", "title": "Form", "to": "FOR SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: zerit, Active Ingredient: stavudine", "title": "Last Updated", "to": "12/17/2018"}, {"arrows": "to", "from": "Drug Name: zerit, Active Ingredient: stavudine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020412s041,020413s033lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: ziagen, Active Ingredient: abacavir sulfate", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: ziagen, Active Ingredient: abacavir sulfate", "title": "Last Updated", "to": "11/24/2020"}, {"arrows": "to", "from": "Drug Name: ziagen, Active Ingredient: abacavir sulfate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020977s035,020978s038lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: zilbrysq, Active Ingredient: zilucoplan", "title": "Form", "to": "INJECTABLE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: zilbrysq, Active Ingredient: zilucoplan", "title": "Last Updated", "to": "04/26/2024"}, {"arrows": "to", "from": "Drug Name: zilbrysq, Active Ingredient: zilucoplan", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216834s000lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: zinbryta, Active Ingredient: daclizumab", "title": "Form", "to": "INJECTABLE;INJECTION"}, {"arrows": "to", "from": "Drug Name: zinbryta, Active Ingredient: daclizumab", "title": "Last Updated", "to": "11/01/2017"}, {"arrows": "to", "from": "Drug Name: zinbryta, Active Ingredient: daclizumab", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761029s001lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: zipsor, Active Ingredient: diclofenac potassium", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: zipsor, Active Ingredient: diclofenac potassium", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: zipsor, Active Ingredient: diclofenac potassium", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022202s016lbl.pdf#page=24"}, {"arrows": "to", "from": "Drug Name: zituvimet, Active Ingredient: sitagliptin, metformin hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: zituvimet, Active Ingredient: sitagliptin, metformin hydrochloride", "title": "Last Updated", "to": "11/03/2023"}, {"arrows": "to", "from": "Drug Name: zituvimet, Active Ingredient: sitagliptin, metformin hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216743s000lbl.pdf#page=38"}, {"arrows": "to", "from": "Drug Name: zituvio, Active Ingredient: sitagliptin", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: zituvio, Active Ingredient: sitagliptin", "title": "Last Updated", "to": "10/18/2023"}, {"arrows": "to", "from": "Drug Name: zituvio, Active Ingredient: sitagliptin", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211566s000lbl.pdf#page=33"}, {"arrows": "to", "from": "Drug Name: zohydro er, Active Ingredient: hydrocodone bitartrate", "title": "Form", "to": "CAPSULE"}, {"arrows": "to", "from": "Drug Name: zohydro er, Active Ingredient: hydrocodone bitartrate", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: zohydro er, Active Ingredient: hydrocodone bitartrate", "title": "Last Updated", "to": "03/04/2021"}, {"arrows": "to", "from": "Drug Name: zohydro er, Active Ingredient: hydrocodone bitartrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202880s020lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: zoloft, Active Ingredient: sertraline hydrochloride", "title": "Form", "to": "CONCENTRATE;ORAL"}, {"arrows": "to", "from": "Drug Name: zoloft, Active Ingredient: sertraline hydrochloride", "title": "Last Updated", "to": "08/18/2023"}, {"arrows": "to", "from": "Drug Name: zoloft, Active Ingredient: sertraline hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019839s108,20990s062lbl.pdf#page=37"}, {"arrows": "to", "from": "Drug Name: zoloft, Active Ingredient: sertraline hydrochloride", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: zolpidem tartrate, Active Ingredient: zolpidem tartrate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: zolpidem tartrate, Active Ingredient: zolpidem tartrate", "title": "Last Updated", "to": "03/07/2023"}, {"arrows": "to", "from": "Drug Name: zolpidem tartrate, Active Ingredient: zolpidem tartrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Zolpidem.pdf"}, {"arrows": "to", "from": "Drug Name: zolpidem tartrate capsules, Active Ingredient: zolpidem tartrate", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: zolpidem tartrate capsules, Active Ingredient: zolpidem tartrate", "title": "Last Updated", "to": "05/09/2023"}, {"arrows": "to", "from": "Drug Name: zolpidem tartrate capsules, Active Ingredient: zolpidem tartrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215721s000lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: zolpimist, Active Ingredient: zolpidem tartrate", "title": "Form", "to": "SPRAY"}, {"arrows": "to", "from": "Drug Name: zolpimist, Active Ingredient: zolpidem tartrate", "title": "Other", "to": "METERED;ORAL"}, {"arrows": "to", "from": "Drug Name: zolpimist, Active Ingredient: zolpidem tartrate", "title": "Last Updated", "to": "08/18/2019"}, {"arrows": "to", "from": "Drug Name: zolpimist, Active Ingredient: zolpidem tartrate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022196s012lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: zonegran, Active Ingredient: zonisamide", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: zonegran, Active Ingredient: zonisamide", "title": "Last Updated", "to": "04/13/2020"}, {"arrows": "to", "from": "Drug Name: zonegran, Active Ingredient: zonisamide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020789s036lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: zonisade, Active Ingredient: zonisamide", "title": "Form", "to": "SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: zonisade, Active Ingredient: zonisamide", "title": "Last Updated", "to": "07/15/2022"}, {"arrows": "to", "from": "Drug Name: zonisade, Active Ingredient: zonisamide", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214273s000lbl.pdf#page=27"}, {"arrows": "to", "from": "Drug Name: zontivity, Active Ingredient: vorapaxar sulfate", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: zontivity, Active Ingredient: vorapaxar sulfate", "title": "Last Updated", "to": "11/07/2019"}, {"arrows": "to", "from": "Drug Name: zontivity, Active Ingredient: vorapaxar sulfate", "title": "More Info", "to": "http://www.fda.gov/downloads/Drugs/DrugSafety/UCM447698.pdf"}, {"arrows": "to", "from": "Drug Name: zortress, Active Ingredient: everolimus", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: zortress, Active Ingredient: everolimus", "title": "Last Updated", "to": "02/28/2024"}, {"arrows": "to", "from": "Drug Name: zortress, Active Ingredient: everolimus", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021560s033lbl.pdf#page=31"}, {"arrows": "to", "from": "Drug Name: zorvolex, Active Ingredient: diclofenac", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: zorvolex, Active Ingredient: diclofenac", "title": "Last Updated", "to": "11/21/2024"}, {"arrows": "to", "from": "Drug Name: zorvolex, Active Ingredient: diclofenac", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204592s014lbl.pdf#page=26"}, {"arrows": "to", "from": "Drug Name: ztalmy, Active Ingredient: ganaxolone", "title": "Form", "to": "SUSPENSION;ORAL"}, {"arrows": "to", "from": "Drug Name: ztalmy, Active Ingredient: ganaxolone", "title": "Last Updated", "to": "06/21/2023"}, {"arrows": "to", "from": "Drug Name: ztalmy, Active Ingredient: ganaxolone", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215904s003s004lbl.pdf#page=16"}, {"arrows": "to", "from": "Drug Name: zubsolv, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "title": "Form", "to": "TABLET;SUBLINGUAL"}, {"arrows": "to", "from": "Drug Name: zubsolv, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "title": "Last Updated", "to": "03/20/2024"}, {"arrows": "to", "from": "Drug Name: zubsolv, Active Ingredient: buprenorphine hydrochloride; naloxone hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204242s027lbl.pdf#page=19"}, {"arrows": "to", "from": "Drug Name: zulresso, Active Ingredient: brexanolone", "title": "Form", "to": "SOLUTION;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: zulresso, Active Ingredient: brexanolone", "title": "Last Updated", "to": "10/17/2023"}, {"arrows": "to", "from": "Drug Name: zulresso, Active Ingredient: brexanolone", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211371s007lbl.pdf#page=20"}, {"arrows": "to", "from": "Drug Name: zurampic, Active Ingredient: lesinurad", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: zurampic, Active Ingredient: lesinurad", "title": "Last Updated", "to": "08/04/2016"}, {"arrows": "to", "from": "Drug Name: zurampic, Active Ingredient: lesinurad", "title": "More Info", "to": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207988lbl.pdf#page=17"}, {"arrows": "to", "from": "Drug Name: zurzuvae, Active Ingredient: zuranolone", "title": "Form", "to": "CAPSULE;ORAL"}, {"arrows": "to", "from": "Drug Name: zurzuvae, Active Ingredient: zuranolone", "title": "Last Updated", "to": "08/04/2023"}, {"arrows": "to", "from": "Drug Name: zurzuvae, Active Ingredient: zuranolone", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217369Orig2s000Corrected_lbl.pdf#page=22"}, {"arrows": "to", "from": "Drug Name: zutripro, Active Ingredient: chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride", "title": "Form", "to": "SOLUTION;ORAL"}, {"arrows": "to", "from": "Drug Name: zutripro, Active Ingredient: chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride", "title": "Last Updated", "to": "06/28/2018"}, {"arrows": "to", "from": "Drug Name: zutripro, Active Ingredient: chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022439s010lbl.pdf#page=28"}, {"arrows": "to", "from": "Drug Name: zyban, Active Ingredient: bupropion hydrochloride", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: zyban, Active Ingredient: bupropion hydrochloride", "title": "Other", "to": "EXTENDED RELEASE;ORAL"}, {"arrows": "to", "from": "Drug Name: zyban, Active Ingredient: bupropion hydrochloride", "title": "Last Updated", "to": "03/09/2021"}, {"arrows": "to", "from": "Drug Name: zyban, Active Ingredient: bupropion hydrochloride", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020711s052lbl.pdf#page=38"}, {"arrows": "to", "from": "Drug Name: zydelig, Active Ingredient: idelalisib", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: zydelig, Active Ingredient: idelalisib", "title": "Last Updated", "to": "07/06/2022"}, {"arrows": "to", "from": "Drug Name: zydelig, Active Ingredient: idelalisib", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205858s016lbl.pdf#page=25"}, {"arrows": "to", "from": "Drug Name: zymfentra, Active Ingredient: infliximab-dyyb", "title": "Form", "to": "INJECTABLE;SUBCUTANEOUS"}, {"arrows": "to", "from": "Drug Name: zymfentra, Active Ingredient: infliximab-dyyb", "title": "Last Updated", "to": "02/22/2024"}, {"arrows": "to", "from": "Drug Name: zymfentra, Active Ingredient: infliximab-dyyb", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761358s000lbl.pdf#page=30"}, {"arrows": "to", "from": "Drug Name: zynyz, Active Ingredient: retifanlimab-dlwr", "title": "Form", "to": "INJECTABLE;INTRAVENOUS"}, {"arrows": "to", "from": "Drug Name: zynyz, Active Ingredient: retifanlimab-dlwr", "title": "Last Updated", "to": "04/22/2024"}, {"arrows": "to", "from": "Drug Name: zynyz, Active Ingredient: retifanlimab-dlwr", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761334s000lbl.pdf#page=18"}, {"arrows": "to", "from": "Drug Name: zyprexa, Active Ingredient: olanzapine", "title": "Form", "to": "TABLET;ORAL"}, {"arrows": "to", "from": "Drug Name: zyprexa, Active Ingredient: olanzapine", "title": "Last Updated", "to": "04/23/2020"}, {"arrows": "to", "from": "Drug Name: zyprexa, Active Ingredient: olanzapine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s075,021086s049,021253s062lbl.pdf#page=37"}, {"arrows": "to", "from": "Drug Name: zyprexa, Active Ingredient: olanzapine", "title": "Form", "to": "INJECTABLE;INTRAMUSCULAR"}, {"arrows": "to", "from": "Drug Name: zyprexa relprevv, Active Ingredient: olanzapine pamoate", "title": "Form", "to": "SUSPENSION"}, {"arrows": "to", "from": "Drug Name: zyprexa relprevv, Active Ingredient: olanzapine pamoate", "title": "Other", "to": "EXTENDED RELEASE;INTRAMUSCULAR"}, {"arrows": "to", "from": "Drug Name: zyprexa relprevv, Active Ingredient: olanzapine pamoate", "title": "Last Updated", "to": "04/28/2021"}, {"arrows": "to", "from": "Drug Name: zyprexa relprevv, Active Ingredient: olanzapine pamoate", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022173s036lbl.pdf#page=29"}, {"arrows": "to", "from": "Drug Name: zyprexa zydis, Active Ingredient: olanzapine", "title": "Form", "to": "TABLET"}, {"arrows": "to", "from": "Drug Name: zyprexa zydis, Active Ingredient: olanzapine", "title": "Other", "to": "ORALLY DISINTEGRATING;ORAL"}, {"arrows": "to", "from": "Drug Name: zyprexa zydis, Active Ingredient: olanzapine", "title": "Last Updated", "to": "04/23/2020"}, {"arrows": "to", "from": "Drug Name: zyprexa zydis, Active Ingredient: olanzapine", "title": "More Info", "to": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s075,021086s049,021253s062lbl.pdf#page=37"}]);

                  nodeColors = {};
                  allNodes = nodes.get({ returnType: "Object" });
                  for (nodeId in allNodes) {
                    nodeColors[nodeId] = allNodes[nodeId].color;
                  }
                  allEdges = edges.get({ returnType: "Object" });
                  // adding nodes and edges to the graph
                  data = {nodes: nodes, edges: edges};

                  var options = {
    "configure": {
        "enabled": false
    },
    "edges": {
        "color": {
            "inherit": true
        },
        "smooth": {
            "enabled": true,
            "type": "dynamic"
        }
    },
    "interaction": {
        "dragNodes": true,
        "hideEdgesOnDrag": false,
        "hideNodesOnDrag": false
    },
    "physics": {
        "enabled": true,
        "stabilization": {
            "enabled": true,
            "fit": true,
            "iterations": 1000,
            "onlyDynamicEdges": false,
            "updateInterval": 50
        }
    }
};

                  


                  

                  network = new vis.Network(container, data, options);

                  

                  

                  


                  
                      network.on("stabilizationProgress", function(params) {
                          document.getElementById('loadingBar').removeAttribute("style");
                          var maxWidth = 496;
                          var minWidth = 20;
                          var widthFactor = params.iterations/params.total;
                          var width = Math.max(minWidth,maxWidth * widthFactor);
                          document.getElementById('bar').style.width = width + 'px';
                          document.getElementById('text').innerHTML = Math.round(widthFactor*100) + '%';
                      });
                      network.once("stabilizationIterationsDone", function() {
                          document.getElementById('text').innerHTML = '100%';
                          document.getElementById('bar').style.width = '496px';
                          document.getElementById('loadingBar').style.opacity = 0;
                          // really clean the dom element
                          setTimeout(function () {document.getElementById('loadingBar').style.display = 'none';}, 500);
                      });
                  

                  return network;

              }
              drawGraph();
        </script>
    </body>
</html>